data_1ej5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ej5 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.19 137.94 27.58 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.657 0.265 . . . . 0.0 110.747 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.67 -26.48 3.79 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.688 2.259 . . . . 0.0 112.351 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -95.38 -41.39 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -88.87 -26.26 21.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.95 -148.81 19.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.443 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.94 146.84 29.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 110.706 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -81.77 57.32 3.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.987 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.426 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 2.9 m -48.32 -26.02 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.243 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.01 -22.28 61.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.121 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -130.69 21.11 5.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.456 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 16.7 mt -70.25 159.47 33.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 111.082 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -83.47 139.76 41.45 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 45.4 Cg_exo -55.97 -18.27 21.93 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.479 2.119 . . . . 0.0 112.62 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.405 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 1.2 m-20 -80.87 -58.94 2.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.941 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD23 ' CD1' ' A' ' 59' ' ' LEU . 3.9 pp -71.68 -39.06 70.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.248 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -61.63 -36.03 79.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.855 0.359 . . . . 0.0 110.499 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.3 t -63.85 -36.27 83.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' CD1' HG22 ' A' ' 82' ' ' VAL . 17.6 tp -57.16 -58.04 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.59 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -50.27 -41.83 51.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.731 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -49.12 78.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.561 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -58.25 -32.57 68.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.619 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.66 4.81 23.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.74 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.49 17.08 78.87 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.821 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 35' ' ' ILE . 52.8 mt -86.79 120.25 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 111.056 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.8 p -86.92 157.26 19.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.99 -34.04 54.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.07 -36.13 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -78.58 -35.27 46.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.519 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.419 ' CD1' HG11 ' A' ' 19' ' ' VAL . 78.1 mt -70.35 -24.46 62.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.734 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -96.08 -7.98 34.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.542 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 46' ' ' SER . 5.8 t70 -81.49 123.31 28.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.687 0.28 . . . . 0.0 110.674 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.24 -37.21 45.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.631 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.25 -60.04 2.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.342 . . . . 0.0 111.534 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.415 HG22 ' CD1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -66.82 -29.7 69.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.956 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 57.7 p -59.56 -43.66 93.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.441 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 7.4 tptt -60.29 -52.83 63.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.56 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.83 -33.04 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.483 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' CD1' HG22 ' A' ' 45' ' ' THR . 59.4 mt -68.82 -64.33 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 1.9 p90 -52.53 -36.59 55.79 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.48 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -55.62 -32.51 63.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.519 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.475 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 67.3 t80 -64.88 -41.79 95.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.116 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.0 mt -54.72 -27.77 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.365 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.65 -36.16 67.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.592 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.475 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -72.56 -25.45 61.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.609 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 52' ' ' PHE . 83.3 mm-40 -85.54 9.31 16.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.466 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.29 16.46 32.27 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.563 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.37 171.36 47.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.921 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD1' HD23 ' A' ' 26' ' ' LEU . 8.3 tp -48.82 -42.29 35.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.805 0.336 . . . . 0.0 110.988 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 15.0 mm-40 -63.62 -34.47 77.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.034 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.28 -32.73 64.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.348 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.43 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 38.6 t -65.75 -63.61 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.917 0.389 . . . . 0.0 110.622 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.405 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -54.06 -38.23 65.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.05 0.452 . . . . 0.0 109.986 177.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.415 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 58.1 mt-30 -64.59 -52.63 56.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.768 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -68.05 -31.19 70.68 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.169 -177.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.424 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 1.3 mmt . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 121.094 0.473 . . . . 0.0 109.873 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.433 HG22 ' CD1' ' A' ' 29' ' ' LEU . 23.3 t . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.876 0.369 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.88 -39.15 85.62 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.569 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.95 -55.36 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 110.602 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.467 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 20.0 tp -52.83 -39.09 62.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.578 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.9 mtt -53.59 -34.28 57.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.224 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -77.1 -44.59 29.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.359 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.447 HG21 ' CD1' ' A' ' 52' ' ' PHE . 53.4 t -53.85 -38.05 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.635 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 95.7 mmm . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.272 178.856 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.483 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.707 0.289 . . . . 0.0 110.299 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.39 138.59 28.49 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.29 -43.74 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.593 2.195 . . . . 0.0 112.274 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -81.9 -39.86 23.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -87.38 -30.96 20.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.028 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.65 -149.55 18.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.678 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.69 136.66 35.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.341 . . . . 0.0 110.981 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -77.94 65.65 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.981 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.435 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 2.7 m -51.85 -23.47 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.237 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -72.3 -22.93 61.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.029 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -128.97 19.34 6.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.529 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.1 mt -70.38 159.7 33.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.881 0.372 . . . . 0.0 111.174 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.18 138.87 42.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.803 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.436 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 48.4 Cg_exo -55.79 -18.35 21.16 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.54 2.16 . . . . 0.0 112.587 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -81.2 -58.11 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.216 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.472 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 3.5 pp -70.64 -42.25 71.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.233 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.436 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -54.96 -38.39 67.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.915 0.388 . . . . 0.0 110.467 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -37.97 89.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.85 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.7 tp -56.03 -55.62 30.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.747 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.504 ' CD2' ' CD2' ' A' ' 40' ' ' LEU . 10.9 m-30 -50.32 -47.47 55.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.599 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -62.12 -52.58 63.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.472 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -53.27 -31.95 46.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.525 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.45 -20.64 39.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.034 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.44 11.2 34.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.938 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.8 mt -86.9 120.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 111.255 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 p -86.91 160.39 18.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' HG2' ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -51.93 -25.8 8.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.709 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.94 -45.17 74.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -78.39 -29.22 47.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.761 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.504 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 88.4 mt -70.39 -26.83 63.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.52 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.0 p -96.63 -3.93 41.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.531 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 46' ' ' SER . 15.3 t0 -82.73 124.37 30.17 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.776 0.322 . . . . 0.0 110.782 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.52 -40.19 59.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.42 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -72.69 -58.99 2.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.658 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -66.13 -33.62 76.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.337 -178.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 88.1 p -58.71 -39.32 80.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.84 0.352 . . . . 0.0 110.456 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -62.53 -54.96 32.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.555 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 45' ' ' THR . 1.9 pp -63.25 -31.06 72.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.053 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 57.6 mt -69.7 -64.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.418 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.483 ' CE1' ' CZ2' ' A' ' 11' ' ' TRP . 1.9 p90 -53.99 -39.87 66.44 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.167 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.4 ' OD1' ' CZ ' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -55.86 -33.66 64.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.745 178.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 49' ' ' ILE . 26.4 t80 -64.65 -31.79 73.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 110.053 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.403 ' CG2' HG21 ' A' ' 62' ' ' VAL . 31.4 mt -61.72 -29.56 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.118 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -41.3 79.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.301 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.75 -26.84 67.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.442 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 13.3 mm100 -86.2 11.38 12.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.525 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 95.42 18.96 31.47 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.503 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.19 168.24 39.66 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.626 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.472 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 34.9 tp -49.18 -38.08 24.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.46 -35.99 82.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.435 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.09 -34.61 66.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.497 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.403 HG21 ' CG2' ' A' ' 53' ' ' ILE . 22.0 t -65.78 -52.37 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.701 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.63 -44.88 69.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.115 0.483 . . . . 0.0 110.046 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -62.52 -50.89 69.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.691 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 62' ' ' VAL . 22.3 pt-20 -68.89 -30.77 69.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.715 0.293 . . . . 0.0 111.027 -178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.559 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.2 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.805 0.336 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.09 -38.76 73.51 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.621 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.22 -51.7 62.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 110.951 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.8 tp -52.47 -46.3 66.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.701 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 39.9 mtm -52.99 -42.34 65.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.327 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.48 73.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.347 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 51.2 t -72.62 -38.29 58.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.587 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.1 mmm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.532 179.166 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.554 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.312 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -90.19 140.56 27.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.743 0.306 . . . . 0.0 110.604 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.69 -24.73 5.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.683 2.255 . . . . 0.0 112.479 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.31 -40.24 6.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -87.58 -21.14 25.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 95.58 -142.62 16.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.319 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.14 -174.34 5.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 0.0 110.866 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.85 57.22 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.332 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.432 ' CG1' ' CD1' ' A' ' 40' ' ' LEU . 1.5 m -47.87 -25.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.402 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -70.4 -22.07 62.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -134.95 23.61 3.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.596 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.7 mt -69.69 159.94 32.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 111.12 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.51 138.89 44.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.766 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.66 -18.08 19.61 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.587 2.192 . . . . 0.0 112.519 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.34 -58.08 3.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.097 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.429 HD23 ' CD1' ' A' ' 59' ' ' LEU . 2.3 pp -71.45 -41.58 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.299 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -51.9 -40.74 61.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.422 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -64.74 -37.63 88.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.421 ' CD1' HG21 ' A' ' 82' ' ' VAL . 6.1 tp -56.74 -57.16 13.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -52.24 -41.88 63.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.8 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -53.97 50.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.6 mtt85 -54.11 -32.12 54.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.44 7.72 15.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.836 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.54 8.99 84.62 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.032 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.41 HD13 ' CG ' ' A' ' 89' ' ' MET . 61.0 mt -86.15 112.88 23.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.869 0.366 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.16 166.19 15.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.875 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.422 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 0.8 OUTLIER -53.38 -29.77 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.09 -42.6 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.75 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -77.91 -29.7 50.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.616 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' CD1' ' CG1' ' A' ' 19' ' ' VAL . 53.9 mt -70.85 -25.3 62.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.3 p -96.65 -5.72 38.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.706 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.26 119.23 23.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.878 0.371 . . . . 0.0 110.821 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.79 -34.81 28.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.358 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.99 -58.86 3.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.178 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.2 -30.56 71.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.822 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.8 p -59.36 -43.49 92.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.546 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 1.5 tptm -61.0 -51.71 68.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.593 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.421 ' CD1' HG13 ' A' ' 88' ' ' VAL . 1.8 pp -67.09 -34.45 77.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.678 0.275 . . . . 0.0 111.197 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.435 ' CG1' ' HE2' ' A' ' 89' ' ' MET . 44.5 mt -68.65 -64.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.843 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.554 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 0.9 OUTLIER -53.72 -35.33 61.07 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.234 -178.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.452 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -54.05 -34.59 60.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.178 178.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.54 -44.21 91.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.043 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.481 HD12 HG21 ' A' ' 53' ' ' ILE . 23.8 mt -53.31 -25.18 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.336 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.49 -35.94 53.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.23 -25.21 61.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 110.769 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 27.9 mm-40 -86.04 11.58 11.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.494 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.92 19.26 27.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.491 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.32 167.65 38.76 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.648 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.429 ' CD1' HD23 ' A' ' 26' ' ' LEU . 25.4 tp -48.67 -37.01 17.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.088 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -64.99 -37.57 88.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.142 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.439 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.65 -33.32 66.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.49 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 53' ' ' ILE . 60.3 t -65.97 -52.24 51.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.871 0.367 . . . . 0.0 110.581 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -53.89 -44.68 70.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.18 0.515 . . . . 0.0 109.934 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -48.65 78.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.918 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 13.4 pt-20 -69.09 -41.66 77.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.687 0.279 . . . . 0.0 111.307 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.391 . . . . 0.0 110.683 179.866 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.421 HG21 ' CD1' ' A' ' 29' ' ' LEU . 28.2 t . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 120.786 0.327 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.75 -39.04 86.22 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.959 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.74 -49.66 67.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.591 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -55.93 -45.51 78.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.0 mtm -53.2 -39.57 63.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.15 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -62.92 -41.95 99.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.039 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.421 HG13 ' CD1' ' A' ' 48' ' ' LEU . 65.8 t -57.55 -36.47 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.488 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.435 ' HE2' ' CG1' ' A' ' 49' ' ' ILE . 15.8 mmt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.69 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 120.72 0.295 . . . . 0.0 110.256 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -91.96 134.48 28.71 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.626 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.41 -30.16 62.63 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.468 2.112 . . . . 0.0 112.56 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -105.24 -39.53 6.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.73 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -85.67 -9.8 56.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 82.1 -139.06 19.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.405 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -80.94 -169.37 2.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.964 0.411 . . . . 0.0 110.865 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -117.74 52.81 0.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.412 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.437 ' CG1' ' CD1' ' A' ' 40' ' ' LEU . 2.8 m -46.98 -26.36 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.494 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -70.24 -23.23 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -134.75 25.55 3.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.61 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.7 mt -69.99 159.59 33.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 111.271 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.72 139.73 40.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.767 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 44.3 Cg_exo -55.41 -18.68 19.94 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.506 2.137 . . . . 0.0 112.461 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -81.09 -57.67 3.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.123 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.428 HD21 ' CD1' ' A' ' 59' ' ' LEU . 3.6 pp -70.63 -41.85 71.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.143 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.429 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -57.11 -37.35 71.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 110.471 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.411 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 34.0 t -63.44 -37.03 85.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.714 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.443 ' CD1' HG22 ' A' ' 82' ' ' VAL . 38.3 tp -56.92 -53.59 56.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.689 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.407 ' CD2' HD11 ' A' ' 40' ' ' LEU . 17.7 m-85 -51.99 -43.44 63.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.574 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -61.74 -53.59 53.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.769 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.43 ' CB ' HG11 ' A' ' 82' ' ' VAL . 32.8 mtt180 -57.96 -30.57 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.833 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.11 -22.49 36.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.174 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.6 13.02 39.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.806 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.8 mt -86.53 118.67 33.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 111.132 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.19 162.78 17.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.43 ' HG2' ' CG2' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -53.14 -30.04 34.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.86 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.63 -41.15 69.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.845 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -78.03 -30.44 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.72 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' CD1' ' CG1' ' A' ' 19' ' ' VAL . 51.5 mt -71.48 -27.79 63.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.729 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 p -97.4 -1.53 44.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.714 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 46' ' ' SER . 14.8 t70 -82.6 124.28 30.01 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.18 -41.44 60.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.55 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -72.53 -57.79 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.641 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.67 -37.53 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.353 -178.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 91.5 p -56.3 -38.72 71.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 0.0 110.279 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -62.19 -55.46 28.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.391 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 45' ' ' THR . 1.7 pp -66.1 -31.98 73.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.301 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 59.8 mt -67.78 -64.11 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.633 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.479 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 1.5 p90 -54.33 -39.85 67.45 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.387 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -55.49 -32.88 63.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.786 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.482 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 85.5 t80 -63.43 -38.42 91.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.911 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.43 ' CG2' HG22 ' A' ' 62' ' ' VAL . 22.0 mt -58.89 -28.84 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.219 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.43 -38.2 80.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.636 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.482 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -66.01 -25.37 67.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.614 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.476 ' OE1' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -84.15 -8.17 59.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.202 178.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 112.39 21.3 6.24 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.007 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.93 171.6 47.99 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.428 ' CD1' HD21 ' A' ' 26' ' ' LEU . 8.7 tp -48.24 -40.38 24.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.155 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -65.69 -35.02 79.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.432 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.83 -35.01 67.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.676 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.43 HG22 ' CG2' ' A' ' 53' ' ' ILE . 47.6 t -64.73 -62.1 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 110.74 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -36.2 39.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.208 0.527 . . . . 0.0 109.926 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -65.34 -51.83 57.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.881 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 16.7 pt-20 -68.17 -40.34 82.33 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.718 0.294 . . . . 0.0 111.359 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 C--N 1.326 -0.43 0 CA-C-O 120.962 0.41 . . . . 0.0 110.512 179.4 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.443 HG22 ' CD1' ' A' ' 29' ' ' LEU . 22.6 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.832 0.348 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.05 -38.46 73.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.56 -55.44 20.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 111.008 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 12.4 tp -49.71 -41.17 42.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.791 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.4 mtm -54.19 -44.01 71.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -43.71 90.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.315 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.4 t -55.36 -41.76 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.64 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 84.0 mmm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.714 179.511 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 110.371 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.39 135.24 26.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.735 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -63.96 -45.89 9.54 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.486 2.124 . . . . 0.0 112.629 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -90.09 -38.24 13.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.839 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -85.71 -21.04 28.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.192 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.55 -149.5 20.62 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.558 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.01 138.05 34.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.789 0.328 . . . . 0.0 111.028 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -78.2 67.33 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.745 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.426 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.4 m -51.64 -23.59 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.227 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.21 -20.2 60.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -130.29 20.27 5.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.603 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 18.9 mt -70.19 159.46 33.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 111.158 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.33 140.95 39.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 46.3 Cg_exo -56.12 -19.56 27.39 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.597 2.198 . . . . 0.0 112.512 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -81.4 -56.82 3.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.176 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD23 ' CD1' ' A' ' 59' ' ' LEU . 3.7 pp -70.0 -42.02 73.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.23 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.414 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -54.53 -38.82 67.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.929 0.395 . . . . 0.0 110.123 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 t -63.1 -40.72 98.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.486 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.431 ' CD1' HG23 ' A' ' 82' ' ' VAL . 13.5 tp -57.11 -52.51 65.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.396 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CG ' HD21 ' A' ' 40' ' ' LEU . 22.9 m-85 -53.45 -47.63 69.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.514 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 m -61.73 -51.51 68.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.831 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 mtt85 -57.08 -31.93 65.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.91 -10.91 59.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.477 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.63 13.54 55.07 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.77 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 39' ' ' GLN . 64.1 mt -87.08 115.43 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.747 0.308 . . . . 0.0 111.29 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.3 p -87.26 160.76 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.72 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' CG ' HG13 ' A' ' 19' ' ' VAL . 1.1 mt-10 -52.55 -31.8 37.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.821 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.97 -42.47 72.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.643 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 35' ' ' ILE . 14.2 mt-30 -78.09 -30.64 49.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.749 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.478 HD21 ' CG ' ' A' ' 30' ' ' PHE . 73.4 mt -69.81 -26.71 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.547 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.6 p -96.27 -3.06 44.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.64 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -81.94 116.13 21.43 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 120.786 0.327 . . . . 0.0 110.611 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.49 -35.09 8.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.569 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -72.19 -59.11 2.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.276 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -33.17 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.304 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.0 p -58.42 -42.03 86.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.794 0.33 . . . . 0.0 110.612 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.81 -53.39 56.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.712 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 pp -64.89 -33.69 76.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.782 0.325 . . . . 0.0 110.908 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.467 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 75.1 mt -67.55 -63.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.23 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.1 p90 -52.26 -40.27 61.49 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.086 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -36.55 64.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.522 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 78.6 t80 -63.46 -29.82 71.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.8 mt -66.28 -27.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.088 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -71.46 -39.27 71.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.586 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.4 p30 -64.42 -25.29 67.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.559 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 8.5 mt-30 -84.73 -9.91 57.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.175 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.14 21.37 5.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.134 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.53 168.94 45.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.424 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD1' HD23 ' A' ' 26' ' ' LEU . 25.1 tp -48.23 -36.23 13.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 111.106 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.12 -37.24 85.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.197 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.433 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.61 -34.66 67.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.561 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.48 -49.65 77.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 110.615 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -54.51 -48.25 72.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.152 0.501 . . . . 0.0 110.035 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.32 -43.2 95.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.465 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -67.87 -37.51 81.9 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.721 0.296 . . . . 0.0 111.392 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.801 179.4 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.431 HG23 ' CD1' ' A' ' 29' ' ' LEU . 16.5 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.858 0.361 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.35 84.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.15 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.03 -43.31 95.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.907 0.384 . . . . 0.0 110.67 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 tp -55.74 -49.72 72.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.793 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.4 mtt -49.62 -28.21 5.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.858 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.81 -41.93 20.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.526 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.47 -42.0 94.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.028 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 79.1 mmm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.375 178.216 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.571 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.42 138.69 28.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.673 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.99 -27.74 3.62 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.611 2.207 . . . . 0.0 112.286 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -97.97 -39.26 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -87.92 -25.83 23.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.34 -149.68 19.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.628 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.427 ' CE2' ' CB ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -82.46 148.17 28.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 110.943 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.95 63.47 8.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.441 HG11 ' CG ' ' A' ' 37' ' ' GLU . 2.6 m -50.9 -24.0 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.282 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.14 -21.0 60.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -132.3 23.49 4.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.529 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 18.4 mt -70.29 159.62 33.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.377 . . . . 0.0 111.029 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -83.22 140.33 42.33 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.864 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -55.91 -18.3 21.67 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.608 2.205 . . . . 0.0 112.659 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.68 -58.14 3.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.049 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 59' ' ' LEU . 3.3 pp -70.45 -40.3 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.094 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -51.99 -38.54 57.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.979 0.418 . . . . 0.0 110.198 179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.433 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -64.54 -34.79 79.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.53 178.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.1 tp -56.76 -59.48 4.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.654 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.441 ' CD2' HD22 ' A' ' 40' ' ' LEU . 8.5 m-85 -51.2 -47.55 62.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.614 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.94 -54.85 36.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.873 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.8 mtt-85 -56.54 -29.82 62.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.95 -15.06 55.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.431 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.19 9.25 54.07 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.806 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.403 HD13 ' HG ' ' A' ' 85' ' ' LEU . 42.4 mt -86.7 120.52 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 0.0 111.218 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.2 p -87.14 161.52 18.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.441 ' CG ' HG11 ' A' ' 19' ' ' VAL . 2.7 tt0 -52.96 -31.47 40.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.89 -42.34 71.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -77.9 -30.73 50.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.441 HD22 ' CD2' ' A' ' 30' ' ' PHE . 96.0 mt -70.36 -25.06 63.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.726 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.3 p -96.22 -5.24 40.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.53 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.93 122.43 27.76 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 110.77 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.79 -37.93 45.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.52 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -71.72 -59.56 2.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.665 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -31.63 72.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.765 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.6 p -58.55 -44.22 89.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.357 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 7.8 tptt -59.87 -55.07 38.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.439 HD13 ' CG1' ' A' ' 88' ' ' VAL . 1.8 pp -64.75 -32.91 74.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.504 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.69 -64.17 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.493 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.571 ' CE1' ' CZ2' ' A' ' 11' ' ' TRP . 1.6 p90 -52.75 -37.34 59.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.973 0.416 . . . . 0.0 110.06 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.99 -31.64 61.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.413 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.465 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 66.1 t80 -64.49 -41.52 96.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.095 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.2 mt -54.46 -27.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.29 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -72.7 -38.51 67.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.698 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.465 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -69.05 -25.89 64.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.688 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 18.4 mm100 -85.19 9.09 16.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.402 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.52 19.59 24.79 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.415 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.26 168.87 42.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.588 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.439 ' CD1' HD21 ' A' ' 26' ' ' LEU . 16.1 tp -49.42 -39.63 33.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.691 0.282 . . . . 0.0 111.07 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -63.95 -36.37 83.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.032 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.05 -32.66 65.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 22.8 t -66.13 -52.86 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -54.15 -43.79 70.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.124 0.487 . . . . 0.0 110.127 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -63.32 -47.72 81.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.27 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 25.5 pt-20 -68.31 -40.43 81.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.693 0.282 . . . . 0.0 111.299 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.137 0.494 . . . . 0.0 110.284 179.131 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.5 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.816 0.341 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.02 -42.15 78.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.318 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.2 84.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.373 . . . . 0.0 110.74 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HG ' HD13 ' A' ' 35' ' ' ILE . 8.3 tp -52.72 -48.92 66.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.498 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.9 mtt -49.05 -44.05 41.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.659 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.04 -43.51 87.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.361 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.439 ' CG1' HD13 ' A' ' 48' ' ' LEU . 62.5 t -55.58 -42.94 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.464 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 82.2 mmm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.448 179.067 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.802 0.334 . . . . 0.0 110.564 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -92.92 132.51 30.85 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.425 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.13 -31.59 83.08 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.452 2.101 . . . . 0.0 112.59 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -98.04 -41.22 8.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.668 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -86.44 -14.77 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.694 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 87.22 -140.74 17.07 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.216 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 11' ' ' TRP . 0.1 OUTLIER -81.79 -169.12 2.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.91 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.3 54.17 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.392 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.413 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 1.5 m -47.09 -26.33 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.384 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -70.2 -23.68 62.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.046 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -135.52 26.58 3.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.731 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.428 ' CD2' HD12 ' A' ' 26' ' ' LEU . 17.1 mt -69.65 159.36 33.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.816 0.341 . . . . 0.0 110.996 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.56 140.16 41.3 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 51.6 Cg_exo -54.84 -19.31 18.75 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.621 2.214 . . . . 0.0 112.51 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -81.19 -58.32 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.074 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.436 HD22 ' CD1' ' A' ' 59' ' ' LEU . 3.8 pp -71.44 -39.14 71.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.245 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -58.67 -35.57 72.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.383 . . . . 0.0 110.149 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.426 ' O ' ' CD ' ' A' ' 32' ' ' ARG . 25.8 t -63.75 -38.25 90.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.757 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.439 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 8.0 tp -54.86 -53.85 50.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.423 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.468 ' CD2' HD11 ' A' ' 40' ' ' LEU . 22.6 m-85 -51.35 -46.12 62.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.402 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 m -62.39 -48.03 81.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.736 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.426 ' CD ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -62.05 -33.39 74.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.847 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.3 -21.55 36.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.18 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.91 16.77 32.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.703 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.417 HD12 ' CG ' ' A' ' 89' ' ' MET . 65.9 mt -86.65 121.76 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.341 . . . . 0.0 111.14 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 p -87.02 159.13 19.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -30.7 37.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.25 68.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -78.47 -31.3 47.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.807 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.468 HD11 ' CD2' ' A' ' 30' ' ' PHE . 81.7 mt -70.71 -24.55 62.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.7 p -97.66 -7.75 30.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.602 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -82.02 116.45 21.63 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.809 0.338 . . . . 0.0 110.819 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.79 -32.05 8.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.4 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.53 -59.96 2.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 111.407 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.412 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.59 -33.79 75.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.969 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.9 m -59.41 -39.48 83.6 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.478 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 5.5 tptt -62.12 -49.17 76.96 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.433 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 45' ' ' THR . 1.5 pp -69.96 -34.36 73.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.748 0.309 . . . . 0.0 110.913 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.89 -64.31 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.73 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 0.7 OUTLIER -52.42 -36.13 53.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.913 0.387 . . . . 0.0 110.384 -179.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -33.97 66.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.421 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.449 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 65.3 t80 -64.61 -40.12 94.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.327 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.438 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 23.2 mt -55.92 -29.92 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.042 0.449 . . . . 0.0 110.181 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -43.21 78.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.631 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.449 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -59.86 -24.39 64.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.934 0.397 . . . . 0.0 110.484 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.432 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 71.3 mm-40 -84.96 -13.91 49.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.159 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.403 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 115.9 24.83 3.81 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.817 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.24 168.79 43.83 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.38 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.438 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 10.5 tp -47.35 -33.88 6.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.903 0.383 . . . . 0.0 111.069 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 12.6 mt-10 -68.62 -35.82 77.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.001 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.469 ' HA ' ' HB2' ' A' ' 64' ' ' GLN . . . -72.95 -36.09 67.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.596 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.1 -63.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.277 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -30.17 40.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 61' ' ' ALA . 9.0 mt-30 -63.17 -56.6 15.35 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.088 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -69.67 -38.36 77.02 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.628 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.1 mmt . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.059 0.457 . . . . 0.0 110.412 179.941 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 3.3 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.789 0.328 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.39 -43.28 70.59 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.416 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 -48.55 73.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 14.8 tp -61.31 -40.73 95.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 7.0 mtm -53.28 -37.57 62.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.266 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -72.23 -44.08 63.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.407 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.1 t -53.92 -39.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.563 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.417 ' CG ' HD12 ' A' ' 35' ' ' ILE . 96.4 mmm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.914 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.49 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.1 m-20 -89.42 140.28 28.43 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.749 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.16 -18.43 12.76 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.658 2.239 . . . . 0.0 112.584 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -110.93 -38.16 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.024 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -87.25 -21.55 25.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 96.34 -138.29 13.85 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.249 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.71 -169.81 2.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.893 0.378 . . . . 0.0 110.919 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -118.2 53.23 0.97 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.569 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.422 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -47.01 -26.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.577 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.54 -22.91 61.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.049 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -134.54 25.43 3.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.569 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.5 mt -69.89 159.09 34.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 111.234 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -85.23 140.25 36.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.755 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.84 -19.61 19.74 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.539 2.159 . . . . 0.0 112.559 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.407 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 4.5 m-20 -82.2 -57.12 3.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.328 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 pp -69.93 -41.36 74.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.069 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.97 -35.46 69.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.933 0.396 . . . . 0.0 110.262 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -39.45 93.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.593 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.439 ' CD1' HG21 ' A' ' 82' ' ' VAL . 23.3 tp -57.34 -50.86 71.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.801 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 22.8 m-85 -54.65 -48.3 72.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.739 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -61.24 -46.44 90.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.882 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -35.98 73.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.54 0.04 44.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.753 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.74 12.54 77.35 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.912 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.4 mt -86.67 112.91 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.783 0.325 . . . . 0.0 111.129 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.74 164.43 15.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -29.66 24.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.643 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.83 -44.46 73.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.791 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -78.13 -29.06 48.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.694 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.422 HD22 ' CG ' ' A' ' 30' ' ' PHE . 75.0 mt -70.69 -26.29 63.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.692 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.0 p -97.28 -7.54 31.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.576 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.61 112.59 18.96 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.906 0.384 . . . . 0.0 110.717 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.49 -32.22 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.6 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.23 -58.47 3.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.933 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.402 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -68.62 -35.95 77.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.233 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.94 -39.74 75.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.854 0.359 . . . . 0.0 110.201 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 1.1 tppm? -60.78 -55.52 32.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.337 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 45' ' ' THR . 1.7 pp -66.03 -33.47 75.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.035 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.426 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 60.4 mt -68.44 -63.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.654 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 1.8 p90 -51.09 -38.21 50.34 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.029 0.443 . . . . 0.0 110.018 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.68 -34.21 69.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.523 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 80.9 t80 -63.94 -28.93 70.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.039 0.447 . . . . 0.0 110.259 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.402 ' CG2' HG22 ' A' ' 62' ' ' VAL . 20.1 mt -68.5 -27.8 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.087 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.49 -35.07 70.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.594 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.3 p30 -69.28 -25.46 64.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.585 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.523 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 10.9 mt-30 -84.5 -8.76 58.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.089 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.02 21.39 5.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.064 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.52 168.9 44.95 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.396 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.1 tp -48.45 -38.67 20.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.02 -34.5 78.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.84 -33.91 66.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.607 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.402 HG22 ' CG2' ' A' ' 53' ' ' ILE . 44.5 t -65.32 -63.57 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.333 . . . . 0.0 110.804 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.407 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -52.64 -41.42 63.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 110.244 178.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -63.64 -49.15 74.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.644 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -33.84 73.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.175 -178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 110.36 179.532 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.439 HG21 ' CD1' ' A' ' 29' ' ' LEU . 20.7 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.84 0.352 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.65 -41.3 84.33 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.185 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.09 72.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 110.585 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD13 ' CD2' ' A' ' 52' ' ' PHE . 9.5 tp -50.89 -52.9 37.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.762 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 12.6 mtm -51.01 -31.37 17.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -79.25 -29.34 42.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.489 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.402 HG13 ' CD1' ' A' ' 48' ' ' LEU . 64.8 t -72.38 -42.97 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.629 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 83.1 mmm . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.393 178.931 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.559 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.42 140.28 28.43 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.674 0.273 . . . . 0.0 110.729 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.98 -37.59 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.686 2.257 . . . . 0.0 112.393 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -90.42 -38.06 13.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.954 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -87.2 -27.73 22.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.41 -149.68 19.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.624 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 11' ' ' TRP . 0.1 OUTLIER -82.65 146.58 29.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 111.003 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.08 67.17 9.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.434 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.8 m -50.53 -29.51 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -70.86 -19.92 62.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.139 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -130.72 20.43 5.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.449 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.3 mt -70.49 159.74 33.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -83.03 139.44 42.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.3 Cg_exo -54.28 -19.61 17.31 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.623 2.215 . . . . 0.0 112.636 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -81.06 -58.16 3.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.061 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' A' ' 59' ' ' LEU . 4.0 pp -70.95 -38.29 72.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.148 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.42 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -61.98 -34.71 76.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.376 . . . . 0.0 110.086 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.415 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 23.1 t -64.21 -36.86 85.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.597 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.43 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 3.4 tp -56.1 -58.12 9.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.302 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.449 ' CG ' HD22 ' A' ' 40' ' ' LEU . 17.7 m-85 -49.59 -38.36 31.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.986 0.422 . . . . 0.0 110.519 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.41 -57.78 10.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.763 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.415 ' NE ' ' OG ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -60.5 -25.5 66.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.787 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.14 -18.3 43.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.305 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.08 17.99 56.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.604 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.474 HG22 HD11 ' A' ' 35' ' ' ILE . 60.7 mt -86.24 126.14 40.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.177 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.69 152.79 21.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.429 ' HG2' ' CG2' ' A' ' 19' ' ' VAL . 1.5 mt-10 -51.9 -25.37 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.737 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.89 -42.76 72.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.875 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -78.37 -30.06 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.796 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.449 HD22 ' CG ' ' A' ' 30' ' ' PHE . 95.9 mt -70.67 -27.56 64.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.887 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 p -98.33 -2.44 39.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.552 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 46' ' ' SER . 5.4 t70 -82.85 123.77 29.68 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.52 -37.14 47.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.592 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.74 -59.88 2.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.529 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.5 -36.03 80.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.203 -179.066 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 87.3 p -56.5 -37.59 70.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.88 0.372 . . . . 0.0 110.173 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 11.1 tptt -61.92 -55.69 27.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.427 HD13 ' CG1' ' A' ' 88' ' ' VAL . 1.7 pp -66.86 -28.98 68.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.276 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.428 HG12 ' CE ' ' A' ' 89' ' ' MET . 56.0 mt -67.38 -64.8 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.274 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.559 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.8 p90 -55.28 -34.27 63.95 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.75 -35.65 68.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.45 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.519 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 71.2 t80 -63.79 -30.19 71.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.028 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 17.6 mt -65.43 -27.95 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.033 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.83 -41.77 71.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.571 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.4 p30 -61.4 -25.32 67.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.509 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.519 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 7.7 mt-30 -85.0 -10.61 56.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.252 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.21 21.73 5.47 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.03 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.28 168.5 44.78 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.657 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.449 ' CD1' HD21 ' A' ' 26' ' ' LEU . 14.9 tp -47.67 -37.13 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 110.969 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.0 -36.96 83.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.611 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.54 -36.06 68.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.432 ' CG2' HG23 ' A' ' 53' ' ' ILE . 43.8 t -65.12 -62.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.699 0.285 . . . . 0.0 110.941 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -39.04 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.958 0.409 . . . . 0.0 110.206 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -53.96 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.258 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.19 -28.15 65.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.5 mmm . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.833 179.031 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.43 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 3.8 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.756 0.312 . . . . 0.0 111.33 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.34 -41.71 77.26 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.561 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.64 -51.08 64.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.598 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.95 -40.01 83.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.264 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.5 mtm -54.05 -38.57 65.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.198 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -69.89 -44.66 69.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.389 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.427 ' CG1' HD13 ' A' ' 48' ' ' LEU . 44.8 t -56.11 -38.99 56.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.812 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.432 ' CG ' HD13 ' A' ' 35' ' ' ILE . 28.7 mmt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.048 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 110.901 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.14 140.24 25.81 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.408 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.09 -36.17 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.598 2.199 . . . . 0.0 112.531 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -83.75 -41.35 17.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.129 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -87.62 -28.43 21.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.935 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.95 -146.8 17.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.8 135.7 35.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.26 62.85 0.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.438 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 2.3 m -53.44 -23.22 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.789 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.85 -20.77 59.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.903 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -128.64 18.31 6.28 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.517 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.4 mt -70.0 159.35 33.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 111.133 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -84.54 140.88 38.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.926 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 33.6 Cg_exo -57.24 -17.75 27.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.589 2.193 . . . . 0.0 112.589 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.91 -57.94 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.151 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.57 -41.53 75.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.947 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' HD2' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -55.58 -35.81 66.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 110.295 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.418 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -62.61 -39.24 93.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.719 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.437 ' CA ' ' CE ' ' A' ' 66' ' ' MET . 28.9 tp -56.81 -51.28 69.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.587 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.45 ' CD2' HD22 ' A' ' 40' ' ' LEU . 21.5 m-85 -53.42 -43.46 67.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.577 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.3 m -61.82 -51.55 67.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.89 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -59.9 -32.73 71.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.813 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.94 -18.28 44.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.34 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.33 8.56 54.83 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.937 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.98 109.56 18.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.3 p -86.46 167.23 14.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.041 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -53.2 -34.52 57.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.037 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.23 -42.5 66.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -77.68 -35.1 52.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.552 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 HD22 ' CD2' ' A' ' 30' ' ' PHE . 25.2 mt -69.95 -20.7 63.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -94.32 -9.53 35.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.402 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -81.07 121.67 26.37 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.754 0.311 . . . . 0.0 110.708 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.72 -34.62 27.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.432 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.35 -59.91 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.59 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.413 ' CG2' ' HE2' ' A' ' 89' ' ' MET . 0.2 OUTLIER -67.72 -37.94 82.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.2 p -56.87 -39.52 74.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.818 0.342 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 1.3 tppm? -61.29 -55.79 27.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.348 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.431 HD13 ' CG1' ' A' ' 88' ' ' VAL . 1.8 pp -65.25 -32.08 73.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.328 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.413 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 55.4 mt -66.49 -63.98 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.124 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.565 ' CE1' ' CZ2' ' A' ' 11' ' ' TRP . 2.0 p90 -53.41 -37.96 62.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.97 0.414 . . . . 0.0 110.043 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.9 -35.57 66.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.481 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.45 ' CD2' HG22 ' A' ' 88' ' ' VAL . 37.4 t80 -64.0 -34.55 78.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.097 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 23.8 mt -60.77 -28.63 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.072 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.36 -38.84 78.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.459 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.83 -25.53 64.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 61.3 mm-40 -87.5 13.38 10.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.455 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 95.21 17.41 37.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.572 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.18 170.55 46.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.879 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.443 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 10.2 tp -49.49 -41.56 40.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.713 0.292 . . . . 0.0 111.27 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -65.1 -34.8 79.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.438 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.5 -34.29 65.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.656 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.29 -61.92 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.56 -38.6 55.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.082 0.468 . . . . 0.0 110.008 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.87 -51.5 64.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.329 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.74 -33.95 74.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.762 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.437 ' CE ' ' CA ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.779 0.323 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -34.87 78.23 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.298 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -51.28 62.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 110.681 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.5 tp -62.94 -42.5 99.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.477 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -33.36 53.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.403 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -75.17 -30.31 60.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.349 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.45 HG22 ' CD2' ' A' ' 52' ' ' PHE . 96.8 t -66.36 -40.24 86.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.626 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.413 ' HE2' ' CG2' ' A' ' 45' ' ' THR . 74.1 mmm . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.614 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.809 0.337 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -88.83 140.23 29.38 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.545 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.23 -33.5 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.671 2.247 . . . . 0.0 112.572 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -93.22 -41.11 10.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -87.1 -26.94 23.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.043 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 101.62 -145.11 16.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.386 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.43 138.9 35.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -76.01 62.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.249 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.412 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.8 m -51.24 -24.69 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.9 -21.39 60.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -128.55 19.91 6.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.383 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 16.4 mt -71.02 159.06 35.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.793 0.33 . . . . 0.0 111.189 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.88 142.56 39.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.989 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 43.3 Cg_exo -56.01 -20.02 28.51 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.606 2.204 . . . . 0.0 112.529 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.82 -56.97 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.14 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.436 HD23 ' CD1' ' A' ' 59' ' ' LEU . 3.7 pp -71.12 -37.46 72.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 2.0 ppt_? -59.59 -36.27 75.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.948 0.404 . . . . 0.0 110.214 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.1 t -63.68 -37.2 86.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.652 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 25.6 tp -56.71 -57.07 14.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.625 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.413 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 20.3 m-85 -48.35 -43.63 33.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.25 -58.48 7.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.631 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -29.86 59.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.826 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.77 3.52 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.806 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.8 4.28 90.37 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.994 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.2 mt -85.67 162.35 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.893 0.347 . . . . 0.0 110.851 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.4 172.77 12.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.033 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.407 ' O ' ' CG2' ' A' ' 41' ' ' THR . 1.0 OUTLIER -53.45 -37.78 62.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.025 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.71 -46.42 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.71 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -78.54 -34.02 47.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.668 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.0 -23.14 63.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.407 ' CG2' ' O ' ' A' ' 37' ' ' GLU . 46.9 p -94.99 -7.65 39.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.537 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -81.3 119.17 23.32 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.757 0.313 . . . . 0.0 110.715 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.85 -34.48 12.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.493 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -72.75 -59.89 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.415 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.411 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.21 -34.41 76.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.409 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.2 p -58.32 -42.3 86.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.847 0.356 . . . . 0.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -60.99 -53.14 60.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.499 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 45' ' ' THR . 1.5 pp -65.04 -32.26 73.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.741 0.305 . . . . 0.0 110.828 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.413 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 49.9 mt -68.42 -64.0 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.384 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.3 p90 -52.08 -40.7 61.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.885 0.374 . . . . 0.0 110.303 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.449 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -53.57 -32.68 51.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 178.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.46 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 69.3 t80 -63.85 -41.74 97.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.122 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.424 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 59.9 mt -55.39 -25.11 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.41 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.83 -35.54 59.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.783 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.46 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -72.93 -25.63 61.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.8 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -87.4 13.98 8.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.552 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.97 14.72 41.7 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.635 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.91 170.19 46.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.127 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.436 ' CD1' HD23 ' A' ' 26' ' ' LEU . 12.5 tp -48.99 -40.13 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 110.899 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -65.07 -36.19 83.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.302 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.446 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.08 -35.76 66.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.899 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.0 t -65.0 -63.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.756 0.312 . . . . 0.0 110.912 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -44.53 63.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.071 0.462 . . . . 0.0 110.235 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.0 -52.58 62.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.41 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -70.4 -23.3 62.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.212 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 0.0 110.241 179.037 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.446 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 16.8 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.824 0.345 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -46.47 60.05 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.037 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.35 -46.49 79.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.948 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.6 tp -55.97 -46.83 78.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.7 mtp -53.62 -29.97 40.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.441 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -80.08 -30.17 39.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.525 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.48 -42.45 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 110.308 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.3 mmm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.138 178.141 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.569 ' CH2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.745 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.09 140.8 29.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.552 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.05 -38.2 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.652 2.235 . . . . 0.0 112.772 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -94.17 -35.6 12.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.19 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.77 -25.29 23.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.112 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.85 -150.19 19.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.393 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.471 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.28 136.36 35.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.332 . . . . 0.0 110.891 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -74.83 62.95 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.277 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.402 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -52.0 -23.83 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.288 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.43 -21.76 61.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.194 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -132.68 21.89 4.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.487 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.471 HD21 ' CD1' ' A' ' 17' ' ' PHE . 16.5 mt -70.07 159.03 34.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 111.23 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -85.19 139.84 36.63 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.0 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.19 -18.94 19.35 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.621 2.214 . . . . 0.0 112.684 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -81.19 -57.97 3.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.228 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.436 HD21 ' CD1' ' A' ' 59' ' ' LEU . 3.5 pp -69.91 -42.81 72.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.096 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -34.22 62.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.956 0.407 . . . . 0.0 110.086 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.33 -39.18 93.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.677 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.404 ' N ' ' CE ' ' A' ' 66' ' ' MET . 22.4 tp -56.59 -55.65 31.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.591 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -50.38 -43.61 54.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.617 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 m -62.34 -55.14 30.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.709 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -56.73 -30.89 63.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.827 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.92 -21.46 37.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 8.68 48.31 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.771 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 ' CG ' ' A' ' 89' ' ' MET . 39.3 mt -86.09 112.3 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.83 0.348 . . . . 0.0 111.176 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 p -87.0 167.6 14.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -52.17 -28.91 19.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.821 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.5 -46.14 73.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -78.47 -31.38 47.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.688 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.98 -25.48 63.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.4 p -97.29 -5.33 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.607 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -82.23 113.69 20.22 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.753 0.311 . . . . 0.0 110.649 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.6 -32.28 3.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.59 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.94 -59.66 2.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.122 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.85 -36.5 80.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.295 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.39 -38.16 71.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.848 0.356 . . . . 0.0 110.21 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 4.1 tptm -62.07 -54.95 34.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.363 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.04 -30.67 70.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.258 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.7 mt -68.02 -64.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.517 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.569 ' CZ ' ' CH2' ' A' ' 11' ' ' TRP . 2.1 p90 -52.77 -40.72 63.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.94 0.4 . . . . 0.0 110.224 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.78 -32.69 60.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.7 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.464 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 77.0 t80 -64.54 -38.67 91.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.25 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.413 ' CG2' ' CG2' ' A' ' 62' ' ' VAL . 44.6 mt -59.18 -28.64 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.238 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.67 -33.95 73.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.342 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.464 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -75.08 -24.66 58.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.476 178.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 97.0 mm-40 -85.9 10.48 13.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.339 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.442 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.15 17.08 33.11 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.483 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.64 171.21 46.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.809 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.436 ' CD1' HD21 ' A' ' 26' ' ' LEU . 25.5 tp -49.34 -41.62 39.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 111.281 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -63.87 -34.84 78.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.219 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.442 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -35.57 66.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.255 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.413 ' CG2' ' CG2' ' A' ' 53' ' ' ILE . 22.0 t -66.06 -48.79 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -54.29 -46.55 72.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.112 0.482 . . . . 0.0 109.985 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.53 -49.07 74.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.943 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 20.3 pt-20 -67.56 -24.75 65.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.805 0.336 . . . . 0.0 110.808 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.404 ' CE ' ' N ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.774 0.321 . . . . 0.0 111.272 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.2 -38.51 82.56 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.479 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.94 -48.74 73.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 0.0 110.766 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.461 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 30.7 tp -62.03 -45.18 94.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.4 mtm -54.25 -34.48 60.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.499 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -75.74 -24.46 56.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.28 -37.4 22.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.156 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.423 ' CG ' HD12 ' A' ' 35' ' ' ILE . 67.2 mmm . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 121.046 0.451 . . . . 0.0 110.258 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.556 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.772 0.32 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.8 m-20 -90.57 138.41 26.74 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.467 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.23 -23.45 6.33 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.587 2.191 . . . . 0.0 112.598 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -99.1 -41.14 7.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.088 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -88.15 -29.85 20.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.046 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 109.56 -144.79 16.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.467 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.454 ' CE1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -83.49 147.01 28.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 111.095 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -82.14 58.75 4.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.886 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.6 m -51.38 -24.03 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.069 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -19.77 59.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -131.61 21.34 4.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.401 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.454 HD21 ' CE1' ' A' ' 17' ' ' PHE . 17.6 mt -70.14 159.63 33.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.933 0.397 . . . . 0.0 111.201 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -83.52 145.85 48.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.06 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.66 -22.23 59.64 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.634 2.223 . . . . 0.0 112.645 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.92 -56.37 4.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.328 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 3.6 pp -70.85 -32.77 69.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.333 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.17 -35.56 81.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.234 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -35.82 81.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.642 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.45 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 9.4 tp -56.4 -60.36 3.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.544 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.454 ' CG ' HD22 ' A' ' 40' ' ' LEU . 16.7 m-85 -49.0 -45.24 42.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.817 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 m -62.22 -50.38 72.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -59.5 -33.18 71.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.61 -12.79 58.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.378 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.65 11.77 58.9 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.624 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 39' ' ' GLN . 62.7 mt -86.48 114.79 26.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.807 0.336 . . . . 0.0 111.086 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.9 p -87.53 163.49 16.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.11 -26.7 17.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.39 -44.77 72.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.402 ' HB2' HG21 ' A' ' 35' ' ' ILE . 40.7 mt-30 -78.58 -33.64 47.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.744 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.454 HD22 ' CG ' ' A' ' 30' ' ' PHE . 76.5 mt -68.79 -22.3 64.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.804 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -96.53 -8.75 31.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.555 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -82.22 112.76 19.53 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.783 0.325 . . . . 0.0 110.645 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.96 -31.27 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.7 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -72.37 -59.65 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.882 0.372 . . . . 0.0 110.929 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.413 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.71 -33.33 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.66 -39.5 80.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.269 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 19.1 tptt -61.74 -53.31 57.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.566 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.426 HD13 ' CG1' ' A' ' 88' ' ' VAL . 1.9 pp -66.44 -32.41 73.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.356 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mt -68.2 -64.59 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.554 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.556 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.3 p90 -53.63 -37.43 63.06 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.981 0.419 . . . . 0.0 110.138 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -55.44 -36.41 66.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.426 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.459 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 64.3 t80 -64.32 -37.56 87.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.043 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.425 ' CG2' HG21 ' A' ' 62' ' ' VAL . 49.5 mt -58.62 -29.07 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.178 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -40.27 77.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.587 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.459 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -66.37 -26.24 67.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.458 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.411 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 94.6 mm-40 -85.28 1.35 48.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.338 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 104.41 18.82 12.3 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.475 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.45 170.83 46.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.846 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.455 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 12.1 tp -48.52 -40.33 26.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.322 . . . . 0.0 111.093 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.64 -35.07 79.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.247 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.446 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -74.05 -34.24 63.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.818 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.425 HG21 ' CG2' ' A' ' 53' ' ' ILE . 44.0 t -65.02 -63.29 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.699 0.285 . . . . 0.0 110.873 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -41.64 63.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.052 0.453 . . . . 0.0 110.13 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -63.23 -53.26 55.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.33 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.36 -26.61 64.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.992 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.5 mmt . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.079 0.466 . . . . 0.0 110.238 178.896 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.45 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 3.6 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.24 -48.91 43.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.274 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.39 85.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.794 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 tp -56.8 -40.99 76.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.625 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.7 mtt -53.0 -41.16 64.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.24 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -45.49 74.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.669 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.426 ' CG1' HD13 ' A' ' 48' ' ' LEU . 22.5 t -51.25 -40.02 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.709 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 92.9 mmm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.325 178.699 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.28 137.93 28.98 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.679 0.276 . . . . 0.0 110.795 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.44 -23.36 7.36 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -98.42 -41.4 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -89.45 -25.92 21.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.002 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.74 -142.47 16.1 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.337 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.0 146.4 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 0.0 110.841 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -84.66 61.12 6.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.437 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 5.2 m -49.07 -25.36 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.237 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -72.12 -20.88 61.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.086 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -132.23 20.75 4.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.429 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.0 mt -70.28 159.7 33.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.936 0.398 . . . . 0.0 111.163 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -82.44 139.42 44.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.77 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 49.2 Cg_exo -54.86 -19.17 18.36 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.518 2.146 . . . . 0.0 112.464 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -81.27 -57.68 3.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.127 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD23 ' CD1' ' A' ' 59' ' ' LEU . 3.4 pp -70.64 -40.97 72.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.105 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.427 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.6 OUTLIER -59.04 -39.09 80.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 0.0 110.576 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -64.09 -38.49 91.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.619 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.425 ' CD1' HG23 ' A' ' 82' ' ' VAL . 15.5 tp -56.11 -51.01 69.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.576 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.472 ' CG ' HD22 ' A' ' 40' ' ' LEU . 21.0 m-85 -52.3 -49.04 64.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.512 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.3 m -62.41 -41.49 98.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.791 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -62.48 -35.86 80.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.983 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.1 -14.74 57.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.482 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 10.78 45.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.796 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.41 HD11 ' CD2' ' A' ' 85' ' ' LEU . 62.5 mt -86.64 119.62 34.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.842 0.353 . . . . 0.0 110.939 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -86.6 157.45 19.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.998 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.419 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.82 -30.32 32.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.047 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.65 70.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.858 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.425 ' NE2' HG21 ' A' ' 45' ' ' THR . 9.6 mm100 -77.76 -30.14 51.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.712 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.472 HD22 ' CG ' ' A' ' 30' ' ' PHE . 95.2 mt -69.6 -22.8 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.5 p -97.44 -7.68 31.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.606 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -81.45 115.51 20.81 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.818 0.342 . . . . 0.0 110.63 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.96 -34.2 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.682 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -72.44 -59.9 2.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 0.0 111.491 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.431 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.3 -32.89 74.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.172 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -57.86 -42.1 83.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.599 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.84 -55.2 32.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.358 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.436 HD12 ' CG1' ' A' ' 88' ' ' VAL . 1.6 pp -63.31 -31.61 72.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.723 0.297 . . . . 0.0 110.953 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 70.4 mt -69.76 -64.02 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.381 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.452 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 1.9 p90 -53.35 -38.2 63.06 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.073 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -54.18 -34.32 60.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.638 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.516 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 69.1 t80 -63.93 -30.67 71.73 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.092 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.408 ' CG2' ' CG2' ' A' ' 62' ' ' VAL . 40.2 mt -66.29 -28.5 43.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.034 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -71.8 -34.42 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.816 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.478 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.3 p30 -69.96 -25.59 63.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 0.0 110.497 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.516 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 9.0 mt-30 -83.12 -8.97 59.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.094 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 113.64 22.08 5.54 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.886 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.64 171.02 47.21 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.603 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.432 ' CD1' HD23 ' A' ' 26' ' ' LEU . 13.2 tp -47.8 -41.64 24.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 111.055 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 28.5 mt-10 -64.27 -34.51 78.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.4 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.428 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.16 -35.93 66.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.709 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.408 ' CG2' ' CG2' ' A' ' 53' ' ' ILE . 40.3 t -65.14 -63.56 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.667 0.27 . . . . 0.0 110.812 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.08 -37.94 62.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.98 0.419 . . . . 0.0 109.94 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 43.6 mt-30 -63.17 -50.62 69.67 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.061 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -68.8 -34.88 76.27 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.542 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 121.087 0.47 . . . . 0.0 110.049 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.425 HG23 ' CD1' ' A' ' 29' ' ' LEU . 6.2 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.783 0.325 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.33 -36.96 85.65 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.301 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.22 -47.04 81.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.703 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.41 ' CD2' HD11 ' A' ' 35' ' ' ILE . 5.9 tp -54.08 -49.41 69.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.493 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.4 mtm -51.1 -31.63 19.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.473 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -39.92 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.259 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.436 ' CG1' HD12 ' A' ' 48' ' ' LEU . 57.9 t -56.4 -40.56 67.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.207 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.418 ' CE ' HG23 ' A' ' 45' ' ' THR . 3.3 mmt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.183 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.495 ' CE2' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 120.758 0.313 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.58 136.15 25.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.73 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.15 -58.73 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.494 2.13 . . . . 0.0 112.592 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -81.33 -34.44 31.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.715 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -86.14 -22.76 26.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.651 0.262 . . . . 0.0 111.199 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.65 -150.6 21.83 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.587 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.78 142.87 33.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.862 0.363 . . . . 0.0 110.997 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.7 64.96 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 2.0 m -54.69 -21.5 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.261 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -72.72 -20.84 61.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.143 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -132.11 20.62 4.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.508 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.7 mt -69.8 159.46 33.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.154 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -84.08 137.97 39.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.77 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 44.5 Cg_exo -55.89 -18.53 22.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.558 2.172 . . . . 0.0 112.463 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -80.84 -57.63 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.044 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.438 HD22 ' CD1' ' A' ' 59' ' ' LEU . 4.1 pp -69.53 -44.81 70.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.148 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -55.2 -32.9 62.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.863 0.363 . . . . 0.0 110.534 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.4 t -64.55 -38.06 89.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.44 ' CD1' HG23 ' A' ' 82' ' ' VAL . 16.0 tp -56.35 -54.54 44.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.733 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -50.99 -44.32 60.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.769 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -61.8 -49.32 76.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.915 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -34.05 67.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.054 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.94 -18.55 46.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.39 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.15 11.68 41.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.89 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.413 HG21 ' NE2' ' A' ' 39' ' ' GLN . 52.4 mt -86.21 117.79 31.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.813 0.34 . . . . 0.0 111.057 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.03 161.46 18.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.419 ' HG2' ' CG2' ' A' ' 19' ' ' VAL . 0.6 OUTLIER -52.73 -26.49 14.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.851 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.09 -43.2 73.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.413 ' NE2' HG21 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -78.57 -28.73 45.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.742 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.432 HD12 ' CG1' ' A' ' 19' ' ' VAL . 33.1 mt -71.19 -23.58 62.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.856 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.6 p -98.05 -7.55 29.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.696 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 46' ' ' SER . 29.1 t0 -81.96 122.55 27.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.799 0.333 . . . . 0.0 110.744 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.07 -38.22 37.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.556 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -73.18 -59.81 2.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.672 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 -35.96 81.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.126 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 70.4 m -58.8 -41.98 88.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.855 0.36 . . . . 0.0 110.438 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -60.11 -55.23 36.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.43 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 pp -64.4 -31.99 73.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.383 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.4 mt -67.5 -63.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.203 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.495 ' CE2' ' CE2' ' A' ' 11' ' ' TRP . 2.0 p90 -52.36 -35.84 52.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.925 0.393 . . . . 0.0 110.303 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.8 -32.76 63.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.476 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 74.0 t80 -64.67 -41.03 96.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.167 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.404 ' CG2' HG21 ' A' ' 62' ' ' VAL . 30.8 mt -55.95 -28.23 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.213 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -71.21 -36.13 71.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.589 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -73.49 -25.92 60.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.568 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 89.2 mm-40 -86.22 12.5 9.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.639 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.49 15.04 36.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.607 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.1 170.63 45.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.784 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.438 ' CD1' HD22 ' A' ' 26' ' ' LEU . 17.4 tp -48.95 -37.95 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 111.112 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.01 -35.69 82.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.317 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.439 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.21 -35.8 66.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.668 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.404 HG21 ' CG2' ' A' ' 53' ' ' ILE . 31.3 t -65.32 -63.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.707 0.289 . . . . 0.0 110.768 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.1 -37.47 54.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.06 0.457 . . . . 0.0 110.138 178.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -63.09 -52.07 64.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.53 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.403 ' OE2' ' N ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -69.5 -36.32 76.37 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.803 0.335 . . . . 0.0 110.982 -178.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.403 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 2.8 mmt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.596 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.44 HG23 ' CD1' ' A' ' 29' ' ' LEU . 9.2 t . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.892 0.377 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.29 -41.1 80.09 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.26 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.46 93.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.0 -41.08 97.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.37 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -42.5 67.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.18 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -44.89 92.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.4 HG22 ' CD1' ' A' ' 52' ' ' PHE . 44.7 t -52.33 -41.79 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.56 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 74.5 mmm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.793 179.289 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.486 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.318 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.96 138.58 27.61 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.615 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -78.61 -33.89 1.58 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -92.33 -41.0 10.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.946 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.15 -25.1 24.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.012 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.34 -146.28 18.19 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.505 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.59 140.21 34.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -74.86 60.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.446 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -50.52 -24.64 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -73.48 -22.25 60.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -128.7 20.03 6.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.433 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.1 mt -70.64 159.49 34.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 111.051 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.58 139.3 38.11 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.095 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.67 -19.0 22.49 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.56 2.173 . . . . 0.0 112.399 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -81.34 -57.16 3.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.929 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.453 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 4.2 pp -70.14 -44.37 69.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.041 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.4 ' N ' ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -54.39 -35.9 63.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.917 0.389 . . . . 0.0 110.46 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.06 -38.92 93.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.708 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.421 ' HB2' ' CE ' ' A' ' 66' ' ' MET . 27.8 tp -56.65 -54.23 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.436 ' CG ' HD21 ' A' ' 40' ' ' LEU . 21.7 m-85 -51.93 -46.77 64.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.491 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -62.21 -50.72 70.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.714 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -54.73 -32.25 59.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.812 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.5 -14.24 55.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.469 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.05 13.12 50.58 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.677 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 58.2 mt -86.52 118.9 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 111.047 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.74 163.57 17.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.881 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.423 ' HG2' ' CG2' ' A' ' 19' ' ' VAL . 2.4 mt-10 -53.78 -30.3 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.876 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.91 72.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.074 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -78.27 -31.32 48.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.805 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.436 HD21 ' CG ' ' A' ' 30' ' ' PHE . 96.0 mt -70.97 -27.59 63.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.463 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.5 p -97.75 -3.64 38.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.555 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.72 121.46 26.42 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.9 -37.23 30.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.479 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.86 -59.89 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.595 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.71 -35.52 78.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.394 -178.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.5 p -57.42 -37.57 72.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.822 0.344 . . . . 0.0 110.147 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 18.0 tptt -61.55 -56.07 24.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.146 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 45' ' ' THR . 1.7 pp -65.72 -30.72 71.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.287 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.5 mt -68.03 -64.21 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.532 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.3 p90 -52.57 -38.66 60.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.929 0.395 . . . . 0.0 110.203 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.11 -33.54 65.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.674 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.62 -39.63 94.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.303 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.423 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 21.6 mt -57.39 -29.87 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.241 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.34 -36.41 79.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.433 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.69 -25.12 61.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.558 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 16.9 mm100 -86.51 12.13 11.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.44 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.23 17.86 33.09 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.572 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.76 166.84 39.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.696 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.453 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 32.1 tp -49.08 -37.33 20.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 0.0 111.119 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.9 -34.55 78.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.2 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.435 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.78 -35.53 67.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.267 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 18.5 t -66.09 -48.61 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.925 0.393 . . . . 0.0 110.737 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -53.76 -46.23 70.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.175 0.512 . . . . 0.0 109.956 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.22 -48.68 74.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.135 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 8.0 pt-20 -68.6 -20.73 64.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.612 0.244 . . . . 0.0 111.643 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.421 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 2.2 mmt . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 29' ' ' LEU . 8.5 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.834 0.35 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.75 -41.05 75.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.32 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.66 87.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.815 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.91 -44.85 96.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.481 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -42.6 67.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.373 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -36.07 82.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.542 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.91 -40.18 86.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.766 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 48.5 mmm . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 179.851 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.699 0.285 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.8 m-20 -89.52 140.15 28.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.717 0.294 . . . . 0.0 110.54 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.73 -28.39 5.27 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.662 2.241 . . . . 0.0 112.483 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -98.0 -38.83 9.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -87.48 -21.62 25.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 95.6 -138.2 13.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.206 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.481 ' CE2' ' HB3' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -81.94 -169.08 2.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.942 0.401 . . . . 0.0 110.755 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -123.99 54.15 1.35 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.499 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.433 ' CG1' ' HG3' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -46.15 -26.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.641 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -68.56 -23.94 64.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.031 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -134.78 25.21 3.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.642 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.6 mt -70.2 159.5 33.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.927 0.394 . . . . 0.0 111.167 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.91 137.97 40.47 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.707 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.436 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.6 Cg_exo -54.76 -19.22 18.15 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.584 2.189 . . . . 0.0 112.654 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -81.64 -57.71 3.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.291 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.403 HD23 ' CD1' ' A' ' 59' ' ' LEU . 4.0 pp -70.91 -38.1 72.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.158 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.436 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -62.22 -35.51 79.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.489 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 t -63.24 -36.32 83.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.633 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.437 ' CD1' HG21 ' A' ' 82' ' ' VAL . 25.2 tp -56.6 -50.72 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.644 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 24.4 m-85 -55.47 -43.99 76.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.569 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -50.11 74.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.429 ' CB ' HG13 ' A' ' 82' ' ' VAL . 85.5 mtt180 -60.81 -29.3 69.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.911 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.16 -21.2 36.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.173 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.36 14.51 38.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.643 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.8 mt -86.75 121.54 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.0 111.059 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 p -86.97 158.23 19.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.433 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 0.6 OUTLIER -52.07 -27.12 12.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.842 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.17 -42.17 72.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -78.1 -30.17 49.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.6 mt -70.33 -24.77 63.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.6 p -98.45 -5.98 31.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.705 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.89 121.14 26.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.84 0.353 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.08 -35.54 25.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.276 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -72.53 -59.9 2.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.685 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.16 -33.74 76.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.987 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.4 p -57.6 -40.07 78.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.726 0.298 . . . . 0.0 110.345 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -61.77 -53.93 49.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.356 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.427 ' CD1' HG11 ' A' ' 88' ' ' VAL . 1.7 pp -66.64 -31.44 72.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.19 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.402 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 54.1 mt -69.95 -64.78 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.749 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.481 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -54.18 -36.94 63.94 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.361 -178.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -55.0 -33.17 62.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.446 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.443 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 60.7 t80 -64.87 -39.57 93.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.188 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.405 ' CG2' ' CG2' ' A' ' 62' ' ' VAL . 22.6 mt -56.39 -29.98 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.274 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.75 -36.37 75.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -71.14 -26.51 63.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.636 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 97.1 mm-40 -86.05 11.14 12.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.503 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.33 18.21 29.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.496 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.47 172.33 48.63 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.007 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.403 ' CD1' HD23 ' A' ' 26' ' ' LEU . 8.2 tp -48.43 -44.86 35.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 0.0 111.196 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.5 -35.19 79.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.392 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.447 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -33.73 65.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.572 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.405 ' CG2' ' CG2' ' A' ' 53' ' ' ILE . 48.6 t -64.9 -63.48 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -52.29 -38.54 58.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 110.088 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -64.14 -48.96 74.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.909 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 66' ' ' MET . 10.7 pt-20 -68.52 -43.59 76.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.517 -177.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.429 ' N ' ' HG3' ' A' ' 65' ' ' GLU . 4.9 mmm . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 121.053 0.454 . . . . 0.0 110.57 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.437 HG21 ' CD1' ' A' ' 29' ' ' LEU . 19.4 t . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.87 0.367 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.14 -37.54 82.04 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.292 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.91 -51.28 62.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.5 tp -59.83 -42.37 93.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.72 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.7 mtm -52.92 -37.93 61.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.301 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -69.22 -46.85 66.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.222 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 48' ' ' LEU . 98.5 t -52.09 -41.1 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.62 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 89.1 mmm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.35 179.29 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.25 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.59 141.44 30.27 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.772 0.32 . . . . 0.0 110.826 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.1 -23.2 12.26 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.713 2.275 . . . . 0.0 112.64 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.42 -34.22 5.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.189 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.39 -25.79 23.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.779 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.97 -150.55 19.6 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.642 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.62 147.78 29.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.955 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -82.85 61.19 5.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.42 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.2 m -48.57 -25.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.205 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -71.16 -21.29 62.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.48 19.63 5.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.571 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.42 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.5 mt -70.64 159.28 34.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.975 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -84.26 141.0 39.46 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.026 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.7 Cg_exo -54.36 -21.03 21.87 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.65 2.234 . . . . 0.0 112.371 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -82.16 -56.3 4.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.308 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 59' ' ' LEU . 3.7 pp -71.17 -37.43 72.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.25 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HD2' ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -58.67 -39.67 81.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.38 . . . . 0.0 110.425 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.439 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -63.27 -36.16 82.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.641 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.8 tp -56.38 -43.33 79.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.479 ' CG ' HD23 ' A' ' 40' ' ' LEU . 18.5 m-85 -66.85 -49.42 65.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.615 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.2 m -60.7 -50.57 72.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.9 mtt180 -59.11 -30.23 67.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.521 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.65 4.63 24.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.567 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.86 7.57 88.25 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.986 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.7 mt -87.1 122.57 39.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.837 0.351 . . . . 0.0 111.319 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.35 158.28 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.708 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -29.88 26.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.772 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.22 -38.76 68.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -78.02 -32.39 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.479 HD23 ' CG ' ' A' ' 30' ' ' PHE . 57.9 mt -69.61 -24.21 63.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.722 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.4 p -96.72 -7.45 33.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.528 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -81.41 115.4 20.73 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.826 0.346 . . . . 0.0 110.595 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.22 -35.53 3.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.778 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.22 -59.93 2.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 111.493 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.443 ' CG2' ' HE3' ' A' ' 89' ' ' MET . 0.2 OUTLIER -67.6 -34.89 77.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.487 -178.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -41.17 75.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.412 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.58 -56.25 21.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.346 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 pp -63.51 -30.31 71.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.911 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 80.6 mt -68.81 -64.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.023 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.443 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 1.7 p90 -55.48 -39.13 70.03 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.117 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 0.9 OUTLIER -52.34 -34.59 48.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.521 179.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.47 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 54.7 t80 -64.33 -38.78 92.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.806 178.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 48.6 mt -56.62 -30.81 32.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.136 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -69.5 -33.66 73.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.684 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -75.46 -26.0 57.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.729 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 78.4 mm-40 -86.21 11.39 12.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.52 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 99.33 17.14 27.72 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.585 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.84 169.59 45.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.995 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.435 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 14.0 tp -48.06 -39.72 20.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.712 0.292 . . . . 0.0 111.145 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 24.6 mm-40 -65.73 -35.44 80.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.327 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.422 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.09 -35.96 66.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.768 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 46.2 t -65.24 -62.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 110.97 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -39.03 61.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.186 0.517 . . . . 0.0 110.053 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 50.2 mt-30 -63.85 -50.1 70.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.876 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 16.5 pt-20 -69.47 -40.13 77.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.367 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.217 0.532 . . . . 0.0 110.001 179.146 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.854 0.359 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.82 -36.87 83.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.209 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.36 -52.16 59.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.715 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 tp -51.11 -48.12 61.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.57 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.5 mtt -50.29 -40.85 49.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.706 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -44.08 77.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.237 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.8 -40.28 60.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.527 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.443 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 85.7 mmm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.557 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.564 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 CA-C-O 120.706 0.289 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.8 OUTLIER -89.3 140.62 28.66 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.712 0.292 . . . . 0.0 110.769 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.45 -36.8 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.743 2.295 . . . . 0.0 112.591 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -91.6 -35.95 13.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.7 -30.13 20.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.786 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.29 -144.99 16.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.612 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.43 152.64 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 111.082 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -88.09 57.9 4.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.845 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.438 ' CG2' ' HG2' ' A' ' 37' ' ' GLU . 1.7 m -49.13 -25.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.28 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.85 -20.11 60.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.125 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -130.32 21.39 5.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.42 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.6 mt -70.37 159.2 34.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.885 0.374 . . . . 0.0 111.053 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -85.25 142.86 38.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.085 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.4 -18.86 26.44 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.673 2.248 . . . . 0.0 112.456 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -81.2 -58.81 2.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.917 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 3.7 pp -71.76 -40.85 69.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.217 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -34.09 68.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.021 0.439 . . . . 0.0 110.124 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.6 t -64.23 -38.04 89.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.609 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.44 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 1.3 tp -56.68 -58.26 8.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.279 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -51.11 -42.13 60.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.467 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.6 m -62.7 -56.3 18.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.713 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -25.5 64.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.763 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.98 -19.01 41.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.27 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.73 13.96 53.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.7 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.481 HD12 HG21 ' A' ' 35' ' ' ILE . 60.7 mt -87.26 122.15 38.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.889 0.376 . . . . 0.0 111.152 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -87.73 159.13 18.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.864 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.438 ' HG2' ' CG2' ' A' ' 19' ' ' VAL . 0.8 OUTLIER -53.15 -31.65 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.97 -41.92 68.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.8 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -77.5 -34.59 54.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.683 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.55 -22.72 62.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.979 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -97.03 -5.01 38.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.739 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.37 124.34 29.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.829 0.347 . . . . 0.0 110.78 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.47 -36.71 45.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.635 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -72.08 -59.7 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.815 0.34 . . . . 0.0 111.43 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -32.45 73.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.011 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 91.6 p -58.34 -41.18 84.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.36 . . . . 0.0 110.36 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 4.2 tptm -61.3 -53.02 62.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.473 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 pp -67.42 -31.46 71.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.25 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.2 -65.09 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.535 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.564 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.0 OUTLIER -54.89 -36.0 64.68 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.904 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -56.31 -34.05 66.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.389 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.46 -35.09 79.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.158 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.434 ' CG2' HG22 ' A' ' 62' ' ' VAL . 28.1 mt -62.77 -27.37 42.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.132 178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.64 -33.34 68.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.53 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -73.27 -26.29 61.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.453 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.42 ' NE2' ' HA ' ' A' ' 56' ' ' GLN . 12.6 mm100 -85.0 3.49 38.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.379 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 103.47 19.62 12.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.431 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.86 167.77 41.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.465 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 28.2 tp -49.3 -37.54 24.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.47 -34.08 77.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.208 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.43 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.16 -35.43 66.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.379 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 53' ' ' ILE . 45.5 t -65.71 -54.75 24.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.366 . . . . 0.0 110.815 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -53.62 -46.75 70.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.077 0.465 . . . . 0.0 110.087 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -63.09 -50.03 72.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.818 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.53 -37.52 77.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.323 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.422 . . . . 0.0 110.423 179.156 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.44 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 5.9 t . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.822 0.344 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.63 -43.8 66.4 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.029 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.38 -48.1 74.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.341 . . . . 0.0 110.783 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 tp -54.41 -46.04 73.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.33 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -35.39 61.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.276 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -68.81 -32.19 71.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.167 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.62 -42.19 80.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.564 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.422 ' CG ' HD11 ' A' ' 35' ' ' ILE . 11.0 mmt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.11 178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.762 0.315 . . . . 0.0 110.342 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -88.36 139.61 30.17 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.775 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.94 -37.16 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.652 2.235 . . . . 0.0 112.568 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -88.94 -41.1 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -87.15 -27.21 23.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.15 -144.26 17.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.459 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.57 138.92 35.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 110.804 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.69 64.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.123 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -52.44 -25.62 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.21 -19.56 61.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -130.1 20.52 5.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.466 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 18.3 mt -70.46 159.21 34.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.369 . . . . 0.0 111.17 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.08 142.05 38.14 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.01 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 46.3 Cg_exo -55.75 -19.74 25.75 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.604 2.203 . . . . 0.0 112.543 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.438 ' CB ' ' HA ' ' A' ' 63' ' ' ARG . 13.8 m-20 -82.17 -57.43 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.401 HD23 ' CD1' ' A' ' 59' ' ' LEU . 3.8 pp -70.48 -32.75 70.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.235 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.424 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -64.96 -34.85 79.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 0.0 110.203 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -36.25 82.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.518 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.44 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 7.3 tp -56.13 -58.58 7.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.316 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CG ' HD22 ' A' ' 40' ' ' LEU . 20.9 m-85 -50.27 -40.83 49.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.739 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m -62.7 -54.97 31.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.789 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.403 ' CB ' HG11 ' A' ' 82' ' ' VAL . 8.6 mtt85 -58.39 -29.38 65.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.792 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.35 -21.05 36.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.184 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.34 17.75 41.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.557 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.5 mt -87.07 118.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.228 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.1 p -88.07 160.58 17.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -51.9 -28.42 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.067 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.97 -44.56 70.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.662 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -79.15 -31.88 44.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.731 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.46 HD22 ' CG ' ' A' ' 30' ' ' PHE . 91.6 mt -70.24 -27.89 64.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.636 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -97.71 -3.41 39.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.512 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -81.62 119.87 24.35 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.83 0.348 . . . . 0.0 110.625 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.08 -35.21 24.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.454 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -72.61 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.454 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.433 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.6 -37.05 81.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.223 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.3 p -55.69 -40.37 72.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 110.286 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -60.46 -55.84 28.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.191 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 45' ' ' THR . 1.4 pp -65.48 -30.79 71.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.521 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.3 mt -67.62 -63.92 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.447 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.5 p90 -52.29 -36.15 52.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.934 0.397 . . . . 0.0 110.376 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.92 -33.28 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.472 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 79.2 t80 -64.63 -41.92 95.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.241 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.422 ' CG2' ' CG2' ' A' ' 62' ' ' VAL . 43.3 mt -55.69 -29.66 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.331 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.91 -36.32 75.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.746 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -71.01 -26.42 63.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.617 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 17.0 mm100 -86.11 9.77 16.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.475 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.73 17.96 26.74 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.594 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.79 169.93 45.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.823 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 14.4 tp -48.87 -42.14 35.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.726 0.298 . . . . 0.0 111.016 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -63.6 -35.24 79.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.21 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.428 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -34.25 66.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.484 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.422 ' CG2' ' CG2' ' A' ' 53' ' ' ILE . 21.7 t -66.76 -63.35 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.208 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.438 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -51.85 -41.14 61.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.016 0.436 . . . . 0.0 110.233 178.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -63.14 -52.99 60.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.278 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -70.78 -29.0 65.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.859 0.361 . . . . 0.0 111.138 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.2 mmt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.695 179.757 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.44 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 6.0 t . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.79 0.328 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.39 -43.9 67.67 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.554 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.41 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.87 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.7 tp -55.97 -47.17 78.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.892 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.4 mtm -53.41 -28.84 31.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -41.88 25.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.25 -42.36 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 110.318 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 38.8 mmm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.306 178.653 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.858 0.361 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.7 31.26 45.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.491 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.442 ' O ' ' CD1' ' A' ' 3' ' ' PHE . 9.3 p90 -87.21 141.98 28.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.344 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.54 153.17 21.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.463 ' N ' ' CD2' ' A' ' 5' ' ' HIS . 1.6 p80 -128.07 123.74 35.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t -105.17 131.53 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -90.28 130.14 36.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.716 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -74.05 78.73 1.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.66 -48.08 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.582 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.07 36.19 72.01 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.038 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -88.74 153.43 21.1 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.19 137.94 27.58 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.657 0.265 . . . . 0.0 110.747 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.67 -26.48 3.79 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.688 2.259 . . . . 0.0 112.351 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -95.38 -41.39 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -88.87 -26.26 21.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.95 -148.81 19.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.443 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.94 146.84 29.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 110.706 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -81.77 57.32 3.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.987 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.426 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 2.9 m -48.32 -26.02 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.243 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.01 -22.28 61.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.121 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -130.69 21.11 5.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.456 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 16.7 mt -70.25 159.47 33.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 111.082 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -83.47 139.76 41.45 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.816 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 45.4 Cg_exo -55.97 -18.27 21.93 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.479 2.119 . . . . 0.0 112.62 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.405 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 1.2 m-20 -80.87 -58.94 2.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.941 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD23 ' CD1' ' A' ' 59' ' ' LEU . 3.9 pp -71.68 -39.06 70.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.248 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -61.63 -36.03 79.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.855 0.359 . . . . 0.0 110.499 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.3 t -63.85 -36.27 83.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' CD1' HG22 ' A' ' 82' ' ' VAL . 17.6 tp -57.16 -58.04 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.59 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -50.27 -41.83 51.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.731 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -49.12 78.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.561 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -58.25 -32.57 68.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.619 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.66 4.81 23.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.74 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.49 17.08 78.87 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.821 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 35' ' ' ILE . 52.8 mt -86.79 120.25 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 111.056 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.8 p -86.92 157.26 19.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.99 -34.04 54.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.07 -36.13 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -78.58 -35.27 46.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.519 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' CD1' HG11 ' A' ' 19' ' ' VAL . 78.1 mt -70.35 -24.46 62.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.734 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -96.08 -7.98 34.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.542 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 46' ' ' SER . 5.8 t70 -81.49 123.31 28.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.687 0.28 . . . . 0.0 110.674 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.24 -37.21 45.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.631 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.25 -60.04 2.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.342 . . . . 0.0 111.534 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.415 HG22 ' CD1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -66.82 -29.7 69.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.956 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 57.7 p -59.56 -43.66 93.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.441 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 7.4 tptt -60.29 -52.83 63.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.56 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 pp -65.83 -33.04 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.483 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' CD1' HG22 ' A' ' 45' ' ' THR . 59.4 mt -68.82 -64.33 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 1.9 p90 -52.53 -36.59 55.79 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.48 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -55.62 -32.51 63.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.519 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.475 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 67.3 t80 -64.88 -41.79 95.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.116 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.0 mt -54.72 -27.77 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.365 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.65 -36.16 67.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.592 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.475 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -72.56 -25.45 61.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.609 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 52' ' ' PHE . 83.3 mm-40 -85.54 9.31 16.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.466 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.29 16.46 32.27 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.563 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.37 171.36 47.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.921 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD1' HD23 ' A' ' 26' ' ' LEU . 8.3 tp -48.82 -42.29 35.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.805 0.336 . . . . 0.0 110.988 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 15.0 mm-40 -63.62 -34.47 77.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.034 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.28 -32.73 64.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.348 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.43 ' O ' ' HG3' ' A' ' 65' ' ' GLU . 38.6 t -65.75 -63.61 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.917 0.389 . . . . 0.0 110.622 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.405 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -54.06 -38.23 65.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.05 0.452 . . . . 0.0 109.986 177.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.415 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 58.1 mt-30 -64.59 -52.63 56.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.768 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -68.05 -31.19 70.68 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.169 -177.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.424 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 1.3 mmt -58.65 -33.13 69.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.094 0.473 . . . . 0.0 109.873 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -40.78 40.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.592 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -72.79 -25.67 61.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.11 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.418 ' NE2' ' OE1' ' A' ' 65' ' ' GLU . 36.6 mt-30 -90.58 18.24 6.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.357 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -115.93 18.53 14.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.409 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.71 -52.73 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.448 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 t -68.26 129.07 38.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 0.0 110.754 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.04 125.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.261 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.24 -108.65 1.05 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.272 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.7 t 179.23 -36.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 0.0 110.714 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.402 ' O ' ' NE2' ' A' ' 76' ' ' GLN . 1.9 pm0 -74.74 134.95 41.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.189 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.5 122.53 32.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.483 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.423 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 11.0 p 168.88 -40.31 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.282 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.24 83.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.173 0.511 . . . . 0.0 110.542 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.25 -99.47 0.15 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.619 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.1 -34.22 69.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.776 0.322 . . . . 0.0 111.221 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.433 HG22 ' CD1' ' A' ' 29' ' ' LEU . 23.3 t -60.52 -30.56 46.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.631 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.88 -39.15 85.62 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.569 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.95 -55.36 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 110.602 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.467 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 20.0 tp -52.83 -39.09 62.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.578 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.9 mtt -53.59 -34.28 57.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.224 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -77.1 -44.59 29.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.359 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.447 HG21 ' CD1' ' A' ' 52' ' ' PHE . 53.4 t -53.85 -38.05 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.635 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 95.7 mmm -63.01 -28.91 70.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.272 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -77.03 -5.53 49.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.393 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -70.39 -11.69 61.08 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.475 0.178 . . . . 0.0 111.241 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.473 ' CB ' ' HB3' ' A' ' 95' ' ' ALA . 12.0 mmm180 -74.75 -24.94 58.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.651 0.262 . . . . 0.0 110.742 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 0.3 OUTLIER 82.1 -41.01 0.12 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.352 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -151.33 20.69 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 92' ' ' ARG . . . -70.76 114.35 8.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.269 0.557 . . . . 0.0 111.246 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 96' ' ' ILE . 10.3 tt -132.58 112.32 18.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.086 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.423 ' O ' ' CG ' ' A' ' 97' ' ' HIS . 56.4 p-80 -67.72 72.0 0.15 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.192 0.52 . . . . 0.0 110.416 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' ILE . 1.1 t -123.35 170.97 9.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.655 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 p -122.46 127.46 49.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.004 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.52 99.17 11.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -20.01 20.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 172.37 47.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.411 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.42 172.5 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.827 0.346 . . . . 0.0 110.784 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -168.03 104.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -40.63 89.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.977 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.1 141.4 34.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.024 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.469 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.785 0.326 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.45 -22.17 29.24 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.545 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -117.9 132.57 56.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.316 . . . . 0.0 110.884 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 121.7 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -120.33 103.36 9.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.8 t -80.15 115.8 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.271 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.1 m -91.26 152.6 20.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.628 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -106.0 93.54 4.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.125 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.0 t -68.39 -50.5 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.673 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.08 32.49 35.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.981 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.483 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -88.75 153.43 21.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.707 0.289 . . . . 0.0 110.299 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.39 138.59 28.49 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.29 -43.74 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.593 2.195 . . . . 0.0 112.274 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -81.9 -39.86 23.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -87.38 -30.96 20.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.028 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.65 -149.55 18.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.678 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.69 136.66 35.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.341 . . . . 0.0 110.981 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -77.94 65.65 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.981 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.435 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 2.7 m -51.85 -23.47 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.237 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -72.3 -22.93 61.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.029 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -128.97 19.34 6.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.529 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.1 mt -70.38 159.7 33.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.881 0.372 . . . . 0.0 111.174 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.18 138.87 42.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.803 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.436 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 48.4 Cg_exo -55.79 -18.35 21.16 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.54 2.16 . . . . 0.0 112.587 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -81.2 -58.11 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.216 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.472 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 3.5 pp -70.64 -42.25 71.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.233 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -54.96 -38.39 67.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.915 0.388 . . . . 0.0 110.467 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -37.97 89.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.85 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.7 tp -56.03 -55.62 30.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.747 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.504 ' CD2' ' CD2' ' A' ' 40' ' ' LEU . 10.9 m-30 -50.32 -47.47 55.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.599 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -62.12 -52.58 63.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.472 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -53.27 -31.95 46.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.525 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.45 -20.64 39.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.034 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.44 11.2 34.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.938 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.8 mt -86.9 120.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 111.255 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 p -86.91 160.39 18.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' HG2' ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -51.93 -25.8 8.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.709 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.94 -45.17 74.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -78.39 -29.22 47.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.761 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.504 ' CD2' ' CD2' ' A' ' 30' ' ' PHE . 88.4 mt -70.39 -26.83 63.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.52 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.0 p -96.63 -3.93 41.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.531 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 46' ' ' SER . 15.3 t0 -82.73 124.37 30.17 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.776 0.322 . . . . 0.0 110.782 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.52 -40.19 59.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.42 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -72.69 -58.99 2.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.658 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.417 ' OG1' ' NH1' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -66.13 -33.62 76.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.337 -178.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 88.1 p -58.71 -39.32 80.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.84 0.352 . . . . 0.0 110.456 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -62.53 -54.96 32.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.555 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.421 ' CD2' ' CG ' ' A' ' 92' ' ' ARG . 1.9 pp -63.25 -31.06 72.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.053 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 57.6 mt -69.7 -64.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.418 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.483 ' CE1' ' CZ2' ' A' ' 11' ' ' TRP . 1.9 p90 -53.99 -39.87 66.44 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.167 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.4 ' OD1' ' CZ ' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -55.86 -33.66 64.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.745 178.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 49' ' ' ILE . 26.4 t80 -64.65 -31.79 73.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 110.053 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.403 ' CG2' HG21 ' A' ' 62' ' ' VAL . 31.4 mt -61.72 -29.56 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.118 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -41.3 79.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.301 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -65.75 -26.84 67.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.442 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 13.3 mm100 -86.2 11.38 12.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.525 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 95.42 18.96 31.47 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.503 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.19 168.24 39.66 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.626 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.472 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 34.9 tp -49.18 -38.08 24.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.46 -35.99 82.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.435 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.09 -34.61 66.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.497 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.403 HG21 ' CG2' ' A' ' 53' ' ' ILE . 22.0 t -65.78 -52.37 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.701 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.63 -44.88 69.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.115 0.483 . . . . 0.0 110.046 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -62.52 -50.89 69.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.691 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 62' ' ' VAL . 22.3 pt-20 -68.89 -30.77 69.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.715 0.293 . . . . 0.0 111.027 -178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -27.6 66.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.559 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -43.46 33.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -32.58 68.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 77' ' ' SER . 0.5 OUTLIER -86.4 -21.7 26.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.05 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -137.96 67.88 0.52 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.446 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.47 -83.18 1.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.569 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.4 m -51.71 166.62 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 111.001 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.42 111.22 4.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.442 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.41 -43.93 1.46 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.401 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.0 m -84.37 61.71 6.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.813 0.339 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -74.48 145.05 43.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.419 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 13.7 m -122.35 90.51 3.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.404 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -89.18 -18.02 27.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.881 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.59 95.96 2.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.057 0.456 . . . . 0.0 110.785 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.21 -94.71 0.15 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.856 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.428 ' HG ' ' N ' ' A' ' 82' ' ' VAL . 2.7 pt? -63.37 -41.31 98.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.798 0.332 . . . . 0.0 111.203 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.428 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 6.2 t -64.47 -31.28 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.203 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.09 -38.76 73.51 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.621 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.22 -51.7 62.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 110.951 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.8 tp -52.47 -46.3 66.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.701 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 39.9 mtm -52.99 -42.34 65.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.327 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.48 73.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.347 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 51.2 t -72.62 -38.29 58.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.587 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.1 mmm -63.49 -32.79 74.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.532 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -57.39 -17.36 12.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.973 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 2.2 tptp -68.98 -33.04 73.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.045 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 92' ' ' ARG . 15.2 mmm-85 -71.82 -20.16 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.003 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.434 ' CB ' ' HD2' ' A' ' 94' ' ' ARG . 49.9 m -75.95 -31.2 58.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.434 ' HD2' ' CB ' ' A' ' 93' ' ' SER . 5.7 mpt_? -133.75 28.54 3.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 91' ' ' LYS . . . -73.46 173.76 9.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.424 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.5 mm -76.23 106.83 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.237 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -47.1 -39.04 12.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.83 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.5 p 44.14 38.57 2.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.159 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 m -170.03 95.32 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.795 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.87 -177.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -144.41 -43.37 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.017 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.21 103.64 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.679 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.92 124.17 24.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.746 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 40.44 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.632 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -46.66 108.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.313 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.24 125.67 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.039 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.401 -1.222 . . . . 0.0 112.475 -179.921 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.872 0.368 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.39 -22.16 38.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -118.59 143.66 46.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.765 0.317 . . . . 0.0 110.96 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -87.58 152.98 21.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.958 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -88.3 69.86 9.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.7 t -111.69 140.32 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.51 141.54 28.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.598 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -134.75 96.53 3.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.364 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 t -66.3 -38.93 82.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.001 0.429 . . . . 0.0 110.536 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.59 29.37 72.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.121 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.554 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.48 153.26 20.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.715 0.293 . . . . 0.0 110.312 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -90.19 140.56 27.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.743 0.306 . . . . 0.0 110.604 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.69 -24.73 5.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.683 2.255 . . . . 0.0 112.479 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.31 -40.24 6.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -87.58 -21.14 25.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 95.58 -142.62 16.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.319 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.14 -174.34 5.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 0.0 110.866 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.85 57.22 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.332 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.432 ' CG1' ' CD1' ' A' ' 40' ' ' LEU . 1.5 m -47.87 -25.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.402 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -70.4 -22.07 62.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -134.95 23.61 3.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.596 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.7 mt -69.69 159.94 32.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 111.12 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.51 138.89 44.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.766 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.66 -18.08 19.61 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.587 2.192 . . . . 0.0 112.519 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.34 -58.08 3.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.097 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.429 HD23 ' CD1' ' A' ' 59' ' ' LEU . 2.3 pp -71.45 -41.58 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.299 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -51.9 -40.74 61.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.422 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -64.74 -37.63 88.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.434 ' CD1' ' HG ' ' A' ' 81' ' ' LEU . 6.1 tp -56.74 -57.16 13.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -52.24 -41.88 63.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.8 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -53.97 50.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.6 mtt85 -54.11 -32.12 54.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.44 7.72 15.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.836 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.54 8.99 84.62 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.032 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.41 HD13 ' CG ' ' A' ' 89' ' ' MET . 61.0 mt -86.15 112.88 23.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.869 0.366 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.16 166.19 15.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.875 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.422 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 0.8 OUTLIER -53.38 -29.77 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.09 -42.6 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.75 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -77.91 -29.7 50.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.616 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' CD1' ' CG1' ' A' ' 19' ' ' VAL . 53.9 mt -70.85 -25.3 62.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.3 p -96.65 -5.72 38.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.706 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.26 119.23 23.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.878 0.371 . . . . 0.0 110.821 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.79 -34.81 28.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.358 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.99 -58.86 3.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.178 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.2 -30.56 71.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.822 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.8 p -59.36 -43.49 92.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.546 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 1.5 tptm -61.0 -51.71 68.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.593 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.452 ' CD2' ' CG ' ' A' ' 92' ' ' ARG . 1.8 pp -67.09 -34.45 77.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.678 0.275 . . . . 0.0 111.197 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.435 ' CG1' ' HE2' ' A' ' 89' ' ' MET . 44.5 mt -68.65 -64.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.843 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.554 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 0.9 OUTLIER -53.72 -35.33 61.07 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.234 -178.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -54.05 -34.59 60.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.178 178.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -64.54 -44.21 91.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.043 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.481 HD12 HG21 ' A' ' 53' ' ' ILE . 23.8 mt -53.31 -25.18 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.336 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.49 -35.94 53.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.23 -25.21 61.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 110.769 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 27.9 mm-40 -86.04 11.58 11.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.494 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.92 19.26 27.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.491 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.32 167.65 38.76 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.648 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.429 ' CD1' HD23 ' A' ' 26' ' ' LEU . 25.4 tp -48.67 -37.01 17.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.088 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -64.99 -37.57 88.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.142 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.439 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.65 -33.32 66.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.49 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.436 ' CG2' HG22 ' A' ' 53' ' ' ILE . 60.3 t -65.97 -52.24 51.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.871 0.367 . . . . 0.0 110.581 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 25.7 mtp180 -53.89 -44.68 70.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.18 0.515 . . . . 0.0 109.934 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -48.65 78.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.918 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 13.4 pt-20 -69.09 -41.66 77.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.687 0.279 . . . . 0.0 111.307 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.3 mmt -61.98 -30.46 70.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.391 . . . . 0.0 110.683 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 4.2 mmt180 -77.73 -41.41 37.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.448 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 mtp85 -69.69 -31.29 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.416 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -71.05 -6.58 40.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.808 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.69 82.02 1.43 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.403 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -143.97 18.81 2.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.661 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p 51.8 176.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.38 . . . . 0.0 111.045 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.27 -159.41 53.35 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.719 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.42 151.92 31.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.582 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 t 53.3 48.46 21.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.13 162.43 28.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.08 162.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.036 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 m 77.85 -57.32 0.49 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.998 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -74.44 87.85 2.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.915 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.36 -89.69 0.11 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.39 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.434 ' HG ' ' CD1' ' A' ' 29' ' ' LEU . 2.6 pt? -61.09 -39.32 89.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.357 . . . . 0.0 110.812 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.432 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 28.2 t -62.52 -25.35 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.75 -39.04 86.22 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.959 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.74 -49.66 67.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.591 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -55.93 -45.51 78.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.0 mtm -53.2 -39.57 63.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.15 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -62.92 -41.95 99.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.039 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.421 HG13 ' CD1' ' A' ' 48' ' ' LEU . 65.8 t -57.55 -36.47 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.488 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.435 ' HE2' ' CG1' ' A' ' 49' ' ' ILE . 15.8 mmt -65.26 -27.03 68.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.69 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -69.88 -11.89 61.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.668 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -70.31 -36.8 74.52 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.939 0.399 . . . . 0.0 110.689 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.452 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 5.3 mmp_? -74.43 -22.07 59.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.0 t -75.68 -31.3 59.67 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.074 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -92.74 -5.49 51.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.665 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.6 174.36 9.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.05 0.453 . . . . 0.0 111.297 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 98' ' ' SER . 39.3 mm -70.42 107.91 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.221 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -67.04 66.81 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.925 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -96.19 150.12 20.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.185 -177.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.3 t 61.03 -82.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.015 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -154.42 116.14 4.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.93 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.4 pm0 -62.24 -22.27 65.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.042 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 152.86 122.67 0.93 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.502 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -96.43 135.16 38.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 110.836 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -167.75 133.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.834 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -101.43 160.94 14.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.807 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.27 132.39 35.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.154 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.356 -1.247 . . . . 0.0 112.472 179.893 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.803 0.335 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.82 20.73 23.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.536 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.438 ' O ' ' CD1' ' A' ' 3' ' ' PHE . 27.5 p90 -122.89 128.08 49.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.4 164.89 15.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.042 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -143.8 68.03 1.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 t -75.55 145.52 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.191 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 m 59.88 176.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -145.4 62.47 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.224 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.14 -46.68 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.075 0.464 . . . . 0.0 110.378 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.3 57.49 4.29 Favored Glycine 0 CA--C 1.518 0.233 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.395 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.37 152.73 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 0.0 110.256 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -91.96 134.48 28.71 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.626 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.41 -30.16 62.63 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.468 2.112 . . . . 0.0 112.56 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -105.24 -39.53 6.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.73 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -85.67 -9.8 56.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 82.1 -139.06 19.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.405 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CE2' ' HB3' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -80.94 -169.37 2.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.964 0.411 . . . . 0.0 110.865 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -117.74 52.81 0.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.412 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.437 ' CG1' ' CD1' ' A' ' 40' ' ' LEU . 2.8 m -46.98 -26.36 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.494 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -70.24 -23.23 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -134.75 25.55 3.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.61 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.7 mt -69.99 159.59 33.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 111.271 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.72 139.73 40.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.767 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 44.3 Cg_exo -55.41 -18.68 19.94 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.506 2.137 . . . . 0.0 112.461 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -81.09 -57.67 3.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.123 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.428 HD21 ' CD1' ' A' ' 59' ' ' LEU . 3.6 pp -70.63 -41.85 71.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.143 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.429 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -57.11 -37.35 71.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 110.471 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.411 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 34.0 t -63.44 -37.03 85.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.714 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.443 ' CD1' HG22 ' A' ' 82' ' ' VAL . 38.3 tp -56.92 -53.59 56.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.689 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.407 ' CD2' HD11 ' A' ' 40' ' ' LEU . 17.7 m-85 -51.99 -43.44 63.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.574 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -61.74 -53.59 53.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.769 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.43 ' CB ' HG11 ' A' ' 82' ' ' VAL . 32.8 mtt180 -57.96 -30.57 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.833 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.11 -22.49 36.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.174 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.6 13.02 39.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.806 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.8 mt -86.53 118.67 33.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 111.132 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.19 162.78 17.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.43 ' HG2' ' CG2' ' A' ' 19' ' ' VAL . 0.4 OUTLIER -53.14 -30.04 34.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.86 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.63 -41.15 69.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.845 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -78.03 -30.44 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.72 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' CD1' ' CG1' ' A' ' 19' ' ' VAL . 51.5 mt -71.48 -27.79 63.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.729 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.7 p -97.4 -1.53 44.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.714 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 46' ' ' SER . 14.8 t70 -82.6 124.28 30.01 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.18 -41.44 60.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.55 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -72.53 -57.79 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.641 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.67 -37.53 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.353 -178.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 91.5 p -56.3 -38.72 71.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 0.0 110.279 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -62.19 -55.46 28.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.391 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.458 ' CD2' ' CG ' ' A' ' 92' ' ' ARG . 1.7 pp -66.1 -31.98 73.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.301 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 59.8 mt -67.78 -64.11 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.633 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.479 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 1.5 p90 -54.33 -39.85 67.45 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.387 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -55.49 -32.88 63.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.786 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.482 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 85.5 t80 -63.43 -38.42 91.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.911 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.43 ' CG2' HG22 ' A' ' 62' ' ' VAL . 22.0 mt -58.89 -28.84 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.219 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.43 -38.2 80.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.636 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.482 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -66.01 -25.37 67.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.614 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.476 ' OE1' ' CE2' ' A' ' 52' ' ' PHE . 0.0 OUTLIER -84.15 -8.17 59.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.202 178.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 112.39 21.3 6.24 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.007 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.93 171.6 47.99 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.428 ' CD1' HD21 ' A' ' 26' ' ' LEU . 8.7 tp -48.24 -40.38 24.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.155 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -65.69 -35.02 79.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.432 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.83 -35.01 67.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.676 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG22 ' CG2' ' A' ' 53' ' ' ILE . 47.6 t -64.73 -62.1 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 110.74 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -36.2 39.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.208 0.527 . . . . 0.0 109.926 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -65.34 -51.83 57.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.881 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.451 ' HA ' ' CD ' ' A' ' 68' ' ' ARG . 16.7 pt-20 -68.17 -40.34 82.33 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.718 0.294 . . . . 0.0 111.359 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mmt -56.99 -27.3 61.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.962 0.41 . . . . 0.0 110.512 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -77.98 -43.37 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.577 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.451 ' CD ' ' HA ' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -68.54 -24.88 64.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.79 0.328 . . . . 0.0 110.706 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -82.78 -2.54 54.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.415 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.96 96.77 0.03 OUTLIER Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.492 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.5 -179.27 22.35 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 p -120.96 -41.53 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.329 . . . . 0.0 110.967 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 75' ' ' SER . . . -139.98 146.85 18.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.597 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.32 -82.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.607 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 73' ' ' GLY . 2.1 p -78.68 57.73 2.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -75.9 163.07 27.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.981 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.8 p -68.72 95.88 0.69 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.934 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 166.97 -41.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.923 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.69 80.25 1.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.974 0.416 . . . . 0.0 110.666 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.96 -90.84 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.108 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -62.46 -38.79 91.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.78 0.324 . . . . 0.0 111.008 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.443 HG22 ' CD1' ' A' ' 29' ' ' LEU . 22.6 t -61.61 -28.07 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.05 -38.46 73.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.56 -55.44 20.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 111.008 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 12.4 tp -49.71 -41.17 42.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.791 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.4 mtm -54.19 -44.01 71.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -43.71 90.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.315 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.4 t -55.36 -41.76 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.64 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 84.0 mmm -63.79 -32.02 73.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.714 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -65.85 -13.29 59.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.367 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tptt -70.5 -31.5 68.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.905 0.383 . . . . 0.0 110.652 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.458 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 14.1 mmm-85 -74.71 -21.81 59.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.842 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.4 t -74.92 -25.43 58.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.826 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -108.37 -17.56 13.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.316 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.28 117.41 16.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.998 0.427 . . . . 0.0 111.111 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.8 tp -123.01 106.58 17.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.667 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -42.47 -29.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.476 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.8 p -96.47 -162.93 1.0 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.749 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 t 60.58 123.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.055 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t0 59.72 98.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -166.57 166.04 16.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -178.19 -169.23 38.76 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.576 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.45 175.95 5.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 t70 42.13 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.63 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -102.57 19.65 18.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.224 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.87 101.68 10.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.792 0.329 . . . . 0.0 111.043 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.425 -1.208 . . . . 0.0 112.523 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.772 0.32 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.78 24.68 76.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.467 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.15 156.42 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.357 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -87.41 145.1 26.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.127 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 71.84 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.749 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.7 t -82.51 138.4 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.2 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.9 m -90.66 -51.79 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 79.21 -53.36 0.44 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.567 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.1 t 70.23 -63.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 110.737 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.74 27.1 5.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.113 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.38 152.76 21.33 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.878 0.339 . . . . 0.0 110.371 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.39 135.24 26.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.735 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -63.96 -45.89 9.54 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.486 2.124 . . . . 0.0 112.629 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -90.09 -38.24 13.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.839 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -85.71 -21.04 28.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.192 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.55 -149.5 20.62 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.558 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.01 138.05 34.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.789 0.328 . . . . 0.0 111.028 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -78.2 67.33 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.745 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.426 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.4 m -51.64 -23.59 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.227 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.21 -20.2 60.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -130.29 20.27 5.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.603 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 18.9 mt -70.19 159.46 33.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 111.158 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.33 140.95 39.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.414 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 46.3 Cg_exo -56.12 -19.56 27.39 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.597 2.198 . . . . 0.0 112.512 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -81.4 -56.82 3.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.176 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD23 ' CD1' ' A' ' 59' ' ' LEU . 3.7 pp -70.0 -42.02 73.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.23 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.414 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -54.53 -38.82 67.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.929 0.395 . . . . 0.0 110.123 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 t -63.1 -40.72 98.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.486 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.431 ' CD1' HG23 ' A' ' 82' ' ' VAL . 13.5 tp -57.11 -52.51 65.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.396 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CG ' HD21 ' A' ' 40' ' ' LEU . 22.9 m-85 -53.45 -47.63 69.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.514 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 m -61.73 -51.51 68.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.831 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 mtt85 -57.08 -31.93 65.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.91 -10.91 59.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.477 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.63 13.54 55.07 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.77 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.404 HG23 ' HB2' ' A' ' 39' ' ' GLN . 64.1 mt -87.08 115.43 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.747 0.308 . . . . 0.0 111.29 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.3 p -87.26 160.76 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.72 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' CG ' HG13 ' A' ' 19' ' ' VAL . 1.1 mt-10 -52.55 -31.8 37.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.821 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.97 -42.47 72.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.643 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 35' ' ' ILE . 14.2 mt-30 -78.09 -30.64 49.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.749 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.478 HD21 ' CG ' ' A' ' 30' ' ' PHE . 73.4 mt -69.81 -26.71 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.547 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.6 p -96.27 -3.06 44.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.64 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -81.94 116.13 21.43 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 120.786 0.327 . . . . 0.0 110.611 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.49 -35.09 8.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.569 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -72.19 -59.11 2.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.276 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -33.17 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.304 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.0 p -58.42 -42.03 86.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.794 0.33 . . . . 0.0 110.612 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.81 -53.39 56.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.712 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.435 ' CD2' ' HG2' ' A' ' 92' ' ' ARG . 1.6 pp -64.89 -33.69 76.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.782 0.325 . . . . 0.0 110.908 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.467 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 75.1 mt -67.55 -63.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.23 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.1 p90 -52.26 -40.27 61.49 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.086 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -36.55 64.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.522 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 78.6 t80 -63.46 -29.82 71.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 92.8 mt -66.28 -27.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.088 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -71.46 -39.27 71.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.586 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.4 p30 -64.42 -25.29 67.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.559 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 8.5 mt-30 -84.73 -9.91 57.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.175 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.433 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.14 21.37 5.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.134 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.53 168.94 45.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.424 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD1' HD23 ' A' ' 26' ' ' LEU . 25.1 tp -48.23 -36.23 13.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 111.106 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.12 -37.24 85.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.197 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.433 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.61 -34.66 67.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.561 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.48 -49.65 77.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 110.615 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -54.51 -48.25 72.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.152 0.501 . . . . 0.0 110.035 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.32 -43.2 95.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.465 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 68' ' ' ARG . 9.5 pt-20 -67.87 -37.51 81.9 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.721 0.296 . . . . 0.0 111.392 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.1 mmt -64.19 -24.12 67.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.801 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -55.95 4.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.665 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 65' ' ' GLU . 1.1 ptm180 -70.53 -36.17 73.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.667 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -67.99 -9.86 48.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.472 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.421 ' CA ' ' HB2' ' A' ' 77' ' ' SER . . . -100.24 62.9 0.64 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.452 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.44 -176.44 14.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.633 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 t 64.09 125.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.796 0.332 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.46 -110.95 3.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.395 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.72 34.8 5.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.387 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.06 55.08 10.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 110.643 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.87 102.64 4.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.157 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.421 ' HB2' ' CA ' ' A' ' 70' ' ' GLY . 9.1 t -110.46 98.12 7.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.559 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.419 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 0.0 OUTLIER 175.11 -44.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.547 -179.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -71.87 67.51 0.61 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.155 0.503 . . . . 0.0 110.684 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.39 -91.01 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.966 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 82' ' ' VAL . 2.7 pt? -62.18 -38.91 90.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 110.566 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.431 HG23 ' CD1' ' A' ' 29' ' ' LEU . 16.5 t -61.95 -26.15 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.682 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.35 84.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.15 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.03 -43.31 95.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.907 0.384 . . . . 0.0 110.67 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.2 tp -55.74 -49.72 72.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.793 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.4 mtt -49.62 -28.21 5.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.858 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.81 -41.93 20.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.526 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.47 -42.0 94.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.028 178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 79.1 mmm -64.94 -31.44 72.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.375 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -62.51 -18.57 62.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.475 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.424 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 5.9 tptt -69.97 -49.91 46.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.205 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.435 ' HG2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -72.06 -18.61 61.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.472 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.2 m -76.09 -30.18 58.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 0.0 110.991 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -121.46 4.13 10.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.887 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 91' ' ' LYS . . . -74.77 147.7 41.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 111.074 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -59.65 102.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.138 0.494 . . . . 0.0 110.81 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.403 ' O ' ' CB ' ' A' ' 98' ' ' SER . 65.8 m80 -51.83 123.6 10.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.866 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 97' ' ' HIS . 1.9 m 76.53 56.62 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.596 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 p -67.74 -173.94 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.823 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -154.36 150.58 28.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.797 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -124.09 32.24 5.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.73 18.48 78.89 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.637 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.02 108.03 17.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.831 0.348 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 40.86 -164.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.639 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 69.47 114.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.905 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.23 126.9 32.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.039 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.345 -1.253 . . . . 0.0 112.432 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.84 0.352 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.99 -20.16 39.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.607 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -129.33 123.31 31.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 0.0 110.96 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 101.0 13.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -104.64 100.06 9.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.56 113.96 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.984 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 p 59.81 176.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -166.8 59.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -72.74 -44.26 59.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.633 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.85 41.9 36.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.069 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.571 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -88.33 153.51 21.14 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.42 138.69 28.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.673 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.99 -27.74 3.62 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.611 2.207 . . . . 0.0 112.286 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -97.97 -39.26 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -87.92 -25.83 23.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.34 -149.68 19.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.628 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.427 ' CE2' ' CB ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -82.46 148.17 28.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 110.943 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.95 63.47 8.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.441 HG11 ' CG ' ' A' ' 37' ' ' GLU . 2.6 m -50.9 -24.0 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.282 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.14 -21.0 60.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -132.3 23.49 4.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.529 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 18.4 mt -70.29 159.62 33.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.377 . . . . 0.0 111.029 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -83.22 140.33 42.33 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.864 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -55.91 -18.3 21.67 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.608 2.205 . . . . 0.0 112.659 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.68 -58.14 3.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.049 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 59' ' ' LEU . 3.3 pp -70.45 -40.3 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.094 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.433 ' HD2' ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -51.99 -38.54 57.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.979 0.418 . . . . 0.0 110.198 179.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.433 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -64.54 -34.79 79.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.53 178.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.419 ' CD1' ' HG ' ' A' ' 81' ' ' LEU . 59.1 tp -56.76 -59.48 4.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.654 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.441 ' CD2' HD22 ' A' ' 40' ' ' LEU . 8.5 m-85 -51.2 -47.55 62.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.614 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.94 -54.85 36.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.873 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.8 mtt-85 -56.54 -29.82 62.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.95 -15.06 55.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.431 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.19 9.25 54.07 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.806 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.403 HD13 ' HG ' ' A' ' 85' ' ' LEU . 42.4 mt -86.7 120.52 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 0.0 111.218 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.2 p -87.14 161.52 18.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.441 ' CG ' HG11 ' A' ' 19' ' ' VAL . 2.7 tt0 -52.96 -31.47 40.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.89 -42.34 71.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -77.9 -30.73 50.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.441 HD22 ' CD2' ' A' ' 30' ' ' PHE . 96.0 mt -70.36 -25.06 63.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.726 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.3 p -96.22 -5.24 40.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.53 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.93 122.43 27.76 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 110.77 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.79 -37.93 45.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.52 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.471 ' CG ' ' CZ ' ' A' ' 92' ' ' ARG . 15.6 tp10 -71.72 -59.56 2.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.665 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -31.63 72.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.765 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.6 p -58.55 -44.22 89.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.357 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 7.8 tptt -59.87 -55.07 38.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.439 HD13 ' CG1' ' A' ' 88' ' ' VAL . 1.8 pp -64.75 -32.91 74.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.504 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.7 mt -69.69 -64.17 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.493 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.571 ' CE1' ' CZ2' ' A' ' 11' ' ' TRP . 1.6 p90 -52.75 -37.34 59.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.973 0.416 . . . . 0.0 110.06 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.99 -31.64 61.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.413 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.465 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 66.1 t80 -64.49 -41.52 96.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.095 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.2 mt -54.46 -27.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.29 178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -72.7 -38.51 67.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.698 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.465 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -69.05 -25.89 64.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.688 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 18.4 mm100 -85.19 9.09 16.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.402 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.52 19.59 24.79 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.415 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.26 168.87 42.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.588 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.439 ' CD1' HD21 ' A' ' 26' ' ' LEU . 16.1 tp -49.42 -39.63 33.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.691 0.282 . . . . 0.0 111.07 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -63.95 -36.37 83.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.032 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.05 -32.66 65.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 22.8 t -66.13 -52.86 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -54.15 -43.79 70.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.124 0.487 . . . . 0.0 110.127 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -63.32 -47.72 81.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.27 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 25.5 pt-20 -68.31 -40.43 81.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.693 0.282 . . . . 0.0 111.299 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.6 mmt -57.91 -34.27 69.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.137 0.494 . . . . 0.0 110.284 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -78.79 -33.49 46.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -69.64 -21.55 63.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -96.54 -0.88 48.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.803 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.14 92.41 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.324 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . -107.48 -20.31 8.68 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.672 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.88 -83.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.626 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . -93.4 100.96 2.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.183 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.21 128.92 1.16 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.001 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.19 52.92 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.99 0.424 . . . . 0.0 110.37 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -73.82 161.86 29.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.274 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -68.7 99.92 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.733 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t 179.35 -48.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.158 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.94 84.64 1.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.08 0.467 . . . . 0.0 110.726 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.52 -91.46 0.1 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.902 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 82' ' ' VAL . 2.7 pt? -62.92 -40.02 96.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.907 0.384 . . . . 0.0 110.707 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.438 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 10.5 t -63.77 -26.43 40.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.097 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.02 -42.15 78.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.318 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.33 -46.2 84.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.373 . . . . 0.0 110.74 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.403 ' HG ' HD13 ' A' ' 35' ' ' ILE . 8.3 tp -52.72 -48.92 66.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.498 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.9 mtt -49.05 -44.05 41.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.659 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.04 -43.51 87.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.361 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.439 ' CG1' HD13 ' A' ' 48' ' ' LEU . 62.5 t -55.58 -42.94 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.464 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 82.2 mmm -63.79 -31.71 72.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.448 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -68.67 -15.73 63.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.008 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 95' ' ' ALA . 3.3 tptp -70.3 -25.87 63.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.734 0.302 . . . . 0.0 110.646 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.471 ' CZ ' ' CG ' ' A' ' 44' ' ' GLU . 9.3 mmm180 -73.92 -33.29 63.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.126 0.489 . . . . 0.0 110.112 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 t -75.15 -28.84 60.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.117 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -116.89 26.13 10.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.676 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 91' ' ' LYS . . . -74.35 153.05 39.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.892 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 98' ' ' SER . 2.0 tp -86.59 98.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -46.24 92.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.044 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ILE . 1.2 p -125.57 26.16 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.006 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.56 173.7 11.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -154.7 -175.52 5.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.012 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 178.86 -36.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.53 168.51 21.05 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.527 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -95.85 107.91 20.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.754 0.312 . . . . 0.0 110.923 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t0 39.76 38.26 0.42 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.73 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -153.69 161.39 42.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.81 151.5 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.073 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.362 -1.244 . . . . 0.0 112.52 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.826 0.346 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.2 -24.14 23.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.477 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -118.46 158.51 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.969 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -87.11 111.45 20.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.802 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -88.42 75.65 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.111 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.94 139.18 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.825 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -91.61 173.12 8.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.434 0.635 . . . . 0.0 111.806 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.416 ' C ' ' CG2' ' A' ' 9' ' ' VAL . 2.8 t60 -93.45 -26.07 17.36 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.918 174.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.416 ' CG2' ' C ' ' A' ' 8' ' ' HIS . 0.2 OUTLIER -163.87 -70.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.437 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.92 28.89 12.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.848 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.95 152.38 21.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.802 0.334 . . . . 0.0 110.564 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -92.92 132.51 30.85 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.425 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.13 -31.59 83.08 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.452 2.101 . . . . 0.0 112.59 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -98.04 -41.22 8.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.668 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -86.44 -14.77 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.694 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 87.22 -140.74 17.07 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.216 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.405 ' HA ' ' HB2' ' A' ' 11' ' ' TRP . 0.1 OUTLIER -81.79 -169.12 2.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.91 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.3 54.17 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.392 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.413 ' HA ' ' HG ' ' A' ' 22' ' ' LEU . 1.5 m -47.09 -26.33 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.384 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -70.2 -23.68 62.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.046 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -135.52 26.58 3.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.731 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.428 ' CD2' HD12 ' A' ' 26' ' ' LEU . 17.1 mt -69.65 159.36 33.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.816 0.341 . . . . 0.0 110.996 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.56 140.16 41.3 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.431 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 51.6 Cg_exo -54.84 -19.31 18.75 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.621 2.214 . . . . 0.0 112.51 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -81.19 -58.32 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.074 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.436 HD22 ' CD1' ' A' ' 59' ' ' LEU . 3.8 pp -71.44 -39.14 71.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.245 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -58.67 -35.57 72.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.383 . . . . 0.0 110.149 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.426 ' O ' ' CD ' ' A' ' 32' ' ' ARG . 25.8 t -63.75 -38.25 90.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.757 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.439 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 8.0 tp -54.86 -53.85 50.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.423 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.468 ' CD2' HD11 ' A' ' 40' ' ' LEU . 22.6 m-85 -51.35 -46.12 62.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.402 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 m -62.39 -48.03 81.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.736 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.426 ' CD ' ' O ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -62.05 -33.39 74.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.847 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.3 -21.55 36.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.18 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.91 16.77 32.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.703 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.417 HD12 ' CG ' ' A' ' 89' ' ' MET . 65.9 mt -86.65 121.76 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.341 . . . . 0.0 111.14 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 p -87.02 159.13 19.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -30.7 37.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.25 68.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -78.47 -31.3 47.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.807 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.468 HD11 ' CD2' ' A' ' 30' ' ' PHE . 81.7 mt -70.71 -24.55 62.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.7 p -97.66 -7.75 30.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.602 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -82.02 116.45 21.63 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.809 0.338 . . . . 0.0 110.819 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.79 -32.05 8.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.4 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.53 -59.96 2.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 111.407 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.412 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.59 -33.79 75.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.969 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.9 m -59.41 -39.48 83.6 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.478 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 5.5 tptt -62.12 -49.17 76.96 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.433 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' CD2' ' CG ' ' A' ' 92' ' ' ARG . 1.5 pp -69.96 -34.36 73.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.748 0.309 . . . . 0.0 110.913 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.89 -64.31 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.73 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 0.7 OUTLIER -52.42 -36.13 53.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.913 0.387 . . . . 0.0 110.384 -179.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -33.97 66.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.421 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.449 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 65.3 t80 -64.61 -40.12 94.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.327 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.438 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 23.2 mt -55.92 -29.92 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.042 0.449 . . . . 0.0 110.181 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -43.21 78.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.631 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.449 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -59.86 -24.39 64.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.934 0.397 . . . . 0.0 110.484 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.432 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 71.3 mm-40 -84.96 -13.91 49.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.159 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.403 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 115.9 24.83 3.81 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.817 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.24 168.79 43.83 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.38 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.438 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 10.5 tp -47.35 -33.88 6.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.903 0.383 . . . . 0.0 111.069 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 12.6 mt-10 -68.62 -35.82 77.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.001 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.469 ' HA ' ' HB2' ' A' ' 64' ' ' GLN . . . -72.95 -36.09 67.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.596 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.1 -63.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.277 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -30.17 40.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 61' ' ' ALA . 9.0 mt-30 -63.17 -56.6 15.35 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.088 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -69.67 -38.36 77.02 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.628 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.1 mmt -57.19 -37.38 72.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.059 0.457 . . . . 0.0 110.412 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -77.88 -37.0 49.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.081 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -69.92 -22.83 63.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.125 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -108.97 -16.94 14.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.536 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -51.81 -44.08 54.97 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.474 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.73 -146.16 47.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.345 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.78 179.24 9.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.932 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 54.79 40.33 71.3 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.429 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.52 46.81 83.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.448 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -109.03 44.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.302 . . . . 0.0 111.066 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.33 123.98 25.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.607 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.1 p -118.89 112.28 19.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.975 0.417 . . . . 0.0 111.442 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 57.0 p -89.0 -11.38 44.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.117 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' OE1' ' N ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -70.94 63.57 0.31 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.187 0.518 . . . . 0.0 111.158 -178.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.86 -101.26 0.16 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.705 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.431 HD11 ' CD2' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -64.77 -30.72 71.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 110.847 178.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 3.3 t -65.76 -37.57 80.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.399 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.39 -43.28 70.59 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.416 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 -48.55 73.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 14.8 tp -61.31 -40.73 95.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 7.0 mtm -53.28 -37.57 62.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.266 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -72.23 -44.08 63.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.407 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.1 t -53.92 -39.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.563 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.417 ' CG ' HD12 ' A' ' 35' ' ' ILE . 96.4 mmm -65.51 -29.44 70.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.914 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -66.05 -10.56 41.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -69.79 -38.39 76.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.947 0.403 . . . . 0.0 110.454 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.418 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 30.4 mmm180 -74.71 -26.72 60.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.537 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.35 -37.35 57.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.036 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 -90.84 -5.42 55.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.842 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.83 120.85 20.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 110.643 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 98' ' ' SER . 3.2 tp -107.17 101.27 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.176 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.9 88.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.553 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -115.91 41.46 2.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.111 -178.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.7 p -116.34 74.33 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -155.02 -46.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.975 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -58.79 156.06 11.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.26 -19.24 4.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.639 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.83 131.35 37.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 111.094 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.33 151.0 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.893 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.49 172.83 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.01 93.46 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.538 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.843 0.354 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.76 -17.6 45.38 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.675 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -114.66 176.22 5.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.35 . . . . 0.0 110.97 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -133.05 175.91 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.941 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -111.68 44.69 1.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.535 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.77 144.87 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.85 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.7 m 66.82 -64.41 0.24 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.937 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.415 ' O ' ' CD2' ' A' ' 59' ' ' LEU . 3.1 t60 75.47 51.06 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.524 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.18 -41.76 26.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.106 0.479 . . . . 0.0 110.134 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.0 47.61 7.95 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.302 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.49 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.28 153.15 21.12 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.1 m-20 -89.42 140.28 28.43 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.749 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.16 -18.43 12.76 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.658 2.239 . . . . 0.0 112.584 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -110.93 -38.16 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.024 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -87.25 -21.55 25.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 96.34 -138.29 13.85 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.249 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.71 -169.81 2.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.893 0.378 . . . . 0.0 110.919 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -118.2 53.23 0.97 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.569 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.422 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -47.01 -26.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.577 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.54 -22.91 61.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.049 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -134.54 25.43 3.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.569 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.5 mt -69.89 159.09 34.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 111.234 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -85.23 140.25 36.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.755 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.84 -19.61 19.74 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.539 2.159 . . . . 0.0 112.559 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.407 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 4.5 m-20 -82.2 -57.12 3.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.328 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 pp -69.93 -41.36 74.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.069 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.97 -35.46 69.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.933 0.396 . . . . 0.0 110.262 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -39.45 93.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.593 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.439 ' CD1' HG21 ' A' ' 82' ' ' VAL . 23.3 tp -57.34 -50.86 71.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.801 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 22.8 m-85 -54.65 -48.3 72.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.739 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -61.24 -46.44 90.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.882 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -35.98 73.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.54 0.04 44.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.753 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.74 12.54 77.35 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.912 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.4 mt -86.67 112.91 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.783 0.325 . . . . 0.0 111.129 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.74 164.43 15.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.35 -29.66 24.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.643 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.83 -44.46 73.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.791 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -78.13 -29.06 48.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.694 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.422 HD22 ' CG ' ' A' ' 30' ' ' PHE . 75.0 mt -70.69 -26.29 63.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.692 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 49.0 p -97.28 -7.54 31.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.576 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.61 112.59 18.96 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.906 0.384 . . . . 0.0 110.717 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.49 -32.22 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.6 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.23 -58.47 3.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.933 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.402 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -68.62 -35.95 77.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.233 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.94 -39.74 75.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.854 0.359 . . . . 0.0 110.201 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 1.1 tppm? -60.78 -55.52 32.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.337 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' CD2' ' HG2' ' A' ' 92' ' ' ARG . 1.7 pp -66.03 -33.47 75.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.035 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.426 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 60.4 mt -68.44 -63.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.654 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 1.8 p90 -51.09 -38.21 50.34 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.029 0.443 . . . . 0.0 110.018 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.68 -34.21 69.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.523 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 80.9 t80 -63.94 -28.93 70.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.039 0.447 . . . . 0.0 110.259 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.402 ' CG2' HG22 ' A' ' 62' ' ' VAL . 20.1 mt -68.5 -27.8 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.087 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.49 -35.07 70.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.594 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.3 p30 -69.28 -25.46 64.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.585 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.523 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 10.9 mt-30 -84.5 -8.76 58.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.089 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.02 21.39 5.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.064 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.52 168.9 44.95 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.396 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 11.1 tp -48.45 -38.67 20.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.02 -34.5 78.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.84 -33.91 66.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.607 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.402 HG22 ' CG2' ' A' ' 53' ' ' ILE . 44.5 t -65.32 -63.57 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.333 . . . . 0.0 110.804 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.407 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -52.64 -41.42 63.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 110.244 178.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -63.64 -49.15 74.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.644 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' OE1' ' NE2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.44 -33.84 73.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.175 -178.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mmt -60.5 -31.47 70.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 110.36 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -76.75 -38.99 53.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.49 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -69.66 -29.04 66.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.931 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.423 ' NE2' ' OE1' ' A' ' 65' ' ' GLU . 41.7 mt-30 -90.65 16.17 9.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.856 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.33 -23.98 20.34 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.448 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.3 120.9 1.01 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.439 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.0 t -175.78 -68.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 110.816 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.95 -81.39 1.47 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.331 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 75' ' ' SER . . . -78.89 -19.89 71.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER 88.18 -23.8 0.11 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.956 0.503 . . . . 0.0 111.612 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -75.83 144.27 41.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 111.051 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.8 OUTLIER -108.15 109.47 20.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.693 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 77' ' ' SER . 0.7 OUTLIER 164.74 -37.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.497 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.2 101.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.087 0.47 . . . . 0.0 110.795 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.31 -97.3 0.19 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.998 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.402 ' CD1' ' CD ' ' A' ' 65' ' ' GLU . 2.4 pt? -59.72 -38.79 82.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.654 0.264 . . . . 0.0 111.365 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.439 HG21 ' CD1' ' A' ' 29' ' ' LEU . 20.7 t -62.68 -25.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 110.712 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.65 -41.3 84.33 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.185 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.54 -49.09 72.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 110.585 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD13 ' CD2' ' A' ' 52' ' ' PHE . 9.5 tp -50.89 -52.9 37.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.762 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 12.6 mtm -51.01 -31.37 17.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -79.25 -29.34 42.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.489 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.402 HG13 ' CD1' ' A' ' 48' ' ' LEU . 64.8 t -72.38 -42.97 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.629 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 83.1 mmm -62.71 -35.49 79.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.393 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -54.14 -21.55 8.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.261 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 11.1 tptt -70.66 -56.59 6.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.31 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.412 ' HG2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -72.74 -24.48 60.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.29 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.43 -29.34 52.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.42 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -108.92 -15.46 14.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.867 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 91' ' ' LYS . . . -74.73 172.6 11.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.171 0.51 . . . . 0.0 111.667 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 mm -61.01 107.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.633 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.422 ' O ' ' CB ' ' A' ' 98' ' ' SER . 95.7 m-70 -55.38 144.39 25.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.389 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 97' ' ' HIS . 1.4 t 80.34 -57.29 0.34 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.338 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.5 171.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.462 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -154.97 126.55 7.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.708 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.86 -25.73 57.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 176.43 133.82 1.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.394 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -110.34 149.07 30.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.46 -179.06 4.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.18 99.42 2.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.003 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.95 122.39 27.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.469 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.77 0.319 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.9 29.99 40.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.393 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -71.39 141.93 50.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 174.16 8.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.79 94.24 2.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.772 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t -112.41 143.46 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.344 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.1 -161.33 0.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.595 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -140.55 -56.51 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.196 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t 41.18 95.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 111.518 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.33 50.83 4.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.967 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.559 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -87.74 153.63 21.2 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.42 140.28 28.43 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.674 0.273 . . . . 0.0 110.729 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.98 -37.59 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.686 2.257 . . . . 0.0 112.393 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -90.42 -38.06 13.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.954 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -87.2 -27.73 22.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.41 -149.68 19.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.624 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.447 ' CD1' ' HB2' ' A' ' 11' ' ' TRP . 0.1 OUTLIER -82.65 146.58 29.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 111.003 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.08 67.17 9.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.434 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.8 m -50.53 -29.51 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -70.86 -19.92 62.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.139 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -130.72 20.43 5.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.449 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.434 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.3 mt -70.49 159.74 33.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -83.03 139.44 42.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.3 Cg_exo -54.28 -19.61 17.31 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.623 2.215 . . . . 0.0 112.636 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -81.06 -58.16 3.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.061 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.449 HD21 ' CD1' ' A' ' 59' ' ' LEU . 4.0 pp -70.95 -38.29 72.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.148 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.42 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -61.98 -34.71 76.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.376 . . . . 0.0 110.086 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.415 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 23.1 t -64.21 -36.86 85.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.597 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.438 ' CD1' HD11 ' A' ' 81' ' ' LEU . 3.4 tp -56.1 -58.12 9.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.302 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.449 ' CG ' HD22 ' A' ' 40' ' ' LEU . 17.7 m-85 -49.59 -38.36 31.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.986 0.422 . . . . 0.0 110.519 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.41 -57.78 10.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.763 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.415 ' NE ' ' OG ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -60.5 -25.5 66.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.787 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.14 -18.3 43.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.305 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.08 17.99 56.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.604 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.474 HG22 HD11 ' A' ' 35' ' ' ILE . 60.7 mt -86.24 126.14 40.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.177 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.69 152.79 21.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.429 ' HG2' ' CG2' ' A' ' 19' ' ' VAL . 1.5 mt-10 -51.9 -25.37 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.737 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.89 -42.76 72.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.875 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -78.37 -30.06 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.796 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.449 HD22 ' CG ' ' A' ' 30' ' ' PHE . 95.9 mt -70.67 -27.56 64.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.887 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 p -98.33 -2.44 39.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.552 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 46' ' ' SER . 5.4 t70 -82.85 123.77 29.68 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.52 -37.14 47.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.592 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.74 -59.88 2.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.529 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.401 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.5 -36.03 80.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.203 -179.066 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 87.3 p -56.5 -37.59 70.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.88 0.372 . . . . 0.0 110.173 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 11.1 tptt -61.92 -55.69 27.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.427 HD13 ' CG1' ' A' ' 88' ' ' VAL . 1.7 pp -66.86 -28.98 68.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.276 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.428 HG12 ' CE ' ' A' ' 89' ' ' MET . 56.0 mt -67.38 -64.8 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.274 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.559 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.8 p90 -55.28 -34.27 63.95 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.75 -35.65 68.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.45 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.519 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 71.2 t80 -63.79 -30.19 71.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.028 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 17.6 mt -65.43 -27.95 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.033 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.83 -41.77 71.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.571 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.4 p30 -61.4 -25.32 67.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.509 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.519 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 7.7 mt-30 -85.0 -10.61 56.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.252 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.21 21.73 5.47 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.03 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.28 168.5 44.78 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.657 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.449 ' CD1' HD21 ' A' ' 26' ' ' LEU . 14.9 tp -47.67 -37.13 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 110.969 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.0 -36.96 83.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.611 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.54 -36.06 68.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.432 ' CG2' HG23 ' A' ' 53' ' ' ILE . 43.8 t -65.12 -62.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.699 0.285 . . . . 0.0 110.941 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -39.04 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.958 0.409 . . . . 0.0 110.206 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -53.96 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.258 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HA ' ' CD ' ' A' ' 68' ' ' ARG . 11.0 pt-20 -70.19 -28.15 65.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.5 mmm -71.74 -22.72 61.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.833 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -76.08 -49.39 17.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.155 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.432 ' CD ' ' HA ' ' A' ' 65' ' ' GLU . 0.2 OUTLIER -70.74 -29.35 65.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.064 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -20.87 60.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.173 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -108.41 -41.79 1.45 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.637 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.14 103.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.398 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 68.94 -63.97 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 110.904 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.43 153.25 6.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.495 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.78 145.99 0.25 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.433 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.88 33.13 22.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -74.63 163.6 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.8 m -95.4 103.81 15.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.403 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -71.51 -10.33 59.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.365 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -71.6 88.91 0.96 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.135 0.493 . . . . 0.0 110.818 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.49 -100.89 0.18 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.811 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.438 HD11 ' CD1' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -65.07 -34.09 77.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.62 0.247 . . . . 0.0 111.148 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.43 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 3.8 t -64.99 -37.48 80.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.756 0.312 . . . . 0.0 111.33 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.34 -41.71 77.26 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.561 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.64 -51.08 64.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.598 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.95 -40.01 83.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.264 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.5 mtm -54.05 -38.57 65.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.198 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -69.89 -44.66 69.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.389 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.427 ' CG1' HD13 ' A' ' 48' ' ' LEU . 44.8 t -56.11 -38.99 56.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.812 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.432 ' CG ' HD13 ' A' ' 35' ' ' ILE . 28.7 mmt -61.39 -37.62 84.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.048 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -74.41 -16.98 60.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.276 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -68.64 -56.96 6.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.058 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -73.31 -17.24 61.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.436 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.92 -34.23 59.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.808 0.337 . . . . 0.0 110.934 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.71 -15.37 21.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.461 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.08 119.04 17.74 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.07 0.462 . . . . 0.0 111.442 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.451 ' CG2' ' O ' ' A' ' 96' ' ' ILE . 4.5 tt -128.85 108.3 17.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.351 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.83 78.87 0.08 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.527 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -110.71 -168.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.759 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -100.97 177.39 4.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.932 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.98 -68.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 99' ' ' SER . 2.1 pt-20 -137.63 83.74 2.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.1 62.77 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.457 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.62 174.5 5.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.826 0.346 . . . . 0.0 110.917 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.03 178.65 3.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -129.94 36.31 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.969 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.88 143.07 32.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.055 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 CA-C-O 118.384 -1.231 . . . . 0.0 112.58 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.829 0.347 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.48 -23.5 22.3 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -139.92 115.65 10.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -87.1 152.03 22.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.41 73.79 2.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 8' ' ' HIS . 48.1 t -103.43 145.72 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.234 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 60' ' ' GLU . 0.6 OUTLIER 48.13 -89.2 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.633 178.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' VAL . 25.6 t60 45.94 45.43 11.97 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t 32.18 101.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.78 58.4 0.52 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.249 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.8 153.79 20.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 110.901 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.14 140.24 25.81 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.408 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.09 -36.17 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.598 2.199 . . . . 0.0 112.531 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -83.75 -41.35 17.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.129 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -87.62 -28.43 21.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.935 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.95 -146.8 17.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.8 135.7 35.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.941 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.26 62.85 0.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.438 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 2.3 m -53.44 -23.22 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.789 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.85 -20.77 59.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.903 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -128.64 18.31 6.28 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.517 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.4 mt -70.0 159.35 33.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 111.133 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -84.54 140.88 38.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.926 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 33.6 Cg_exo -57.24 -17.75 27.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.589 2.193 . . . . 0.0 112.589 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.91 -57.94 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.151 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.57 -41.53 75.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.947 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' HD2' ' N ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -55.58 -35.81 66.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 110.295 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.418 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -62.61 -39.24 93.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.719 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.437 ' CA ' ' CE ' ' A' ' 66' ' ' MET . 28.9 tp -56.81 -51.28 69.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.587 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.45 ' CD2' HD22 ' A' ' 40' ' ' LEU . 21.5 m-85 -53.42 -43.46 67.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.577 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.3 m -61.82 -51.55 67.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.89 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -59.9 -32.73 71.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.813 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.94 -18.28 44.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.34 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.33 8.56 54.83 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.937 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 72.8 mt -85.98 109.56 18.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.3 p -86.46 167.23 14.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.041 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -53.2 -34.52 57.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.037 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.23 -42.5 66.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -77.68 -35.1 52.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.552 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 HD22 ' CD2' ' A' ' 30' ' ' PHE . 25.2 mt -69.95 -20.7 63.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -94.32 -9.53 35.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.402 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -81.07 121.67 26.37 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.754 0.311 . . . . 0.0 110.708 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.72 -34.62 27.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.432 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.35 -59.91 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.59 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.413 ' CG2' ' HE2' ' A' ' 89' ' ' MET . 0.2 OUTLIER -67.72 -37.94 82.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.2 p -56.87 -39.52 74.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.818 0.342 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 1.3 tppm? -61.29 -55.79 27.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.348 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.461 ' CD2' ' CG ' ' A' ' 92' ' ' ARG . 1.8 pp -65.25 -32.08 73.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.328 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.413 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 55.4 mt -66.49 -63.98 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.124 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.565 ' CE1' ' CZ2' ' A' ' 11' ' ' TRP . 2.0 p90 -53.41 -37.96 62.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.97 0.414 . . . . 0.0 110.043 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.9 -35.57 66.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.481 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.45 ' CD2' HG22 ' A' ' 88' ' ' VAL . 37.4 t80 -64.0 -34.55 78.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.097 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 23.8 mt -60.77 -28.63 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.072 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.36 -38.84 78.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.459 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.83 -25.53 64.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 61.3 mm-40 -87.5 13.38 10.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.455 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 95.21 17.41 37.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.572 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.18 170.55 46.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.879 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.443 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 10.2 tp -49.49 -41.56 40.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.713 0.292 . . . . 0.0 111.27 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 7' ' ' SER . 29.1 mt-10 -65.1 -34.8 79.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.165 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.438 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.5 -34.29 65.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.656 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -64.29 -61.92 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -51.56 -38.6 55.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.082 0.468 . . . . 0.0 110.008 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.87 -51.5 64.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.329 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HB2' ' NE2' ' A' ' 69' ' ' GLN . 11.3 pt-20 -68.74 -33.95 74.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.762 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.437 ' CE ' ' CA ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -64.63 -23.77 67.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.5 -47.38 27.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.475 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.3 mtt180 -70.56 -40.33 73.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.419 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.44 ' NE2' ' HB2' ' A' ' 65' ' ' GLU . 31.6 mt-30 -88.9 9.96 23.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.653 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -114.93 -26.95 3.38 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.496 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.43 47.56 50.12 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.442 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.2 m 50.84 29.28 4.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.33 171.77 38.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.561 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.75 -97.5 1.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.53 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.7 p -75.37 65.39 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.808 0.337 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.1 146.72 43.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.811 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.46 85.49 2.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.218 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 80.3 p -68.25 -16.24 63.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.02 93.68 1.79 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.125 0.488 . . . . 0.0 110.805 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.44 -94.92 0.15 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.984 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.435 ' HG ' ' N ' ' A' ' 82' ' ' VAL . 2.7 pt? -63.39 -39.91 95.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.799 0.333 . . . . 0.0 111.232 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.435 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 6.5 t -62.92 -33.29 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.385 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -34.87 78.23 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.298 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -51.28 62.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 110.681 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.5 tp -62.94 -42.5 99.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.477 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -53.37 -33.36 53.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.403 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -75.17 -30.31 60.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.349 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.45 HG22 ' CD2' ' A' ' 52' ' ' PHE . 96.8 t -66.36 -40.24 86.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.626 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.413 ' HE2' ' CG2' ' A' ' 45' ' ' THR . 74.1 mmm -62.38 -26.77 68.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.614 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -73.98 -16.62 61.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.236 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -70.57 -35.26 72.97 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.811 0.338 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.461 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.21 -24.05 59.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.844 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 m -73.18 -24.2 60.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.871 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -107.97 -21.08 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.005 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.65 129.82 38.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.258 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 96' ' ' ILE . 20.2 tt -106.13 99.6 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.96 -23.59 21.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.26 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.1 t -66.55 -22.04 66.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.053 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.62 -26.17 61.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 0.0 111.014 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.02 90.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.973 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -132.98 49.04 2.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.974 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.46 142.21 0.14 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.446 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -82.88 130.52 35.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.38 . . . . 0.0 110.843 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -167.65 147.55 5.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.968 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -100.13 144.4 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.02 93.58 6.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.022 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.387 -1.23 . . . . 0.0 112.518 -179.909 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.847 0.356 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.57 25.62 8.07 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.508 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -112.8 145.07 41.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.754 0.312 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.13 157.55 19.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.977 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -112.5 71.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.54 130.88 59.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.188 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 p -90.72 164.39 14.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.503 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -116.48 -38.95 3.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.064 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t 67.22 -66.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.818 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.79 36.35 6.84 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.976 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.29 153.55 20.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.337 . . . . 0.0 110.25 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -88.83 140.23 29.38 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.545 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.23 -33.5 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.671 2.247 . . . . 0.0 112.572 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -93.22 -41.11 10.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -87.1 -26.94 23.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.043 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 101.62 -145.11 16.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.386 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.43 138.9 35.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -76.01 62.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.249 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.412 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.8 m -51.24 -24.69 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.9 -21.39 60.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -128.55 19.91 6.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.383 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 16.4 mt -71.02 159.06 35.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.793 0.33 . . . . 0.0 111.189 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.88 142.56 39.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.989 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 43.3 Cg_exo -56.01 -20.02 28.51 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.606 2.204 . . . . 0.0 112.529 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.82 -56.97 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.14 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.436 HD23 ' CD1' ' A' ' 59' ' ' LEU . 3.7 pp -71.12 -37.46 72.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 2.0 ppt_? -59.59 -36.27 75.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.948 0.404 . . . . 0.0 110.214 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.1 t -63.68 -37.2 86.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.652 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 25.6 tp -56.71 -57.07 14.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.625 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.413 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 20.3 m-85 -48.35 -43.63 33.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.25 -58.48 7.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.631 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.54 -29.86 59.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.826 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.77 3.52 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.806 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.8 4.28 90.37 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.994 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.2 mt -85.67 162.35 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.893 0.347 . . . . 0.0 110.851 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.4 172.77 12.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.033 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.407 ' O ' ' CG2' ' A' ' 41' ' ' THR . 1.0 OUTLIER -53.45 -37.78 62.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.025 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.71 -46.42 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.71 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -78.54 -34.02 47.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.668 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.0 -23.14 63.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.407 ' CG2' ' O ' ' A' ' 37' ' ' GLU . 46.9 p -94.99 -7.65 39.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.537 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -81.3 119.17 23.32 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.757 0.313 . . . . 0.0 110.715 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.85 -34.48 12.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.493 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' OE1' ' NH2' ' A' ' 92' ' ' ARG . 36.5 tt0 -72.75 -59.89 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.415 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.411 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.21 -34.41 76.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.409 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.2 p -58.32 -42.3 86.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.847 0.356 . . . . 0.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -60.99 -53.14 60.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.499 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.426 ' CD2' ' CG ' ' A' ' 92' ' ' ARG . 1.5 pp -65.04 -32.26 73.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.741 0.305 . . . . 0.0 110.828 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.413 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 49.9 mt -68.42 -64.0 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.384 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.3 p90 -52.08 -40.7 61.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.885 0.374 . . . . 0.0 110.303 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.449 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -53.57 -32.68 51.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 178.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.46 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 69.3 t80 -63.85 -41.74 97.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.122 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.424 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 59.9 mt -55.39 -25.11 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.41 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.83 -35.54 59.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.783 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.46 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -72.93 -25.63 61.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.8 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -87.4 13.98 8.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.552 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.97 14.72 41.7 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.635 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.91 170.19 46.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.127 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.436 ' CD1' HD23 ' A' ' 26' ' ' LEU . 12.5 tp -48.99 -40.13 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 110.899 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -65.07 -36.19 83.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.302 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.446 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.08 -35.76 66.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.899 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.0 t -65.0 -63.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.756 0.312 . . . . 0.0 110.912 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -51.69 -44.53 63.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.071 0.462 . . . . 0.0 110.235 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.0 -52.58 62.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.41 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -70.4 -23.3 62.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.212 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mmt -69.01 -35.15 76.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 0.0 110.241 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -77.36 -33.43 55.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.667 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.82 -22.01 62.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.882 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -88.2 -18.67 28.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.311 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.68 108.65 2.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.516 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.67 -157.39 19.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.573 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.69 146.04 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.333 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.13 101.08 2.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.87 -29.98 7.74 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.473 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.72 50.37 0.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 110.845 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -74.58 151.95 39.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.032 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.406 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.2 OUTLIER -53.03 154.95 2.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.411 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 0.1 OUTLIER 82.97 -48.22 0.15 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.341 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.99 70.57 1.04 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.092 0.472 . . . . 0.0 110.762 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.31 -93.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.009 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.437 HD13 ' CD2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -62.46 -29.81 70.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.76 179.127 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.446 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 16.8 t -64.58 -30.04 49.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.768 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -46.47 60.05 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.037 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.35 -46.49 79.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.948 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.6 tp -55.97 -46.83 78.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.7 mtp -53.62 -29.97 40.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.441 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -80.08 -30.17 39.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.525 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.9 t -69.48 -42.45 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 110.308 178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.3 mmm -63.51 -28.39 69.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.138 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.13 -18.75 63.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.343 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 9.8 tptt -69.75 -36.46 75.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.994 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.426 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 14.5 mmm-85 -73.66 -19.45 60.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.99 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.0 m -75.01 -31.54 61.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -130.84 25.74 4.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.28 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 91' ' ' LYS . . . -74.09 136.05 42.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.935 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.7 tp -132.45 82.53 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.119 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -136.45 73.65 1.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.299 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m 75.6 25.83 1.17 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.234 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.14 -26.18 14.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.927 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 54.07 179.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -61.58 -27.57 68.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.33 -130.96 11.69 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.477 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.51 157.68 15.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.917 0.389 . . . . 0.0 110.747 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.89 169.34 11.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.041 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 64.17 33.21 12.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.03 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.7 114.65 19.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.946 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 CA-C-O 118.365 -1.242 . . . . 0.0 112.509 -179.746 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.821 0.343 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.89 18.35 47.77 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.6 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -147.1 162.8 38.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.344 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.76 126.86 35.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.054 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -145.07 100.32 3.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.898 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.5 t -83.5 139.98 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.219 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.93 -27.79 18.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 68.44 114.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.036 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 t -81.83 -55.12 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.956 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.13 18.82 8.44 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.785 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.569 ' CH2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.4 153.81 20.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.745 -179.596 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.09 140.8 29.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.552 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.05 -38.2 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.652 2.235 . . . . 0.0 112.772 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -94.17 -35.6 12.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.19 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.77 -25.29 23.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.112 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.85 -150.19 19.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.393 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.471 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.28 136.36 35.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.332 . . . . 0.0 110.891 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -74.83 62.95 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.277 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.402 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -52.0 -23.83 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.288 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.43 -21.76 61.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.194 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -132.68 21.89 4.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.487 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.471 HD21 ' CD1' ' A' ' 17' ' ' PHE . 16.5 mt -70.07 159.03 34.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 111.23 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -85.19 139.84 36.63 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.0 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.19 -18.94 19.35 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.621 2.214 . . . . 0.0 112.684 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -81.19 -57.97 3.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.228 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.436 HD21 ' CD1' ' A' ' 59' ' ' LEU . 3.5 pp -69.91 -42.81 72.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.096 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.72 -34.22 62.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.956 0.407 . . . . 0.0 110.086 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.33 -39.18 93.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.677 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.404 ' N ' ' CE ' ' A' ' 66' ' ' MET . 22.4 tp -56.59 -55.65 31.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.591 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -50.38 -43.61 54.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.617 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 m -62.34 -55.14 30.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.709 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -56.73 -30.89 63.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.827 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.92 -21.46 37.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 8.68 48.31 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.771 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 ' CG ' ' A' ' 89' ' ' MET . 39.3 mt -86.09 112.3 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.83 0.348 . . . . 0.0 111.176 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 p -87.0 167.6 14.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -52.17 -28.91 19.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.821 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.5 -46.14 73.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -78.47 -31.38 47.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.688 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.98 -25.48 63.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.4 p -97.29 -5.33 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.607 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -82.23 113.69 20.22 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.753 0.311 . . . . 0.0 110.649 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.6 -32.28 3.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.59 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.94 -59.66 2.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.122 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.85 -36.5 80.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.295 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.39 -38.16 71.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.848 0.356 . . . . 0.0 110.21 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 4.1 tptm -62.07 -54.95 34.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.363 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.489 ' CD2' ' CG ' ' A' ' 92' ' ' ARG . 1.6 pp -67.04 -30.67 70.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.258 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.7 mt -68.02 -64.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.517 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.569 ' CZ ' ' CH2' ' A' ' 11' ' ' TRP . 2.1 p90 -52.77 -40.72 63.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.94 0.4 . . . . 0.0 110.224 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.78 -32.69 60.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.7 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.464 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 77.0 t80 -64.54 -38.67 91.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.25 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.413 ' CG2' ' CG2' ' A' ' 62' ' ' VAL . 44.6 mt -59.18 -28.64 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.238 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.67 -33.95 73.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.342 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.464 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -75.08 -24.66 58.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.476 178.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 97.0 mm-40 -85.9 10.48 13.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.339 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.442 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.15 17.08 33.11 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.483 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.64 171.21 46.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.809 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.436 ' CD1' HD21 ' A' ' 26' ' ' LEU . 25.5 tp -49.34 -41.62 39.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 111.281 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -63.87 -34.84 78.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.219 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.442 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -35.57 66.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.255 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.413 ' CG2' ' CG2' ' A' ' 53' ' ' ILE . 22.0 t -66.06 -48.79 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -54.29 -46.55 72.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.112 0.482 . . . . 0.0 109.985 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.53 -49.07 74.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.943 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 20.3 pt-20 -67.56 -24.75 65.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.805 0.336 . . . . 0.0 110.808 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.404 ' CE ' ' N ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -72.93 -22.53 60.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 178.466 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 -75.93 -51.7 11.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.909 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -32.42 69.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.849 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -91.03 -6.88 53.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.582 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.51 104.8 0.96 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.499 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.19 -70.32 1.02 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.68 -71.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 0.0 110.995 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.52 66.73 0.5 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.57 -22.23 3.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.446 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.68 29.98 4.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.7 129.64 38.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.93 94.33 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.987 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.1 p -79.7 -5.72 55.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.557 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.75 102.08 3.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.965 0.412 . . . . 0.0 110.969 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.29 -94.38 0.18 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.356 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 82' ' ' VAL . 2.7 pt? -63.71 -41.11 98.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.684 0.278 . . . . 0.0 111.48 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.427 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 6.0 t -63.61 -37.13 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.774 0.321 . . . . 0.0 111.272 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.2 -38.51 82.56 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.479 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.94 -48.74 73.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 0.0 110.766 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.461 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 30.7 tp -62.03 -45.18 94.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.4 mtm -54.25 -34.48 60.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.499 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -75.74 -24.46 56.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.28 -37.4 22.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.156 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.423 ' CG ' HD12 ' A' ' 35' ' ' ILE . 67.2 mmm -62.49 -37.11 84.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.046 0.451 . . . . 0.0 110.258 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -68.14 -11.25 58.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.229 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 1.4 tptp -69.26 -27.94 65.88 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.678 0.275 . . . . 0.0 111.257 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.489 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 21.3 mmm180 -73.07 -22.24 60.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 0.0 110.963 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.5 m -76.06 -24.84 55.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.441 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -130.7 11.02 5.19 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 91' ' ' LYS . . . -74.37 173.63 9.99 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.084 0.469 . . . . 0.0 111.377 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 98' ' ' SER . 16.3 mm -75.7 106.79 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.014 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.88 90.71 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.548 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.5 OUTLIER -147.52 111.4 5.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.068 -178.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.7 m -146.55 -44.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.051 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 58.43 73.34 0.48 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.98 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -108.04 173.42 6.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.74 86.02 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.37 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 104' ' ' ASP . 2.5 tt0 -76.7 169.98 17.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 110.789 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER 80.36 151.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.612 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.37 110.53 0.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.68 133.01 35.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.988 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.506 -179.913 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.836 0.351 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.27 -20.83 48.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.535 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -124.39 136.61 54.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -86.94 141.61 28.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -124.85 52.38 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.92 145.15 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.078 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -49.53 6.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.75 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.6 t60 69.72 80.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.147 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 t -60.32 -54.87 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.743 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.27 19.56 16.14 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.806 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.556 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.16 153.44 20.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 0.0 110.383 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.8 m-20 -90.57 138.41 26.74 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.467 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.23 -23.45 6.33 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.587 2.191 . . . . 0.0 112.598 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -99.1 -41.14 7.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.088 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -88.15 -29.85 20.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.046 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 109.56 -144.79 16.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.467 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.454 ' CE1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -83.49 147.01 28.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 111.095 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -82.14 58.75 4.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.886 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.6 m -51.38 -24.03 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.069 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -19.77 59.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -131.61 21.34 4.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.401 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.454 HD21 ' CE1' ' A' ' 17' ' ' PHE . 17.6 mt -70.14 159.63 33.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.933 0.397 . . . . 0.0 111.201 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -83.52 145.85 48.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.06 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.66 -22.23 59.64 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.634 2.223 . . . . 0.0 112.645 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.92 -56.37 4.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.328 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 3.6 pp -70.85 -32.77 69.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.333 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.17 -35.56 81.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.234 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -35.82 81.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.642 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.45 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 9.4 tp -56.4 -60.36 3.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.544 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.454 ' CG ' HD22 ' A' ' 40' ' ' LEU . 16.7 m-85 -49.0 -45.24 42.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.817 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 m -62.22 -50.38 72.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -59.5 -33.18 71.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.61 -12.79 58.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.378 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.65 11.77 58.9 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.624 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 39' ' ' GLN . 62.7 mt -86.48 114.79 26.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.807 0.336 . . . . 0.0 111.086 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.9 p -87.53 163.49 16.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.11 -26.7 17.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.39 -44.77 72.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.402 ' HB2' HG21 ' A' ' 35' ' ' ILE . 40.7 mt-30 -78.58 -33.64 47.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.744 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.454 HD22 ' CG ' ' A' ' 30' ' ' PHE . 76.5 mt -68.79 -22.3 64.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.804 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -96.53 -8.75 31.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.555 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -82.22 112.76 19.53 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.783 0.325 . . . . 0.0 110.645 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.96 -31.27 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.7 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -72.37 -59.65 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.882 0.372 . . . . 0.0 110.929 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.413 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.71 -33.33 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.66 -39.5 80.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.269 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 19.1 tptt -61.74 -53.31 57.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.566 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.426 HD13 ' CG1' ' A' ' 88' ' ' VAL . 1.9 pp -66.44 -32.41 73.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.356 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mt -68.2 -64.59 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.554 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.556 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.3 p90 -53.63 -37.43 63.06 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.981 0.419 . . . . 0.0 110.138 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -55.44 -36.41 66.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.426 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.459 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 64.3 t80 -64.32 -37.56 87.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.043 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.425 ' CG2' HG21 ' A' ' 62' ' ' VAL . 49.5 mt -58.62 -29.07 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.178 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -40.27 77.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.587 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.459 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -66.37 -26.24 67.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.458 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.411 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 94.6 mm-40 -85.28 1.35 48.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.338 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 104.41 18.82 12.3 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.475 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.45 170.83 46.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.846 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.455 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 12.1 tp -48.52 -40.33 26.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.322 . . . . 0.0 111.093 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.64 -35.07 79.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.247 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.446 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -74.05 -34.24 63.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.818 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.425 HG21 ' CG2' ' A' ' 53' ' ' ILE . 44.0 t -65.02 -63.29 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.699 0.285 . . . . 0.0 110.873 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -41.64 63.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.052 0.453 . . . . 0.0 110.13 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -63.23 -53.26 55.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.33 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.36 -26.61 64.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.992 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.5 mmt -67.29 -29.5 69.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.079 0.466 . . . . 0.0 110.238 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -77.64 -44.8 27.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.0 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -71.91 -29.49 64.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.006 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.54 -18.09 62.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.323 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.71 -20.59 59.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.531 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.83 96.16 0.32 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.706 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.9 t -163.45 72.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.945 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.97 -43.01 1.78 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.571 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.29 -99.95 0.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.525 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.0 t -154.5 38.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.354 . . . . 0.0 111.018 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -74.94 106.65 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.976 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.4 OUTLIER -115.61 141.6 47.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.674 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 77' ' ' SER . 8.3 t 88.22 -27.19 0.07 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.617 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.7 84.04 1.17 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.047 0.451 . . . . 0.0 110.765 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.49 -98.36 0.14 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.958 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' CD1' HD12 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -64.41 -33.66 76.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.68 0.276 . . . . 0.0 110.926 179.219 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.45 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 3.6 t -65.32 -32.29 57.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.24 -48.91 43.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.274 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.39 85.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.794 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.4 tp -56.8 -40.99 76.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.625 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.7 mtt -53.0 -41.16 64.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.24 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -45.49 74.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.669 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.426 ' CG1' HD13 ' A' ' 48' ' ' LEU . 22.5 t -51.25 -40.02 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.709 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 92.9 mmm -63.0 -28.53 70.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.325 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -69.26 -17.13 63.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.171 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -67.85 -53.64 25.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.301 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -18.23 62.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.413 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 m -76.35 -28.77 56.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.8 0.334 . . . . 0.0 111.082 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -110.66 -14.19 14.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.616 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.8 118.17 17.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.961 0.41 . . . . 0.0 111.236 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 96' ' ' ILE . 0.0 OUTLIER -105.3 105.08 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 110.871 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -43.5 102.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.493 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.99 142.86 23.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.21 175.3 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.002 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 t0 60.16 178.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -140.6 76.34 1.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.937 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -118.42 -136.97 5.57 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.653 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.98 122.46 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.35 . . . . 0.0 111.085 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.43 82.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -169.61 -176.44 2.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.01 97.85 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.068 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.41 -1.216 . . . . 0.0 112.474 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.8 0.333 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.17 29.62 4.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -121.43 154.83 36.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.938 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.35 147.77 25.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -123.12 48.67 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 t -117.94 141.73 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.025 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.4 t 58.76 176.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.723 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -174.85 63.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.344 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.92 -48.68 86.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 110.529 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.09 40.92 97.76 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.036 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -88.5 153.44 21.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.28 137.93 28.98 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.679 0.276 . . . . 0.0 110.795 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.44 -23.36 7.36 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -98.42 -41.4 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -89.45 -25.92 21.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.002 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.74 -142.47 16.1 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.337 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.0 146.4 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 0.0 110.841 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -84.66 61.12 6.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.437 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 5.2 m -49.07 -25.36 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.237 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -72.12 -20.88 61.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.086 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -132.23 20.75 4.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.429 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.0 mt -70.28 159.7 33.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.936 0.398 . . . . 0.0 111.163 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -82.44 139.42 44.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.77 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 49.2 Cg_exo -54.86 -19.17 18.36 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.518 2.146 . . . . 0.0 112.464 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -81.27 -57.68 3.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.127 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD23 ' CD1' ' A' ' 59' ' ' LEU . 3.4 pp -70.64 -40.97 72.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.105 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.427 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.6 OUTLIER -59.04 -39.09 80.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 0.0 110.576 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -64.09 -38.49 91.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.619 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.425 ' CD1' HG23 ' A' ' 82' ' ' VAL . 15.5 tp -56.11 -51.01 69.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.576 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.472 ' CG ' HD22 ' A' ' 40' ' ' LEU . 21.0 m-85 -52.3 -49.04 64.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.512 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.3 m -62.41 -41.49 98.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.791 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -62.48 -35.86 80.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.983 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.1 -14.74 57.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.482 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 10.78 45.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.796 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.41 HD11 ' CD2' ' A' ' 85' ' ' LEU . 62.5 mt -86.64 119.62 34.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.842 0.353 . . . . 0.0 110.939 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -86.6 157.45 19.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.998 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.419 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.82 -30.32 32.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.047 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.65 70.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.858 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.425 ' NE2' HG21 ' A' ' 45' ' ' THR . 9.6 mm100 -77.76 -30.14 51.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.712 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.472 HD22 ' CG ' ' A' ' 30' ' ' PHE . 95.2 mt -69.6 -22.8 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.5 p -97.44 -7.68 31.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.606 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -81.45 115.51 20.81 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.818 0.342 . . . . 0.0 110.63 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.96 -34.2 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.682 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 92' ' ' ARG . 5.6 tp10 -72.44 -59.9 2.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 0.0 111.491 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.431 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.3 -32.89 74.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.172 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -57.86 -42.1 83.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.599 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.84 -55.2 32.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.358 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.436 HD12 ' CG1' ' A' ' 88' ' ' VAL . 1.6 pp -63.31 -31.61 72.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.723 0.297 . . . . 0.0 110.953 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 70.4 mt -69.76 -64.02 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.381 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.452 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 1.9 p90 -53.35 -38.2 63.06 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.073 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -54.18 -34.32 60.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.638 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.516 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 69.1 t80 -63.93 -30.67 71.73 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.092 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.408 ' CG2' ' CG2' ' A' ' 62' ' ' VAL . 40.2 mt -66.29 -28.5 43.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.034 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -71.8 -34.42 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.816 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.478 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.3 p30 -69.96 -25.59 63.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 0.0 110.497 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.516 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 9.0 mt-30 -83.12 -8.97 59.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.094 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 113.64 22.08 5.54 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.886 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.64 171.02 47.21 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.603 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.432 ' CD1' HD23 ' A' ' 26' ' ' LEU . 13.2 tp -47.8 -41.64 24.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 111.055 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 28.5 mt-10 -64.27 -34.51 78.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.4 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.16 -35.93 66.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.709 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.408 ' CG2' ' CG2' ' A' ' 53' ' ' ILE . 40.3 t -65.14 -63.56 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.667 0.27 . . . . 0.0 110.812 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.08 -37.94 62.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.98 0.419 . . . . 0.0 109.94 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 43.6 mt-30 -63.17 -50.62 69.67 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.061 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -68.8 -34.88 76.27 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.542 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -60.51 -29.32 69.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.087 0.47 . . . . 0.0 110.049 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -76.56 -41.4 46.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.388 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -72.19 -32.49 66.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.485 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.414 ' NE2' ' O ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -82.43 -20.49 36.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.983 179.199 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.7 109.46 3.43 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.132 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -41.69 -95.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.213 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.1 t -148.8 79.22 1.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.35 116.65 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.577 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.63 -34.26 4.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.521 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.21 40.23 1.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -74.79 131.9 41.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.831 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.414 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 63.5 m -113.77 122.81 48.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.121 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.414 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 88.4 p -95.02 -6.26 42.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.367 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.45 102.37 3.18 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.01 0.433 . . . . 0.0 110.932 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.63 -95.24 0.18 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.376 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.434 ' HG ' ' N ' ' A' ' 82' ' ' VAL . 2.7 pt? -62.85 -41.15 99.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.625 0.25 . . . . 0.0 111.361 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.434 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 6.2 t -63.8 -28.51 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 111.078 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.33 -36.96 85.65 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.301 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.22 -47.04 81.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.703 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.41 ' CD2' HD11 ' A' ' 35' ' ' ILE . 5.9 tp -54.08 -49.41 69.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.493 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.4 mtm -51.1 -31.63 19.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.473 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -39.92 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.259 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.436 ' CG1' HD12 ' A' ' 48' ' ' LEU . 57.9 t -56.4 -40.56 67.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.207 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.418 ' CE ' HG23 ' A' ' 45' ' ' THR . 3.3 mmt -63.99 -39.22 93.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.183 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -58.38 -21.83 51.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.863 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -68.32 -56.82 7.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.076 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.482 ' CZ ' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -69.54 -25.22 63.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.778 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 m -73.73 -30.71 62.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.07 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.73 23.9 11.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.606 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.12 143.11 45.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.234 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 98' ' ' SER . 1.2 tp -105.92 99.22 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.46 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -40.21 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.639 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 96' ' ' ILE . 4.8 p -86.79 106.35 17.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.061 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.28 -161.22 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.25 31.33 8.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.892 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 101' ' ' GLU . 4.0 pt-20 -155.4 105.3 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.44 -103.95 0.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.588 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -95.87 97.21 9.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 0.0 111.019 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -167.74 54.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' ' 105' ' ' GLN . 0.3 OUTLIER -76.68 82.84 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.97 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.05 98.55 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.415 -1.214 . . . . 0.0 112.419 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.784 0.326 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.58 29.51 39.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.621 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.37 178.08 4.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 0.0 110.944 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -86.89 110.59 20.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -112.81 87.65 2.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.19 140.88 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.2 137.79 32.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.683 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -107.99 114.22 27.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.204 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 t -71.82 -62.82 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.541 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.54 34.91 5.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.93 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.495 ' CE2' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -88.7 152.61 21.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.214 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.58 136.15 25.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.73 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.15 -58.73 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.494 2.13 . . . . 0.0 112.592 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -81.33 -34.44 31.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.715 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -86.14 -22.76 26.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.651 0.262 . . . . 0.0 111.199 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.65 -150.6 21.83 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.587 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.78 142.87 33.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.862 0.363 . . . . 0.0 110.997 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.7 64.96 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 2.0 m -54.69 -21.5 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.261 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -72.72 -20.84 61.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.143 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -132.11 20.62 4.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.508 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.7 mt -69.8 159.46 33.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.154 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -84.08 137.97 39.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.77 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 44.5 Cg_exo -55.89 -18.53 22.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.558 2.172 . . . . 0.0 112.463 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -80.84 -57.63 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.044 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.438 HD22 ' CD1' ' A' ' 59' ' ' LEU . 4.1 pp -69.53 -44.81 70.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.148 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -55.2 -32.9 62.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.863 0.363 . . . . 0.0 110.534 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.4 t -64.55 -38.06 89.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' CD1' HG23 ' A' ' 82' ' ' VAL . 16.0 tp -56.35 -54.54 44.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.733 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -50.99 -44.32 60.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.769 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -61.8 -49.32 76.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.915 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -34.05 67.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.054 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.94 -18.55 46.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.39 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.15 11.68 41.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.89 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.413 HG21 ' NE2' ' A' ' 39' ' ' GLN . 52.4 mt -86.21 117.79 31.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.813 0.34 . . . . 0.0 111.057 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.03 161.46 18.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.419 ' HG2' ' CG2' ' A' ' 19' ' ' VAL . 0.6 OUTLIER -52.73 -26.49 14.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.851 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.09 -43.2 73.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.413 ' NE2' HG21 ' A' ' 35' ' ' ILE . 0.5 OUTLIER -78.57 -28.73 45.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.742 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.432 HD12 ' CG1' ' A' ' 19' ' ' VAL . 33.1 mt -71.19 -23.58 62.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.856 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.6 p -98.05 -7.55 29.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.696 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 46' ' ' SER . 29.1 t0 -81.96 122.55 27.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.799 0.333 . . . . 0.0 110.744 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.07 -38.22 37.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.556 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' OE2' ' CZ ' ' A' ' 92' ' ' ARG . 18.3 tt0 -73.18 -59.81 2.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.672 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 -35.96 81.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.126 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 70.4 m -58.8 -41.98 88.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.855 0.36 . . . . 0.0 110.438 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -60.11 -55.23 36.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.43 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.453 ' CD2' ' CG ' ' A' ' 92' ' ' ARG . 1.6 pp -64.4 -31.99 73.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.383 -178.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.4 mt -67.5 -63.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.203 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.495 ' CE2' ' CE2' ' A' ' 11' ' ' TRP . 2.0 p90 -52.36 -35.84 52.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.925 0.393 . . . . 0.0 110.303 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.8 -32.76 63.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.476 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 74.0 t80 -64.67 -41.03 96.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.167 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.404 ' CG2' HG21 ' A' ' 62' ' ' VAL . 30.8 mt -55.95 -28.23 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.213 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -71.21 -36.13 71.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.589 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -73.49 -25.92 60.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.568 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 89.2 mm-40 -86.22 12.5 9.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.639 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.49 15.04 36.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.607 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.1 170.63 45.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.784 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.438 ' CD1' HD22 ' A' ' 26' ' ' LEU . 17.4 tp -48.95 -37.95 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 111.112 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.01 -35.69 82.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.317 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.439 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.21 -35.8 66.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.668 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.404 HG21 ' CG2' ' A' ' 53' ' ' ILE . 31.3 t -65.32 -63.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.707 0.289 . . . . 0.0 110.768 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -52.1 -37.47 54.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.06 0.457 . . . . 0.0 110.138 178.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -63.09 -52.07 64.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.53 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.403 ' OE2' ' N ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -69.5 -36.32 76.37 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.803 0.335 . . . . 0.0 110.982 -178.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.403 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 2.8 mmt -66.66 -28.81 68.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.596 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 11.5 mmt180 -77.92 -35.84 50.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.067 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -18.32 62.14 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.819 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -90.41 -14.45 32.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.542 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.97 -60.87 7.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.604 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.18 -118.05 4.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.629 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.3 p -57.93 148.85 24.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.877 0.37 . . . . 0.0 111.014 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.17 -70.96 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.39 -175.15 36.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.437 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.9 m -99.88 1.08 42.53 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -74.91 119.37 18.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.838 0.352 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -122.18 90.47 3.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.683 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 77' ' ' SER . 4.6 p 88.33 -22.74 0.13 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.491 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -74.35 88.18 2.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.012 0.434 . . . . 0.0 110.842 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.17 -92.45 0.11 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.096 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.423 ' HG ' ' N ' ' A' ' 82' ' ' VAL . 2.6 pt? -63.39 -39.12 93.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.956 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.44 HG23 ' CD1' ' A' ' 29' ' ' LEU . 9.2 t -62.67 -27.41 42.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.29 -41.1 80.09 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.26 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.46 93.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.0 -41.08 97.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.37 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -42.5 67.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.18 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -44.89 92.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.4 HG22 ' CD1' ' A' ' 52' ' ' PHE . 44.7 t -52.33 -41.79 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.56 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 74.5 mmm -65.17 -33.59 76.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.793 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -59.53 -19.46 48.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.538 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -68.26 -35.56 78.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.843 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 30.5 mmm-85 -74.74 -26.51 59.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.564 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.5 t -77.34 -31.71 54.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.023 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.9 mmm-85 -113.66 18.29 17.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.61 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.61 116.79 16.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.99 0.424 . . . . 0.0 111.059 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.42 ' O ' ' N ' ' A' ' 98' ' ' SER . 2.2 tp -132.55 104.64 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.976 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -48.77 92.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 96' ' ' ILE . 2.2 t -130.29 159.45 36.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.954 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.8 m -117.21 33.33 5.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.64 72.81 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -166.45 -174.52 2.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.09 75.41 0.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.406 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -111.44 162.39 15.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.941 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.3 t70 39.44 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.756 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -129.71 129.35 44.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.16 128.6 33.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.526 179.937 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.833 0.349 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.39 -24.28 29.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.615 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -143.17 152.61 41.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -87.2 148.3 25.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.916 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.3 57.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.738 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.91 141.4 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.14 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.29 113.04 24.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.728 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -100.43 112.79 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.155 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.486 HG11 ' CZ ' ' A' ' 17' ' ' PHE . 12.6 t -75.92 -34.55 27.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.442 . . . . 0.0 110.685 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.05 32.59 63.1 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.984 -0.626 . . . . 0.0 113.131 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.486 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.06 153.45 20.98 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.851 0.325 . . . . 0.0 110.318 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.96 138.58 27.61 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.615 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -78.61 -33.89 1.58 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -92.33 -41.0 10.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.946 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.15 -25.1 24.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.012 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.34 -146.28 18.19 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.505 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.486 ' CZ ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -81.59 140.21 34.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.882 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -74.86 60.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.446 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -50.52 -24.64 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -73.48 -22.25 60.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -128.7 20.03 6.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.433 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.1 mt -70.64 159.49 34.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 111.051 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -84.58 139.3 38.11 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.095 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.67 -19.0 22.49 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.56 2.173 . . . . 0.0 112.399 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -81.34 -57.16 3.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.929 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.453 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 4.2 pp -70.14 -44.37 69.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.041 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.4 ' N ' ' CD1' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -54.39 -35.9 63.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.917 0.389 . . . . 0.0 110.46 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.06 -38.92 93.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.708 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.421 ' HB2' ' CE ' ' A' ' 66' ' ' MET . 27.8 tp -56.65 -54.23 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.436 ' CG ' HD21 ' A' ' 40' ' ' LEU . 21.7 m-85 -51.93 -46.77 64.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.491 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -62.21 -50.72 70.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.714 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -54.73 -32.25 59.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.812 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.5 -14.24 55.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.469 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.05 13.12 50.58 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.677 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 58.2 mt -86.52 118.9 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 111.047 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.74 163.57 17.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.881 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.423 ' HG2' ' CG2' ' A' ' 19' ' ' VAL . 2.4 mt-10 -53.78 -30.3 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.876 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.91 72.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.074 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -78.27 -31.32 48.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.805 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.436 HD21 ' CG ' ' A' ' 30' ' ' PHE . 96.0 mt -70.97 -27.59 63.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.463 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.5 p -97.75 -3.64 38.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.555 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.72 121.46 26.42 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.9 -37.23 30.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.479 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.86 -59.89 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.595 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.71 -35.52 78.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.394 -178.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.5 p -57.42 -37.57 72.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.822 0.344 . . . . 0.0 110.147 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 18.0 tptt -61.55 -56.07 24.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.146 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' CD2' ' HG2' ' A' ' 92' ' ' ARG . 1.7 pp -65.72 -30.72 71.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.287 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.5 mt -68.03 -64.21 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.532 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.3 p90 -52.57 -38.66 60.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.929 0.395 . . . . 0.0 110.203 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.11 -33.54 65.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.674 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.62 -39.63 94.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.303 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.423 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 21.6 mt -57.39 -29.87 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.241 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.34 -36.41 79.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.433 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.69 -25.12 61.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.558 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 16.9 mm100 -86.51 12.13 11.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.44 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.23 17.86 33.09 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.572 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.76 166.84 39.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.696 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.453 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 32.1 tp -49.08 -37.33 20.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 0.0 111.119 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.9 -34.55 78.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.2 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.435 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.78 -35.53 67.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.267 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.408 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 18.5 t -66.09 -48.61 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.925 0.393 . . . . 0.0 110.737 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -53.76 -46.23 70.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.175 0.512 . . . . 0.0 109.956 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.22 -48.68 74.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.135 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 8.0 pt-20 -68.6 -20.73 64.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.612 0.244 . . . . 0.0 111.643 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.421 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 2.2 mmt -85.85 -33.71 21.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -78.73 -37.88 40.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.427 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -20.91 61.94 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.868 -179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.12 -8.15 59.64 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.57 -42.64 39.58 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.595 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.55 34.32 4.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 m -70.85 170.22 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.771 0.32 . . . . 0.0 110.925 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.46 -65.34 3.57 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.37 178.06 53.14 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.528 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 m -98.99 29.34 3.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -74.75 106.31 6.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.447 ' O ' ' CB ' ' A' ' 78' ' ' SER . 88.5 p -122.04 115.2 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 77' ' ' SER . 1.5 m 87.76 -25.94 0.08 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.675 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.72 91.68 2.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 110.783 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.32 -91.91 0.12 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.087 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 82' ' ' VAL . 2.4 pt? -64.0 -39.59 94.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 111.055 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.436 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 8.5 t -63.54 -30.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.106 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.75 -41.05 75.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.32 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.2 -45.66 87.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.815 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.4 tp -60.91 -44.85 96.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.481 179.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -42.6 67.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.373 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -36.07 82.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.542 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.91 -40.18 86.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.766 179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 48.5 mmm -62.11 -39.03 91.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' A' ' 90' ' ' GLN . 14.7 mm100 -62.83 -14.24 43.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.967 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 2.2 tptp -70.7 -48.88 52.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.384 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.428 ' HG2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -71.16 -20.62 62.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.717 -178.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.9 t -77.03 -24.25 52.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.942 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.432 ' HD3' ' N ' ' A' ' 94' ' ' ARG . 1.1 mpp_? -135.09 14.32 3.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.047 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 91' ' ' LYS . . . -72.91 174.26 8.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.98 0.419 . . . . 0.0 111.233 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 98' ' ' SER . 5.3 mp -58.33 110.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.176 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.42 66.65 0.08 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.829 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.415 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -92.71 -34.46 13.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.953 -177.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -159.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.77 135.16 34.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.95 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.7 101.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.068 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.08 57.4 0.32 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -93.6 112.86 24.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.975 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 103' ' ' GLU . 3.3 t0 81.39 -61.53 0.2 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.23 158.22 23.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.989 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.22 107.1 13.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.065 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.354 -1.248 . . . . 0.0 112.537 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.853 0.359 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.65 -24.07 33.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -140.65 170.7 15.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.788 0.327 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.23 112.94 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -99.63 111.88 24.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.703 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.57 139.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.366 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.9 m 59.19 -177.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -150.53 74.13 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.259 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 t -72.87 -35.55 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.468 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.89 39.61 8.86 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.071 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.11 153.35 21.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.699 0.285 . . . . 0.0 110.264 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.8 m-20 -89.52 140.15 28.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.717 0.294 . . . . 0.0 110.54 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.73 -28.39 5.27 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.662 2.241 . . . . 0.0 112.483 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -98.0 -38.83 9.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -87.48 -21.62 25.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 95.6 -138.2 13.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.206 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.481 ' CE2' ' HB3' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -81.94 -169.08 2.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.942 0.401 . . . . 0.0 110.755 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -123.99 54.15 1.35 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.499 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.433 ' CG1' ' HG3' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -46.15 -26.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.641 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -68.56 -23.94 64.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.031 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -134.78 25.21 3.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.642 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.6 mt -70.2 159.5 33.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.927 0.394 . . . . 0.0 111.167 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.91 137.97 40.47 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.707 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.436 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.6 Cg_exo -54.76 -19.22 18.15 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.584 2.189 . . . . 0.0 112.654 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -81.64 -57.71 3.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.291 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.403 HD23 ' CD1' ' A' ' 59' ' ' LEU . 4.0 pp -70.91 -38.1 72.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.158 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -62.22 -35.51 79.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.489 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 t -63.24 -36.32 83.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.633 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.437 ' CD1' HG21 ' A' ' 82' ' ' VAL . 25.2 tp -56.6 -50.72 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.644 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 24.4 m-85 -55.47 -43.99 76.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.569 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -50.11 74.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.429 ' CB ' HG13 ' A' ' 82' ' ' VAL . 85.5 mtt180 -60.81 -29.3 69.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.911 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.16 -21.2 36.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.173 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.36 14.51 38.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.643 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.8 mt -86.75 121.54 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.0 111.059 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 p -86.97 158.23 19.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' HG3' ' CG1' ' A' ' 19' ' ' VAL . 0.6 OUTLIER -52.07 -27.12 12.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.842 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.17 -42.17 72.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -78.1 -30.17 49.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.6 mt -70.33 -24.77 63.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.6 p -98.45 -5.98 31.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.705 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.89 121.14 26.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.84 0.353 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.08 -35.54 25.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.276 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' CG ' ' CZ ' ' A' ' 92' ' ' ARG . 4.1 tp10 -72.53 -59.9 2.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.685 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.16 -33.74 76.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.987 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.4 p -57.6 -40.07 78.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.726 0.298 . . . . 0.0 110.345 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -61.77 -53.93 49.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.356 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.427 ' CD1' HG11 ' A' ' 88' ' ' VAL . 1.7 pp -66.64 -31.44 72.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.19 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.402 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 54.1 mt -69.95 -64.78 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.749 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.481 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -54.18 -36.94 63.94 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.361 -178.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -55.0 -33.17 62.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.446 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.443 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 60.7 t80 -64.87 -39.57 93.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.188 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.405 ' CG2' ' CG2' ' A' ' 62' ' ' VAL . 22.6 mt -56.39 -29.98 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.274 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.75 -36.37 75.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -71.14 -26.51 63.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.636 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 97.1 mm-40 -86.05 11.14 12.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.503 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.447 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.33 18.21 29.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.496 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.47 172.33 48.63 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.007 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.403 ' CD1' HD23 ' A' ' 26' ' ' LEU . 8.2 tp -48.43 -44.86 35.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 0.0 111.196 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.5 -35.19 79.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.392 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.447 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -33.73 65.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.572 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.405 ' CG2' ' CG2' ' A' ' 53' ' ' ILE . 48.6 t -64.9 -63.48 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -52.29 -38.54 58.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 110.088 177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -64.14 -48.96 74.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.909 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 66' ' ' MET . 10.7 pt-20 -68.52 -43.59 76.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.517 -177.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.429 ' N ' ' HG3' ' A' ' 65' ' ' GLU . 4.9 mmm -55.31 -30.58 60.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.053 0.454 . . . . 0.0 110.57 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -78.23 -40.38 37.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -68.43 -27.18 65.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.736 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.43 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.57 -19.2 63.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.343 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.62 71.87 2.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.488 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.0 165.07 23.14 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.6 t 54.98 105.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 0.0 110.951 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 54.7 89.87 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.318 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.14 66.47 1.31 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.378 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 t -57.91 -18.71 24.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.652 0.263 . . . . 0.0 111.331 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.15 130.97 41.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.845 0.355 . . . . 0.0 111.049 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.2 OUTLIER -116.75 149.39 39.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.936 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 77' ' ' SER . 0.7 OUTLIER 85.59 -40.82 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.616 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -74.63 74.02 2.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.431 . . . . 0.0 110.826 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.58 -88.15 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.167 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 82' ' ' VAL . 2.6 pt? -62.36 -39.11 92.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 110.739 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.437 HG21 ' CD1' ' A' ' 29' ' ' LEU . 19.4 t -62.62 -27.06 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.886 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.14 -37.54 82.04 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.292 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.91 -51.28 62.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.5 tp -59.83 -42.37 93.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.72 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.7 mtm -52.92 -37.93 61.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.301 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.449 ' CD2' ' OE1' ' A' ' 90' ' ' GLN . 1.2 t-160 -69.22 -46.85 66.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.222 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 48' ' ' LEU . 98.5 t -52.09 -41.1 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.62 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 89.1 mmm -63.9 -38.25 90.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.35 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.449 ' OE1' ' CD2' ' A' ' 87' ' ' HIS . 64.6 mt-30 -62.93 -20.48 65.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.703 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -67.71 -57.11 6.93 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.21 0.529 . . . . 0.0 110.941 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.477 ' CZ ' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -69.82 -26.61 64.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.79 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 m -75.83 -38.09 58.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.307 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -102.55 20.11 17.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.061 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.91 164.51 26.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.112 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.409 ' CG2' ' O ' ' A' ' 96' ' ' ILE . 3.8 tp -84.03 92.86 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 69.84 -58.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.507 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.3 t 177.65 80.9 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.792 0.33 . . . . 0.0 110.989 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 89.9 p -68.64 152.52 45.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.853 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -153.87 -46.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.845 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.11 137.76 34.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.66 -170.51 12.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.24 128.83 50.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.852 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -167.74 163.03 14.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -110.82 -75.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.91 102.09 9.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.089 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.382 -1.232 . . . . 0.0 112.534 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.843 0.354 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.25 26.46 8.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -83.65 160.16 21.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.17 162.75 30.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.23 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -127.22 75.11 1.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.691 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.54 119.8 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.251 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.9 p 56.44 -163.2 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -168.21 66.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.265 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -82.07 99.9 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.347 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.92 57.28 1.27 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.722 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -87.17 153.77 21.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.59 141.44 30.27 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.772 0.32 . . . . 0.0 110.826 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.1 -23.2 12.26 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.713 2.275 . . . . 0.0 112.64 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.42 -34.22 5.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.189 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.39 -25.79 23.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.779 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.97 -150.55 19.6 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.642 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.62 147.78 29.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.955 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -82.85 61.19 5.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.42 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.2 m -48.57 -25.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.205 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -71.16 -21.29 62.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.48 19.63 5.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.571 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.42 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.5 mt -70.64 159.28 34.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.975 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -84.26 141.0 39.46 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.026 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.413 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.7 Cg_exo -54.36 -21.03 21.87 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.65 2.234 . . . . 0.0 112.371 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -82.16 -56.3 4.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.308 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 59' ' ' LEU . 3.7 pp -71.17 -37.43 72.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.25 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HD2' ' N ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -58.67 -39.67 81.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.38 . . . . 0.0 110.425 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.439 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -63.27 -36.16 82.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.641 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.8 tp -56.38 -43.33 79.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.479 ' CG ' HD23 ' A' ' 40' ' ' LEU . 18.5 m-85 -66.85 -49.42 65.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.615 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.2 m -60.7 -50.57 72.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.9 mtt180 -59.11 -30.23 67.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.521 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.65 4.63 24.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.567 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.86 7.57 88.25 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.986 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 48.7 mt -87.1 122.57 39.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.837 0.351 . . . . 0.0 111.319 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.35 158.28 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.708 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.38 -29.88 26.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.772 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.22 -38.76 68.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -78.02 -32.39 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.479 HD23 ' CG ' ' A' ' 30' ' ' PHE . 57.9 mt -69.61 -24.21 63.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.722 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.4 p -96.72 -7.45 33.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.528 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -81.41 115.4 20.73 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.826 0.346 . . . . 0.0 110.595 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.22 -35.53 3.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.778 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.22 -59.93 2.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 111.493 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.443 ' CG2' ' HE3' ' A' ' 89' ' ' MET . 0.2 OUTLIER -67.6 -34.89 77.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.487 -178.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.19 -41.17 75.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.412 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.58 -56.25 21.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.346 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 pp -63.51 -30.31 71.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.911 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 80.6 mt -68.81 -64.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.023 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.443 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 1.7 p90 -55.48 -39.13 70.03 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.117 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 0.9 OUTLIER -52.34 -34.59 48.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.521 179.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.47 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 54.7 t80 -64.33 -38.78 92.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.806 178.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.435 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 48.6 mt -56.62 -30.81 32.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.136 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -69.5 -33.66 73.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.684 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -75.46 -26.0 57.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.729 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 78.4 mm-40 -86.21 11.39 12.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.52 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 99.33 17.14 27.72 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.585 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.84 169.59 45.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.995 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.435 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 14.0 tp -48.06 -39.72 20.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.712 0.292 . . . . 0.0 111.145 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 24.6 mm-40 -65.73 -35.44 80.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.327 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.422 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.09 -35.96 66.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.768 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.416 ' O ' ' HG2' ' A' ' 65' ' ' GLU . 46.2 t -65.24 -62.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 110.97 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.78 -39.03 61.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.186 0.517 . . . . 0.0 110.053 177.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 50.2 mt-30 -63.85 -50.1 70.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.876 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 16.5 pt-20 -69.47 -40.13 77.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.367 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.3 mmt -56.77 -41.99 78.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.217 0.532 . . . . 0.0 110.001 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -44.25 21.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.278 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -71.04 -25.7 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.809 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.7 -9.04 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 43.99 -101.58 0.03 OUTLIER Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.91 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.26 118.39 0.49 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.429 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.0 m -63.81 109.93 1.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.835 0.35 . . . . 0.0 110.965 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.19 -27.35 18.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.428 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.25 -134.67 1.68 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.39 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.06 17.21 18.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.641 0.258 . . . . 0.0 111.24 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -75.91 117.38 17.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.842 0.354 . . . . 0.0 111.074 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.0 t -119.01 119.34 33.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.485 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 p 169.3 -40.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.653 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 105.37 3.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.956 0.408 . . . . 0.0 111.133 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.08 -93.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.502 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 82' ' ' VAL . 2.6 pt? -60.79 -39.65 89.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.0 110.958 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.427 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 22.8 t -63.19 -24.95 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.804 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.82 -36.87 83.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.209 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.36 -52.16 59.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.715 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 tp -51.11 -48.12 61.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.57 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.5 mtt -50.29 -40.85 49.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.706 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -44.08 77.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.237 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 93.9 t -55.8 -40.28 60.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.527 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.443 ' HE3' ' CG2' ' A' ' 45' ' ' THR . 85.7 mmm -62.94 -37.64 87.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.557 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -61.23 -21.33 63.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.522 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -68.59 -57.83 5.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.045 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -73.32 -15.28 61.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.622 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.9 t -75.67 -36.67 60.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.914 0.387 . . . . 0.0 110.871 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -21.56 35.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.053 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.4 121.13 20.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.932 0.396 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.431 ' CG2' ' O ' ' A' ' 96' ' ' ILE . 5.5 tp -119.3 102.99 13.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.895 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.4 67.34 9.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.4 p 177.62 37.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.851 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.77 -162.97 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.9 t0 60.35 63.75 1.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -166.64 172.27 10.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.16 122.45 2.09 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.591 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.89 99.92 12.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.885 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.77 -34.92 69.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.89 109.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.911 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.03 147.15 30.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.031 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.369 -1.239 . . . . 0.0 112.559 -179.923 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.818 0.342 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.27 -24.27 32.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.44 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.42 ' O ' ' CD2' ' A' ' 3' ' ' PHE . 17.4 p90 -130.81 102.2 5.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.849 0.357 . . . . 0.0 110.826 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.52 156.35 19.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.089 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -109.68 55.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.741 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -61.41 119.79 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.231 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -91.05 111.04 22.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.752 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -91.37 -24.25 19.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 43.7 t 68.36 8.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.743 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.6 25.68 1.5 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.357 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.564 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.59 153.44 20.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.99 0.395 . . . . 0.0 110.301 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.8 OUTLIER -89.3 140.62 28.66 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.712 0.292 . . . . 0.0 110.769 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.45 -36.8 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.743 2.295 . . . . 0.0 112.591 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -91.6 -35.95 13.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.7 -30.13 20.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.786 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.29 -144.99 16.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.612 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -82.43 152.64 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 111.082 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -88.09 57.9 4.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.845 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.438 ' CG2' ' HG2' ' A' ' 37' ' ' GLU . 1.7 m -49.13 -25.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.28 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.85 -20.11 60.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.125 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -130.32 21.39 5.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.42 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 17.6 mt -70.37 159.2 34.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.885 0.374 . . . . 0.0 111.053 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -85.25 142.86 38.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.085 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.4 -18.86 26.44 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.673 2.248 . . . . 0.0 112.456 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -81.2 -58.81 2.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.917 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 3.7 pp -71.76 -40.85 69.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.217 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.26 -34.09 68.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.021 0.439 . . . . 0.0 110.124 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.6 t -64.23 -38.04 89.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.609 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 1.3 tp -56.68 -58.26 8.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.279 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -51.11 -42.13 60.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.467 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.6 m -62.7 -56.3 18.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.713 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.435 ' CD ' ' HB3' ' A' ' 78' ' ' SER . 0.2 OUTLIER -59.32 -25.5 64.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.763 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.98 -19.01 41.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.27 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.73 13.96 53.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.7 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.481 HG21 HD12 ' A' ' 35' ' ' ILE . 60.7 mt -87.26 122.15 38.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.889 0.376 . . . . 0.0 111.152 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -87.73 159.13 18.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.864 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.438 ' HG2' ' CG2' ' A' ' 19' ' ' VAL . 0.8 OUTLIER -53.15 -31.65 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.97 -41.92 68.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.8 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -77.5 -34.59 54.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.683 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.0 mt -70.55 -22.72 62.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.979 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -97.03 -5.01 38.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.739 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.37 124.34 29.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.829 0.347 . . . . 0.0 110.78 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.47 -36.71 45.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.635 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -72.08 -59.7 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.815 0.34 . . . . 0.0 111.43 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.42 -32.45 73.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.011 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 91.6 p -58.34 -41.18 84.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.36 . . . . 0.0 110.36 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 4.2 tptm -61.3 -53.02 62.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.473 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.485 ' CD2' ' CG ' ' A' ' 92' ' ' ARG . 1.6 pp -67.42 -31.46 71.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.25 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.2 -65.09 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.535 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.564 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.0 OUTLIER -54.89 -36.0 64.68 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.904 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -56.31 -34.05 66.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.389 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.46 -35.09 79.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.158 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.434 ' CG2' HG22 ' A' ' 62' ' ' VAL . 28.1 mt -62.77 -27.37 42.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.132 178.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.64 -33.34 68.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.53 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -73.27 -26.29 61.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.453 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.42 ' NE2' ' HA ' ' A' ' 56' ' ' GLN . 12.6 mm100 -85.0 3.49 38.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.379 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 103.47 19.62 12.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.431 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.86 167.77 41.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.465 ' CD1' ' CD2' ' A' ' 26' ' ' LEU . 28.2 tp -49.3 -37.54 24.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.47 -34.08 77.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.208 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.43 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.16 -35.43 66.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.379 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.434 HG22 ' CG2' ' A' ' 53' ' ' ILE . 45.5 t -65.71 -54.75 24.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.366 . . . . 0.0 110.815 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -53.62 -46.75 70.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.077 0.465 . . . . 0.0 110.087 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -63.09 -50.03 72.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.818 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.53 -37.52 77.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.323 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mmt -57.76 -32.44 67.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.422 . . . . 0.0 110.423 179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -77.89 -41.66 35.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.067 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -71.06 -26.59 63.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.07 -21.68 58.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -133.65 96.18 0.29 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.384 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -48.06 139.64 10.48 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.609 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.42 -178.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.68 135.03 12.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.524 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.93 -23.48 29.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.388 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.52 49.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.432 ' HG3' ' CZ ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -74.57 139.79 43.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.822 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.61 110.27 19.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.435 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 1.7 p -66.81 -12.34 58.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.344 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -71.22 96.18 1.37 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.128 0.489 . . . . 0.0 110.718 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.25 -101.54 0.21 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.003 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.436 ' CD1' ' HB2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -65.22 -34.14 77.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.532 0.206 . . . . 0.0 111.33 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.44 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 5.9 t -64.46 -32.58 58.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.822 0.344 . . . . 0.0 111.053 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.63 -43.8 66.4 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.029 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.38 -48.1 74.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.341 . . . . 0.0 110.783 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 13.2 tp -54.41 -46.04 73.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.33 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -35.39 61.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.276 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -68.81 -32.19 71.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.167 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 58.4 t -69.62 -42.19 80.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.564 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.422 ' CG ' HD11 ' A' ' 35' ' ' ILE . 11.0 mmt -62.43 -38.78 91.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.11 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -54.44 -21.97 11.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.179 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -70.25 -43.56 70.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.492 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.485 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 23.1 mmm-85 -74.82 -31.48 61.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.582 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.0 m -76.96 -30.71 56.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.114 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -105.85 5.14 30.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.782 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.82 173.91 10.54 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.248 0.546 . . . . 0.0 111.301 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.457 ' N ' ' CD1' ' A' ' 96' ' ' ILE . 1.6 mp -111.93 95.76 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.873 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -56.86 89.69 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.095 0.474 . . . . 0.0 110.179 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -129.25 160.26 33.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.788 -178.003 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.0 m -162.76 -84.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 53.87 91.62 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.877 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 101' ' ' GLU . 10.8 pt-20 -173.52 67.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.076 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 57.07 -113.58 4.55 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.487 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -54.58 118.36 4.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -71.54 66.45 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.66 119.45 39.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.964 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.97 104.41 11.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.025 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 CA-C-O 118.403 -1.22 . . . . 0.0 112.516 -179.929 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.806 0.336 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.71 31.61 4.78 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.419 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -83.73 138.66 33.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.83 157.25 19.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -162.67 62.18 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.05 137.13 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.19 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.3 p -149.04 134.35 18.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.833 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.422 ' O ' ' CD2' ' A' ' 59' ' ' LEU . 8.9 t60 -109.39 61.17 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -71.68 -66.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.939 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.49 44.66 10.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.582 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -87.97 153.88 20.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.342 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -88.36 139.61 30.17 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.775 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.94 -37.16 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.652 2.235 . . . . 0.0 112.568 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -88.94 -41.1 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -87.15 -27.21 23.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.15 -144.26 17.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.459 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.57 138.92 35.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 110.804 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.69 64.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.123 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -52.44 -25.62 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.21 -19.56 61.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -130.1 20.52 5.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.466 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 18.3 mt -70.46 159.21 34.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.369 . . . . 0.0 111.17 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.08 142.05 38.14 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.01 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 46.3 Cg_exo -55.75 -19.74 25.75 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.604 2.203 . . . . 0.0 112.543 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.438 ' CB ' ' HA ' ' A' ' 63' ' ' ARG . 13.8 m-20 -82.17 -57.43 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.401 HD23 ' CD1' ' A' ' 59' ' ' LEU . 3.8 pp -70.48 -32.75 70.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.235 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.424 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -64.96 -34.85 79.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 0.0 110.203 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -36.25 82.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.518 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 7.3 tp -56.13 -58.58 7.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.316 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CG ' HD22 ' A' ' 40' ' ' LEU . 20.9 m-85 -50.27 -40.83 49.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.739 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m -62.7 -54.97 31.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.789 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' CB ' HG11 ' A' ' 82' ' ' VAL . 8.6 mtt85 -58.39 -29.38 65.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.792 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.35 -21.05 36.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.184 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.34 17.75 41.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.557 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.5 mt -87.07 118.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.228 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.1 p -88.07 160.58 17.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.4 mp0 -51.9 -28.42 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.067 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.97 -44.56 70.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.662 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -79.15 -31.88 44.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.731 179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.46 HD22 ' CG ' ' A' ' 30' ' ' PHE . 91.6 mt -70.24 -27.89 64.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.636 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -97.71 -3.41 39.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.512 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -81.62 119.87 24.35 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.83 0.348 . . . . 0.0 110.625 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.08 -35.21 24.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.454 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -72.61 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.454 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.433 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.6 -37.05 81.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.223 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.3 p -55.69 -40.37 72.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 110.286 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -60.46 -55.84 28.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.191 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' CD2' ' HA ' ' A' ' 45' ' ' THR . 1.4 pp -65.48 -30.79 71.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.521 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 54.3 mt -67.62 -63.92 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.447 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.5 p90 -52.29 -36.15 52.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.934 0.397 . . . . 0.0 110.376 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.92 -33.28 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.472 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 79.2 t80 -64.63 -41.92 95.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.241 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.422 ' CG2' ' CG2' ' A' ' 62' ' ' VAL . 43.3 mt -55.69 -29.66 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.331 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.91 -36.32 75.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.746 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -71.01 -26.42 63.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.617 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 17.0 mm100 -86.11 9.77 16.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.475 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.428 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.73 17.96 26.74 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.594 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.79 169.93 45.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.823 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 14.4 tp -48.87 -42.14 35.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.726 0.298 . . . . 0.0 111.016 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -63.6 -35.24 79.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.21 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -34.25 66.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.484 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.422 ' CG2' ' CG2' ' A' ' 53' ' ' ILE . 21.7 t -66.76 -63.35 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.208 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.438 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -51.85 -41.14 61.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.016 0.436 . . . . 0.0 110.233 178.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -63.14 -52.99 60.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.278 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -70.78 -29.0 65.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.859 0.361 . . . . 0.0 111.138 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.417 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.2 mmt -63.87 -34.37 77.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.695 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.49 -37.16 57.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.614 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -71.14 -23.68 62.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.581 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -87.82 -21.9 24.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.021 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 151.91 -44.3 0.65 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.462 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 66' ' ' MET . . . 69.31 -157.53 53.45 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.61 69.37 2.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 110.972 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.83 131.25 1.45 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.531 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.68 -131.46 10.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.532 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.6 m -80.51 64.88 5.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.82 0.343 . . . . 0.0 110.972 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.53 110.01 8.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.677 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 t -118.46 120.16 36.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.303 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.421 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 60.9 p -78.85 -1.05 33.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.402 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.6 98.6 1.51 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.176 0.512 . . . . 0.0 110.854 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.85 -102.7 0.23 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.019 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.428 HD12 ' CD1' ' A' ' 29' ' ' LEU . 0.8 OUTLIER -65.21 -34.64 78.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.44 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 6.0 t -64.77 -35.06 74.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.79 0.328 . . . . 0.0 111.378 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.39 -43.9 67.67 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.554 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.41 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.87 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.7 tp -55.97 -47.17 78.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.892 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.4 mtm -53.41 -28.84 31.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -41.88 25.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.7 t -58.25 -42.36 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 110.318 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 38.8 mmm -63.37 -33.42 75.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.306 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -65.04 -22.88 67.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.814 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -68.34 -57.68 5.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.951 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.96 -23.7 63.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.315 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.9 m -74.43 -25.26 59.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.536 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.48 2.54 36.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.53 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.91 169.68 16.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.214 0.531 . . . . 0.0 111.434 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.7 mt -133.8 82.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.386 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.06 -41.09 2.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 110.335 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.78 25.98 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.255 178.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 p -70.57 176.89 3.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.987 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 59.62 94.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -58.48 -23.12 57.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.029 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 168.33 -93.78 0.11 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.413 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -61.1 134.94 57.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.967 0.413 . . . . 0.0 110.739 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.23 -24.89 62.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -91.86 -171.51 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.859 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.03 130.68 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.152 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.419 -1.212 . . . . 0.0 112.522 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.19 137.94 27.58 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.657 0.265 . . . . 0.0 110.747 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.67 -26.48 3.79 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.688 2.259 . . . . 0.0 112.351 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -95.38 -41.39 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -88.87 -26.26 21.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.95 -148.81 19.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.443 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.411 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -81.94 146.84 29.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 110.706 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -81.77 57.32 3.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.987 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.595 HG12 HD13 ' A' ' 40' ' ' LEU . 2.9 m -48.32 -26.02 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.243 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.01 -22.28 61.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.121 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -130.69 21.11 5.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.456 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.925 HD22 HD11 ' A' ' 26' ' ' LEU . 16.7 mt -70.25 159.47 33.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 111.082 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 11.9 t70 -83.47 139.76 41.45 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.816 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.489 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 45.4 Cg_exo -55.97 -18.27 21.93 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.479 2.119 . . . . 0.0 112.62 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 1.2 m-20 -80.87 -58.94 2.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.941 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.925 HD11 HD22 ' A' ' 22' ' ' LEU . 3.9 pp -71.68 -39.06 70.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.248 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.494 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.63 -36.03 79.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.855 0.359 . . . . 0.0 110.499 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.3 t -63.85 -36.27 83.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 82' ' ' VAL . 17.6 tp -57.16 -58.04 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.59 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.625 ' HZ ' HD11 ' A' ' 53' ' ' ILE . 9.8 m-85 -50.27 -41.83 51.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.731 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -49.12 78.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.561 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.507 ' HB3' HG11 ' A' ' 82' ' ' VAL . 8.5 mtt85 -58.25 -32.57 68.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.619 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.66 4.81 23.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.74 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.49 17.08 78.87 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.821 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.533 HD12 HD21 ' A' ' 85' ' ' LEU . 52.8 mt -86.79 120.25 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 111.056 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.8 p -86.92 157.26 19.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -52.99 -34.04 54.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.07 -36.13 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 45' ' ' THR . 1.6 mt-30 -78.58 -35.27 46.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.519 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.595 HD13 HG12 ' A' ' 19' ' ' VAL . 78.1 mt -70.35 -24.46 62.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.734 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 37' ' ' GLU . 44.7 p -96.08 -7.98 34.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.542 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 46' ' ' SER . 5.8 t70 -81.49 123.31 28.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.687 0.28 . . . . 0.0 110.674 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.24 -37.21 45.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.631 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.25 -60.04 2.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.342 . . . . 0.0 111.534 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.638 HG22 HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -66.82 -29.7 69.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.956 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 57.7 p -59.56 -43.66 93.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.441 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 7.4 tptt -60.29 -52.83 63.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.56 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.534 ' C ' HD12 ' A' ' 48' ' ' LEU . 1.9 pp -65.83 -33.04 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.483 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.638 HD11 HG22 ' A' ' 45' ' ' THR . 59.4 mt -68.82 -64.33 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 1.9 p90 -52.53 -36.59 55.79 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.48 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -55.62 -32.51 63.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.519 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.726 ' HD1' HG21 ' A' ' 88' ' ' VAL . 67.3 t80 -64.88 -41.79 95.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.116 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.975 HG23 HG21 ' A' ' 62' ' ' VAL . 22.0 mt -54.72 -27.77 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.365 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.65 -36.16 67.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.592 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.475 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -72.56 -25.45 61.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.609 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.453 ' HG3' ' CE2' ' A' ' 52' ' ' PHE . 83.3 mm-40 -85.54 9.31 16.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.466 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.29 16.46 32.27 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.563 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.37 171.36 47.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.921 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 59' ' ' LEU . 8.3 tp -48.82 -42.29 35.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.805 0.336 . . . . 0.0 110.988 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 15.0 mm-40 -63.62 -34.47 77.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.034 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.28 -32.73 64.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.348 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.975 HG21 HG23 ' A' ' 53' ' ' ILE . 38.6 t -65.75 -63.61 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.917 0.389 . . . . 0.0 110.622 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -54.06 -38.23 65.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.05 0.452 . . . . 0.0 109.986 177.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.415 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 58.1 mt-30 -64.59 -52.63 56.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.768 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -68.05 -31.19 70.68 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.169 -177.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.424 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 1.3 mmt . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 121.094 0.473 . . . . 0.0 109.873 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 29' ' ' LEU . 23.3 t . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.876 0.369 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.88 -39.15 85.62 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.569 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.95 -55.36 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 110.602 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.533 HD21 HD12 ' A' ' 35' ' ' ILE . 20.0 tp -52.83 -39.09 62.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.578 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.9 mtt -53.59 -34.28 57.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.224 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -77.1 -44.59 29.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.359 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.726 HG21 ' HD1' ' A' ' 52' ' ' PHE . 53.4 t -53.85 -38.05 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.635 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 95.7 mmm . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.272 178.856 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.483 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.707 0.289 . . . . 0.0 110.299 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.39 138.59 28.49 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.29 -43.74 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.593 2.195 . . . . 0.0 112.274 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -81.9 -39.86 23.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -87.38 -30.96 20.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.028 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.65 -149.55 18.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.678 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.639 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.69 136.66 35.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.341 . . . . 0.0 110.981 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -77.94 65.65 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.981 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.808 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.7 m -51.85 -23.47 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.237 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -72.3 -22.93 61.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.029 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -128.97 19.34 6.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.529 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.896 HD22 HD11 ' A' ' 26' ' ' LEU . 17.1 mt -70.38 159.7 33.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.881 0.372 . . . . 0.0 111.174 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.18 138.87 42.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.803 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.508 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 48.4 Cg_exo -55.79 -18.35 21.16 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.54 2.16 . . . . 0.0 112.587 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -81.2 -58.11 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.216 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.896 HD11 HD22 ' A' ' 22' ' ' LEU . 3.5 pp -70.64 -42.25 71.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.233 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.508 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -54.96 -38.39 67.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.915 0.388 . . . . 0.0 110.467 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -37.97 89.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.85 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.494 HD12 HG22 ' A' ' 82' ' ' VAL . 22.7 tp -56.03 -55.62 30.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.747 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.679 ' CD2' HD21 ' A' ' 40' ' ' LEU . 10.9 m-30 -50.32 -47.47 55.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.599 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -62.12 -52.58 63.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.472 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.55 ' HB3' HG11 ' A' ' 82' ' ' VAL . 74.4 mtt-85 -53.27 -31.95 46.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.525 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.45 -20.64 39.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.034 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.44 11.2 34.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.938 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.561 HD12 HD21 ' A' ' 85' ' ' LEU . 31.8 mt -86.9 120.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 111.255 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 p -86.91 160.39 18.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.808 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -51.93 -25.8 8.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.709 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.94 -45.17 74.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.425 ' CG ' HG21 ' A' ' 45' ' ' THR . 75.9 mt-30 -78.39 -29.22 47.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.761 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.679 HD21 ' CD2' ' A' ' 30' ' ' PHE . 88.4 mt -70.39 -26.83 63.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.52 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 37' ' ' GLU . 33.0 p -96.63 -3.93 41.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.531 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 46' ' ' SER . 15.3 t0 -82.73 124.37 30.17 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.776 0.322 . . . . 0.0 110.782 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.52 -40.19 59.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.42 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -72.69 -58.99 2.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.658 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.446 HG22 HD11 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -66.13 -33.62 76.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.337 -178.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 88.1 p -58.71 -39.32 80.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.84 0.352 . . . . 0.0 110.456 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -62.53 -54.96 32.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.555 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.662 HD13 HG12 ' A' ' 88' ' ' VAL . 1.9 pp -63.25 -31.06 72.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.053 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 45' ' ' THR . 57.6 mt -69.7 -64.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.418 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.483 ' CE1' ' CZ2' ' A' ' 11' ' ' TRP . 1.9 p90 -53.99 -39.87 66.44 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.167 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.4 ' OD1' ' CZ ' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -55.86 -33.66 64.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.745 178.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.72 ' HD2' HG21 ' A' ' 88' ' ' VAL . 26.4 t80 -64.65 -31.79 73.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 110.053 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.943 HG23 HG21 ' A' ' 62' ' ' VAL . 31.4 mt -61.72 -29.56 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.118 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -41.3 79.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.301 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 52' ' ' PHE . 1.1 p30 -65.75 -26.84 67.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.442 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 62.4 mm-40 -86.2 11.38 12.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.525 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 95.42 18.96 31.47 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.503 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.19 168.24 39.66 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.626 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.516 ' CD1' HD22 ' A' ' 26' ' ' LEU . 34.9 tp -49.18 -38.08 24.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.46 -35.99 82.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 56' ' ' GLN . . . -73.09 -34.61 66.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.497 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.943 HG21 HG23 ' A' ' 53' ' ' ILE . 22.0 t -65.78 -52.37 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.701 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.63 -44.88 69.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.115 0.483 . . . . 0.0 110.046 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -62.52 -50.89 69.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.691 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 22.3 pt-20 -68.89 -30.77 69.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.715 0.293 . . . . 0.0 111.027 -178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.559 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.55 HG11 ' HB3' ' A' ' 32' ' ' ARG . 6.2 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.805 0.336 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.09 -38.76 73.51 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.621 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.22 -51.7 62.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 110.951 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.561 HD21 HD12 ' A' ' 35' ' ' ILE . 45.8 tp -52.47 -46.3 66.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.701 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 39.9 mtm -52.99 -42.34 65.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.327 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.48 73.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.347 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.72 HG21 ' HD2' ' A' ' 52' ' ' PHE . 51.2 t -72.62 -38.29 58.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.587 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.1 mmm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.532 179.166 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.554 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.312 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -90.19 140.56 27.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.743 0.306 . . . . 0.0 110.604 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.69 -24.73 5.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.683 2.255 . . . . 0.0 112.479 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.31 -40.24 6.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -87.58 -21.14 25.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 95.58 -142.62 16.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.319 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.14 -174.34 5.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 0.0 110.866 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.85 57.22 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.332 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.794 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.5 m -47.87 -25.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.402 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -70.4 -22.07 62.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -134.95 23.61 3.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.596 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.033 HD22 HD11 ' A' ' 26' ' ' LEU . 17.7 mt -69.69 159.94 32.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 111.12 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.51 138.89 44.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.766 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.452 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 46.2 Cg_exo -55.66 -18.08 19.61 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.587 2.192 . . . . 0.0 112.519 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.34 -58.08 3.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.097 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.033 HD11 HD22 ' A' ' 22' ' ' LEU . 2.3 pp -71.45 -41.58 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.299 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -51.9 -40.74 61.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.427 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -64.74 -37.63 88.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.901 HD12 HG22 ' A' ' 82' ' ' VAL . 6.1 tp -56.74 -57.16 13.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.483 ' HZ ' HD11 ' A' ' 53' ' ' ILE . 15.6 m-85 -52.24 -41.88 63.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.8 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -53.97 50.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.623 ' HB3' HG11 ' A' ' 82' ' ' VAL . 12.6 mtt85 -54.11 -32.12 54.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.44 7.72 15.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.836 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.54 8.99 84.62 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.032 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.45 HD11 ' CG ' ' A' ' 89' ' ' MET . 61.0 mt -86.15 112.88 23.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.869 0.366 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.16 166.19 15.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.875 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.794 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -53.38 -29.77 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.09 -42.6 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.75 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -77.91 -29.7 50.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.616 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' CD1' ' CG1' ' A' ' 19' ' ' VAL . 53.9 mt -70.85 -25.3 62.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 37' ' ' GLU . 28.3 p -96.65 -5.72 38.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.706 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.26 119.23 23.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.878 0.371 . . . . 0.0 110.821 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.79 -34.81 28.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.358 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.99 -58.86 3.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.178 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.431 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.2 -30.56 71.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.822 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.8 p -59.36 -43.49 92.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.546 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 1.5 tptm -61.0 -51.71 68.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.593 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.691 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -67.09 -34.45 77.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.678 0.275 . . . . 0.0 111.197 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.56 HD11 ' HE3' ' A' ' 89' ' ' MET . 44.5 mt -68.65 -64.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.843 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.554 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 0.9 OUTLIER -53.72 -35.33 61.07 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.234 -178.536 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.452 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -54.05 -34.59 60.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.178 178.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.544 ' HD2' HG21 ' A' ' 88' ' ' VAL . 57.0 t80 -64.54 -44.21 91.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.043 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.529 HG23 HG21 ' A' ' 62' ' ' VAL . 23.8 mt -53.31 -25.18 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.336 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.49 -35.94 53.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 52' ' ' PHE . 0.9 OUTLIER -72.23 -25.21 61.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 110.769 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 27.9 mm-40 -86.04 11.58 11.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.494 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.92 19.26 27.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.491 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.32 167.65 38.76 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.648 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.489 ' CD1' HD22 ' A' ' 26' ' ' LEU . 25.4 tp -48.67 -37.01 17.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.088 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -64.99 -37.57 88.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.142 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.432 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.65 -33.32 66.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.49 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 53' ' ' ILE . 60.3 t -65.97 -52.24 51.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.871 0.367 . . . . 0.0 110.581 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -53.89 -44.68 70.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.18 0.515 . . . . 0.0 109.934 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -48.65 78.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.918 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 13.4 pt-20 -69.09 -41.66 77.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.687 0.279 . . . . 0.0 111.307 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.391 . . . . 0.0 110.683 179.866 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.901 HG22 HD12 ' A' ' 29' ' ' LEU . 28.2 t . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 120.786 0.327 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.75 -39.04 86.22 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.959 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.74 -49.66 67.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.591 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -55.93 -45.51 78.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.0 mtm -53.2 -39.57 63.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.15 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -62.92 -41.95 99.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.039 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.691 HG12 HD13 ' A' ' 48' ' ' LEU . 65.8 t -57.55 -36.47 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.488 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.623 ' HE1' HD11 ' A' ' 48' ' ' LEU . 15.8 mmt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.69 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 120.72 0.295 . . . . 0.0 110.256 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -91.96 134.48 28.71 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.626 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.41 -30.16 62.63 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.468 2.112 . . . . 0.0 112.56 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -105.24 -39.53 6.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.73 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -85.67 -9.8 56.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 82.1 -139.06 19.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.405 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -80.94 -169.37 2.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.964 0.411 . . . . 0.0 110.865 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -117.74 52.81 0.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.412 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.769 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.8 m -46.98 -26.36 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.494 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -70.24 -23.23 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -134.75 25.55 3.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.61 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.043 HD22 HD11 ' A' ' 26' ' ' LEU . 17.7 mt -69.99 159.59 33.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 111.271 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.72 139.73 40.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.767 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.491 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 44.3 Cg_exo -55.41 -18.68 19.94 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.506 2.137 . . . . 0.0 112.461 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -81.09 -57.67 3.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.123 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.043 HD11 HD22 ' A' ' 22' ' ' LEU . 3.6 pp -70.63 -41.85 71.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.143 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -57.11 -37.35 71.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 110.471 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.411 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 34.0 t -63.44 -37.03 85.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.714 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.726 HD12 HG22 ' A' ' 82' ' ' VAL . 38.3 tp -56.92 -53.59 56.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.689 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.469 ' CD2' HD11 ' A' ' 40' ' ' LEU . 17.7 m-85 -51.99 -43.44 63.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.574 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -61.74 -53.59 53.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.769 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.466 ' HB3' HG11 ' A' ' 82' ' ' VAL . 32.8 mtt180 -57.96 -30.57 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.833 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.11 -22.49 36.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.174 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.6 13.02 39.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.806 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.525 HD12 HD21 ' A' ' 85' ' ' LEU . 72.8 mt -86.53 118.67 33.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 111.132 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.19 162.78 17.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.769 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -53.14 -30.04 34.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.86 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.63 -41.15 69.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.845 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -78.03 -30.44 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.72 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.469 HD11 ' CD2' ' A' ' 30' ' ' PHE . 51.5 mt -71.48 -27.79 63.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.729 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 37' ' ' GLU . 10.7 p -97.4 -1.53 44.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.714 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 46' ' ' SER . 14.8 t70 -82.6 124.28 30.01 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.18 -41.44 60.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.55 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -72.53 -57.79 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.641 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.581 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.67 -37.53 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.353 -178.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 91.5 p -56.3 -38.72 71.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 0.0 110.279 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -62.19 -55.46 28.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.391 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.787 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.1 -31.98 73.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.301 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.581 HD11 HG22 ' A' ' 45' ' ' THR . 59.8 mt -67.78 -64.11 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.633 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.504 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 1.5 p90 -54.33 -39.85 67.45 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.387 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -55.49 -32.88 63.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.786 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.635 ' CD1' HG21 ' A' ' 88' ' ' VAL . 85.5 t80 -63.43 -38.42 91.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.911 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.009 HG23 HG21 ' A' ' 62' ' ' VAL . 22.0 mt -58.89 -28.84 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.219 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.43 -38.2 80.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.636 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.482 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -66.01 -25.37 67.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.614 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.477 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -84.15 -8.17 59.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.202 178.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 112.39 21.3 6.24 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.007 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.93 171.6 47.99 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.464 HD13 HD22 ' A' ' 26' ' ' LEU . 8.7 tp -48.24 -40.38 24.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.155 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -65.69 -35.02 79.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.432 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.83 -35.01 67.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.676 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 1.009 HG21 HG23 ' A' ' 53' ' ' ILE . 47.6 t -64.73 -62.1 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 110.74 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -36.2 39.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.208 0.527 . . . . 0.0 109.926 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -65.34 -51.83 57.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.881 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 16.7 pt-20 -68.17 -40.34 82.33 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.718 0.294 . . . . 0.0 111.359 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 C--N 1.326 -0.43 0 CA-C-O 120.962 0.41 . . . . 0.0 110.512 179.4 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.726 HG22 HD12 ' A' ' 29' ' ' LEU . 22.6 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.832 0.348 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.05 -38.46 73.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB3' ' HZ ' ' A' ' 52' ' ' PHE . . . -64.56 -55.44 20.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 111.008 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.525 HD21 HD12 ' A' ' 35' ' ' ILE . 12.4 tp -49.71 -41.17 42.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.791 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.4 mtm -54.19 -44.01 71.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -43.71 90.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.315 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.787 HG12 HD13 ' A' ' 48' ' ' LEU . 59.4 t -55.36 -41.76 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.64 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 84.0 mmm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.714 179.511 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 110.371 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -92.39 135.24 26.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.735 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 20.5 Cg_exo -63.96 -45.89 9.54 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.486 2.124 . . . . 0.0 112.629 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -90.09 -38.24 13.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.839 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -85.71 -21.04 28.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.192 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.55 -149.5 20.62 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.558 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.88 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.01 138.05 34.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.789 0.328 . . . . 0.0 111.028 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -78.2 67.33 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.745 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.783 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.4 m -51.64 -23.59 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.227 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.21 -20.2 60.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -130.29 20.27 5.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.603 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.977 HD22 HD11 ' A' ' 26' ' ' LEU . 18.9 mt -70.19 159.46 33.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 111.158 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.33 140.95 39.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 46.3 Cg_exo -56.12 -19.56 27.39 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.597 2.198 . . . . 0.0 112.512 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -81.4 -56.82 3.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.176 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.977 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -70.0 -42.02 73.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.23 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -54.53 -38.82 67.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.929 0.395 . . . . 0.0 110.123 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 t -63.1 -40.72 98.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.486 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.714 HD12 HG22 ' A' ' 82' ' ' VAL . 13.5 tp -57.11 -52.51 65.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.396 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.467 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 22.9 m-85 -53.45 -47.63 69.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.514 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 m -61.73 -51.51 68.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.831 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.604 ' HB3' HG11 ' A' ' 82' ' ' VAL . 13.8 mtt85 -57.08 -31.93 65.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.406 ' HB2' HG13 ' A' ' 82' ' ' VAL . . . -81.91 -10.91 59.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.477 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.63 13.54 55.07 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.77 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.455 HD12 HD21 ' A' ' 85' ' ' LEU . 64.1 mt -87.08 115.43 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.747 0.308 . . . . 0.0 111.29 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.3 p -87.26 160.76 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.72 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.783 ' HG2' HG21 ' A' ' 19' ' ' VAL . 1.1 mt-10 -52.55 -31.8 37.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.821 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.97 -42.47 72.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.643 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -78.09 -30.64 49.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.749 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 37' ' ' GLU . 73.4 mt -69.81 -26.71 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.547 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 37' ' ' GLU . 61.6 p -96.27 -3.06 44.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.64 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -81.94 116.13 21.43 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 120.786 0.327 . . . . 0.0 110.611 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.49 -35.09 8.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.569 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -72.19 -59.11 2.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.276 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.87 -33.17 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.304 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.0 p -58.42 -42.03 86.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.794 0.33 . . . . 0.0 110.612 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.81 -53.39 56.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.712 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.862 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -64.89 -33.69 76.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.782 0.325 . . . . 0.0 110.908 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.467 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 75.1 mt -67.55 -63.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.23 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.1 p90 -52.26 -40.27 61.49 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.086 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -36.55 64.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.47 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 78.6 t80 -63.46 -29.82 71.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.933 HG23 ' CG2' ' A' ' 62' ' ' VAL . 92.8 mt -66.28 -27.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.088 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -71.46 -39.27 71.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.586 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.4 p30 -64.42 -25.29 67.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.559 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.472 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 30.6 mt-30 -84.73 -9.91 57.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.175 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.14 21.37 5.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.134 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.53 168.94 45.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.424 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.1 tp -48.23 -36.23 13.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 111.106 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.12 -37.24 85.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.197 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.61 -34.66 67.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.561 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.933 ' CG2' HG23 ' A' ' 53' ' ' ILE . 61.5 t -65.48 -49.65 77.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 110.615 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -54.51 -48.25 72.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.152 0.501 . . . . 0.0 110.035 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.32 -43.2 95.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.465 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.441 ' OE2' ' NE2' ' A' ' 56' ' ' GLN . 9.5 pt-20 -67.87 -37.51 81.9 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.721 0.296 . . . . 0.0 111.392 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.425 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 2.1 mmt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.801 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.714 HG22 HD12 ' A' ' 29' ' ' LEU . 16.5 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.858 0.361 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.35 84.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.15 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.03 -43.31 95.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.907 0.384 . . . . 0.0 110.67 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.455 HD21 HD12 ' A' ' 35' ' ' ILE . 8.2 tp -55.74 -49.72 72.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.793 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.4 mtt -49.62 -28.21 5.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.858 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.81 -41.93 20.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.526 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.862 HG12 HD13 ' A' ' 48' ' ' LEU . 70.5 t -63.47 -42.0 94.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.028 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 79.1 mmm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.375 178.216 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.571 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 15' ' ' ASN . 1.3 m-20 -89.42 138.69 28.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.673 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.99 -27.74 3.62 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.611 2.207 . . . . 0.0 112.286 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -97.97 -39.26 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 26.3 m120 -87.92 -25.83 23.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.34 -149.68 19.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.628 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.632 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -82.46 148.17 28.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 110.943 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.95 63.47 8.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.818 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.6 m -50.9 -24.0 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.282 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.14 -21.0 60.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -132.3 23.49 4.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.529 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.003 HD22 HD11 ' A' ' 26' ' ' LEU . 18.4 mt -70.29 159.62 33.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.377 . . . . 0.0 111.029 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 10.5 t70 -83.22 140.33 42.33 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.864 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 45.1 Cg_exo -55.91 -18.3 21.67 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.608 2.205 . . . . 0.0 112.659 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.68 -58.14 3.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.049 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.003 HD11 HD22 ' A' ' 22' ' ' LEU . 3.3 pp -70.45 -40.3 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.094 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -51.99 -38.54 57.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.979 0.418 . . . . 0.0 110.198 179.309 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.441 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -64.54 -34.79 79.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.53 178.668 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.613 HD12 HG22 ' A' ' 82' ' ' VAL . 59.1 tp -56.76 -59.48 4.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.654 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.509 ' CG ' HD21 ' A' ' 40' ' ' LEU . 8.5 m-85 -51.2 -47.55 62.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.614 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.94 -54.85 36.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.873 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.461 ' HB3' HG11 ' A' ' 82' ' ' VAL . 58.8 mtt-85 -56.54 -29.82 62.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.95 -15.06 55.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.431 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.19 9.25 54.07 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.806 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.482 HD11 ' HG ' ' A' ' 85' ' ' LEU . 42.4 mt -86.7 120.52 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 0.0 111.218 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.2 p -87.14 161.52 18.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.818 ' HG2' HG21 ' A' ' 19' ' ' VAL . 2.7 tt0 -52.96 -31.47 40.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.89 -42.34 71.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -77.9 -30.73 50.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.509 HD21 ' CG ' ' A' ' 30' ' ' PHE . 96.0 mt -70.36 -25.06 63.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.726 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.3 p -96.22 -5.24 40.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.53 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.93 122.43 27.76 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 110.77 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.79 -37.93 45.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.52 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -71.72 -59.56 2.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.665 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -31.63 72.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.765 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.6 p -58.55 -44.22 89.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.357 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 7.8 tptt -59.87 -55.07 38.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.587 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -64.75 -32.91 74.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.504 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 69.7 mt -69.69 -64.17 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.493 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.646 ' HA ' HD12 ' A' ' 53' ' ' ILE . 1.6 p90 -52.75 -37.34 59.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.973 0.416 . . . . 0.0 110.06 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.99 -31.64 61.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.413 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.465 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 66.1 t80 -64.49 -41.52 96.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.095 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.941 HG23 HG21 ' A' ' 62' ' ' VAL . 37.2 mt -54.46 -27.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.29 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -72.7 -38.51 67.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.698 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.465 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -69.05 -25.89 64.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.688 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.458 ' NE2' ' OD1' ' A' ' 55' ' ' ASP . 82.3 mm-40 -85.19 9.09 16.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.402 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.52 19.59 24.79 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.415 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 82.26 168.87 42.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.588 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.1 tp -49.42 -39.63 33.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.691 0.282 . . . . 0.0 111.07 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -63.95 -36.37 83.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.032 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.43 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.05 -32.66 65.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.941 HG21 HG23 ' A' ' 53' ' ' ILE . 22.8 t -66.13 -52.86 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -54.15 -43.79 70.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.124 0.487 . . . . 0.0 110.127 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -63.32 -47.72 81.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.27 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 25.5 pt-20 -68.31 -40.43 81.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.693 0.282 . . . . 0.0 111.299 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.137 0.494 . . . . 0.0 110.284 179.131 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.613 HG22 HD12 ' A' ' 29' ' ' LEU . 10.5 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.816 0.341 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.02 -42.15 78.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.318 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.33 -46.2 84.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.373 . . . . 0.0 110.74 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.482 ' HG ' HD11 ' A' ' 35' ' ' ILE . 8.3 tp -52.72 -48.92 66.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.498 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.9 mtt -49.05 -44.05 41.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.659 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.04 -43.51 87.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.361 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.587 HG12 HD13 ' A' ' 48' ' ' LEU . 62.5 t -55.58 -42.94 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.464 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 82.2 mmm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.448 179.067 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.802 0.334 . . . . 0.0 110.564 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -92.92 132.51 30.85 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.425 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 24.4 Cg_exo -62.13 -31.59 83.08 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.452 2.101 . . . . 0.0 112.59 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -98.04 -41.22 8.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.668 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -86.44 -14.77 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.694 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 87.22 -140.74 17.07 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.216 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.441 ' HZ ' HD12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -81.79 -169.12 2.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.91 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.3 54.17 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.392 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.678 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.5 m -47.09 -26.33 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.384 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -70.2 -23.68 62.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.046 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -135.52 26.58 3.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.731 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.018 HD22 HD11 ' A' ' 26' ' ' LEU . 17.1 mt -69.65 159.36 33.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.816 0.341 . . . . 0.0 110.996 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.56 140.16 41.3 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 51.6 Cg_exo -54.84 -19.31 18.75 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.621 2.214 . . . . 0.0 112.51 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -81.19 -58.32 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.074 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.018 HD11 HD22 ' A' ' 22' ' ' LEU . 3.8 pp -71.44 -39.14 71.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.245 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.497 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -58.67 -35.57 72.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.383 . . . . 0.0 110.149 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.426 ' O ' ' CD ' ' A' ' 32' ' ' ARG . 25.8 t -63.75 -38.25 90.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.757 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.456 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 8.0 tp -54.86 -53.85 50.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.423 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.441 ' CD2' HD11 ' A' ' 40' ' ' LEU . 22.6 m-85 -51.35 -46.12 62.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.402 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 m -62.39 -48.03 81.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.736 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -62.05 -33.39 74.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.847 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.3 -21.55 36.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.18 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.91 16.77 32.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.703 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.9 mt -86.65 121.76 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.341 . . . . 0.0 111.14 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 p -87.02 159.13 19.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.678 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -53.03 -30.7 37.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.25 68.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.426 ' HB3' HG21 ' A' ' 45' ' ' THR . 33.3 mt-30 -78.47 -31.3 47.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.807 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.441 HD11 ' CD2' ' A' ' 30' ' ' PHE . 81.7 mt -70.71 -24.55 62.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.7 p -97.66 -7.75 30.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.602 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -82.02 116.45 21.63 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.809 0.338 . . . . 0.0 110.819 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.79 -32.05 8.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.4 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.53 -59.96 2.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 111.407 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.477 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.59 -33.79 75.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.969 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.9 m -59.41 -39.48 83.6 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.478 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 5.5 tptt -62.12 -49.17 76.96 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.433 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.507 ' CD1' HG12 ' A' ' 88' ' ' VAL . 1.5 pp -69.96 -34.36 73.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.748 0.309 . . . . 0.0 110.913 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 36.0 mt -67.89 -64.31 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.73 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 0.7 OUTLIER -52.42 -36.13 53.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.913 0.387 . . . . 0.0 110.384 -179.15 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -33.97 66.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.421 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.622 ' HD1' HG21 ' A' ' 88' ' ' VAL . 65.3 t80 -64.61 -40.12 94.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.327 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.931 HG23 ' CG2' ' A' ' 62' ' ' VAL . 23.2 mt -55.92 -29.92 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.042 0.449 . . . . 0.0 110.181 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -43.21 78.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.631 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.449 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -59.86 -24.39 64.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.934 0.397 . . . . 0.0 110.484 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.548 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 71.3 mm-40 -84.96 -13.91 49.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.159 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.9 24.83 3.81 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.817 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.449 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 83.24 168.79 43.83 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.38 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.457 ' HA ' HG21 ' A' ' 53' ' ' ILE . 10.5 tp -47.35 -33.88 6.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.903 0.383 . . . . 0.0 111.069 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 12.6 mt-10 -68.62 -35.82 77.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.001 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.95 -36.09 67.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.596 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.931 ' CG2' HG23 ' A' ' 53' ' ' ILE . 48.7 t -64.1 -63.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.277 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -30.17 40.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HB2' ' HA ' ' A' ' 61' ' ' ALA . 6.7 mt-30 -63.17 -56.6 15.35 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.088 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 15.7 pt-20 -69.67 -38.36 77.02 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.628 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.401 ' HE3' ' HB3' ' A' ' 28' ' ' SER . 2.1 mmt . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.059 0.457 . . . . 0.0 110.412 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 32' ' ' ARG . 3.3 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.789 0.328 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.39 -43.28 70.59 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.416 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -65.13 -48.55 73.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 14.8 tp -61.31 -40.73 95.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 7.0 mtm -53.28 -37.57 62.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.266 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -72.23 -44.08 63.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.407 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.622 HG21 ' HD1' ' A' ' 52' ' ' PHE . 59.1 t -53.92 -39.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.563 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.914 179.247 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.49 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.1 m-20 -89.42 140.28 28.43 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.749 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.426 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 71.9 Cg_endo -78.16 -18.43 12.76 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.658 2.239 . . . . 0.0 112.584 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -110.93 -38.16 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.024 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -87.25 -21.55 25.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 96.34 -138.29 13.85 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.249 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.409 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -81.71 -169.81 2.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.893 0.378 . . . . 0.0 110.919 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -118.2 53.23 0.97 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.569 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.717 HG11 ' HG3' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -47.01 -26.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.577 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.54 -22.91 61.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.049 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -134.54 25.43 3.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.569 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.056 HD22 HD11 ' A' ' 26' ' ' LEU . 17.5 mt -69.89 159.09 34.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 111.234 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -85.23 140.25 36.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.755 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 50.4 Cg_exo -54.84 -19.61 19.74 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.539 2.159 . . . . 0.0 112.559 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 4.5 m-20 -82.2 -57.12 3.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.328 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.056 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -69.93 -41.36 74.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.069 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.469 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -56.97 -35.46 69.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.933 0.396 . . . . 0.0 110.262 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -39.45 93.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.593 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.756 HD12 HG22 ' A' ' 82' ' ' VAL . 23.3 tp -57.34 -50.86 71.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.801 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 22.8 m-85 -54.65 -48.3 72.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.739 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -61.24 -46.44 90.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.882 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.74 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -58.9 -35.98 73.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.54 0.04 44.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.753 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.74 12.54 77.35 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.912 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.599 HD12 HD21 ' A' ' 85' ' ' LEU . 66.4 mt -86.67 112.91 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.783 0.325 . . . . 0.0 111.129 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.74 164.43 15.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.717 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.35 -29.66 24.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.643 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.83 -44.46 73.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.791 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -78.13 -29.06 48.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.694 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.409 HD21 ' CG ' ' A' ' 30' ' ' PHE . 75.0 mt -70.69 -26.29 63.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.692 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 37' ' ' GLU . 49.0 p -97.28 -7.54 31.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.576 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' SER . 6.1 t0 -81.61 112.59 18.96 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.906 0.384 . . . . 0.0 110.717 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 13' ' ' PRO . . . -46.49 -32.22 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.6 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.23 -58.47 3.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.933 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -68.62 -35.95 77.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.233 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -56.94 -39.74 75.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.854 0.359 . . . . 0.0 110.201 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 1.1 tppm? -60.78 -55.52 32.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.337 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.774 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.03 -33.47 75.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.035 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 60.4 mt -68.44 -63.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.654 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 1.8 p90 -51.09 -38.21 50.34 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.029 0.443 . . . . 0.0 110.018 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.68 -34.21 69.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.472 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 80.9 t80 -63.94 -28.93 70.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.039 0.447 . . . . 0.0 110.259 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.953 HG23 ' CG2' ' A' ' 62' ' ' VAL . 20.1 mt -68.5 -27.8 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.087 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.49 -35.07 70.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.594 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.3 p30 -69.28 -25.46 64.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.585 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.458 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 33.5 mt-30 -84.5 -8.76 58.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.089 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.02 21.39 5.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.064 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.405 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 84.52 168.9 44.95 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.396 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.496 HD13 HD22 ' A' ' 26' ' ' LEU . 11.1 tp -48.45 -38.67 20.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.02 -34.5 78.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.84 -33.91 66.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.607 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.953 ' CG2' HG23 ' A' ' 53' ' ' ILE . 44.5 t -65.32 -63.57 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.333 . . . . 0.0 110.804 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -52.64 -41.42 63.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 110.244 178.184 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -63.64 -49.15 74.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.644 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -69.44 -33.84 73.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.175 -178.117 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 110.36 179.532 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.756 HG22 HD12 ' A' ' 29' ' ' LEU . 20.7 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.84 0.352 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.65 -41.3 84.33 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.185 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.54 -49.09 72.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 110.585 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.599 HD21 HD12 ' A' ' 35' ' ' ILE . 9.5 tp -50.89 -52.9 37.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.762 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 12.6 mtm -51.01 -31.37 17.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -79.25 -29.34 42.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.489 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.774 HG12 HD13 ' A' ' 48' ' ' LEU . 64.8 t -72.38 -42.97 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.629 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.425 ' SD ' HD11 ' A' ' 35' ' ' ILE . 83.1 mmm . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.393 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.559 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.42 140.28 28.43 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.674 0.273 . . . . 0.0 110.729 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.98 -37.59 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.686 2.257 . . . . 0.0 112.393 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -90.42 -38.06 13.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.954 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -87.2 -27.73 22.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.41 -149.68 19.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.624 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 11' ' ' TRP . 0.1 OUTLIER -82.65 146.58 29.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 111.003 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.08 67.17 9.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.782 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.8 m -50.53 -29.51 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -70.86 -19.92 62.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.139 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -130.72 20.43 5.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.449 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.939 HD22 HD11 ' A' ' 26' ' ' LEU . 17.3 mt -70.49 159.74 33.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -83.03 139.44 42.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.3 Cg_exo -54.28 -19.61 17.31 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.623 2.215 . . . . 0.0 112.636 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 75.3 m-20 -81.06 -58.16 3.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.061 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.939 HD11 HD22 ' A' ' 22' ' ' LEU . 4.0 pp -70.95 -38.29 72.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.148 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.485 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -61.98 -34.71 76.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.376 . . . . 0.0 110.086 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.415 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 23.1 t -64.21 -36.86 85.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.597 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.448 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 3.4 tp -56.1 -58.12 9.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.302 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.47 ' HD1' HD21 ' A' ' 85' ' ' LEU . 17.7 m-85 -49.59 -38.36 31.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.986 0.422 . . . . 0.0 110.519 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.41 -57.78 10.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.763 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.635 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -60.5 -25.5 66.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.787 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.14 -18.3 43.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.305 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.08 17.99 56.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.604 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.687 HD13 ' HE3' ' A' ' 89' ' ' MET . 60.7 mt -86.24 126.14 40.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.177 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.69 152.79 21.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.782 ' HG2' HG21 ' A' ' 19' ' ' VAL . 1.5 mt-10 -51.9 -25.37 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.737 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.89 -42.76 72.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.875 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -78.37 -30.06 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.796 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.569 HD23 HD13 ' A' ' 49' ' ' ILE . 95.9 mt -70.67 -27.56 64.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.887 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 37' ' ' GLU . 23.4 p -98.33 -2.44 39.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.552 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 46' ' ' SER . 5.4 t70 -82.85 123.77 29.68 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.52 -37.14 47.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.592 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.74 -59.88 2.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.529 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.5 -36.03 80.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.203 -179.066 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 87.3 p -56.5 -37.59 70.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.88 0.372 . . . . 0.0 110.173 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 11.1 tptt -61.92 -55.69 27.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.742 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.86 -28.98 68.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.276 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.569 HD13 HD23 ' A' ' 40' ' ' LEU . 56.0 mt -67.38 -64.8 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.274 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.559 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.8 p90 -55.28 -34.27 63.95 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.75 -35.65 68.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.45 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.477 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 71.2 t80 -63.79 -30.19 71.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.028 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.939 HG23 HG21 ' A' ' 62' ' ' VAL . 17.6 mt -65.43 -27.95 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.033 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.83 -41.77 71.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.571 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.4 p30 -61.4 -25.32 67.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.509 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.406 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 28.1 mt-30 -85.0 -10.61 56.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.252 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.42 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.21 21.73 5.47 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.03 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.445 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 85.28 168.5 44.78 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.657 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.438 ' HA ' HG21 ' A' ' 53' ' ' ILE . 14.9 tp -47.67 -37.13 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 110.969 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.0 -36.96 83.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.611 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.42 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.54 -36.06 68.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.939 HG21 HG23 ' A' ' 53' ' ' ILE . 43.8 t -65.12 -62.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.699 0.285 . . . . 0.0 110.941 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.408 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -49.45 -39.04 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.958 0.409 . . . . 0.0 110.206 178.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -53.96 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.258 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 11.0 pt-20 -70.19 -28.15 65.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.5 mmm . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.833 179.031 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.635 HG11 ' HB3' ' A' ' 32' ' ' ARG . 3.8 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.756 0.312 . . . . 0.0 111.33 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.34 -41.71 77.26 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.561 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.64 -51.08 64.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.598 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.477 HD21 HD12 ' A' ' 35' ' ' ILE . 12.3 tp -58.95 -40.01 83.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.264 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.5 mtm -54.05 -38.57 65.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.198 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -69.89 -44.66 69.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.389 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.742 HG12 HD13 ' A' ' 48' ' ' LEU . 44.8 t -56.11 -38.99 56.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.812 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.687 ' HE3' HD13 ' A' ' 35' ' ' ILE . 28.7 mmt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.048 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 110.901 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.14 140.24 25.81 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.408 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.09 -36.17 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.598 2.199 . . . . 0.0 112.531 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -83.75 -41.35 17.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.129 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -87.62 -28.43 21.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.935 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.95 -146.8 17.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.712 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.8 135.7 35.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.941 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.26 62.85 0.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.563 HG11 ' HG3' ' A' ' 37' ' ' GLU . 2.3 m -53.44 -23.22 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.789 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.85 -20.77 59.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.903 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -128.64 18.31 6.28 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.517 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.925 HD22 HD11 ' A' ' 26' ' ' LEU . 17.4 mt -70.0 159.35 33.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 111.133 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 6.2 t70 -84.54 140.88 38.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.926 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 33.6 Cg_exo -57.24 -17.75 27.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.589 2.193 . . . . 0.0 112.589 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.427 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 0.6 OUTLIER -81.91 -57.94 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.151 -179.529 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.925 HD11 HD22 ' A' ' 22' ' ' LEU . 4.0 pp -69.57 -41.53 75.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.947 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.508 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -55.58 -35.81 66.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 110.295 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -62.61 -39.24 93.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.719 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.501 HD11 ' HA ' ' A' ' 82' ' ' VAL . 28.9 tp -56.81 -51.28 69.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.587 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.413 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 21.5 m-85 -53.42 -43.46 67.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.577 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.3 m -61.82 -51.55 67.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.89 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.52 ' HB3' HG11 ' A' ' 82' ' ' VAL . 9.9 mtt180 -59.9 -32.73 71.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.813 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HB1' ' HG2' ' A' ' 86' ' ' MET . . . -81.94 -18.28 44.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.34 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.33 8.56 54.83 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.937 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.712 HD12 HD21 ' A' ' 85' ' ' LEU . 72.8 mt -85.98 109.56 18.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.3 p -86.46 167.23 14.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.041 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.563 ' HG3' HG11 ' A' ' 19' ' ' VAL . 1.4 mp0 -53.2 -34.52 57.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.037 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.23 -42.5 66.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -77.68 -35.1 52.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.552 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.523 HD23 HD13 ' A' ' 49' ' ' ILE . 25.2 mt -69.95 -20.7 63.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 37' ' ' GLU . 68.1 p -94.32 -9.53 35.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.402 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -81.07 121.67 26.37 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.754 0.311 . . . . 0.0 110.708 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.72 -34.62 27.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.432 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.35 -59.91 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.59 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.415 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.72 -37.94 82.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.2 p -56.87 -39.52 74.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.818 0.342 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 1.3 tppm? -61.29 -55.79 27.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.348 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.732 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -65.25 -32.08 73.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.328 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.523 HD13 HD23 ' A' ' 40' ' ' LEU . 55.4 mt -66.49 -63.98 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.124 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.565 ' CE1' ' CZ2' ' A' ' 11' ' ' TRP . 2.0 p90 -53.41 -37.96 62.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.97 0.414 . . . . 0.0 110.043 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.9 -35.57 66.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.481 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.493 ' HD2' HG21 ' A' ' 88' ' ' VAL . 37.4 t80 -64.0 -34.55 78.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.097 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.988 HG23 HG21 ' A' ' 62' ' ' VAL . 23.8 mt -60.77 -28.63 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.072 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.36 -38.84 78.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.459 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.83 -25.53 64.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 61.3 mm-40 -87.5 13.38 10.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.455 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 95.21 17.41 37.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.572 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.18 170.55 46.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.879 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 10.2 tp -49.49 -41.56 40.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.713 0.292 . . . . 0.0 111.27 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -65.1 -34.8 79.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.5 -34.29 65.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.656 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.988 HG21 HG23 ' A' ' 53' ' ' ILE . 61.5 t -64.29 -61.92 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -51.56 -38.6 55.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.082 0.468 . . . . 0.0 110.008 177.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.87 -51.5 64.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.329 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 11.3 pt-20 -68.74 -33.95 74.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.762 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.437 ' CE ' ' CA ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.52 HG11 ' HB3' ' A' ' 32' ' ' ARG . 6.5 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.779 0.323 . . . . 0.0 111.385 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -34.87 78.23 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.298 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -51.28 62.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 110.681 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.712 HD21 HD12 ' A' ' 35' ' ' ILE . 14.5 tp -62.94 -42.5 99.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.477 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.512 ' HG2' ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -53.37 -33.36 53.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.403 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -75.17 -30.31 60.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.349 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.732 HG12 HD13 ' A' ' 48' ' ' LEU . 96.8 t -66.36 -40.24 86.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.626 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.484 ' SD ' HD11 ' A' ' 35' ' ' ILE . 74.1 mmm . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.614 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.809 0.337 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -88.83 140.23 29.38 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.545 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.23 -33.5 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.671 2.247 . . . . 0.0 112.572 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -93.22 -41.11 10.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -87.1 -26.94 23.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.043 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 101.62 -145.11 16.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.386 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.559 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.43 138.9 35.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -76.01 62.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.249 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.583 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.8 m -51.24 -24.69 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.9 -21.39 60.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -128.55 19.91 6.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.383 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.074 HD22 HD11 ' A' ' 26' ' ' LEU . 16.4 mt -71.02 159.06 35.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.793 0.33 . . . . 0.0 111.189 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.88 142.56 39.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.989 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 43.3 Cg_exo -56.01 -20.02 28.51 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.606 2.204 . . . . 0.0 112.529 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.42 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 1.1 m-20 -81.82 -56.97 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.14 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.074 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -71.12 -37.46 72.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.476 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 2.0 ppt_? -59.59 -36.27 75.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.948 0.404 . . . . 0.0 110.214 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.1 t -63.68 -37.2 86.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.652 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 82' ' ' VAL . 25.6 tp -56.71 -57.07 14.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.625 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CG ' HD21 ' A' ' 40' ' ' LEU . 20.3 m-85 -48.35 -43.63 33.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.25 -58.48 7.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.631 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.668 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -55.54 -29.86 59.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.826 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.77 3.52 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.806 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.8 4.28 90.37 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.994 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 36' ' ' SER . 35.2 mt -85.67 162.35 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.893 0.347 . . . . 0.0 110.851 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -145.4 172.77 12.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.033 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 41' ' ' THR . 1.0 OUTLIER -53.45 -37.78 62.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.025 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.71 -46.42 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.71 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -78.54 -34.02 47.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.668 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD21 ' CG ' ' A' ' 30' ' ' PHE . 83.6 mt -70.0 -23.14 63.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 37' ' ' GLU . 46.9 p -94.99 -7.65 39.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.537 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -81.3 119.17 23.32 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.757 0.313 . . . . 0.0 110.715 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.85 -34.48 12.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.493 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -72.75 -59.89 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.415 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.426 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -68.21 -34.41 76.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.409 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.2 p -58.32 -42.3 86.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.847 0.356 . . . . 0.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -60.99 -53.14 60.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.499 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.874 HD13 HG12 ' A' ' 88' ' ' VAL . 1.5 pp -65.04 -32.26 73.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.741 0.305 . . . . 0.0 110.828 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.442 HD13 HD23 ' A' ' 40' ' ' LEU . 49.9 mt -68.42 -64.0 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.384 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.3 p90 -52.08 -40.7 61.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.885 0.374 . . . . 0.0 110.303 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.449 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -53.57 -32.68 51.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 178.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.46 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 69.3 t80 -63.85 -41.74 97.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.122 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.796 HG23 HG21 ' A' ' 62' ' ' VAL . 59.9 mt -55.39 -25.11 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.41 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.83 -35.54 59.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.783 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.46 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -72.93 -25.63 61.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.8 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -87.4 13.98 8.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.552 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.97 14.72 41.7 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.635 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.91 170.19 46.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.127 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.414 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 12.5 tp -48.99 -40.13 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 110.899 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -65.07 -36.19 83.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.302 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.08 -35.76 66.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.899 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.796 HG21 HG23 ' A' ' 53' ' ' ILE . 24.0 t -65.0 -63.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.756 0.312 . . . . 0.0 110.912 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -51.69 -44.53 63.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.071 0.462 . . . . 0.0 110.235 178.341 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -63.0 -52.58 62.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.41 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 4.4 pt-20 -70.4 -23.3 62.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.212 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 0.0 110.241 179.037 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 32' ' ' ARG . 16.8 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.824 0.345 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -46.47 60.05 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.037 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.35 -46.49 79.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.948 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.496 HD21 HD12 ' A' ' 35' ' ' ILE . 13.6 tp -55.97 -46.83 78.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.7 mtp -53.62 -29.97 40.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.441 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -80.08 -30.17 39.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.525 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.874 HG12 HD13 ' A' ' 48' ' ' LEU . 59.9 t -69.48 -42.45 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 110.308 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.3 mmm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.138 178.141 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.569 ' CH2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.745 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.09 140.8 29.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.552 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.05 -38.2 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.652 2.235 . . . . 0.0 112.772 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -94.17 -35.6 12.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.19 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -87.77 -25.29 23.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.112 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.85 -150.19 19.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.393 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.686 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.28 136.36 35.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.332 . . . . 0.0 110.891 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -74.83 62.95 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.277 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.608 HG21 ' HG2' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -52.0 -23.83 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.288 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.43 -21.76 61.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.194 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -132.68 21.89 4.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.487 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.015 HD22 HD11 ' A' ' 26' ' ' LEU . 16.5 mt -70.07 159.03 34.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 111.23 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -85.19 139.84 36.63 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.0 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 52.5 Cg_exo -55.19 -18.94 19.35 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.621 2.214 . . . . 0.0 112.684 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -81.19 -57.97 3.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.228 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.015 HD11 HD22 ' A' ' 22' ' ' LEU . 3.5 pp -69.91 -42.81 72.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.096 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -54.72 -34.22 62.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.956 0.407 . . . . 0.0 110.086 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.33 -39.18 93.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.677 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 82' ' ' VAL . 22.4 tp -56.59 -55.65 31.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.591 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.43 ' CG ' HD21 ' A' ' 40' ' ' LEU . 9.9 m-30 -50.38 -43.61 54.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.617 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 m -62.34 -55.14 30.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.709 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.467 ' HB3' HG11 ' A' ' 82' ' ' VAL . 2.6 mtp180 -56.73 -30.89 63.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.827 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.92 -21.46 37.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 8.68 48.31 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.771 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.569 HD12 HD21 ' A' ' 85' ' ' LEU . 39.3 mt -86.09 112.3 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.83 0.348 . . . . 0.0 111.176 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 p -87.0 167.6 14.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' THR . 3.5 mt-10 -52.17 -28.91 19.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.821 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.5 -46.14 73.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 35' ' ' ILE . 2.7 mt-30 -78.47 -31.38 47.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.688 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.43 HD21 ' CG ' ' A' ' 30' ' ' PHE . 87.4 mt -69.98 -25.48 63.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 37' ' ' GLU . 44.4 p -97.29 -5.33 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.607 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 46' ' ' SER . 20.9 t0 -82.23 113.69 20.22 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.753 0.311 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.6 -32.28 3.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.59 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.94 -59.66 2.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.122 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.413 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.85 -36.5 80.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.295 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -56.39 -38.16 71.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.848 0.356 . . . . 0.0 110.21 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 4.1 tptm -62.07 -54.95 34.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.363 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.693 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -67.04 -30.67 70.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.258 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 48.7 mt -68.02 -64.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.517 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.569 ' CZ ' ' CH2' ' A' ' 11' ' ' TRP . 2.1 p90 -52.77 -40.72 63.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.94 0.4 . . . . 0.0 110.224 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.78 -32.69 60.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.7 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 85' ' ' LEU . 77.0 t80 -64.54 -38.67 91.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.25 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.047 HG23 HG21 ' A' ' 62' ' ' VAL . 44.6 mt -59.18 -28.64 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.238 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.67 -33.95 73.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.342 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.464 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -75.08 -24.66 58.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.476 178.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 97.0 mm-40 -85.9 10.48 13.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.339 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.15 17.08 33.11 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.483 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 82.64 171.21 46.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.809 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.5 tp -49.34 -41.62 39.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 111.281 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -63.87 -34.84 78.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.219 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -35.57 66.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.255 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 1.047 HG21 HG23 ' A' ' 53' ' ' ILE . 22.0 t -66.06 -48.79 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -54.29 -46.55 72.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.112 0.482 . . . . 0.0 109.985 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.53 -49.07 74.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.943 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 20.3 pt-20 -67.56 -24.75 65.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.805 0.336 . . . . 0.0 110.808 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.404 ' CE ' ' N ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 32' ' ' ARG . 6.0 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.774 0.321 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.2 -38.51 82.56 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.479 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.576 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.94 -48.74 73.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.569 HD21 HD12 ' A' ' 35' ' ' ILE . 30.7 tp -62.03 -45.18 94.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.4 mtm -54.25 -34.48 60.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.499 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -75.74 -24.46 56.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.693 HG12 HD13 ' A' ' 48' ' ' LEU . 48.2 t -78.28 -37.4 22.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.156 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 67.2 mmm . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 121.046 0.451 . . . . 0.0 110.258 179.207 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.556 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.772 0.32 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.8 m-20 -90.57 138.41 26.74 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.467 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.23 -23.45 6.33 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.587 2.191 . . . . 0.0 112.598 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -99.1 -41.14 7.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.088 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -88.15 -29.85 20.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.046 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 109.56 -144.79 16.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.467 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.861 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -83.49 147.01 28.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 111.095 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -82.14 58.75 4.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.886 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.473 HG12 HD13 ' A' ' 40' ' ' LEU . 1.6 m -51.38 -24.03 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.069 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -19.77 59.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -131.61 21.34 4.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.401 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.036 HD22 HD11 ' A' ' 26' ' ' LEU . 17.6 mt -70.14 159.63 33.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.933 0.397 . . . . 0.0 111.201 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -83.52 145.85 48.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.06 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 31.4 Cg_exo -58.66 -22.23 59.64 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.634 2.223 . . . . 0.0 112.645 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.92 -56.37 4.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.328 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.036 HD11 HD22 ' A' ' 22' ' ' LEU . 3.6 pp -70.85 -32.77 69.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.333 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -64.17 -35.56 81.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.234 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -35.82 81.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.642 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 9.4 tp -56.4 -60.36 3.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.544 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CG ' HD21 ' A' ' 40' ' ' LEU . 16.7 m-85 -49.0 -45.24 42.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.817 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 m -62.22 -50.38 72.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -59.5 -33.18 71.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.61 -12.79 58.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.378 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.65 11.77 58.9 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.624 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -86.48 114.79 26.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.807 0.336 . . . . 0.0 111.086 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.9 p -87.53 163.49 16.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.815 ' O ' HG23 ' A' ' 41' ' ' THR . 0.4 OUTLIER -53.11 -26.7 17.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.39 -44.77 72.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.405 ' HB3' HG21 ' A' ' 45' ' ' THR . 40.7 mt-30 -78.58 -33.64 47.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.744 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.473 HD13 HG12 ' A' ' 19' ' ' VAL . 76.5 mt -68.79 -22.3 64.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.804 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 37' ' ' GLU . 35.1 p -96.53 -8.75 31.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.555 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.6 t70 -82.22 112.76 19.53 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.783 0.325 . . . . 0.0 110.645 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.96 -31.27 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.7 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -72.37 -59.65 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.882 0.372 . . . . 0.0 110.929 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.71 -33.33 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -58.66 -39.5 80.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.269 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 19.1 tptt -61.74 -53.31 57.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.566 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.937 HD13 HG12 ' A' ' 88' ' ' VAL . 1.9 pp -66.44 -32.41 73.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.356 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 46.3 mt -68.2 -64.59 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.554 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.556 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.3 p90 -53.63 -37.43 63.06 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.981 0.419 . . . . 0.0 110.138 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -55.44 -36.41 66.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.426 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.459 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 64.3 t80 -64.32 -37.56 87.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.043 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.967 HG23 HG21 ' A' ' 62' ' ' VAL . 49.5 mt -58.62 -29.07 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.178 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -40.27 77.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.587 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.459 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -66.37 -26.24 67.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.458 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.46 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 94.6 mm-40 -85.28 1.35 48.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.338 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 104.41 18.82 12.3 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.475 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.45 170.83 46.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.846 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.582 HD13 HD22 ' A' ' 26' ' ' LEU . 12.1 tp -48.52 -40.33 26.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.322 . . . . 0.0 111.093 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.64 -35.07 79.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.247 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -74.05 -34.24 63.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.818 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.967 HG21 HG23 ' A' ' 53' ' ' ILE . 44.0 t -65.02 -63.29 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.699 0.285 . . . . 0.0 110.873 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -52.47 -41.64 63.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.052 0.453 . . . . 0.0 110.13 177.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -63.23 -53.26 55.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.33 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 10.1 pt-20 -69.36 -26.61 64.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.992 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.5 mmt . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.079 0.466 . . . . 0.0 110.238 178.896 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.47 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 3.6 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.24 -48.91 43.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.274 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -65.12 -45.39 85.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.794 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 29' ' ' LEU . 11.4 tp -56.8 -40.99 76.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.625 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.7 mtt -53.0 -41.16 64.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.24 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -45.49 74.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.669 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.937 HG12 HD13 ' A' ' 48' ' ' LEU . 22.5 t -51.25 -40.02 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.709 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 92.9 mmm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.325 178.699 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.28 137.93 28.98 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.679 0.276 . . . . 0.0 110.795 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.44 -23.36 7.36 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -98.42 -41.4 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -89.45 -25.92 21.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.002 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.74 -142.47 16.1 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.337 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.589 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -83.0 146.4 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 0.0 110.841 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -84.66 61.12 6.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.731 HG11 ' HG3' ' A' ' 37' ' ' GLU . 5.2 m -49.07 -25.36 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.237 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -72.12 -20.88 61.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.086 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -132.23 20.75 4.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.429 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.0 HD22 HD11 ' A' ' 26' ' ' LEU . 17.0 mt -70.28 159.7 33.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.936 0.398 . . . . 0.0 111.163 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -82.44 139.42 44.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.77 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 49.2 Cg_exo -54.86 -19.17 18.36 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.518 2.146 . . . . 0.0 112.464 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' ' HE2' ' A' ' 66' ' ' MET . 7.2 m-20 -81.27 -57.68 3.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.127 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.0 HD11 HD22 ' A' ' 22' ' ' LEU . 3.4 pp -70.64 -40.97 72.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.105 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.5 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.6 OUTLIER -59.04 -39.09 80.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 0.0 110.576 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -64.09 -38.49 91.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.619 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.694 HD12 HG22 ' A' ' 82' ' ' VAL . 15.5 tp -56.11 -51.01 69.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.576 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.444 ' CG ' HD21 ' A' ' 40' ' ' LEU . 21.0 m-85 -52.3 -49.04 64.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.512 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.3 m -62.41 -41.49 98.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.791 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.545 ' HB3' HG11 ' A' ' 82' ' ' VAL . 34.7 mtt180 -62.48 -35.86 80.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.983 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.1 -14.74 57.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.482 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 10.78 45.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.796 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.511 HD11 ' HG ' ' A' ' 85' ' ' LEU . 62.5 mt -86.64 119.62 34.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.842 0.353 . . . . 0.0 110.939 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -86.6 157.45 19.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.998 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.731 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.82 -30.32 32.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.047 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.65 70.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.858 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.432 ' NE2' HG21 ' A' ' 45' ' ' THR . 9.6 mm100 -77.76 -30.14 51.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.712 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.444 HD21 ' CG ' ' A' ' 30' ' ' PHE . 95.2 mt -69.6 -22.8 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.5 p -97.44 -7.68 31.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.606 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' SER . 2.1 t70 -81.45 115.51 20.81 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.818 0.342 . . . . 0.0 110.63 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.96 -34.2 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.682 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -72.44 -59.9 2.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 0.0 111.491 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.442 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.3 -32.89 74.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.172 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 1.4 t -57.86 -42.1 83.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.599 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.469 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.84 -55.2 32.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.358 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.633 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -63.31 -31.61 72.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.723 0.297 . . . . 0.0 110.953 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.431 HD13 HD23 ' A' ' 40' ' ' LEU . 70.4 mt -69.76 -64.02 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.381 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 1.9 p90 -53.35 -38.2 63.06 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.073 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -54.18 -34.32 60.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.638 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.478 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 69.1 t80 -63.93 -30.67 71.73 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.092 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.981 HG23 HG21 ' A' ' 62' ' ' VAL . 40.2 mt -66.29 -28.5 43.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.034 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -71.8 -34.42 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.816 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.478 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.3 p30 -69.96 -25.59 63.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 0.0 110.497 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.471 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 29.4 mt-30 -83.12 -8.97 59.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.094 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 113.64 22.08 5.54 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.886 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.64 171.02 47.21 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.603 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 13.2 tp -47.8 -41.64 24.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 111.055 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 28.5 mt-10 -64.27 -34.51 78.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.4 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -73.16 -35.93 66.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.709 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.981 HG21 HG23 ' A' ' 53' ' ' ILE . 40.3 t -65.14 -63.56 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.667 0.27 . . . . 0.0 110.812 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -53.08 -37.94 62.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.98 0.419 . . . . 0.0 109.94 177.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 43.6 mt-30 -63.17 -50.62 69.67 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.061 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -68.8 -34.88 76.27 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.542 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.415 ' HE2' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 121.087 0.47 . . . . 0.0 110.049 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.694 HG22 HD12 ' A' ' 29' ' ' LEU . 6.2 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.783 0.325 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.33 -36.96 85.65 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.301 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.22 -47.04 81.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.703 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.511 ' HG ' HD11 ' A' ' 35' ' ' ILE . 5.9 tp -54.08 -49.41 69.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.493 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.4 mtm -51.1 -31.63 19.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.473 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -39.92 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.259 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.633 HG12 HD13 ' A' ' 48' ' ' LEU . 57.9 t -56.4 -40.56 67.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.207 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.42 ' CE ' HG22 ' A' ' 45' ' ' THR . 3.3 mmt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.183 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.495 ' CE2' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 120.758 0.313 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.428 ' HB2' ' HB2' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -92.58 136.15 25.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.73 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.15 -58.73 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.494 2.13 . . . . 0.0 112.592 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -81.33 -34.44 31.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.715 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 47.9 m-20 -86.14 -22.76 26.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.651 0.262 . . . . 0.0 111.199 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.65 -150.6 21.83 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.587 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.78 142.87 33.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.862 0.363 . . . . 0.0 110.997 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.7 64.96 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.771 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.0 m -54.69 -21.5 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.261 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -72.72 -20.84 61.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.143 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -132.11 20.62 4.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.508 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.867 HD22 HD11 ' A' ' 26' ' ' LEU . 17.7 mt -69.8 159.46 33.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.154 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 9.2 t70 -84.08 137.97 39.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.77 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 44.5 Cg_exo -55.89 -18.53 22.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.558 2.172 . . . . 0.0 112.463 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 68.3 m-20 -80.84 -57.63 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.044 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.867 HD11 HD22 ' A' ' 22' ' ' LEU . 4.1 pp -69.53 -44.81 70.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.148 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.622 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.2 -32.9 62.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.863 0.363 . . . . 0.0 110.534 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.4 t -64.55 -38.06 89.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 82' ' ' VAL . 16.0 tp -56.35 -54.54 44.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.733 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.566 ' CD2' HD11 ' A' ' 40' ' ' LEU . 8.2 m-85 -50.99 -44.32 60.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.769 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -61.8 -49.32 76.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.915 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -34.05 67.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.054 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.94 -18.55 46.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.39 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.15 11.68 41.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.89 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 85' ' ' LEU . 52.4 mt -86.21 117.79 31.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.813 0.34 . . . . 0.0 111.057 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.03 161.46 18.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.771 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -52.73 -26.49 14.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.851 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.09 -43.2 73.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HG2' HG21 ' A' ' 45' ' ' THR . 1.7 mt-30 -78.57 -28.73 45.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.742 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 30' ' ' PHE . 33.1 mt -71.19 -23.58 62.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.856 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 37' ' ' GLU . 45.6 p -98.05 -7.55 29.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.696 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 46' ' ' SER . 29.1 t0 -81.96 122.55 27.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.799 0.333 . . . . 0.0 110.744 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.07 -38.22 37.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.556 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -73.18 -59.81 2.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.672 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.487 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.75 -35.96 81.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.126 -178.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 70.4 m -58.8 -41.98 88.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.855 0.36 . . . . 0.0 110.438 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -60.11 -55.23 36.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.43 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.824 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -64.4 -31.99 73.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.383 -178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 45' ' ' THR . 60.4 mt -67.5 -63.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.203 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.495 ' CE2' ' CE2' ' A' ' 11' ' ' TRP . 2.0 p90 -52.36 -35.84 52.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.925 0.393 . . . . 0.0 110.303 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.8 -32.76 63.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.476 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 74.0 t80 -64.67 -41.03 96.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.167 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.927 HG23 HG21 ' A' ' 62' ' ' VAL . 30.8 mt -55.95 -28.23 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.213 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -71.21 -36.13 71.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.589 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -73.49 -25.92 60.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.568 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 89.2 mm-40 -86.22 12.5 9.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.639 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.49 15.04 36.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.607 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.1 170.63 45.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.784 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.4 tp -48.95 -37.95 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 111.112 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.01 -35.69 82.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.317 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.21 -35.8 66.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.668 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.927 HG21 HG23 ' A' ' 53' ' ' ILE . 31.3 t -65.32 -63.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.707 0.289 . . . . 0.0 110.768 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.425 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -52.1 -37.47 54.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.06 0.457 . . . . 0.0 110.138 178.016 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -63.09 -52.07 64.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.53 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.403 ' OE2' ' N ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -69.5 -36.32 76.37 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.803 0.335 . . . . 0.0 110.982 -178.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.403 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 2.8 mmt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.596 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 29' ' ' LEU . 9.2 t . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.892 0.377 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.29 -41.1 80.09 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.26 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.49 -39.46 93.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 35' ' ' ILE . 10.3 tp -64.0 -41.08 97.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.37 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -42.5 67.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.18 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -44.89 92.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.824 HG12 HD13 ' A' ' 48' ' ' LEU . 44.7 t -52.33 -41.79 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.56 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 74.5 mmm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.793 179.289 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.486 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.318 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.96 138.58 27.61 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.615 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -78.61 -33.89 1.58 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -92.33 -41.0 10.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.946 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.15 -25.1 24.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.012 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.34 -146.28 18.19 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.505 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.59 140.21 34.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -74.86 60.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.772 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -50.52 -24.64 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -73.48 -22.25 60.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -128.7 20.03 6.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.433 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.825 HD22 HD11 ' A' ' 26' ' ' LEU . 17.1 mt -70.64 159.49 34.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 111.051 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 2.6 t70 -84.58 139.3 38.11 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.095 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 48.3 Cg_exo -55.67 -19.0 22.49 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.56 2.173 . . . . 0.0 112.399 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -81.34 -57.16 3.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.929 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.825 HD11 HD22 ' A' ' 22' ' ' LEU . 4.2 pp -70.14 -44.37 69.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.041 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.707 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -54.39 -35.9 63.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.917 0.389 . . . . 0.0 110.46 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.06 -38.92 93.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.708 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.633 HD12 HG22 ' A' ' 82' ' ' VAL . 27.8 tp -56.65 -54.23 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.572 ' HD1' HD21 ' A' ' 85' ' ' LEU . 21.7 m-85 -51.93 -46.77 64.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.491 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -62.21 -50.72 70.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.714 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.554 ' HB3' HG11 ' A' ' 82' ' ' VAL . 43.9 mtt180 -54.73 -32.25 59.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.555 ' HB1' ' HG2' ' A' ' 86' ' ' MET . . . -82.5 -14.24 55.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.469 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.05 13.12 50.58 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.677 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.476 HD12 HD21 ' A' ' 85' ' ' LEU . 58.2 mt -86.52 118.9 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 111.047 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.74 163.57 17.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.881 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.772 ' HG2' HG21 ' A' ' 19' ' ' VAL . 2.4 mt-10 -53.78 -30.3 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.876 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.91 72.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.074 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -78.27 -31.32 48.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.805 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.485 HD21 ' CG ' ' A' ' 30' ' ' PHE . 96.0 mt -70.97 -27.59 63.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.463 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 37' ' ' GLU . 31.5 p -97.75 -3.64 38.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.555 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.72 121.46 26.42 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.9 -37.23 30.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.479 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.86 -59.89 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.595 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.71 -35.52 78.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.394 -178.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.5 p -57.42 -37.57 72.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.822 0.344 . . . . 0.0 110.147 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 18.0 tptt -61.55 -56.07 24.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.146 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.82 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -65.72 -30.72 71.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.287 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.455 HD13 HD23 ' A' ' 40' ' ' LEU . 39.5 mt -68.03 -64.21 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.532 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.3 p90 -52.57 -38.66 60.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.929 0.395 . . . . 0.0 110.203 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.11 -33.54 65.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.674 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 49' ' ' ILE . 53.1 t80 -64.62 -39.63 94.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.303 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.951 HG23 HG21 ' A' ' 62' ' ' VAL . 21.6 mt -57.39 -29.87 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.241 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.34 -36.41 79.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.433 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.506 ' OD1' ' NE2' ' A' ' 56' ' ' GLN . 1.0 OUTLIER -72.69 -25.12 61.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.558 179.102 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.506 ' NE2' ' OD1' ' A' ' 55' ' ' ASP . 79.2 mm-40 -86.51 12.13 11.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.44 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.23 17.86 33.09 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.572 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.76 166.84 39.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.696 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.49 HD11 ' CD2' ' A' ' 26' ' ' LEU . 32.1 tp -49.08 -37.33 20.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 0.0 111.119 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.9 -34.55 78.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.2 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.78 -35.53 67.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.267 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.951 HG21 HG23 ' A' ' 53' ' ' ILE . 18.5 t -66.09 -48.61 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.925 0.393 . . . . 0.0 110.737 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -53.76 -46.23 70.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.175 0.512 . . . . 0.0 109.956 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -64.22 -48.68 74.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.135 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 8.0 pt-20 -68.6 -20.73 64.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.612 0.244 . . . . 0.0 111.643 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.525 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 2.2 mmt . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.633 HG22 HD12 ' A' ' 29' ' ' LEU . 8.5 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.834 0.35 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.75 -41.05 75.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.32 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.2 -45.66 87.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.815 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.572 HD21 ' HD1' ' A' ' 30' ' ' PHE . 13.4 tp -60.91 -44.85 96.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.481 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.555 ' HG2' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -53.56 -42.6 67.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.373 178.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -36.07 82.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.542 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.82 HG12 HD13 ' A' ' 48' ' ' LEU . 65.4 t -65.91 -40.18 86.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.766 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 48.5 mmm . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 179.851 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.699 0.285 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.8 m-20 -89.52 140.15 28.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.717 0.294 . . . . 0.0 110.54 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.73 -28.39 5.27 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.662 2.241 . . . . 0.0 112.483 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -98.0 -38.83 9.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -87.48 -21.62 25.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 95.6 -138.2 13.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.206 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.58 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -81.94 -169.08 2.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.942 0.401 . . . . 0.0 110.755 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -123.99 54.15 1.35 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.499 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.798 HG11 ' HG3' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -46.15 -26.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.641 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -68.56 -23.94 64.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.031 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -134.78 25.21 3.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.642 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.892 HD22 HD11 ' A' ' 26' ' ' LEU . 17.6 mt -70.2 159.5 33.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.927 0.394 . . . . 0.0 111.167 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.91 137.97 40.47 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.707 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.6 Cg_exo -54.76 -19.22 18.15 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.584 2.189 . . . . 0.0 112.654 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 52.2 m-20 -81.64 -57.71 3.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.291 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.892 HD11 HD22 ' A' ' 22' ' ' LEU . 4.0 pp -70.91 -38.1 72.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.158 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.604 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -62.22 -35.51 79.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.489 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 t -63.24 -36.32 83.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.633 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 82' ' ' VAL . 25.2 tp -56.6 -50.72 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.644 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 24.4 m-85 -55.47 -43.99 76.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.569 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -50.11 74.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.81 -29.3 69.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.16 -21.2 36.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.173 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.36 14.51 38.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.643 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.482 HD12 HD21 ' A' ' 85' ' ' LEU . 64.8 mt -86.75 121.54 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.0 111.059 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 p -86.97 158.23 19.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.798 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -52.07 -27.12 12.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.842 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.17 -42.17 72.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -78.1 -30.17 49.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.432 HD23 HD13 ' A' ' 49' ' ' ILE . 70.6 mt -70.33 -24.77 63.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 37' ' ' GLU . 31.6 p -98.45 -5.98 31.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.705 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.89 121.14 26.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.84 0.353 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.08 -35.54 25.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.276 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -72.53 -59.9 2.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.685 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -67.16 -33.74 76.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.987 -179.131 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.4 p -57.6 -40.07 78.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.726 0.298 . . . . 0.0 110.345 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -61.77 -53.93 49.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.356 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.58 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.64 -31.44 72.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.19 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.432 HD13 HD23 ' A' ' 40' ' ' LEU . 54.1 mt -69.95 -64.78 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.749 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.504 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -54.18 -36.94 63.94 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.361 -178.418 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -55.0 -33.17 62.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.446 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.443 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 60.7 t80 -64.87 -39.57 93.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.188 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 62' ' ' VAL . 22.6 mt -56.39 -29.98 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.274 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.75 -36.37 75.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -71.14 -26.51 63.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.636 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 25.2 mm100 -86.05 11.14 12.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.503 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.33 18.21 29.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.496 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.47 172.33 48.63 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.007 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 59' ' ' LEU . 8.2 tp -48.43 -44.86 35.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 0.0 111.196 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.5 -35.19 79.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.392 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -33.73 65.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.572 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.976 HG21 HG23 ' A' ' 53' ' ' ILE . 48.6 t -64.9 -63.48 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.43 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 1.4 ptp180 -52.29 -38.54 58.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 110.088 177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -64.14 -48.96 74.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.909 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 66' ' ' MET . 10.7 pt-20 -68.52 -43.59 76.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.517 -177.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.445 ' N ' ' HG3' ' A' ' 65' ' ' GLU . 4.9 mmm . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 121.053 0.454 . . . . 0.0 110.57 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.712 HG22 HD12 ' A' ' 29' ' ' LEU . 19.4 t . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.87 0.367 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.14 -37.54 82.04 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.292 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.91 -51.28 62.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.482 HD21 HD12 ' A' ' 35' ' ' ILE . 29.5 tp -59.83 -42.37 93.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.72 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.7 mtm -52.92 -37.93 61.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.301 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -69.22 -46.85 66.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.222 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.58 HG12 HD13 ' A' ' 48' ' ' LEU . 98.5 t -52.09 -41.1 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.62 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 89.1 mmm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.35 179.29 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.25 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.59 141.44 30.27 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.772 0.32 . . . . 0.0 110.826 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.1 -23.2 12.26 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.713 2.275 . . . . 0.0 112.64 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.42 -34.22 5.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.189 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.39 -25.79 23.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.779 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.97 -150.55 19.6 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.642 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.62 147.78 29.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.955 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -82.85 61.19 5.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.711 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.2 m -48.57 -25.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.205 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -71.16 -21.29 62.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.48 19.63 5.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.571 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.993 HD22 HD11 ' A' ' 26' ' ' LEU . 17.5 mt -70.64 159.28 34.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.975 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -84.26 141.0 39.46 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.026 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.491 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.7 Cg_exo -54.36 -21.03 21.87 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.65 2.234 . . . . 0.0 112.371 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -82.16 -56.3 4.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.308 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.993 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -71.17 -37.43 72.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.25 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.504 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -58.67 -39.67 81.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.38 . . . . 0.0 110.425 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.448 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -63.27 -36.16 82.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.641 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.65 HD12 HG22 ' A' ' 82' ' ' VAL . 14.8 tp -56.38 -43.33 79.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CG ' HD21 ' A' ' 40' ' ' LEU . 18.5 m-85 -66.85 -49.42 65.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.615 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.2 m -60.7 -50.57 72.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.63 ' HB3' HG11 ' A' ' 82' ' ' VAL . 11.9 mtt180 -59.11 -30.23 67.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.521 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.65 4.63 24.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.567 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.86 7.57 88.25 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.986 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.53 HD11 ' HG ' ' A' ' 85' ' ' LEU . 48.7 mt -87.1 122.57 39.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.837 0.351 . . . . 0.0 111.319 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.35 158.28 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.708 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.711 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.38 -29.88 26.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.772 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.22 -38.76 68.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 45' ' ' THR . 37.0 mt-30 -78.02 -32.39 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD21 ' CG ' ' A' ' 30' ' ' PHE . 57.9 mt -69.61 -24.21 63.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.722 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 37' ' ' GLU . 20.4 p -96.72 -7.45 33.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.528 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 46' ' ' SER . 22.7 t0 -81.41 115.4 20.73 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.826 0.346 . . . . 0.0 110.595 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.22 -35.53 3.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.778 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.22 -59.93 2.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 111.493 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -67.6 -34.89 77.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.487 -178.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -56.19 -41.17 75.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.412 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.58 -56.25 21.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.346 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -63.51 -30.31 71.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.911 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 80.6 mt -68.81 -64.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.023 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 1.7 p90 -55.48 -39.13 70.03 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.117 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 0.9 OUTLIER -52.34 -34.59 48.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.521 179.056 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.47 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 54.7 t80 -64.33 -38.78 92.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.806 178.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 62' ' ' VAL . 48.6 mt -56.62 -30.81 32.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.136 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -69.5 -33.66 73.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.684 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -75.46 -26.0 57.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.729 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 78.4 mm-40 -86.21 11.39 12.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.52 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 99.33 17.14 27.72 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.585 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.84 169.59 45.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.995 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 14.0 tp -48.06 -39.72 20.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.712 0.292 . . . . 0.0 111.145 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 24.6 mm-40 -65.73 -35.44 80.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.327 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 56' ' ' GLN . . . -73.09 -35.96 66.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.768 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.976 HG21 HG23 ' A' ' 53' ' ' ILE . 46.2 t -65.24 -62.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 110.97 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -52.78 -39.03 61.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.186 0.517 . . . . 0.0 110.053 177.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 50.2 mt-30 -63.85 -50.1 70.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.876 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 16.5 pt-20 -69.47 -40.13 77.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.367 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.217 0.532 . . . . 0.0 110.001 179.146 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.65 HG22 HD12 ' A' ' 29' ' ' LEU . 22.8 t . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.854 0.359 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.82 -36.87 83.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.209 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.36 -52.16 59.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.715 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 35' ' ' ILE . 3.9 tp -51.11 -48.12 61.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.57 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.5 mtt -50.29 -40.85 49.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.706 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -44.08 77.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.237 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.686 HG12 HD13 ' A' ' 48' ' ' LEU . 93.9 t -55.8 -40.28 60.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.527 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 85.7 mmm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.557 179.214 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.564 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 CA-C-O 120.706 0.289 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.8 OUTLIER -89.3 140.62 28.66 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.712 0.292 . . . . 0.0 110.769 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.45 -36.8 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.743 2.295 . . . . 0.0 112.591 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -91.6 -35.95 13.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 48.0 m-80 -87.7 -30.13 20.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.786 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.29 -144.99 16.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.612 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.748 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.43 152.64 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 111.082 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -88.09 57.9 4.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.845 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.74 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.7 m -49.13 -25.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.28 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.85 -20.11 60.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.125 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -130.32 21.39 5.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.42 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.068 HD22 HD11 ' A' ' 26' ' ' LEU . 17.6 mt -70.37 159.2 34.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.885 0.374 . . . . 0.0 111.053 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -85.25 142.86 38.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.085 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 47.5 Cg_exo -56.4 -18.86 26.44 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.673 2.248 . . . . 0.0 112.456 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -81.2 -58.81 2.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.917 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.068 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -71.76 -40.85 69.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.217 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.458 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -57.26 -34.09 68.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.021 0.439 . . . . 0.0 110.124 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.6 t -64.23 -38.04 89.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.609 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 1.3 tp -56.68 -58.26 8.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.279 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -51.11 -42.13 60.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.467 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.6 m -62.7 -56.3 18.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.713 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -25.5 64.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.763 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.98 -19.01 41.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.27 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.73 13.96 53.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.7 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.453 HD12 HD21 ' A' ' 85' ' ' LEU . 60.7 mt -87.26 122.15 38.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.889 0.376 . . . . 0.0 111.152 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -87.73 159.13 18.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.864 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.74 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -53.15 -31.65 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.97 -41.92 68.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.8 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -77.5 -34.59 54.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.683 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.497 HD23 HD13 ' A' ' 49' ' ' ILE . 82.0 mt -70.55 -22.72 62.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.979 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 37' ' ' GLU . 34.8 p -97.03 -5.01 38.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.739 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.37 124.34 29.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.829 0.347 . . . . 0.0 110.78 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.47 -36.71 45.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.635 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -72.08 -59.7 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.815 0.34 . . . . 0.0 111.43 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.42 -32.45 73.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.011 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 91.6 p -58.34 -41.18 84.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.36 . . . . 0.0 110.36 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 4.2 tptm -61.3 -53.02 62.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.473 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.751 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -67.42 -31.46 71.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.25 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.497 HD13 HD23 ' A' ' 40' ' ' LEU . 55.7 mt -68.2 -65.09 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.535 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.564 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.0 OUTLIER -54.89 -36.0 64.68 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.904 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -56.31 -34.05 66.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.389 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.531 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.7 t80 -64.46 -35.09 79.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.158 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.836 HG23 HG21 ' A' ' 62' ' ' VAL . 28.1 mt -62.77 -27.37 42.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.132 178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.64 -33.34 68.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.53 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -73.27 -26.29 61.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.453 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.42 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 58.6 mm-40 -85.0 3.49 38.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.379 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 103.47 19.62 12.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.431 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.407 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 82.86 167.77 41.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.486 ' CD1' HD22 ' A' ' 26' ' ' LEU . 28.2 tp -49.3 -37.54 24.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.47 -34.08 77.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.208 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.422 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.16 -35.43 66.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.379 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.836 HG21 HG23 ' A' ' 53' ' ' ILE . 45.5 t -65.71 -54.75 24.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.366 . . . . 0.0 110.815 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -53.62 -46.75 70.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.077 0.465 . . . . 0.0 110.087 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -63.09 -50.03 72.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.818 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 9.8 pt-20 -69.53 -37.52 77.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.323 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.422 . . . . 0.0 110.423 179.156 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 5.9 t . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.822 0.344 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.63 -43.8 66.4 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.029 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 87' ' ' HIS . . . -65.38 -48.1 74.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.341 . . . . 0.0 110.783 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.453 HD21 HD12 ' A' ' 35' ' ' ILE . 13.2 tp -54.41 -46.04 73.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.33 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -35.39 61.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.276 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 3.3 t60 -68.81 -32.19 71.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.167 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.751 HG12 HD13 ' A' ' 48' ' ' LEU . 58.4 t -69.62 -42.19 80.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.564 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.0 mmt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.11 178.611 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.762 0.315 . . . . 0.0 110.342 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -88.36 139.61 30.17 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.775 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.94 -37.16 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.652 2.235 . . . . 0.0 112.568 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -88.94 -41.1 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -87.15 -27.21 23.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.15 -144.26 17.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.459 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.45 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.57 138.92 35.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 110.804 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.69 64.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.123 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.573 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -52.44 -25.62 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.21 -19.56 61.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -130.1 20.52 5.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.466 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.034 HD22 HD11 ' A' ' 26' ' ' LEU . 18.3 mt -70.46 159.21 34.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.369 . . . . 0.0 111.17 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.08 142.05 38.14 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.01 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 46.3 Cg_exo -55.75 -19.74 25.75 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.604 2.203 . . . . 0.0 112.543 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.453 ' CB ' ' HA ' ' A' ' 63' ' ' ARG . 13.8 m-20 -82.17 -57.43 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.034 HD11 HD22 ' A' ' 22' ' ' LEU . 3.8 pp -70.48 -32.75 70.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.235 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.495 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -64.96 -34.85 79.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 0.0 110.203 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -36.25 82.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.518 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.522 HD21 HD22 ' A' ' 85' ' ' LEU . 7.3 tp -56.13 -58.58 7.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.316 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.505 ' CG ' HD21 ' A' ' 40' ' ' LEU . 20.9 m-85 -50.27 -40.83 49.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.739 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m -62.7 -54.97 31.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.789 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.617 ' HB3' HG11 ' A' ' 82' ' ' VAL . 8.6 mtt85 -58.39 -29.38 65.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.792 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.35 -21.05 36.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.184 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.34 17.75 41.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.557 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.438 HD12 HD21 ' A' ' 85' ' ' LEU . 66.5 mt -87.07 118.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.228 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.1 p -88.07 160.58 17.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 41' ' ' THR . 30.4 mp0 -51.9 -28.42 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.067 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.97 -44.56 70.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.662 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.467 ' HB3' HG21 ' A' ' 45' ' ' THR . 53.0 mt-30 -79.15 -31.88 44.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.731 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.505 HD21 ' CG ' ' A' ' 30' ' ' PHE . 91.6 mt -70.24 -27.89 64.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.636 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 37' ' ' GLU . 30.3 p -97.71 -3.41 39.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.512 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -81.62 119.87 24.35 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.83 0.348 . . . . 0.0 110.625 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.08 -35.21 24.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.454 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -72.61 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.454 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.483 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.6 -37.05 81.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.223 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.3 p -55.69 -40.37 72.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 110.286 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -60.46 -55.84 28.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.191 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.512 HD13 HG12 ' A' ' 88' ' ' VAL . 1.4 pp -65.48 -30.79 71.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.521 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 45' ' ' THR . 54.3 mt -67.62 -63.92 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.447 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.5 p90 -52.29 -36.15 52.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.934 0.397 . . . . 0.0 110.376 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.92 -33.28 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.472 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 79.2 t80 -64.63 -41.92 95.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.241 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 62' ' ' VAL . 43.3 mt -55.69 -29.66 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.331 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.91 -36.32 75.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.746 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -71.01 -26.42 63.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.617 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 17.0 mm100 -86.11 9.77 16.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.475 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.42 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.73 17.96 26.74 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.594 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 83.79 169.93 45.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.823 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 14.4 tp -48.87 -42.14 35.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.726 0.298 . . . . 0.0 111.016 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -63.6 -35.24 79.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.21 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.42 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -34.25 66.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.484 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 53' ' ' ILE . 21.7 t -66.76 -63.35 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.208 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.453 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -51.85 -41.14 61.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.016 0.436 . . . . 0.0 110.233 178.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -63.14 -52.99 60.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.278 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 20.2 pt-20 -70.78 -29.0 65.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.859 0.361 . . . . 0.0 111.138 -179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.404 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 1.2 mmt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.695 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' A' ' 32' ' ' ARG . 6.0 t . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.79 0.328 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.39 -43.9 67.67 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.554 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.41 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.87 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.522 HD22 HD21 ' A' ' 29' ' ' LEU . 15.7 tp -55.97 -47.17 78.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.892 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.4 mtm -53.41 -28.84 31.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -41.88 25.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 48' ' ' LEU . 48.7 t -58.25 -42.36 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 110.318 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 38.8 mmm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.306 178.653 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.858 0.361 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.7 31.26 45.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.491 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.442 ' CD1' ' O ' ' A' ' 3' ' ' PHE . 9.3 p90 -87.21 141.98 28.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.344 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' HE2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -87.54 153.17 21.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -128.07 123.74 35.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.441 HG22 ' HE2' ' A' ' 4' ' ' LYS . 4.0 t -105.17 131.53 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -90.28 130.14 36.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.716 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.616 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.2 t-80 -74.05 78.73 1.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.66 -48.08 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.582 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.07 36.19 72.01 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.038 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -88.74 153.43 21.1 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.19 137.94 27.58 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.657 0.265 . . . . 0.0 110.747 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.67 -26.48 3.79 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.688 2.259 . . . . 0.0 112.351 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -95.38 -41.39 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -88.87 -26.26 21.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.95 -148.81 19.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.443 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.411 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -81.94 146.84 29.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 110.706 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -81.77 57.32 3.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.987 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.595 HG12 HD13 ' A' ' 40' ' ' LEU . 2.9 m -48.32 -26.02 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.243 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.01 -22.28 61.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.121 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -130.69 21.11 5.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.456 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.925 HD22 HD11 ' A' ' 26' ' ' LEU . 16.7 mt -70.25 159.47 33.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 111.082 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 11.9 t70 -83.47 139.76 41.45 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.816 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.489 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 45.4 Cg_exo -55.97 -18.27 21.93 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.479 2.119 . . . . 0.0 112.62 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 1.2 m-20 -80.87 -58.94 2.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.941 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.925 HD11 HD22 ' A' ' 22' ' ' LEU . 3.9 pp -71.68 -39.06 70.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.248 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.494 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.63 -36.03 79.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.855 0.359 . . . . 0.0 110.499 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.3 t -63.85 -36.27 83.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 82' ' ' VAL . 17.6 tp -57.16 -58.04 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.59 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.625 ' HZ ' HD11 ' A' ' 53' ' ' ILE . 9.8 m-85 -50.27 -41.83 51.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.731 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -49.12 78.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.561 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.507 ' HB3' HG11 ' A' ' 82' ' ' VAL . 8.5 mtt85 -58.25 -32.57 68.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.619 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.66 4.81 23.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.74 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.49 17.08 78.87 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.821 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.533 HD12 HD21 ' A' ' 85' ' ' LEU . 52.8 mt -86.79 120.25 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 111.056 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.8 p -86.92 157.26 19.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -52.99 -34.04 54.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.07 -36.13 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 45' ' ' THR . 1.6 mt-30 -78.58 -35.27 46.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.519 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.595 HD13 HG12 ' A' ' 19' ' ' VAL . 78.1 mt -70.35 -24.46 62.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.734 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 37' ' ' GLU . 44.7 p -96.08 -7.98 34.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.542 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 46' ' ' SER . 5.8 t70 -81.49 123.31 28.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.687 0.28 . . . . 0.0 110.674 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.24 -37.21 45.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.631 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.25 -60.04 2.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.342 . . . . 0.0 111.534 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.638 HG22 HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -66.82 -29.7 69.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.956 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 57.7 p -59.56 -43.66 93.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.441 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 7.4 tptt -60.29 -52.83 63.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.56 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.534 ' C ' HD12 ' A' ' 48' ' ' LEU . 1.9 pp -65.83 -33.04 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.483 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.638 HD11 HG22 ' A' ' 45' ' ' THR . 59.4 mt -68.82 -64.33 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 1.9 p90 -52.53 -36.59 55.79 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.48 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -55.62 -32.51 63.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.519 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.726 ' HD1' HG21 ' A' ' 88' ' ' VAL . 67.3 t80 -64.88 -41.79 95.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.116 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.975 HG23 HG21 ' A' ' 62' ' ' VAL . 22.0 mt -54.72 -27.77 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.365 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.65 -36.16 67.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.592 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.475 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -72.56 -25.45 61.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.609 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.453 ' HG3' ' CE2' ' A' ' 52' ' ' PHE . 83.3 mm-40 -85.54 9.31 16.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.466 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.29 16.46 32.27 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.563 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.37 171.36 47.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.921 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 8' ' ' HIS . 8.3 tp -48.82 -42.29 35.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.805 0.336 . . . . 0.0 110.988 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 15.0 mm-40 -63.62 -34.47 77.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.034 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.28 -32.73 64.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.348 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.975 HG21 HG23 ' A' ' 53' ' ' ILE . 38.6 t -65.75 -63.61 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.917 0.389 . . . . 0.0 110.622 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -54.06 -38.23 65.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.05 0.452 . . . . 0.0 109.986 177.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.415 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 58.1 mt-30 -64.59 -52.63 56.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.768 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.767 ' CD ' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -68.05 -31.19 70.68 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.169 -177.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.424 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 1.3 mmt -58.65 -33.13 69.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.094 0.473 . . . . 0.0 109.873 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -40.78 40.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.592 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -72.79 -25.67 61.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.11 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.418 ' NE2' ' OE1' ' A' ' 65' ' ' GLU . 36.6 mt-30 -90.58 18.24 6.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.357 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -115.93 18.53 14.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.409 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.71 -52.73 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.448 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 t -68.26 129.07 38.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 0.0 110.754 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.04 125.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.261 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.24 -108.65 1.05 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.272 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.7 t 179.23 -36.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 0.0 110.714 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.402 ' O ' ' NE2' ' A' ' 76' ' ' GLN . 1.9 pm0 -74.74 134.95 41.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.189 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.5 122.53 32.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.483 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.424 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 11.0 p 168.88 -40.31 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.282 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.24 83.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.173 0.511 . . . . 0.0 110.542 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.25 -99.47 0.15 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.619 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.767 HD13 ' CD ' ' A' ' 65' ' ' GLU . 2.1 pt? -58.1 -34.22 69.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.776 0.322 . . . . 0.0 111.221 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 29' ' ' LEU . 23.3 t -60.52 -30.56 46.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.631 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.88 -39.15 85.62 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.569 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.95 -55.36 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 110.602 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.533 HD21 HD12 ' A' ' 35' ' ' ILE . 20.0 tp -52.83 -39.09 62.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.578 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.9 mtt -53.59 -34.28 57.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.224 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -77.1 -44.59 29.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.359 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.726 HG21 ' HD1' ' A' ' 52' ' ' PHE . 53.4 t -53.85 -38.05 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.635 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 95.7 mmm -63.01 -28.91 70.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.272 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -77.03 -5.53 49.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.393 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -70.39 -11.69 61.08 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.475 0.178 . . . . 0.0 111.241 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.688 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 12.0 mmm180 -74.75 -24.94 58.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.651 0.262 . . . . 0.0 110.742 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 0.3 OUTLIER 82.1 -41.01 0.12 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.352 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -151.33 20.69 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 92' ' ' ARG . . . -70.76 114.35 8.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.269 0.557 . . . . 0.0 111.246 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 96' ' ' ILE . 10.3 tt -132.58 112.32 18.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.086 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.423 ' O ' ' CG ' ' A' ' 97' ' ' HIS . 56.4 p-80 -67.72 72.0 0.15 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.192 0.52 . . . . 0.0 110.416 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' ILE . 1.1 t -123.35 170.97 9.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.655 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 p -122.46 127.46 49.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.004 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.52 99.17 11.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -20.01 20.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 172.37 47.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.411 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.42 172.5 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.827 0.346 . . . . 0.0 110.784 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -168.03 104.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -40.63 89.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.977 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.1 141.4 34.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.024 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.469 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.785 0.326 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.45 -22.17 29.24 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.545 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -117.9 132.57 56.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.316 . . . . 0.0 110.884 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 121.7 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -120.33 103.36 9.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.8 t -80.15 115.8 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.271 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.1 m -91.26 152.6 20.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.628 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -106.0 93.54 4.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.125 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.0 t -68.39 -50.5 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.673 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.08 32.49 35.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.981 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.483 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -88.75 153.43 21.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.707 0.289 . . . . 0.0 110.299 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.39 138.59 28.49 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.29 -43.74 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.593 2.195 . . . . 0.0 112.274 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -81.9 -39.86 23.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -87.38 -30.96 20.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.028 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.65 -149.55 18.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.678 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.639 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.69 136.66 35.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.341 . . . . 0.0 110.981 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -77.94 65.65 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.981 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.808 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.7 m -51.85 -23.47 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.237 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -72.3 -22.93 61.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.029 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -128.97 19.34 6.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.529 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.896 HD22 HD11 ' A' ' 26' ' ' LEU . 17.1 mt -70.38 159.7 33.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.881 0.372 . . . . 0.0 111.174 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.18 138.87 42.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.803 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.508 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 48.4 Cg_exo -55.79 -18.35 21.16 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.54 2.16 . . . . 0.0 112.587 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -81.2 -58.11 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.216 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.896 HD11 HD22 ' A' ' 22' ' ' LEU . 3.5 pp -70.64 -42.25 71.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.233 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.508 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -54.96 -38.39 67.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.915 0.388 . . . . 0.0 110.467 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -37.97 89.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.85 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.494 HD12 HG22 ' A' ' 82' ' ' VAL . 22.7 tp -56.03 -55.62 30.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.747 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.679 ' CD2' HD21 ' A' ' 40' ' ' LEU . 10.9 m-30 -50.32 -47.47 55.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.599 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -62.12 -52.58 63.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.472 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.55 ' HB3' HG11 ' A' ' 82' ' ' VAL . 74.4 mtt-85 -53.27 -31.95 46.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.525 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.45 -20.64 39.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.034 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.44 11.2 34.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.938 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.561 HD12 HD21 ' A' ' 85' ' ' LEU . 31.8 mt -86.9 120.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 111.255 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 p -86.91 160.39 18.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.808 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -51.93 -25.8 8.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.709 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.94 -45.17 74.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.425 ' CG ' HG21 ' A' ' 45' ' ' THR . 75.9 mt-30 -78.39 -29.22 47.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.761 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.679 HD21 ' CD2' ' A' ' 30' ' ' PHE . 88.4 mt -70.39 -26.83 63.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.52 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 37' ' ' GLU . 33.0 p -96.63 -3.93 41.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.531 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 46' ' ' SER . 15.3 t0 -82.73 124.37 30.17 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.776 0.322 . . . . 0.0 110.782 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.52 -40.19 59.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.42 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -72.69 -58.99 2.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.658 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.446 HG22 HD11 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -66.13 -33.62 76.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.337 -178.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 88.1 p -58.71 -39.32 80.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.84 0.352 . . . . 0.0 110.456 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -62.53 -54.96 32.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.555 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.662 HD13 HG12 ' A' ' 88' ' ' VAL . 1.9 pp -63.25 -31.06 72.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.053 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 45' ' ' THR . 57.6 mt -69.7 -64.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.418 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.483 ' CE1' ' CZ2' ' A' ' 11' ' ' TRP . 1.9 p90 -53.99 -39.87 66.44 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.167 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.4 ' OD1' ' CZ ' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -55.86 -33.66 64.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.745 178.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.72 ' HD2' HG21 ' A' ' 88' ' ' VAL . 26.4 t80 -64.65 -31.79 73.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 110.053 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.943 HG23 HG21 ' A' ' 62' ' ' VAL . 31.4 mt -61.72 -29.56 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.118 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -41.3 79.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.301 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 52' ' ' PHE . 1.1 p30 -65.75 -26.84 67.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.442 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 62.4 mm-40 -86.2 11.38 12.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.525 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 95.42 18.96 31.47 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.503 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.19 168.24 39.66 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.626 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.516 ' CD1' HD22 ' A' ' 26' ' ' LEU . 34.9 tp -49.18 -38.08 24.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.46 -35.99 82.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 56' ' ' GLN . . . -73.09 -34.61 66.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.497 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.943 HG21 HG23 ' A' ' 53' ' ' ILE . 22.0 t -65.78 -52.37 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.701 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.63 -44.88 69.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.115 0.483 . . . . 0.0 110.046 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -62.52 -50.89 69.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.691 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 22.3 pt-20 -68.89 -30.77 69.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.715 0.293 . . . . 0.0 111.027 -178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.624 ' HE3' HD11 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -68.4 -27.6 66.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.559 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -43.46 33.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -32.58 68.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -86.4 -21.7 26.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.05 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -137.96 67.88 0.52 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.446 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.47 -83.18 1.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.569 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.4 m -51.71 166.62 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 111.001 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.42 111.22 4.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.442 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.41 -43.93 1.46 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.401 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.0 m -84.37 61.71 6.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.813 0.339 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -74.48 145.05 43.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.7 m -122.35 90.51 3.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.414 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -89.18 -18.02 27.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.881 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.59 95.96 2.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.057 0.456 . . . . 0.0 110.785 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.21 -94.71 0.15 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.856 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.624 HD11 ' HE3' ' A' ' 66' ' ' MET . 2.7 pt? -63.37 -41.31 98.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.798 0.332 . . . . 0.0 111.203 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.55 HG11 ' HB3' ' A' ' 32' ' ' ARG . 6.2 t -64.47 -31.28 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.203 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.09 -38.76 73.51 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.621 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.22 -51.7 62.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 110.951 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.561 HD21 HD12 ' A' ' 35' ' ' ILE . 45.8 tp -52.47 -46.3 66.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.701 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 39.9 mtm -52.99 -42.34 65.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.327 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.48 73.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.347 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.72 HG21 ' HD2' ' A' ' 52' ' ' PHE . 51.2 t -72.62 -38.29 58.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.587 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.1 mmm -63.49 -32.79 74.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.532 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -57.39 -17.36 12.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.973 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.75 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 2.2 tptp -68.98 -33.04 73.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.045 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.441 ' HG2' ' CD2' ' A' ' 48' ' ' LEU . 15.2 mmm-85 -71.82 -20.16 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.003 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.456 ' CB ' ' HD2' ' A' ' 94' ' ' ARG . 49.9 m -75.95 -31.2 58.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.456 ' HD2' ' CB ' ' A' ' 93' ' ' SER . 5.7 mpt_? -133.75 28.54 3.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.75 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -73.46 173.76 9.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.424 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 98' ' ' SER . 15.5 mm -76.23 106.83 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.237 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -47.1 -39.04 12.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.83 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.514 ' HB3' HG22 ' A' ' 96' ' ' ILE . 1.5 p 44.14 38.57 2.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.159 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 m -170.03 95.32 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.795 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.87 -177.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -144.41 -43.37 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.017 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.21 103.64 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.679 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.92 124.17 24.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.746 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 40.44 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.632 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -46.66 108.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.313 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.24 125.67 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.039 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.401 -1.222 . . . . 0.0 112.475 -179.921 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.872 0.368 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.39 -22.16 38.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -118.59 143.66 46.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.765 0.317 . . . . 0.0 110.96 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -87.58 152.98 21.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.958 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -88.3 69.86 9.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.7 t -111.69 140.32 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.51 141.54 28.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.598 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -134.75 96.53 3.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.364 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG11 ' HB2' ' A' ' 50' ' ' TYR . 4.8 t -66.3 -38.93 82.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.001 0.429 . . . . 0.0 110.536 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.59 29.37 72.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.121 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.554 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.48 153.26 20.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.715 0.293 . . . . 0.0 110.312 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -90.19 140.56 27.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.743 0.306 . . . . 0.0 110.604 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.69 -24.73 5.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.683 2.255 . . . . 0.0 112.479 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.31 -40.24 6.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -87.58 -21.14 25.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 95.58 -142.62 16.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.319 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.14 -174.34 5.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 0.0 110.866 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.85 57.22 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.332 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.794 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.5 m -47.87 -25.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.402 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -70.4 -22.07 62.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -134.95 23.61 3.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.596 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.033 HD22 HD11 ' A' ' 26' ' ' LEU . 17.7 mt -69.69 159.94 32.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 111.12 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.51 138.89 44.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.766 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.452 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 46.2 Cg_exo -55.66 -18.08 19.61 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.587 2.192 . . . . 0.0 112.519 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.34 -58.08 3.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.097 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.033 HD11 HD22 ' A' ' 22' ' ' LEU . 2.3 pp -71.45 -41.58 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.299 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -51.9 -40.74 61.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.427 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -64.74 -37.63 88.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.901 HD12 HG22 ' A' ' 82' ' ' VAL . 6.1 tp -56.74 -57.16 13.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.483 ' HZ ' HD11 ' A' ' 53' ' ' ILE . 15.6 m-85 -52.24 -41.88 63.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.8 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -53.97 50.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.623 ' HB3' HG11 ' A' ' 82' ' ' VAL . 12.6 mtt85 -54.11 -32.12 54.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.44 7.72 15.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.836 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.54 8.99 84.62 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.032 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.45 HD11 ' CG ' ' A' ' 89' ' ' MET . 61.0 mt -86.15 112.88 23.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.869 0.366 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.16 166.19 15.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.875 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.794 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -53.38 -29.77 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.09 -42.6 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.75 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -77.91 -29.7 50.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.616 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' CD1' ' CG1' ' A' ' 19' ' ' VAL . 53.9 mt -70.85 -25.3 62.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 37' ' ' GLU . 28.3 p -96.65 -5.72 38.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.706 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.26 119.23 23.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.878 0.371 . . . . 0.0 110.821 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.79 -34.81 28.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.358 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.99 -58.86 3.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.178 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.431 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.2 -30.56 71.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.822 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.8 p -59.36 -43.49 92.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.546 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 1.5 tptm -61.0 -51.71 68.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.593 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.691 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -67.09 -34.45 77.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.678 0.275 . . . . 0.0 111.197 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.56 HD11 ' HE3' ' A' ' 89' ' ' MET . 44.5 mt -68.65 -64.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.843 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.554 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 0.9 OUTLIER -53.72 -35.33 61.07 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.234 -178.536 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -54.05 -34.59 60.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.178 178.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.544 ' HD2' HG21 ' A' ' 88' ' ' VAL . 57.0 t80 -64.54 -44.21 91.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.043 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.529 HG23 HG21 ' A' ' 62' ' ' VAL . 23.8 mt -53.31 -25.18 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.336 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.49 -35.94 53.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 52' ' ' PHE . 0.9 OUTLIER -72.23 -25.21 61.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 110.769 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 27.9 mm-40 -86.04 11.58 11.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.494 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.92 19.26 27.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.491 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.32 167.65 38.76 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.648 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.489 ' CD1' HD22 ' A' ' 26' ' ' LEU . 25.4 tp -48.67 -37.01 17.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.088 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -64.99 -37.57 88.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.142 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.432 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.65 -33.32 66.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.49 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 53' ' ' ILE . 60.3 t -65.97 -52.24 51.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.871 0.367 . . . . 0.0 110.581 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 25.7 mtp180 -53.89 -44.68 70.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.18 0.515 . . . . 0.0 109.934 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -48.65 78.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.918 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 13.4 pt-20 -69.09 -41.66 77.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.687 0.279 . . . . 0.0 111.307 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.3 mmt -61.98 -30.46 70.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.391 . . . . 0.0 110.683 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 4.2 mmt180 -77.73 -41.41 37.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.448 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 mtp85 -69.69 -31.29 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.416 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -71.05 -6.58 40.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.808 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.69 82.02 1.43 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.403 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -143.97 18.81 2.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.661 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p 51.8 176.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.38 . . . . 0.0 111.045 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.27 -159.41 53.35 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.719 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.42 151.92 31.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.582 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 t 53.3 48.46 21.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.13 162.43 28.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.08 162.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.036 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.409 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.9 m 77.85 -57.32 0.49 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.998 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -74.44 87.85 2.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.915 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.36 -89.69 0.11 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.39 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.556 ' CD1' HD13 ' A' ' 29' ' ' LEU . 2.6 pt? -61.09 -39.32 89.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.357 . . . . 0.0 110.812 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.901 HG22 HD12 ' A' ' 29' ' ' LEU . 28.2 t -62.52 -25.35 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.75 -39.04 86.22 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.959 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.74 -49.66 67.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.591 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -55.93 -45.51 78.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.0 mtm -53.2 -39.57 63.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.15 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -62.92 -41.95 99.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.039 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.691 HG12 HD13 ' A' ' 48' ' ' LEU . 65.8 t -57.55 -36.47 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.488 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.623 ' HE1' HD11 ' A' ' 48' ' ' LEU . 15.8 mmt -65.26 -27.03 68.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.69 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -69.88 -11.89 61.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.668 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -70.31 -36.8 74.52 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.939 0.399 . . . . 0.0 110.689 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.465 ' HG2' HD22 ' A' ' 48' ' ' LEU . 5.3 mmp_? -74.43 -22.07 59.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.0 t -75.68 -31.3 59.67 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.074 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -92.74 -5.49 51.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.665 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.6 174.36 9.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.05 0.453 . . . . 0.0 111.297 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 98' ' ' SER . 39.3 mm -70.42 107.91 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.221 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -67.04 66.81 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.925 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -96.19 150.12 20.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.185 -177.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.3 t 61.03 -82.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.015 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -154.42 116.14 4.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.93 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.4 pm0 -62.24 -22.27 65.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.042 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 152.86 122.67 0.93 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.502 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -96.43 135.16 38.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 110.836 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -167.75 133.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.834 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -101.43 160.94 14.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.807 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.27 132.39 35.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.154 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.356 -1.247 . . . . 0.0 112.472 179.893 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.803 0.335 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.82 20.73 23.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.536 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 3' ' ' PHE . 27.5 p90 -122.89 128.08 49.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.4 164.89 15.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.042 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -143.8 68.03 1.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 t -75.55 145.52 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.191 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 m 59.88 176.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -145.4 62.47 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.224 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 9' ' ' VAL . 1.9 t -72.14 -46.68 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.075 0.464 . . . . 0.0 110.378 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.3 57.49 4.29 Favored Glycine 0 CA--C 1.518 0.233 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.395 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.37 152.73 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 0.0 110.256 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -91.96 134.48 28.71 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.626 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.41 -30.16 62.63 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.468 2.112 . . . . 0.0 112.56 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -105.24 -39.53 6.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.73 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -85.67 -9.8 56.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 82.1 -139.06 19.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.405 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -80.94 -169.37 2.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.964 0.411 . . . . 0.0 110.865 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -117.74 52.81 0.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.412 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.769 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.8 m -46.98 -26.36 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.494 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -70.24 -23.23 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -134.75 25.55 3.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.61 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.043 HD22 HD11 ' A' ' 26' ' ' LEU . 17.7 mt -69.99 159.59 33.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 111.271 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.72 139.73 40.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.767 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.491 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 44.3 Cg_exo -55.41 -18.68 19.94 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.506 2.137 . . . . 0.0 112.461 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -81.09 -57.67 3.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.123 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.043 HD11 HD22 ' A' ' 22' ' ' LEU . 3.6 pp -70.63 -41.85 71.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.143 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -57.11 -37.35 71.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 110.471 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.411 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 34.0 t -63.44 -37.03 85.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.714 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.726 HD12 HG22 ' A' ' 82' ' ' VAL . 38.3 tp -56.92 -53.59 56.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.689 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.469 ' CD2' HD11 ' A' ' 40' ' ' LEU . 17.7 m-85 -51.99 -43.44 63.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.574 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -61.74 -53.59 53.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.769 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.466 ' HB3' HG11 ' A' ' 82' ' ' VAL . 32.8 mtt180 -57.96 -30.57 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.833 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.11 -22.49 36.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.174 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.6 13.02 39.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.806 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.525 HD12 HD21 ' A' ' 85' ' ' LEU . 72.8 mt -86.53 118.67 33.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 111.132 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.19 162.78 17.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.769 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -53.14 -30.04 34.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.86 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.63 -41.15 69.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.845 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -78.03 -30.44 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.72 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.469 HD11 ' CD2' ' A' ' 30' ' ' PHE . 51.5 mt -71.48 -27.79 63.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.729 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 37' ' ' GLU . 10.7 p -97.4 -1.53 44.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.714 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 46' ' ' SER . 14.8 t70 -82.6 124.28 30.01 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.18 -41.44 60.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.55 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -72.53 -57.79 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.641 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.581 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.67 -37.53 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.353 -178.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 91.5 p -56.3 -38.72 71.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 0.0 110.279 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -62.19 -55.46 28.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.391 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.787 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.1 -31.98 73.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.301 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.581 HD11 HG22 ' A' ' 45' ' ' THR . 59.8 mt -67.78 -64.11 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.633 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.504 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 1.5 p90 -54.33 -39.85 67.45 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.387 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -55.49 -32.88 63.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.786 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.635 ' CD1' HG21 ' A' ' 88' ' ' VAL . 85.5 t80 -63.43 -38.42 91.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.911 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.009 HG23 HG21 ' A' ' 62' ' ' VAL . 22.0 mt -58.89 -28.84 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.219 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.43 -38.2 80.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.636 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.482 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -66.01 -25.37 67.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.614 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.477 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -84.15 -8.17 59.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.202 178.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 112.39 21.3 6.24 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.007 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.93 171.6 47.99 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.464 HD13 HD22 ' A' ' 26' ' ' LEU . 8.7 tp -48.24 -40.38 24.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.155 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -65.69 -35.02 79.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.432 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.83 -35.01 67.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.676 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 1.009 HG21 HG23 ' A' ' 53' ' ' ILE . 47.6 t -64.73 -62.1 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 110.74 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -36.2 39.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.208 0.527 . . . . 0.0 109.926 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -65.34 -51.83 57.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.881 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.463 ' HA ' ' CD ' ' A' ' 68' ' ' ARG . 16.7 pt-20 -68.17 -40.34 82.33 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.718 0.294 . . . . 0.0 111.359 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mmt -56.99 -27.3 61.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.962 0.41 . . . . 0.0 110.512 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -77.98 -43.37 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.577 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' CD ' ' HA ' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -68.54 -24.88 64.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.79 0.328 . . . . 0.0 110.706 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.498 ' OE1' HD22 ' A' ' 81' ' ' LEU . 14.7 mt-30 -82.78 -2.54 54.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.415 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.96 96.77 0.03 OUTLIER Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.492 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.5 -179.27 22.35 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 p -120.96 -41.53 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.329 . . . . 0.0 110.967 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 75' ' ' SER . . . -139.98 146.85 18.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.597 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.32 -82.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.607 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 73' ' ' GLY . 2.1 p -78.68 57.73 2.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.402 ' HG3' ' OG ' ' A' ' 78' ' ' SER . 4.9 pt20 -75.9 163.07 27.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.981 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.8 p -68.72 95.88 0.69 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.934 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.402 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 0.3 OUTLIER 166.97 -41.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.923 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.69 80.25 1.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.974 0.416 . . . . 0.0 110.666 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.96 -90.84 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.108 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.498 HD22 ' OE1' ' A' ' 69' ' ' GLN . 2.7 pt? -62.46 -38.79 91.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.78 0.324 . . . . 0.0 111.008 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.726 HG22 HD12 ' A' ' 29' ' ' LEU . 22.6 t -61.61 -28.07 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.05 -38.46 73.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB3' ' HZ ' ' A' ' 52' ' ' PHE . . . -64.56 -55.44 20.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 111.008 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.525 HD21 HD12 ' A' ' 35' ' ' ILE . 12.4 tp -49.71 -41.17 42.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.791 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.4 mtm -54.19 -44.01 71.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -43.71 90.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.315 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.787 HG12 HD13 ' A' ' 48' ' ' LEU . 59.4 t -55.36 -41.76 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.64 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 84.0 mmm -63.79 -32.02 73.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.714 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -65.85 -13.29 59.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.367 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tptt -70.5 -31.5 68.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.905 0.383 . . . . 0.0 110.652 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.458 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 14.1 mmm-85 -74.71 -21.81 59.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.842 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.4 t -74.92 -25.43 58.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.826 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -108.37 -17.56 13.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.316 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.28 117.41 16.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.998 0.427 . . . . 0.0 111.111 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.525 ' O ' HG23 ' A' ' 96' ' ' ILE . 1.8 tp -123.01 106.58 17.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.667 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -42.47 -29.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.476 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.8 p -96.47 -162.93 1.0 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.749 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 t 60.58 123.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.055 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t0 59.72 98.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -166.57 166.04 16.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -178.19 -169.23 38.76 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.576 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.45 175.95 5.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 t70 42.13 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.63 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -102.57 19.65 18.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.224 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.87 101.68 10.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.792 0.329 . . . . 0.0 111.043 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.425 -1.208 . . . . 0.0 112.523 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.772 0.32 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.78 24.68 76.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.467 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.15 156.42 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.357 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -87.41 145.1 26.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.127 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 71.84 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.749 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.7 t -82.51 138.4 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.2 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.9 m -90.66 -51.79 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 79.21 -53.36 0.44 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.567 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.1 t 70.23 -63.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 110.737 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.74 27.1 5.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.113 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.38 152.76 21.33 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.878 0.339 . . . . 0.0 110.371 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -92.39 135.24 26.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.735 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 20.5 Cg_exo -63.96 -45.89 9.54 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.486 2.124 . . . . 0.0 112.629 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -90.09 -38.24 13.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.839 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -85.71 -21.04 28.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.192 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.55 -149.5 20.62 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.558 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.88 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.01 138.05 34.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.789 0.328 . . . . 0.0 111.028 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -78.2 67.33 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.745 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.783 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.4 m -51.64 -23.59 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.227 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.21 -20.2 60.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -130.29 20.27 5.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.603 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.977 HD22 HD11 ' A' ' 26' ' ' LEU . 18.9 mt -70.19 159.46 33.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 111.158 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.33 140.95 39.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 46.3 Cg_exo -56.12 -19.56 27.39 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.597 2.198 . . . . 0.0 112.512 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -81.4 -56.82 3.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.176 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.977 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -70.0 -42.02 73.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.23 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -54.53 -38.82 67.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.929 0.395 . . . . 0.0 110.123 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 t -63.1 -40.72 98.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.486 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.714 HD12 HG22 ' A' ' 82' ' ' VAL . 13.5 tp -57.11 -52.51 65.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.396 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.467 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 22.9 m-85 -53.45 -47.63 69.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.514 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 m -61.73 -51.51 68.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.831 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.604 ' HB3' HG11 ' A' ' 82' ' ' VAL . 13.8 mtt85 -57.08 -31.93 65.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.406 ' HB2' HG13 ' A' ' 82' ' ' VAL . . . -81.91 -10.91 59.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.477 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.63 13.54 55.07 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.77 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.455 HD12 HD21 ' A' ' 85' ' ' LEU . 64.1 mt -87.08 115.43 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.747 0.308 . . . . 0.0 111.29 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.3 p -87.26 160.76 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.72 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.783 ' HG2' HG21 ' A' ' 19' ' ' VAL . 1.1 mt-10 -52.55 -31.8 37.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.821 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.97 -42.47 72.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.643 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -78.09 -30.64 49.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.749 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 37' ' ' GLU . 73.4 mt -69.81 -26.71 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.547 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 37' ' ' GLU . 61.6 p -96.27 -3.06 44.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.64 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -81.94 116.13 21.43 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 120.786 0.327 . . . . 0.0 110.611 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.49 -35.09 8.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.569 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -72.19 -59.11 2.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.276 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.87 -33.17 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.304 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.0 p -58.42 -42.03 86.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.794 0.33 . . . . 0.0 110.612 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.81 -53.39 56.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.712 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.862 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -64.89 -33.69 76.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.782 0.325 . . . . 0.0 110.908 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.467 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 75.1 mt -67.55 -63.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.23 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.1 p90 -52.26 -40.27 61.49 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.086 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -36.55 64.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.522 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 78.6 t80 -63.46 -29.82 71.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.933 HG23 ' CG2' ' A' ' 62' ' ' VAL . 92.8 mt -66.28 -27.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.088 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -71.46 -39.27 71.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.586 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.4 p30 -64.42 -25.29 67.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.559 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 8.5 mt-30 -84.73 -9.91 57.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.175 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.14 21.37 5.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.134 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.53 168.94 45.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.424 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.1 tp -48.23 -36.23 13.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 111.106 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.12 -37.24 85.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.197 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.61 -34.66 67.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.561 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.933 ' CG2' HG23 ' A' ' 53' ' ' ILE . 61.5 t -65.48 -49.65 77.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 110.615 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -54.51 -48.25 72.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.152 0.501 . . . . 0.0 110.035 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.32 -43.2 95.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.465 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 9.5 pt-20 -67.87 -37.51 81.9 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.721 0.296 . . . . 0.0 111.392 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.425 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 2.1 mmt -64.19 -24.12 67.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.801 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -55.95 4.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.665 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HD3' ' HA ' ' A' ' 65' ' ' GLU . 1.1 ptm180 -70.53 -36.17 73.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.667 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 81' ' ' LEU . 48.1 mt-30 -67.99 -9.86 48.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.472 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 77' ' ' SER . . . -100.24 62.9 0.64 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.452 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.44 -176.44 14.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.633 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 t 64.09 125.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.796 0.332 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.46 -110.95 3.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.395 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.72 34.8 5.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.387 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.06 55.08 10.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 110.643 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.87 102.64 4.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.157 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.418 ' HB2' ' CA ' ' A' ' 70' ' ' GLY . 9.1 t -110.46 98.12 7.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.559 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.43 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 0.0 OUTLIER 175.11 -44.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.547 -179.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -71.87 67.51 0.61 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.155 0.503 . . . . 0.0 110.684 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.39 -91.01 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.966 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.536 ' HG ' HD13 ' A' ' 29' ' ' LEU . 2.7 pt? -62.18 -38.91 90.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 110.566 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.714 HG22 HD12 ' A' ' 29' ' ' LEU . 16.5 t -61.95 -26.15 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.682 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.35 84.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.15 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.03 -43.31 95.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.907 0.384 . . . . 0.0 110.67 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.455 HD21 HD12 ' A' ' 35' ' ' ILE . 8.2 tp -55.74 -49.72 72.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.793 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.4 mtt -49.62 -28.21 5.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.858 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.81 -41.93 20.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.526 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.862 HG12 HD13 ' A' ' 48' ' ' LEU . 70.5 t -63.47 -42.0 94.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.028 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 79.1 mmm -64.94 -31.44 72.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.375 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -62.51 -18.57 62.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.475 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 5.9 tptt -69.97 -49.91 46.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.205 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.421 ' HG2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -72.06 -18.61 61.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.472 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.2 m -76.09 -30.18 58.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 0.0 110.991 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -121.46 4.13 10.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.887 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -74.77 147.7 41.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 111.074 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -59.65 102.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.138 0.494 . . . . 0.0 110.81 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.422 ' O ' HD13 ' A' ' 96' ' ' ILE . 65.8 m80 -51.83 123.6 10.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.866 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 97' ' ' HIS . 1.9 m 76.53 56.62 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.596 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 p -67.74 -173.94 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.823 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -154.36 150.58 28.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.797 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -124.09 32.24 5.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.73 18.48 78.89 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.637 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.02 108.03 17.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.831 0.348 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 40.86 -164.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.639 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 69.47 114.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.905 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.23 126.9 32.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.039 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.345 -1.253 . . . . 0.0 112.432 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.84 0.352 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.99 -20.16 39.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.607 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -129.33 123.31 31.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 0.0 110.96 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 101.0 13.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -104.64 100.06 9.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.56 113.96 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.984 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 p 59.81 176.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -166.8 59.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -72.74 -44.26 59.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.633 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.85 41.9 36.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.069 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.571 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -88.33 153.51 21.14 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 15' ' ' ASN . 1.3 m-20 -89.42 138.69 28.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.673 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.99 -27.74 3.62 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.611 2.207 . . . . 0.0 112.286 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -97.97 -39.26 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 26.3 m120 -87.92 -25.83 23.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.34 -149.68 19.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.628 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.632 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -82.46 148.17 28.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 110.943 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.95 63.47 8.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.818 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.6 m -50.9 -24.0 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.282 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.14 -21.0 60.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -132.3 23.49 4.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.529 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.003 HD22 HD11 ' A' ' 26' ' ' LEU . 18.4 mt -70.29 159.62 33.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.377 . . . . 0.0 111.029 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 10.5 t70 -83.22 140.33 42.33 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.864 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 45.1 Cg_exo -55.91 -18.3 21.67 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.608 2.205 . . . . 0.0 112.659 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.68 -58.14 3.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.049 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.003 HD11 HD22 ' A' ' 22' ' ' LEU . 3.3 pp -70.45 -40.3 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.094 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -51.99 -38.54 57.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.979 0.418 . . . . 0.0 110.198 179.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.441 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -64.54 -34.79 79.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.53 178.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.613 HD12 HG22 ' A' ' 82' ' ' VAL . 59.1 tp -56.76 -59.48 4.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.654 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.509 ' CG ' HD21 ' A' ' 40' ' ' LEU . 8.5 m-85 -51.2 -47.55 62.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.614 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.94 -54.85 36.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.873 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.461 ' HB3' HG11 ' A' ' 82' ' ' VAL . 58.8 mtt-85 -56.54 -29.82 62.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.95 -15.06 55.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.431 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.19 9.25 54.07 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.806 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.482 HD11 ' HG ' ' A' ' 85' ' ' LEU . 42.4 mt -86.7 120.52 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 0.0 111.218 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.2 p -87.14 161.52 18.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.818 ' HG2' HG21 ' A' ' 19' ' ' VAL . 2.7 tt0 -52.96 -31.47 40.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.89 -42.34 71.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -77.9 -30.73 50.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.509 HD21 ' CG ' ' A' ' 30' ' ' PHE . 96.0 mt -70.36 -25.06 63.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.726 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.3 p -96.22 -5.24 40.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.53 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.93 122.43 27.76 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 110.77 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.79 -37.93 45.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.52 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.471 ' CG ' ' CZ ' ' A' ' 92' ' ' ARG . 15.6 tp10 -71.72 -59.56 2.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.665 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -31.63 72.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.765 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.6 p -58.55 -44.22 89.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.357 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 7.8 tptt -59.87 -55.07 38.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.587 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -64.75 -32.91 74.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.504 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 69.7 mt -69.69 -64.17 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.493 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.646 ' HA ' HD12 ' A' ' 53' ' ' ILE . 1.6 p90 -52.75 -37.34 59.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.973 0.416 . . . . 0.0 110.06 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.99 -31.64 61.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.413 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.465 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 66.1 t80 -64.49 -41.52 96.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.095 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.941 HG23 HG21 ' A' ' 62' ' ' VAL . 37.2 mt -54.46 -27.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.29 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -72.7 -38.51 67.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.698 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.465 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -69.05 -25.89 64.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.688 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.458 ' NE2' ' OD1' ' A' ' 55' ' ' ASP . 82.3 mm-40 -85.19 9.09 16.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.402 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.52 19.59 24.79 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.415 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 82.26 168.87 42.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.588 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.1 tp -49.42 -39.63 33.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.691 0.282 . . . . 0.0 111.07 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -63.95 -36.37 83.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.032 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.43 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.05 -32.66 65.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.941 HG21 HG23 ' A' ' 53' ' ' ILE . 22.8 t -66.13 -52.86 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -54.15 -43.79 70.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.124 0.487 . . . . 0.0 110.127 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -63.32 -47.72 81.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.27 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 25.5 pt-20 -68.31 -40.43 81.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.693 0.282 . . . . 0.0 111.299 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.6 mmt -57.91 -34.27 69.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.137 0.494 . . . . 0.0 110.284 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -78.79 -33.49 46.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -69.64 -21.55 63.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.52 HE22 HD22 ' A' ' 81' ' ' LEU . 34.4 mt-30 -96.54 -0.88 48.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.803 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.14 92.41 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.324 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . -107.48 -20.31 8.68 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.672 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.88 -83.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.626 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . -93.4 100.96 2.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.183 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.21 128.92 1.16 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.001 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.19 52.92 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.99 0.424 . . . . 0.0 110.37 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -73.82 161.86 29.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.274 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -68.7 99.92 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.733 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.428 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.5 t 179.35 -48.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.158 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.94 84.64 1.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.08 0.467 . . . . 0.0 110.726 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.52 -91.46 0.1 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.902 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.604 ' CD1' HD13 ' A' ' 29' ' ' LEU . 2.7 pt? -62.92 -40.02 96.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.907 0.384 . . . . 0.0 110.707 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.613 HG22 HD12 ' A' ' 29' ' ' LEU . 10.5 t -63.77 -26.43 40.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.097 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.02 -42.15 78.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.318 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.33 -46.2 84.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.373 . . . . 0.0 110.74 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.482 ' HG ' HD11 ' A' ' 35' ' ' ILE . 8.3 tp -52.72 -48.92 66.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.498 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.9 mtt -49.05 -44.05 41.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.659 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.04 -43.51 87.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.361 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.587 HG12 HD13 ' A' ' 48' ' ' LEU . 62.5 t -55.58 -42.94 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.464 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 82.2 mmm -63.79 -31.71 72.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.448 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -68.67 -15.73 63.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.008 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 3.3 tptp -70.3 -25.87 63.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.734 0.302 . . . . 0.0 110.646 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.514 ' HG2' HD22 ' A' ' 48' ' ' LEU . 9.3 mmm180 -73.92 -33.29 63.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.126 0.489 . . . . 0.0 110.112 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 t -75.15 -28.84 60.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.117 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -116.89 26.13 10.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.676 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -74.35 153.05 39.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.892 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 96' ' ' ILE . 2.0 tp -86.59 98.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -46.24 92.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.044 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ILE . 1.2 p -125.57 26.16 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.006 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.56 173.7 11.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -154.7 -175.52 5.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.012 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 178.86 -36.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.53 168.51 21.05 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.527 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -95.85 107.91 20.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.754 0.312 . . . . 0.0 110.923 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t0 39.76 38.26 0.42 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.73 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -153.69 161.39 42.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.81 151.5 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.073 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.362 -1.244 . . . . 0.0 112.52 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.826 0.346 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.2 -24.14 23.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.477 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -118.46 158.51 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.969 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -87.11 111.45 20.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.802 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -88.42 75.65 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.111 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.6 HG11 ' HG2' ' A' ' 60' ' ' GLU . 21.5 t -79.94 139.18 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.825 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -91.61 173.12 8.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.434 0.635 . . . . 0.0 111.806 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.556 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.8 t60 -93.45 -26.07 17.36 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.918 174.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.626 HG11 ' HB2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -163.87 -70.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.437 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.92 28.89 12.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.848 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.95 152.38 21.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.802 0.334 . . . . 0.0 110.564 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -92.92 132.51 30.85 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.425 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 24.4 Cg_exo -62.13 -31.59 83.08 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.452 2.101 . . . . 0.0 112.59 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -98.04 -41.22 8.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.668 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -86.44 -14.77 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.694 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 87.22 -140.74 17.07 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.216 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.441 ' HZ ' HD12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -81.79 -169.12 2.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.91 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.3 54.17 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.392 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.678 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.5 m -47.09 -26.33 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.384 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -70.2 -23.68 62.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.046 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -135.52 26.58 3.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.731 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.018 HD22 HD11 ' A' ' 26' ' ' LEU . 17.1 mt -69.65 159.36 33.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.816 0.341 . . . . 0.0 110.996 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.56 140.16 41.3 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 51.6 Cg_exo -54.84 -19.31 18.75 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.621 2.214 . . . . 0.0 112.51 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -81.19 -58.32 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.074 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.018 HD11 HD22 ' A' ' 22' ' ' LEU . 3.8 pp -71.44 -39.14 71.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.245 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.497 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -58.67 -35.57 72.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.383 . . . . 0.0 110.149 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.426 ' O ' ' CD ' ' A' ' 32' ' ' ARG . 25.8 t -63.75 -38.25 90.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.757 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.969 HD13 HD12 ' A' ' 81' ' ' LEU . 8.0 tp -54.86 -53.85 50.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.423 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.441 ' CD2' HD11 ' A' ' 40' ' ' LEU . 22.6 m-85 -51.35 -46.12 62.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.402 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 m -62.39 -48.03 81.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.736 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -62.05 -33.39 74.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.847 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.3 -21.55 36.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.18 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.91 16.77 32.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.703 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.9 mt -86.65 121.76 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.341 . . . . 0.0 111.14 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 p -87.02 159.13 19.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.678 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -53.03 -30.7 37.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.25 68.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.426 ' HB3' HG21 ' A' ' 45' ' ' THR . 33.3 mt-30 -78.47 -31.3 47.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.807 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.441 HD11 ' CD2' ' A' ' 30' ' ' PHE . 81.7 mt -70.71 -24.55 62.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.7 p -97.66 -7.75 30.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.602 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -82.02 116.45 21.63 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.809 0.338 . . . . 0.0 110.819 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.79 -32.05 8.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.4 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.53 -59.96 2.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 111.407 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.477 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.59 -33.79 75.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.969 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.9 m -59.41 -39.48 83.6 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.478 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 5.5 tptt -62.12 -49.17 76.96 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.433 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.507 ' CD1' HG12 ' A' ' 88' ' ' VAL . 1.5 pp -69.96 -34.36 73.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.748 0.309 . . . . 0.0 110.913 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 36.0 mt -67.89 -64.31 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.73 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.626 ' HB2' HG11 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -52.42 -36.13 53.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.913 0.387 . . . . 0.0 110.384 -179.15 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -33.97 66.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.421 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.622 ' HD1' HG21 ' A' ' 88' ' ' VAL . 65.3 t80 -64.61 -40.12 94.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.327 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.931 HG23 ' CG2' ' A' ' 62' ' ' VAL . 23.2 mt -55.92 -29.92 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.042 0.449 . . . . 0.0 110.181 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -43.21 78.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.631 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.449 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -59.86 -24.39 64.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.934 0.397 . . . . 0.0 110.484 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.548 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 71.3 mm-40 -84.96 -13.91 49.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.159 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.9 24.83 3.81 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.817 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.449 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 83.24 168.79 43.83 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.38 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.457 ' HA ' HG21 ' A' ' 53' ' ' ILE . 10.5 tp -47.35 -33.88 6.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.903 0.383 . . . . 0.0 111.069 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.6 ' HG2' HG11 ' A' ' 6' ' ' VAL . 12.6 mt-10 -68.62 -35.82 77.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.001 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.95 -36.09 67.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.596 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.931 ' CG2' HG23 ' A' ' 53' ' ' ILE . 48.7 t -64.1 -63.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.277 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -30.17 40.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HB2' ' HA ' ' A' ' 61' ' ' ALA . 6.7 mt-30 -63.17 -56.6 15.35 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.088 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 15.7 pt-20 -69.67 -38.36 77.02 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.628 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.401 ' HE3' ' HB3' ' A' ' 28' ' ' SER . 2.1 mmt -57.19 -37.38 72.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.059 0.457 . . . . 0.0 110.412 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -77.88 -37.0 49.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.081 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -69.92 -22.83 63.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.125 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -108.97 -16.94 14.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.536 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -51.81 -44.08 54.97 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.474 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.73 -146.16 47.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.345 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.78 179.24 9.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.932 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 54.79 40.33 71.3 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.429 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.52 46.81 83.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.448 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -109.03 44.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.302 . . . . 0.0 111.066 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.33 123.98 25.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.607 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.1 p -118.89 112.28 19.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.975 0.417 . . . . 0.0 111.442 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.725 ' HB2' HG21 ' A' ' 82' ' ' VAL . 57.0 p -89.0 -11.38 44.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.117 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' OE1' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -70.94 63.57 0.31 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.187 0.518 . . . . 0.0 111.158 -178.377 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.86 -101.26 0.16 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.705 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.969 HD12 HD13 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -64.77 -30.72 71.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 110.847 178.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.725 HG21 ' HB2' ' A' ' 78' ' ' SER . 3.3 t -65.76 -37.57 80.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.399 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.39 -43.28 70.59 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.416 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -65.13 -48.55 73.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 14.8 tp -61.31 -40.73 95.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 7.0 mtm -53.28 -37.57 62.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.266 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -72.23 -44.08 63.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.407 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.622 HG21 ' HD1' ' A' ' 52' ' ' PHE . 59.1 t -53.92 -39.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.563 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.4 mmm -65.51 -29.44 70.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.914 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 86.0 mt-30 -66.05 -10.56 41.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 4.4 mptt -69.79 -38.39 76.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.947 0.403 . . . . 0.0 110.454 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.418 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 30.4 mmm180 -74.71 -26.72 60.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.537 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.35 -37.35 57.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.036 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 90' ' ' GLN . 12.3 mmt85 -90.84 -5.42 55.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.842 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.83 120.85 20.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 110.643 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 96' ' ' ILE . 3.2 tp -107.17 101.27 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.176 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.9 88.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.553 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -115.91 41.46 2.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.111 -178.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.7 p -116.34 74.33 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -155.02 -46.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.975 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -58.79 156.06 11.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.26 -19.24 4.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.639 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.83 131.35 37.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 111.094 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.33 151.0 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.893 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.49 172.83 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.01 93.46 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.538 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.843 0.354 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.76 -17.6 45.38 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.675 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -114.66 176.22 5.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.35 . . . . 0.0 110.97 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HB3' HG23 ' A' ' 6' ' ' VAL . 3.1 mtpt -133.05 175.91 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.941 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -111.68 44.69 1.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.535 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 4' ' ' LYS . 2.4 t -86.77 144.87 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.85 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.7 m 66.82 -64.41 0.24 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.937 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.442 ' O ' HD23 ' A' ' 59' ' ' LEU . 3.1 t60 75.47 51.06 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.524 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.18 -41.76 26.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.106 0.479 . . . . 0.0 110.134 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.0 47.61 7.95 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.302 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.49 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.28 153.15 21.12 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.1 m-20 -89.42 140.28 28.43 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.749 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.426 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 71.9 Cg_endo -78.16 -18.43 12.76 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.658 2.239 . . . . 0.0 112.584 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -110.93 -38.16 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.024 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -87.25 -21.55 25.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 96.34 -138.29 13.85 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.249 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.409 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -81.71 -169.81 2.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.893 0.378 . . . . 0.0 110.919 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -118.2 53.23 0.97 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.569 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.717 HG11 ' HG3' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -47.01 -26.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.577 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.54 -22.91 61.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.049 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -134.54 25.43 3.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.569 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.056 HD22 HD11 ' A' ' 26' ' ' LEU . 17.5 mt -69.89 159.09 34.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 111.234 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -85.23 140.25 36.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.755 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 50.4 Cg_exo -54.84 -19.61 19.74 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.539 2.159 . . . . 0.0 112.559 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 4.5 m-20 -82.2 -57.12 3.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.328 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.056 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -69.93 -41.36 74.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.069 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -56.97 -35.46 69.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.933 0.396 . . . . 0.0 110.262 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -39.45 93.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.593 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.756 HD12 HG22 ' A' ' 82' ' ' VAL . 23.3 tp -57.34 -50.86 71.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.801 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 22.8 m-85 -54.65 -48.3 72.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.739 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -61.24 -46.44 90.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.882 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.74 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -58.9 -35.98 73.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.54 0.04 44.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.753 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.74 12.54 77.35 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.912 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.599 HD12 HD21 ' A' ' 85' ' ' LEU . 66.4 mt -86.67 112.91 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.783 0.325 . . . . 0.0 111.129 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.74 164.43 15.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.717 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.35 -29.66 24.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.643 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.83 -44.46 73.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.791 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -78.13 -29.06 48.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.694 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.409 HD21 ' CG ' ' A' ' 30' ' ' PHE . 75.0 mt -70.69 -26.29 63.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.692 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 37' ' ' GLU . 49.0 p -97.28 -7.54 31.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.576 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' SER . 6.1 t0 -81.61 112.59 18.96 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.906 0.384 . . . . 0.0 110.717 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 13' ' ' PRO . . . -46.49 -32.22 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.6 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.23 -58.47 3.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.933 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -68.62 -35.95 77.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.233 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -56.94 -39.74 75.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.854 0.359 . . . . 0.0 110.201 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 1.1 tppm? -60.78 -55.52 32.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.337 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.774 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.03 -33.47 75.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.035 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 60.4 mt -68.44 -63.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.654 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 1.8 p90 -51.09 -38.21 50.34 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.029 0.443 . . . . 0.0 110.018 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.68 -34.21 69.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.523 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 80.9 t80 -63.94 -28.93 70.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.039 0.447 . . . . 0.0 110.259 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.953 HG23 ' CG2' ' A' ' 62' ' ' VAL . 20.1 mt -68.5 -27.8 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.087 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.49 -35.07 70.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.594 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.3 p30 -69.28 -25.46 64.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.585 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.523 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 10.9 mt-30 -84.5 -8.76 58.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.089 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.02 21.39 5.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.064 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 84.52 168.9 44.95 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.396 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.496 HD13 HD22 ' A' ' 26' ' ' LEU . 11.1 tp -48.45 -38.67 20.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.02 -34.5 78.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.84 -33.91 66.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.607 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.953 ' CG2' HG23 ' A' ' 53' ' ' ILE . 44.5 t -65.32 -63.57 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.333 . . . . 0.0 110.804 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -52.64 -41.42 63.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 110.244 178.184 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -63.64 -49.15 74.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.644 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.883 ' CD ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -69.44 -33.84 73.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.175 -178.117 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mmt -60.5 -31.47 70.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 110.36 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -76.75 -38.99 53.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.49 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -69.66 -29.04 66.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.931 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.423 ' NE2' ' OE1' ' A' ' 65' ' ' GLU . 41.7 mt-30 -90.65 16.17 9.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.856 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.33 -23.98 20.34 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.448 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.3 120.9 1.01 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.439 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.0 t -175.78 -68.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 110.816 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.95 -81.39 1.47 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.331 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 75' ' ' SER . . . -78.89 -19.89 71.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER 88.18 -23.8 0.11 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.956 0.503 . . . . 0.0 111.612 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -75.83 144.27 41.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 111.051 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.8 OUTLIER -108.15 109.47 20.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.693 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.427 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.7 OUTLIER 164.74 -37.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.497 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.2 101.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.087 0.47 . . . . 0.0 110.795 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.31 -97.3 0.19 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.998 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.883 HD13 ' CD ' ' A' ' 65' ' ' GLU . 2.4 pt? -59.72 -38.79 82.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.654 0.264 . . . . 0.0 111.365 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.756 HG22 HD12 ' A' ' 29' ' ' LEU . 20.7 t -62.68 -25.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 110.712 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.65 -41.3 84.33 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.185 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.54 -49.09 72.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 110.585 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.599 HD21 HD12 ' A' ' 35' ' ' ILE . 9.5 tp -50.89 -52.9 37.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.762 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 12.6 mtm -51.01 -31.37 17.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -79.25 -29.34 42.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.489 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.774 HG12 HD13 ' A' ' 48' ' ' LEU . 64.8 t -72.38 -42.97 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.629 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.425 ' SD ' HD11 ' A' ' 35' ' ' ILE . 83.1 mmm -62.71 -35.49 79.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.393 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -54.14 -21.55 8.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.261 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 11.1 tptt -70.66 -56.59 6.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.31 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -24.48 60.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.29 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.43 -29.34 52.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.42 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -108.92 -15.46 14.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.867 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 91' ' ' LYS . . . -74.73 172.6 11.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.171 0.51 . . . . 0.0 111.667 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 mm -61.01 107.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.633 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.422 ' O ' ' CB ' ' A' ' 98' ' ' SER . 95.7 m-70 -55.38 144.39 25.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.389 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 97' ' ' HIS . 1.4 t 80.34 -57.29 0.34 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.338 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.5 171.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.462 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -154.97 126.55 7.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.708 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.86 -25.73 57.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 176.43 133.82 1.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.394 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -110.34 149.07 30.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.46 -179.06 4.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.18 99.42 2.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.003 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.95 122.39 27.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.469 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.77 0.319 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.9 29.99 40.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.393 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -71.39 141.93 50.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 174.16 8.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.79 94.24 2.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.772 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t -112.41 143.46 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.344 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.1 -161.33 0.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.595 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -140.55 -56.51 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.196 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 50' ' ' TYR . 2.2 t 41.18 95.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 111.518 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.33 50.83 4.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.967 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.559 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -87.74 153.63 21.2 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.42 140.28 28.43 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.674 0.273 . . . . 0.0 110.729 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.98 -37.59 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.686 2.257 . . . . 0.0 112.393 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -90.42 -38.06 13.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.954 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -87.2 -27.73 22.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.41 -149.68 19.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.624 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 11' ' ' TRP . 0.1 OUTLIER -82.65 146.58 29.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 111.003 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.08 67.17 9.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.782 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.8 m -50.53 -29.51 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -70.86 -19.92 62.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.139 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -130.72 20.43 5.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.449 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.939 HD22 HD11 ' A' ' 26' ' ' LEU . 17.3 mt -70.49 159.74 33.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -83.03 139.44 42.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.3 Cg_exo -54.28 -19.61 17.31 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.623 2.215 . . . . 0.0 112.636 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 75.3 m-20 -81.06 -58.16 3.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.061 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.939 HD11 HD22 ' A' ' 22' ' ' LEU . 4.0 pp -70.95 -38.29 72.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.148 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.485 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -61.98 -34.71 76.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.376 . . . . 0.0 110.086 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.415 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 23.1 t -64.21 -36.86 85.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.597 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.075 HD13 HD12 ' A' ' 81' ' ' LEU . 3.4 tp -56.1 -58.12 9.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.302 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.47 ' HD1' HD21 ' A' ' 85' ' ' LEU . 17.7 m-85 -49.59 -38.36 31.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.986 0.422 . . . . 0.0 110.519 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.41 -57.78 10.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.763 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.635 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -60.5 -25.5 66.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.787 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.14 -18.3 43.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.305 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.08 17.99 56.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.604 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.687 HD13 ' HE3' ' A' ' 89' ' ' MET . 60.7 mt -86.24 126.14 40.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.177 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.69 152.79 21.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.782 ' HG2' HG21 ' A' ' 19' ' ' VAL . 1.5 mt-10 -51.9 -25.37 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.737 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.89 -42.76 72.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.875 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -78.37 -30.06 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.796 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.569 HD23 HD13 ' A' ' 49' ' ' ILE . 95.9 mt -70.67 -27.56 64.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.887 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 37' ' ' GLU . 23.4 p -98.33 -2.44 39.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.552 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 46' ' ' SER . 5.4 t70 -82.85 123.77 29.68 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.52 -37.14 47.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.592 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.74 -59.88 2.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.529 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.5 -36.03 80.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.203 -179.066 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 87.3 p -56.5 -37.59 70.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.88 0.372 . . . . 0.0 110.173 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 11.1 tptt -61.92 -55.69 27.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.742 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.86 -28.98 68.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.276 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.569 HD13 HD23 ' A' ' 40' ' ' LEU . 56.0 mt -67.38 -64.8 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.274 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.559 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.8 p90 -55.28 -34.27 63.95 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.75 -35.65 68.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.45 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.519 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 71.2 t80 -63.79 -30.19 71.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.028 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.939 HG23 HG21 ' A' ' 62' ' ' VAL . 17.6 mt -65.43 -27.95 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.033 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.83 -41.77 71.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.571 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.4 p30 -61.4 -25.32 67.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.509 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.519 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 7.7 mt-30 -85.0 -10.61 56.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.252 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.42 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.21 21.73 5.47 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.03 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.445 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 85.28 168.5 44.78 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.657 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.438 ' HA ' HG21 ' A' ' 53' ' ' ILE . 14.9 tp -47.67 -37.13 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 110.969 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.0 -36.96 83.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.611 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.42 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.54 -36.06 68.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.939 HG21 HG23 ' A' ' 53' ' ' ILE . 43.8 t -65.12 -62.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.699 0.285 . . . . 0.0 110.941 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.408 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -49.45 -39.04 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.958 0.409 . . . . 0.0 110.206 178.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -53.96 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.258 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.444 ' HA ' ' CD ' ' A' ' 68' ' ' ARG . 11.0 pt-20 -70.19 -28.15 65.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.689 ' SD ' HD21 ' A' ' 81' ' ' LEU . 5.5 mmm -71.74 -22.72 61.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.833 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -76.08 -49.39 17.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.155 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' CD ' ' HA ' ' A' ' 65' ' ' GLU . 0.2 OUTLIER -70.74 -29.35 65.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.064 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -20.87 60.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.173 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 76' ' ' GLN . . . -108.41 -41.79 1.45 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.637 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.14 103.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.398 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 68.94 -63.97 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 110.904 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.43 153.25 6.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.495 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.78 145.99 0.25 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.433 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.88 33.13 22.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.413 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 6.7 pt20 -74.63 163.6 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.8 m -95.4 103.81 15.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.464 ' CB ' HG21 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -71.51 -10.33 59.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.365 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -71.6 88.91 0.96 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.135 0.493 . . . . 0.0 110.818 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.49 -100.89 0.18 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.811 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.075 HD12 HD13 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -65.07 -34.09 77.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.62 0.247 . . . . 0.0 111.148 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.635 HG11 ' HB3' ' A' ' 32' ' ' ARG . 3.8 t -64.99 -37.48 80.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.756 0.312 . . . . 0.0 111.33 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.34 -41.71 77.26 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.561 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.64 -51.08 64.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.598 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.477 HD21 HD12 ' A' ' 35' ' ' ILE . 12.3 tp -58.95 -40.01 83.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.264 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.5 mtm -54.05 -38.57 65.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.198 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -69.89 -44.66 69.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.389 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.742 HG12 HD13 ' A' ' 48' ' ' LEU . 44.8 t -56.11 -38.99 56.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.812 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.687 ' HE3' HD13 ' A' ' 35' ' ' ILE . 28.7 mmt -61.39 -37.62 84.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.048 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -74.41 -16.98 60.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.276 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -68.64 -56.96 6.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.058 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.47 ' HB2' HD22 ' A' ' 48' ' ' LEU . 2.6 tpt180 -73.31 -17.24 61.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.436 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.92 -34.23 59.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.808 0.337 . . . . 0.0 110.934 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.71 -15.37 21.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.461 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.08 119.04 17.74 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.07 0.462 . . . . 0.0 111.442 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 96' ' ' ILE . 4.5 tt -128.85 108.3 17.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.351 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.83 78.87 0.08 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.527 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -110.71 -168.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.759 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -100.97 177.39 4.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.932 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.98 -68.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 99' ' ' SER . 2.1 pt-20 -137.63 83.74 2.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.1 62.77 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.457 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.62 174.5 5.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.826 0.346 . . . . 0.0 110.917 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.03 178.65 3.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -129.94 36.31 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.969 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.88 143.07 32.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.055 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 CA-C-O 118.384 -1.231 . . . . 0.0 112.58 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.829 0.347 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.48 -23.5 22.3 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -139.92 115.65 10.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -87.1 152.03 22.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.41 73.79 2.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 8' ' ' HIS . 48.1 t -103.43 145.72 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.234 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.584 ' CB ' HD23 ' A' ' 59' ' ' LEU . 0.6 OUTLIER 48.13 -89.2 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.633 178.173 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' VAL . 25.6 t60 45.94 45.43 11.97 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.707 HG11 ' HB2' ' A' ' 50' ' ' TYR . 2.1 t 32.18 101.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.78 58.4 0.52 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.249 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.8 153.79 20.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 110.901 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.14 140.24 25.81 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.408 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.09 -36.17 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.598 2.199 . . . . 0.0 112.531 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -83.75 -41.35 17.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.129 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -87.62 -28.43 21.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.935 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.95 -146.8 17.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.712 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.8 135.7 35.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.941 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.26 62.85 0.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.563 HG11 ' HG3' ' A' ' 37' ' ' GLU . 2.3 m -53.44 -23.22 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.789 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.85 -20.77 59.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.903 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -128.64 18.31 6.28 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.517 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.925 HD22 HD11 ' A' ' 26' ' ' LEU . 17.4 mt -70.0 159.35 33.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 111.133 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 6.2 t70 -84.54 140.88 38.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.926 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 33.6 Cg_exo -57.24 -17.75 27.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.589 2.193 . . . . 0.0 112.589 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.427 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 0.6 OUTLIER -81.91 -57.94 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.151 -179.529 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.925 HD11 HD22 ' A' ' 22' ' ' LEU . 4.0 pp -69.57 -41.53 75.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.947 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.508 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -55.58 -35.81 66.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 110.295 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -62.61 -39.24 93.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.719 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.501 HD11 ' HA ' ' A' ' 82' ' ' VAL . 28.9 tp -56.81 -51.28 69.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.587 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.413 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 21.5 m-85 -53.42 -43.46 67.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.577 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.3 m -61.82 -51.55 67.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.89 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.52 ' HB3' HG11 ' A' ' 82' ' ' VAL . 9.9 mtt180 -59.9 -32.73 71.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.813 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HB1' ' HG2' ' A' ' 86' ' ' MET . . . -81.94 -18.28 44.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.34 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.33 8.56 54.83 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.937 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.712 HD12 HD21 ' A' ' 85' ' ' LEU . 72.8 mt -85.98 109.56 18.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.3 p -86.46 167.23 14.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.041 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.563 ' HG3' HG11 ' A' ' 19' ' ' VAL . 1.4 mp0 -53.2 -34.52 57.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.037 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.23 -42.5 66.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -77.68 -35.1 52.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.552 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.523 HD23 HD13 ' A' ' 49' ' ' ILE . 25.2 mt -69.95 -20.7 63.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 37' ' ' GLU . 68.1 p -94.32 -9.53 35.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.402 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -81.07 121.67 26.37 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.754 0.311 . . . . 0.0 110.708 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.72 -34.62 27.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.432 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.35 -59.91 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.59 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.415 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.72 -37.94 82.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.2 p -56.87 -39.52 74.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.818 0.342 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 1.3 tppm? -61.29 -55.79 27.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.348 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.732 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -65.25 -32.08 73.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.328 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.523 HD13 HD23 ' A' ' 40' ' ' LEU . 55.4 mt -66.49 -63.98 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.124 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.707 ' HB2' HG11 ' A' ' 9' ' ' VAL . 2.0 p90 -53.41 -37.96 62.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.97 0.414 . . . . 0.0 110.043 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.9 -35.57 66.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.481 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.493 ' HD2' HG21 ' A' ' 88' ' ' VAL . 37.4 t80 -64.0 -34.55 78.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.097 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.988 HG23 HG21 ' A' ' 62' ' ' VAL . 23.8 mt -60.77 -28.63 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.072 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.36 -38.84 78.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.459 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.83 -25.53 64.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 61.3 mm-40 -87.5 13.38 10.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.455 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 95.21 17.41 37.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.572 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.18 170.55 46.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.879 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.584 HD23 ' CB ' ' A' ' 7' ' ' SER . 10.2 tp -49.49 -41.56 40.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.713 0.292 . . . . 0.0 111.27 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.444 ' CG ' ' HB2' ' A' ' 7' ' ' SER . 29.1 mt-10 -65.1 -34.8 79.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.165 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.5 -34.29 65.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.656 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.988 HG21 HG23 ' A' ' 53' ' ' ILE . 61.5 t -64.29 -61.92 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -51.56 -38.6 55.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.082 0.468 . . . . 0.0 110.008 177.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.87 -51.5 64.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.329 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 11.3 pt-20 -68.74 -33.95 74.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.762 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.437 ' CE ' ' CA ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -64.63 -23.77 67.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.5 -47.38 27.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.475 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.3 mtt180 -70.56 -40.33 73.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.419 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -88.9 9.96 23.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.653 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -114.93 -26.95 3.38 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.496 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.43 47.56 50.12 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.442 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.2 m 50.84 29.28 4.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.33 171.77 38.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.561 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.75 -97.5 1.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.53 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.7 p -75.37 65.39 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.808 0.337 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.1 146.72 43.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.811 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.46 85.49 2.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.218 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.563 ' HB2' HG21 ' A' ' 82' ' ' VAL . 80.3 p -68.25 -16.24 63.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.02 93.68 1.79 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.125 0.488 . . . . 0.0 110.805 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.44 -94.92 0.15 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.984 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.7 pt? -63.39 -39.91 95.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.799 0.333 . . . . 0.0 111.232 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.563 HG21 ' HB2' ' A' ' 78' ' ' SER . 6.5 t -62.92 -33.29 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.385 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -34.87 78.23 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.298 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -51.28 62.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 110.681 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.712 HD21 HD12 ' A' ' 35' ' ' ILE . 14.5 tp -62.94 -42.5 99.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.477 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.512 ' HG2' ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -53.37 -33.36 53.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.403 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -75.17 -30.31 60.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.349 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.732 HG12 HD13 ' A' ' 48' ' ' LEU . 96.8 t -66.36 -40.24 86.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.626 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.484 ' SD ' HD11 ' A' ' 35' ' ' ILE . 74.1 mmm -62.38 -26.77 68.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.614 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -73.98 -16.62 61.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.236 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -70.57 -35.26 72.97 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.811 0.338 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.461 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.21 -24.05 59.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.844 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 m -73.18 -24.2 60.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.871 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -107.97 -21.08 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.005 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.65 129.82 38.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.258 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.701 ' O ' HG23 ' A' ' 96' ' ' ILE . 20.2 tt -106.13 99.6 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.96 -23.59 21.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.26 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.1 t -66.55 -22.04 66.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.053 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.62 -26.17 61.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 0.0 111.014 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.02 90.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.973 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -132.98 49.04 2.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.974 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.46 142.21 0.14 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.446 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -82.88 130.52 35.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.38 . . . . 0.0 110.843 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -167.65 147.55 5.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.968 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -100.13 144.4 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.02 93.58 6.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.022 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.387 -1.23 . . . . 0.0 112.518 -179.909 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.847 0.356 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.57 25.62 8.07 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.508 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -112.8 145.07 41.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.754 0.312 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.13 157.55 19.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.977 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -112.5 71.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.54 130.88 59.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.188 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.419 ' HB3' ' HA3' ' A' ' 58' ' ' GLY . 1.4 p -90.72 164.39 14.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.503 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.426 ' O ' ' N ' ' A' ' 10' ' ' GLY . 50.3 t-80 -116.48 -38.95 3.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.064 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t 67.22 -66.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.818 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . 90.79 36.35 6.84 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.976 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.29 153.55 20.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.337 . . . . 0.0 110.25 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -88.83 140.23 29.38 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.545 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.23 -33.5 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.671 2.247 . . . . 0.0 112.572 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -93.22 -41.11 10.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -87.1 -26.94 23.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.043 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 101.62 -145.11 16.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.386 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.559 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.43 138.9 35.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -76.01 62.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.249 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.583 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.8 m -51.24 -24.69 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.9 -21.39 60.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -128.55 19.91 6.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.383 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.074 HD22 HD11 ' A' ' 26' ' ' LEU . 16.4 mt -71.02 159.06 35.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.793 0.33 . . . . 0.0 111.189 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.88 142.56 39.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.989 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 43.3 Cg_exo -56.01 -20.02 28.51 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.606 2.204 . . . . 0.0 112.529 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.42 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 1.1 m-20 -81.82 -56.97 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.14 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.074 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -71.12 -37.46 72.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.476 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 2.0 ppt_? -59.59 -36.27 75.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.948 0.404 . . . . 0.0 110.214 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.1 t -63.68 -37.2 86.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.652 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.035 HD13 HD12 ' A' ' 81' ' ' LEU . 25.6 tp -56.71 -57.07 14.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.625 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CG ' HD21 ' A' ' 40' ' ' LEU . 20.3 m-85 -48.35 -43.63 33.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.25 -58.48 7.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.631 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.668 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -55.54 -29.86 59.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.826 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.77 3.52 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.806 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.8 4.28 90.37 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.994 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 36' ' ' SER . 35.2 mt -85.67 162.35 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.893 0.347 . . . . 0.0 110.851 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -145.4 172.77 12.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.033 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 41' ' ' THR . 1.0 OUTLIER -53.45 -37.78 62.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.025 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.71 -46.42 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.71 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -78.54 -34.02 47.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.668 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.502 HD21 ' CG ' ' A' ' 30' ' ' PHE . 83.6 mt -70.0 -23.14 63.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 37' ' ' GLU . 46.9 p -94.99 -7.65 39.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.537 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -81.3 119.17 23.32 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.757 0.313 . . . . 0.0 110.715 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.85 -34.48 12.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.493 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' OE1' ' NH2' ' A' ' 92' ' ' ARG . 36.5 tt0 -72.75 -59.89 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.415 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.426 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -68.21 -34.41 76.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.409 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.2 p -58.32 -42.3 86.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.847 0.356 . . . . 0.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -60.99 -53.14 60.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.499 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.874 HD13 HG12 ' A' ' 88' ' ' VAL . 1.5 pp -65.04 -32.26 73.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.741 0.305 . . . . 0.0 110.828 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.442 HD13 HD23 ' A' ' 40' ' ' LEU . 49.9 mt -68.42 -64.0 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.384 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.3 p90 -52.08 -40.7 61.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.885 0.374 . . . . 0.0 110.303 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.449 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -53.57 -32.68 51.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 178.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.46 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 69.3 t80 -63.85 -41.74 97.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.122 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.796 HG23 HG21 ' A' ' 62' ' ' VAL . 59.9 mt -55.39 -25.11 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.41 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.83 -35.54 59.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.783 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.46 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -72.93 -25.63 61.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.8 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -87.4 13.98 8.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.552 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.97 14.72 41.7 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.635 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 7' ' ' SER . . . 84.91 170.19 46.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.127 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.414 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 12.5 tp -48.99 -40.13 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 110.899 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -65.07 -36.19 83.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.302 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.08 -35.76 66.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.899 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.796 HG21 HG23 ' A' ' 53' ' ' ILE . 24.0 t -65.0 -63.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.756 0.312 . . . . 0.0 110.912 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -51.69 -44.53 63.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.071 0.462 . . . . 0.0 110.235 178.341 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -63.0 -52.58 62.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.41 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 4.4 pt-20 -70.4 -23.3 62.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.212 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mmt -69.01 -35.15 76.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 0.0 110.241 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -77.36 -33.43 55.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.667 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.82 -22.01 62.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.882 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 77' ' ' SER . 15.3 mt-30 -88.2 -18.67 28.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.311 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.68 108.65 2.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.516 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.67 -157.39 19.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.573 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.69 146.04 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.333 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.13 101.08 2.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.87 -29.98 7.74 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.473 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.72 50.37 0.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 110.845 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -74.58 151.95 39.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.032 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -53.03 154.95 2.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.423 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 0.1 OUTLIER 82.97 -48.22 0.15 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.341 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.99 70.57 1.04 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.092 0.472 . . . . 0.0 110.762 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.31 -93.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.009 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.035 HD12 HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -62.46 -29.81 70.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.76 179.127 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 32' ' ' ARG . 16.8 t -64.58 -30.04 49.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.768 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -46.47 60.05 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.037 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.35 -46.49 79.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.948 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.496 HD21 HD12 ' A' ' 35' ' ' ILE . 13.6 tp -55.97 -46.83 78.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.7 mtp -53.62 -29.97 40.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.441 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 90' ' ' GLN . 79.0 t60 -80.08 -30.17 39.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.525 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.874 HG12 HD13 ' A' ' 48' ' ' LEU . 59.9 t -69.48 -42.45 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 110.308 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.3 mmm -63.51 -28.39 69.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.138 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 87' ' ' HIS . 1.0 OUTLIER -63.13 -18.75 63.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.343 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.771 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 9.8 tptt -69.75 -36.46 75.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.994 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.426 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 14.5 mmm-85 -73.66 -19.45 60.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.99 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.421 ' HB2' ' HD3' ' A' ' 94' ' ' ARG . 41.0 m -75.01 -31.54 61.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.421 ' HD3' ' HB2' ' A' ' 93' ' ' SER . 1.4 mpp_? -130.84 25.74 4.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.28 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -74.09 136.05 42.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.935 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.588 ' O ' HG23 ' A' ' 96' ' ' ILE . 5.7 tp -132.45 82.53 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.119 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -136.45 73.65 1.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.299 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m 75.6 25.83 1.17 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.234 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.14 -26.18 14.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.927 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 54.07 179.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -61.58 -27.57 68.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.33 -130.96 11.69 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.477 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.51 157.68 15.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.917 0.389 . . . . 0.0 110.747 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.89 169.34 11.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.041 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 64.17 33.21 12.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.03 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.7 114.65 19.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.946 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 CA-C-O 118.365 -1.242 . . . . 0.0 112.509 -179.746 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.821 0.343 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.89 18.35 47.77 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.6 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -147.1 162.8 38.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.344 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.76 126.86 35.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.054 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -145.07 100.32 3.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.898 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.5 t -83.5 139.98 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.219 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.93 -27.79 18.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 68.44 114.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.036 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 t -81.83 -55.12 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.956 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.13 18.82 8.44 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.785 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.569 ' CH2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.4 153.81 20.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.745 -179.596 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.09 140.8 29.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.552 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.05 -38.2 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.652 2.235 . . . . 0.0 112.772 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -94.17 -35.6 12.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.19 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -87.77 -25.29 23.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.112 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.85 -150.19 19.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.393 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.686 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.28 136.36 35.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.332 . . . . 0.0 110.891 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -74.83 62.95 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.277 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.608 HG21 ' HG2' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -52.0 -23.83 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.288 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.43 -21.76 61.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.194 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -132.68 21.89 4.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.487 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.015 HD22 HD11 ' A' ' 26' ' ' LEU . 16.5 mt -70.07 159.03 34.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 111.23 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -85.19 139.84 36.63 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.0 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 52.5 Cg_exo -55.19 -18.94 19.35 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.621 2.214 . . . . 0.0 112.684 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -81.19 -57.97 3.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.228 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.015 HD11 HD22 ' A' ' 22' ' ' LEU . 3.5 pp -69.91 -42.81 72.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.096 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -54.72 -34.22 62.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.956 0.407 . . . . 0.0 110.086 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.33 -39.18 93.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.677 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 82' ' ' VAL . 22.4 tp -56.59 -55.65 31.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.591 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.43 ' CG ' HD21 ' A' ' 40' ' ' LEU . 9.9 m-30 -50.38 -43.61 54.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.617 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 m -62.34 -55.14 30.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.709 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.467 ' HB3' HG11 ' A' ' 82' ' ' VAL . 2.6 mtp180 -56.73 -30.89 63.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.827 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.92 -21.46 37.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 8.68 48.31 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.771 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.569 HD12 HD21 ' A' ' 85' ' ' LEU . 39.3 mt -86.09 112.3 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.83 0.348 . . . . 0.0 111.176 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 p -87.0 167.6 14.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' THR . 3.5 mt-10 -52.17 -28.91 19.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.821 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.5 -46.14 73.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 35' ' ' ILE . 2.7 mt-30 -78.47 -31.38 47.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.688 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.43 HD21 ' CG ' ' A' ' 30' ' ' PHE . 87.4 mt -69.98 -25.48 63.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 37' ' ' GLU . 44.4 p -97.29 -5.33 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.607 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 46' ' ' SER . 20.9 t0 -82.23 113.69 20.22 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.753 0.311 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.6 -32.28 3.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.59 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.94 -59.66 2.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.122 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.413 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.85 -36.5 80.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.295 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -56.39 -38.16 71.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.848 0.356 . . . . 0.0 110.21 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 4.1 tptm -62.07 -54.95 34.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.363 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.693 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -67.04 -30.67 70.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.258 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 48.7 mt -68.02 -64.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.517 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.569 ' CZ ' ' CH2' ' A' ' 11' ' ' TRP . 2.1 p90 -52.77 -40.72 63.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.94 0.4 . . . . 0.0 110.224 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.78 -32.69 60.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.7 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 85' ' ' LEU . 77.0 t80 -64.54 -38.67 91.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.25 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.047 HG23 HG21 ' A' ' 62' ' ' VAL . 44.6 mt -59.18 -28.64 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.238 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.67 -33.95 73.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.342 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.464 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -75.08 -24.66 58.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.476 178.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 97.0 mm-40 -85.9 10.48 13.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.339 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.15 17.08 33.11 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.483 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 82.64 171.21 46.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.809 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.5 tp -49.34 -41.62 39.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 111.281 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -63.87 -34.84 78.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.219 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -35.57 66.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.255 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 1.047 HG21 HG23 ' A' ' 53' ' ' ILE . 22.0 t -66.06 -48.79 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -54.29 -46.55 72.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.112 0.482 . . . . 0.0 109.985 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.53 -49.07 74.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.943 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 20.3 pt-20 -67.56 -24.75 65.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.805 0.336 . . . . 0.0 110.808 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.404 ' CE ' ' N ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -72.93 -22.53 60.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 178.466 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 -75.93 -51.7 11.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.909 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -32.42 69.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.849 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.625 ' OE1' HD22 ' A' ' 81' ' ' LEU . 32.6 mt-30 -91.03 -6.88 53.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.582 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.51 104.8 0.96 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.499 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.19 -70.32 1.02 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.68 -71.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 0.0 110.995 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.52 66.73 0.5 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.57 -22.23 3.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.446 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.68 29.98 4.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.7 129.64 38.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.93 94.33 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.987 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.566 ' CB ' HG21 ' A' ' 82' ' ' VAL . 2.1 p -79.7 -5.72 55.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.557 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.75 102.08 3.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.965 0.412 . . . . 0.0 110.969 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.29 -94.38 0.18 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.356 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.625 HD22 ' OE1' ' A' ' 69' ' ' GLN . 2.7 pt? -63.71 -41.11 98.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.684 0.278 . . . . 0.0 111.48 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.566 HG21 ' CB ' ' A' ' 78' ' ' SER . 6.0 t -63.61 -37.13 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.774 0.321 . . . . 0.0 111.272 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.2 -38.51 82.56 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.479 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.576 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.94 -48.74 73.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.569 HD21 HD12 ' A' ' 35' ' ' ILE . 30.7 tp -62.03 -45.18 94.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.4 mtm -54.25 -34.48 60.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.499 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -75.74 -24.46 56.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.693 HG12 HD13 ' A' ' 48' ' ' LEU . 48.2 t -78.28 -37.4 22.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.156 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 67.2 mmm -62.49 -37.11 84.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.046 0.451 . . . . 0.0 110.258 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -68.14 -11.25 58.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.229 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 1.4 tptp -69.26 -27.94 65.88 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.678 0.275 . . . . 0.0 111.257 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.489 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 21.3 mmm180 -73.07 -22.24 60.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 0.0 110.963 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.423 ' HB2' ' HD2' ' A' ' 94' ' ' ARG . 64.5 m -76.06 -24.84 55.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.441 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 93' ' ' SER . 1.3 mpt_? -130.7 11.02 5.19 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -74.37 173.63 9.99 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.084 0.469 . . . . 0.0 111.377 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 98' ' ' SER . 16.3 mm -75.7 106.79 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.014 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.88 90.71 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.548 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.5 OUTLIER -147.52 111.4 5.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.068 -178.16 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.7 m -146.55 -44.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.051 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 58.43 73.34 0.48 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.98 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -108.04 173.42 6.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.74 86.02 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.37 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 104' ' ' ASP . 2.5 tt0 -76.7 169.98 17.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 110.789 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER 80.36 151.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.612 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.37 110.53 0.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.68 133.01 35.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.988 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.506 -179.913 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.836 0.351 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.27 -20.83 48.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.535 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -124.39 136.61 54.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -86.94 141.61 28.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -124.85 52.38 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.92 145.15 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.078 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -49.53 6.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.75 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.6 t60 69.72 80.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.147 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' A' ' 50' ' ' TYR . 4.0 t -60.32 -54.87 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.743 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.27 19.56 16.14 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.806 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.556 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.16 153.44 20.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 0.0 110.383 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.8 m-20 -90.57 138.41 26.74 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.467 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.23 -23.45 6.33 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.587 2.191 . . . . 0.0 112.598 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -99.1 -41.14 7.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.088 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -88.15 -29.85 20.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.046 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 109.56 -144.79 16.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.467 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.861 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -83.49 147.01 28.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 111.095 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -82.14 58.75 4.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.886 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG12 HD13 ' A' ' 40' ' ' LEU . 1.6 m -51.38 -24.03 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.069 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -19.77 59.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -131.61 21.34 4.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.401 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.036 HD22 HD11 ' A' ' 26' ' ' LEU . 17.6 mt -70.14 159.63 33.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.933 0.397 . . . . 0.0 111.201 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -83.52 145.85 48.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.06 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 31.4 Cg_exo -58.66 -22.23 59.64 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.634 2.223 . . . . 0.0 112.645 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.92 -56.37 4.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.328 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.036 HD11 HD22 ' A' ' 22' ' ' LEU . 3.6 pp -70.85 -32.77 69.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.333 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -64.17 -35.56 81.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.234 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -35.82 81.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.642 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.047 HD13 HD12 ' A' ' 81' ' ' LEU . 9.4 tp -56.4 -60.36 3.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.544 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CG ' HD21 ' A' ' 40' ' ' LEU . 16.7 m-85 -49.0 -45.24 42.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.817 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 m -62.22 -50.38 72.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -59.5 -33.18 71.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.61 -12.79 58.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.378 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.65 11.77 58.9 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.624 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -86.48 114.79 26.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.807 0.336 . . . . 0.0 111.086 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.9 p -87.53 163.49 16.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.815 ' O ' HG23 ' A' ' 41' ' ' THR . 0.4 OUTLIER -53.11 -26.7 17.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.39 -44.77 72.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.405 ' HB3' HG21 ' A' ' 45' ' ' THR . 40.7 mt-30 -78.58 -33.64 47.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.744 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.473 HD13 HG12 ' A' ' 19' ' ' VAL . 76.5 mt -68.79 -22.3 64.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.804 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 37' ' ' GLU . 35.1 p -96.53 -8.75 31.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.555 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.6 t70 -82.22 112.76 19.53 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.783 0.325 . . . . 0.0 110.645 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.96 -31.27 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.7 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -72.37 -59.65 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.882 0.372 . . . . 0.0 110.929 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.71 -33.33 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -58.66 -39.5 80.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.269 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 19.1 tptt -61.74 -53.31 57.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.566 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.937 HD13 HG12 ' A' ' 88' ' ' VAL . 1.9 pp -66.44 -32.41 73.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.356 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 46.3 mt -68.2 -64.59 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.554 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.556 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.3 p90 -53.63 -37.43 63.06 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.981 0.419 . . . . 0.0 110.138 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -55.44 -36.41 66.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.426 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.459 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 64.3 t80 -64.32 -37.56 87.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.043 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.967 HG23 HG21 ' A' ' 62' ' ' VAL . 49.5 mt -58.62 -29.07 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.178 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -40.27 77.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.587 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.459 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -66.37 -26.24 67.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.458 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.46 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 94.6 mm-40 -85.28 1.35 48.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.338 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 104.41 18.82 12.3 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.475 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.45 170.83 46.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.846 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD13 HD22 ' A' ' 26' ' ' LEU . 12.1 tp -48.52 -40.33 26.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.322 . . . . 0.0 111.093 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.64 -35.07 79.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.247 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -74.05 -34.24 63.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.818 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.967 HG21 HG23 ' A' ' 53' ' ' ILE . 44.0 t -65.02 -63.29 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.699 0.285 . . . . 0.0 110.873 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -52.47 -41.64 63.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.052 0.453 . . . . 0.0 110.13 177.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -63.23 -53.26 55.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.33 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 10.1 pt-20 -69.36 -26.61 64.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.992 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.557 ' SD ' HD11 ' A' ' 81' ' ' LEU . 1.5 mmt -67.29 -29.5 69.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.079 0.466 . . . . 0.0 110.238 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -77.64 -44.8 27.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.0 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -71.91 -29.49 64.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.006 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.54 -18.09 62.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.323 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.71 -20.59 59.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.531 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.83 96.16 0.32 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.706 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.9 t -163.45 72.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.945 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.97 -43.01 1.78 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.571 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.29 -99.95 0.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.525 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.0 t -154.5 38.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.354 . . . . 0.0 111.018 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -74.94 106.65 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.976 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.4 OUTLIER -115.61 141.6 47.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.674 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.524 ' OG ' HG21 ' A' ' 82' ' ' VAL . 8.3 t 88.22 -27.19 0.07 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.617 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.7 84.04 1.17 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.047 0.451 . . . . 0.0 110.765 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.49 -98.36 0.14 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.958 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.047 HD12 HD13 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -64.41 -33.66 76.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.68 0.276 . . . . 0.0 110.926 179.219 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG21 ' OG ' ' A' ' 78' ' ' SER . 3.6 t -65.32 -32.29 57.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.24 -48.91 43.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.274 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -65.12 -45.39 85.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.794 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 29' ' ' LEU . 11.4 tp -56.8 -40.99 76.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.625 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.411 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 4.7 mtt -53.0 -41.16 64.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.24 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -45.49 74.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.669 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.937 HG12 HD13 ' A' ' 48' ' ' LEU . 22.5 t -51.25 -40.02 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.709 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 92.9 mmm -63.0 -28.53 70.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.325 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 86' ' ' MET . 42.8 mt-30 -69.26 -17.13 63.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.171 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -67.85 -53.64 25.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.301 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -18.23 62.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.413 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 m -76.35 -28.77 56.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.8 0.334 . . . . 0.0 111.082 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -110.66 -14.19 14.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.616 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.8 118.17 17.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.961 0.41 . . . . 0.0 111.236 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -105.3 105.08 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 110.871 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -43.5 102.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.493 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.99 142.86 23.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.21 175.3 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.002 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 t0 60.16 178.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -140.6 76.34 1.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.937 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -118.42 -136.97 5.57 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.653 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.98 122.46 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.35 . . . . 0.0 111.085 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.43 82.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -169.61 -176.44 2.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.01 97.85 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.068 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.41 -1.216 . . . . 0.0 112.474 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.8 0.333 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.17 29.62 4.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -121.43 154.83 36.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.938 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.35 147.77 25.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -123.12 48.67 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 t -117.94 141.73 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.025 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.4 t 58.76 176.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.723 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -174.85 63.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.344 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 50' ' ' TYR . 3.0 t -59.92 -48.68 86.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 110.529 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.09 40.92 97.76 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.036 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -88.5 153.44 21.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.28 137.93 28.98 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.679 0.276 . . . . 0.0 110.795 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.44 -23.36 7.36 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -98.42 -41.4 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -89.45 -25.92 21.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.002 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.74 -142.47 16.1 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.337 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.589 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -83.0 146.4 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 0.0 110.841 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -84.66 61.12 6.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.731 HG11 ' HG3' ' A' ' 37' ' ' GLU . 5.2 m -49.07 -25.36 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.237 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -72.12 -20.88 61.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.086 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -132.23 20.75 4.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.429 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.0 HD22 HD11 ' A' ' 26' ' ' LEU . 17.0 mt -70.28 159.7 33.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.936 0.398 . . . . 0.0 111.163 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -82.44 139.42 44.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.77 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 49.2 Cg_exo -54.86 -19.17 18.36 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.518 2.146 . . . . 0.0 112.464 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' ' HE2' ' A' ' 66' ' ' MET . 7.2 m-20 -81.27 -57.68 3.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.127 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.0 HD11 HD22 ' A' ' 22' ' ' LEU . 3.4 pp -70.64 -40.97 72.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.105 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.5 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.6 OUTLIER -59.04 -39.09 80.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 0.0 110.576 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -64.09 -38.49 91.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.619 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.694 HD12 HG22 ' A' ' 82' ' ' VAL . 15.5 tp -56.11 -51.01 69.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.576 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.444 ' CG ' HD21 ' A' ' 40' ' ' LEU . 21.0 m-85 -52.3 -49.04 64.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.512 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.3 m -62.41 -41.49 98.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.791 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.545 ' HB3' HG11 ' A' ' 82' ' ' VAL . 34.7 mtt180 -62.48 -35.86 80.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.983 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.1 -14.74 57.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.482 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 10.78 45.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.796 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.511 HD11 ' HG ' ' A' ' 85' ' ' LEU . 62.5 mt -86.64 119.62 34.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.842 0.353 . . . . 0.0 110.939 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -86.6 157.45 19.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.998 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.731 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.82 -30.32 32.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.047 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.65 70.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.858 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.432 ' NE2' HG21 ' A' ' 45' ' ' THR . 9.6 mm100 -77.76 -30.14 51.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.712 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.444 HD21 ' CG ' ' A' ' 30' ' ' PHE . 95.2 mt -69.6 -22.8 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.5 p -97.44 -7.68 31.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.606 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' SER . 2.1 t70 -81.45 115.51 20.81 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.818 0.342 . . . . 0.0 110.63 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.96 -34.2 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.682 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 92' ' ' ARG . 5.6 tp10 -72.44 -59.9 2.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 0.0 111.491 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.442 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.3 -32.89 74.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.172 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 1.4 t -57.86 -42.1 83.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.599 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.469 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.84 -55.2 32.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.358 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.633 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -63.31 -31.61 72.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.723 0.297 . . . . 0.0 110.953 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.431 HD13 HD23 ' A' ' 40' ' ' LEU . 70.4 mt -69.76 -64.02 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.381 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 1.9 p90 -53.35 -38.2 63.06 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.073 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -54.18 -34.32 60.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.638 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.478 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 69.1 t80 -63.93 -30.67 71.73 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.092 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.981 HG23 HG21 ' A' ' 62' ' ' VAL . 40.2 mt -66.29 -28.5 43.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.034 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -71.8 -34.42 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.816 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.478 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.3 p30 -69.96 -25.59 63.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 0.0 110.497 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.471 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 29.4 mt-30 -83.12 -8.97 59.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.094 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 113.64 22.08 5.54 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.886 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.64 171.02 47.21 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.603 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 13.2 tp -47.8 -41.64 24.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 111.055 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 28.5 mt-10 -64.27 -34.51 78.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.4 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -73.16 -35.93 66.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.709 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.981 HG21 HG23 ' A' ' 53' ' ' ILE . 40.3 t -65.14 -63.56 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.667 0.27 . . . . 0.0 110.812 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -53.08 -37.94 62.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.98 0.419 . . . . 0.0 109.94 177.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 43.6 mt-30 -63.17 -50.62 69.67 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.061 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.879 ' CD ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -68.8 -34.88 76.27 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.542 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.415 ' HE2' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -60.51 -29.32 69.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.087 0.47 . . . . 0.0 110.049 178.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -76.56 -41.4 46.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.388 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -72.19 -32.49 66.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.485 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.43 -20.49 36.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.983 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.7 109.46 3.43 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.132 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -41.69 -95.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.213 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.1 t -148.8 79.22 1.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.35 116.65 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.577 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.63 -34.26 4.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.521 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.21 40.23 1.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -74.79 131.9 41.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.831 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 63.5 m -113.77 122.81 48.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.121 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.649 ' HB2' HG21 ' A' ' 82' ' ' VAL . 88.4 p -95.02 -6.26 42.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.367 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.45 102.37 3.18 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.01 0.433 . . . . 0.0 110.932 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.63 -95.24 0.18 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.376 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.879 HD13 ' CD ' ' A' ' 65' ' ' GLU . 2.7 pt? -62.85 -41.15 99.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.625 0.25 . . . . 0.0 111.361 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.694 HG22 HD12 ' A' ' 29' ' ' LEU . 6.2 t -63.8 -28.51 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 111.078 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.33 -36.96 85.65 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.301 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.22 -47.04 81.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.703 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.511 ' HG ' HD11 ' A' ' 35' ' ' ILE . 5.9 tp -54.08 -49.41 69.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.493 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.4 mtm -51.1 -31.63 19.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.473 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -39.92 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.259 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.633 HG12 HD13 ' A' ' 48' ' ' LEU . 57.9 t -56.4 -40.56 67.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.207 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.42 ' CE ' HG22 ' A' ' 45' ' ' THR . 3.3 mmt -63.99 -39.22 93.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.183 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -58.38 -21.83 51.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.863 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -68.32 -56.82 7.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.076 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.482 ' CZ ' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -69.54 -25.22 63.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.778 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 m -73.73 -30.71 62.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.07 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.73 23.9 11.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.606 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 92' ' ' ARG . . . -74.12 143.11 45.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.234 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 96' ' ' ILE . 1.2 tp -105.92 99.22 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.46 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -40.21 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.639 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 96' ' ' ILE . 4.8 p -86.79 106.35 17.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.061 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.28 -161.22 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.25 31.33 8.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.892 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 101' ' ' GLU . 4.0 pt-20 -155.4 105.3 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.44 -103.95 0.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.588 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -95.87 97.21 9.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 0.0 111.019 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -167.74 54.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' ' 105' ' ' GLN . 0.3 OUTLIER -76.68 82.84 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.97 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.05 98.55 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.415 -1.214 . . . . 0.0 112.419 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.784 0.326 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.58 29.51 39.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.621 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.37 178.08 4.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 0.0 110.944 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -86.89 110.59 20.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -112.81 87.65 2.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.19 140.88 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.405 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -90.2 137.79 32.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.683 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -107.99 114.22 27.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.204 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 50' ' ' TYR . 7.0 t -71.82 -62.82 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.541 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.54 34.91 5.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.93 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.495 ' CE2' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -88.7 152.61 21.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.214 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.428 ' HB2' ' HB2' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -92.58 136.15 25.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.73 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.15 -58.73 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.494 2.13 . . . . 0.0 112.592 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -81.33 -34.44 31.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.715 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 47.9 m-20 -86.14 -22.76 26.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.651 0.262 . . . . 0.0 111.199 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.65 -150.6 21.83 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.587 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -80.78 142.87 33.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.862 0.363 . . . . 0.0 110.997 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.7 64.96 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.771 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.0 m -54.69 -21.5 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.261 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -72.72 -20.84 61.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.143 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -132.11 20.62 4.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.508 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.867 HD22 HD11 ' A' ' 26' ' ' LEU . 17.7 mt -69.8 159.46 33.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.154 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 9.2 t70 -84.08 137.97 39.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.77 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 44.5 Cg_exo -55.89 -18.53 22.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.558 2.172 . . . . 0.0 112.463 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 68.3 m-20 -80.84 -57.63 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.044 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.867 HD11 HD22 ' A' ' 22' ' ' LEU . 4.1 pp -69.53 -44.81 70.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.148 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.622 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.2 -32.9 62.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.863 0.363 . . . . 0.0 110.534 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.4 t -64.55 -38.06 89.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 82' ' ' VAL . 16.0 tp -56.35 -54.54 44.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.733 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.566 ' CD2' HD11 ' A' ' 40' ' ' LEU . 8.2 m-85 -50.99 -44.32 60.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.769 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -61.8 -49.32 76.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.915 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -34.05 67.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.054 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.94 -18.55 46.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.39 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.15 11.68 41.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.89 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 85' ' ' LEU . 52.4 mt -86.21 117.79 31.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.813 0.34 . . . . 0.0 111.057 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.03 161.46 18.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.771 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -52.73 -26.49 14.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.851 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.09 -43.2 73.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HG2' HG21 ' A' ' 45' ' ' THR . 1.7 mt-30 -78.57 -28.73 45.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.742 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 30' ' ' PHE . 33.1 mt -71.19 -23.58 62.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.856 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 37' ' ' GLU . 45.6 p -98.05 -7.55 29.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.696 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 46' ' ' SER . 29.1 t0 -81.96 122.55 27.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.799 0.333 . . . . 0.0 110.744 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.07 -38.22 37.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.556 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' OE2' ' CZ ' ' A' ' 92' ' ' ARG . 18.3 tt0 -73.18 -59.81 2.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.672 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.487 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.75 -35.96 81.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.126 -178.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 70.4 m -58.8 -41.98 88.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.855 0.36 . . . . 0.0 110.438 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -60.11 -55.23 36.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.43 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.824 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -64.4 -31.99 73.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.383 -178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 45' ' ' THR . 60.4 mt -67.5 -63.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.203 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.495 ' CE2' ' CE2' ' A' ' 11' ' ' TRP . 2.0 p90 -52.36 -35.84 52.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.925 0.393 . . . . 0.0 110.303 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.8 -32.76 63.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.476 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 74.0 t80 -64.67 -41.03 96.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.167 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.927 HG23 HG21 ' A' ' 62' ' ' VAL . 30.8 mt -55.95 -28.23 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.213 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -71.21 -36.13 71.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.589 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -73.49 -25.92 60.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.568 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 89.2 mm-40 -86.22 12.5 9.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.639 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.49 15.04 36.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.607 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' HA3' ' CB ' ' A' ' 7' ' ' SER . . . 82.1 170.63 45.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.784 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.4 tp -48.95 -37.95 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 111.112 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.01 -35.69 82.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.317 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.21 -35.8 66.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.668 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.927 HG21 HG23 ' A' ' 53' ' ' ILE . 31.3 t -65.32 -63.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.707 0.289 . . . . 0.0 110.768 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.425 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -52.1 -37.47 54.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.06 0.457 . . . . 0.0 110.138 178.016 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -63.09 -52.07 64.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.53 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.688 ' CD ' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -69.5 -36.32 76.37 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.803 0.335 . . . . 0.0 110.982 -178.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.411 ' O ' ' HG3' ' A' ' 69' ' ' GLN . 2.8 mmt -66.66 -28.81 68.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.596 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 11.5 mmt180 -77.92 -35.84 50.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.067 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -18.32 62.14 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.819 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 66' ' ' MET . 4.8 pt20 -90.41 -14.45 32.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.542 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.97 -60.87 7.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.604 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.18 -118.05 4.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.629 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.3 p -57.93 148.85 24.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.877 0.37 . . . . 0.0 111.014 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.17 -70.96 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.39 -175.15 36.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.437 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.9 m -99.88 1.08 42.53 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -74.91 119.37 18.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.838 0.352 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -122.18 90.47 3.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.683 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.568 ' HB2' HG21 ' A' ' 82' ' ' VAL . 4.6 p 88.33 -22.74 0.13 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.491 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -74.35 88.18 2.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.012 0.434 . . . . 0.0 110.842 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.17 -92.45 0.11 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.096 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.688 HD13 ' CD ' ' A' ' 65' ' ' GLU . 2.6 pt? -63.39 -39.12 93.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.956 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 29' ' ' LEU . 9.2 t -62.67 -27.41 42.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.29 -41.1 80.09 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.26 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.49 -39.46 93.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 35' ' ' ILE . 10.3 tp -64.0 -41.08 97.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.37 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.41 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -53.58 -42.5 67.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.18 178.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -44.89 92.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.824 HG12 HD13 ' A' ' 48' ' ' LEU . 44.7 t -52.33 -41.79 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.56 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 74.5 mmm -65.17 -33.59 76.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.793 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 86' ' ' MET . 37.2 mt-30 -59.53 -19.46 48.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.538 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 1.5 tptp -68.26 -35.56 78.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.843 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 30.5 mmm-85 -74.74 -26.51 59.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.564 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.5 t -77.34 -31.71 54.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.023 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.9 mmm-85 -113.66 18.29 17.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.61 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -75.61 116.79 16.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.99 0.424 . . . . 0.0 111.059 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.588 ' O ' HG23 ' A' ' 96' ' ' ILE . 2.2 tp -132.55 104.64 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.976 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -48.77 92.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 96' ' ' ILE . 2.2 t -130.29 159.45 36.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.954 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.8 m -117.21 33.33 5.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.64 72.81 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -166.45 -174.52 2.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.09 75.41 0.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.406 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -111.44 162.39 15.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.941 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.3 t70 39.44 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.756 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -129.71 129.35 44.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.16 128.6 33.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.526 179.937 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.833 0.349 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.39 -24.28 29.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.615 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -143.17 152.61 41.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -87.2 148.3 25.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.916 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.3 57.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.738 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.91 141.4 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.14 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.29 113.04 24.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.728 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -100.43 112.79 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.155 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.477 HG11 ' CZ ' ' A' ' 17' ' ' PHE . 12.6 t -75.92 -34.55 27.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.442 . . . . 0.0 110.685 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.05 32.59 63.1 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.984 -0.626 . . . . 0.0 113.131 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.486 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.06 153.45 20.98 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.851 0.325 . . . . 0.0 110.318 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.96 138.58 27.61 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.615 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -78.61 -33.89 1.58 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -92.33 -41.0 10.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.946 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.15 -25.1 24.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.012 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.34 -146.28 18.19 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.505 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' CZ ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -81.59 140.21 34.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.882 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -74.86 60.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.772 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -50.52 -24.64 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -73.48 -22.25 60.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -128.7 20.03 6.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.433 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.825 HD22 HD11 ' A' ' 26' ' ' LEU . 17.1 mt -70.64 159.49 34.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 111.051 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 2.6 t70 -84.58 139.3 38.11 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.095 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 48.3 Cg_exo -55.67 -19.0 22.49 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.56 2.173 . . . . 0.0 112.399 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -81.34 -57.16 3.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.929 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.825 HD11 HD22 ' A' ' 22' ' ' LEU . 4.2 pp -70.14 -44.37 69.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.041 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.707 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -54.39 -35.9 63.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.917 0.389 . . . . 0.0 110.46 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.06 -38.92 93.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.708 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.633 HD12 HG22 ' A' ' 82' ' ' VAL . 27.8 tp -56.65 -54.23 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.572 ' HD1' HD21 ' A' ' 85' ' ' LEU . 21.7 m-85 -51.93 -46.77 64.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.491 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -62.21 -50.72 70.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.714 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.554 ' HB3' HG11 ' A' ' 82' ' ' VAL . 43.9 mtt180 -54.73 -32.25 59.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.555 ' HB1' ' HG2' ' A' ' 86' ' ' MET . . . -82.5 -14.24 55.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.469 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.05 13.12 50.58 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.677 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.476 HD12 HD21 ' A' ' 85' ' ' LEU . 58.2 mt -86.52 118.9 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 111.047 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.74 163.57 17.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.881 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.772 ' HG2' HG21 ' A' ' 19' ' ' VAL . 2.4 mt-10 -53.78 -30.3 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.876 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.91 72.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.074 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -78.27 -31.32 48.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.805 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.485 HD21 ' CG ' ' A' ' 30' ' ' PHE . 96.0 mt -70.97 -27.59 63.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.463 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 37' ' ' GLU . 31.5 p -97.75 -3.64 38.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.555 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.72 121.46 26.42 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.9 -37.23 30.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.479 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.86 -59.89 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.595 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.71 -35.52 78.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.394 -178.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.5 p -57.42 -37.57 72.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.822 0.344 . . . . 0.0 110.147 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 18.0 tptt -61.55 -56.07 24.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.146 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.82 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -65.72 -30.72 71.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.287 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.455 HD13 HD23 ' A' ' 40' ' ' LEU . 39.5 mt -68.03 -64.21 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.532 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.3 p90 -52.57 -38.66 60.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.929 0.395 . . . . 0.0 110.203 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.11 -33.54 65.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.674 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 49' ' ' ILE . 53.1 t80 -64.62 -39.63 94.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.303 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.951 HG23 HG21 ' A' ' 62' ' ' VAL . 21.6 mt -57.39 -29.87 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.241 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.34 -36.41 79.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.433 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.506 ' OD1' ' NE2' ' A' ' 56' ' ' GLN . 1.0 OUTLIER -72.69 -25.12 61.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.558 179.102 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.506 ' NE2' ' OD1' ' A' ' 55' ' ' ASP . 79.2 mm-40 -86.51 12.13 11.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.44 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.23 17.86 33.09 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.572 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.76 166.84 39.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.696 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.49 HD11 ' CD2' ' A' ' 26' ' ' LEU . 32.1 tp -49.08 -37.33 20.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 0.0 111.119 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.9 -34.55 78.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.2 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.78 -35.53 67.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.267 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.951 HG21 HG23 ' A' ' 53' ' ' ILE . 18.5 t -66.09 -48.61 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.925 0.393 . . . . 0.0 110.737 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -53.76 -46.23 70.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.175 0.512 . . . . 0.0 109.956 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -64.22 -48.68 74.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.135 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 8.0 pt-20 -68.6 -20.73 64.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.612 0.244 . . . . 0.0 111.643 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.525 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 2.2 mmt -85.85 -33.71 21.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -78.73 -37.88 40.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.427 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -71.58 -20.91 61.94 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.868 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 66' ' ' MET . 1.8 pt20 -82.12 -8.15 59.64 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.57 -42.64 39.58 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.595 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.55 34.32 4.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 m -70.85 170.22 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.771 0.32 . . . . 0.0 110.925 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.46 -65.34 3.57 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.37 178.06 53.14 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.528 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 m -98.99 29.34 3.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -74.75 106.31 6.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.447 ' O ' ' CB ' ' A' ' 78' ' ' SER . 88.5 p -122.04 115.2 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 77' ' ' SER . 1.5 m 87.76 -25.94 0.08 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.675 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.72 91.68 2.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 110.783 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.32 -91.91 0.12 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.087 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.537 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.4 pt? -64.0 -39.59 94.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 111.055 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.633 HG22 HD12 ' A' ' 29' ' ' LEU . 8.5 t -63.54 -30.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.106 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.75 -41.05 75.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.32 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.2 -45.66 87.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.815 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.572 HD21 ' HD1' ' A' ' 30' ' ' PHE . 13.4 tp -60.91 -44.85 96.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.481 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.555 ' HG2' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -53.56 -42.6 67.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.373 178.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -36.07 82.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.542 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.82 HG12 HD13 ' A' ' 48' ' ' LEU . 65.4 t -65.91 -40.18 86.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.766 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 48.5 mmm -62.11 -39.03 91.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 53.5 mm-40 -62.83 -14.24 43.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.967 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 2.2 tptp -70.7 -48.88 52.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.384 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.417 ' HG2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -71.16 -20.62 62.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.717 -178.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.9 t -77.03 -24.25 52.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.942 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 94' ' ' ARG . 1.1 mpp_? -135.09 14.32 3.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.047 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -72.91 174.26 8.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.98 0.419 . . . . 0.0 111.233 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.652 ' H ' HD12 ' A' ' 96' ' ' ILE . 5.3 mp -58.33 110.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.176 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -67.42 66.65 0.08 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.829 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -92.71 -34.46 13.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.953 -177.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -159.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.77 135.16 34.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.95 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.7 101.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.068 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.08 57.4 0.32 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -93.6 112.86 24.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.975 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 103' ' ' GLU . 3.3 t0 81.39 -61.53 0.2 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.23 158.22 23.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.989 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.22 107.1 13.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.065 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.354 -1.248 . . . . 0.0 112.537 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.853 0.359 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.65 -24.07 33.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -140.65 170.7 15.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.788 0.327 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.23 112.94 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -99.63 111.88 24.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.703 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.57 139.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.366 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.9 m 59.19 -177.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -150.53 74.13 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.259 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 t -72.87 -35.55 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.468 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.89 39.61 8.86 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.071 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.11 153.35 21.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.699 0.285 . . . . 0.0 110.264 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.8 m-20 -89.52 140.15 28.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.717 0.294 . . . . 0.0 110.54 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.73 -28.39 5.27 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.662 2.241 . . . . 0.0 112.483 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -98.0 -38.83 9.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -87.48 -21.62 25.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 95.6 -138.2 13.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.206 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.58 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -81.94 -169.08 2.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.942 0.401 . . . . 0.0 110.755 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -123.99 54.15 1.35 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.499 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.798 HG11 ' HG3' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -46.15 -26.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.641 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -68.56 -23.94 64.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.031 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -134.78 25.21 3.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.642 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.892 HD22 HD11 ' A' ' 26' ' ' LEU . 17.6 mt -70.2 159.5 33.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.927 0.394 . . . . 0.0 111.167 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.91 137.97 40.47 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.707 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.6 Cg_exo -54.76 -19.22 18.15 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.584 2.189 . . . . 0.0 112.654 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 52.2 m-20 -81.64 -57.71 3.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.291 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.892 HD11 HD22 ' A' ' 22' ' ' LEU . 4.0 pp -70.91 -38.1 72.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.158 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -62.22 -35.51 79.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.489 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 t -63.24 -36.32 83.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.633 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 82' ' ' VAL . 25.2 tp -56.6 -50.72 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.644 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 24.4 m-85 -55.47 -43.99 76.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.569 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -50.11 74.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.81 -29.3 69.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.16 -21.2 36.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.173 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.36 14.51 38.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.643 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.482 HD12 HD21 ' A' ' 85' ' ' LEU . 64.8 mt -86.75 121.54 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.0 111.059 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 p -86.97 158.23 19.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.798 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -52.07 -27.12 12.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.842 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.17 -42.17 72.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -78.1 -30.17 49.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.432 HD23 HD13 ' A' ' 49' ' ' ILE . 70.6 mt -70.33 -24.77 63.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 37' ' ' GLU . 31.6 p -98.45 -5.98 31.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.705 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.89 121.14 26.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.84 0.353 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.08 -35.54 25.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.276 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' CG ' ' CZ ' ' A' ' 92' ' ' ARG . 4.1 tp10 -72.53 -59.9 2.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.685 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -67.16 -33.74 76.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.987 -179.131 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.4 p -57.6 -40.07 78.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.726 0.298 . . . . 0.0 110.345 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -61.77 -53.93 49.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.356 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.58 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.64 -31.44 72.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.19 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.432 HD13 HD23 ' A' ' 40' ' ' LEU . 54.1 mt -69.95 -64.78 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.749 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.504 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -54.18 -36.94 63.94 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.361 -178.418 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -55.0 -33.17 62.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.446 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.443 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 60.7 t80 -64.87 -39.57 93.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.188 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 62' ' ' VAL . 22.6 mt -56.39 -29.98 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.274 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.75 -36.37 75.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -71.14 -26.51 63.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.636 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 25.2 mm100 -86.05 11.14 12.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.503 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.33 18.21 29.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.496 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.47 172.33 48.63 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.007 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 59' ' ' LEU . 8.2 tp -48.43 -44.86 35.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 0.0 111.196 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.5 -35.19 79.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.392 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -33.73 65.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.572 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.976 HG21 HG23 ' A' ' 53' ' ' ILE . 48.6 t -64.9 -63.48 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.43 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 1.4 ptp180 -52.29 -38.54 58.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 110.088 177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -64.14 -48.96 74.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.909 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 66' ' ' MET . 10.7 pt-20 -68.52 -43.59 76.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.517 -177.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.445 ' N ' ' HG3' ' A' ' 65' ' ' GLU . 4.9 mmm -55.31 -30.58 60.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.053 0.454 . . . . 0.0 110.57 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -78.23 -40.38 37.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -68.43 -27.18 65.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.736 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.43 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.57 -19.2 63.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.343 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.62 71.87 2.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.488 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.0 165.07 23.14 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.6 t 54.98 105.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 0.0 110.951 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 54.7 89.87 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.318 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.14 66.47 1.31 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.378 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 t -57.91 -18.71 24.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.652 0.263 . . . . 0.0 111.331 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.15 130.97 41.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.845 0.355 . . . . 0.0 111.049 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.2 OUTLIER -116.75 149.39 39.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.936 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 77' ' ' SER . 0.7 OUTLIER 85.59 -40.82 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.616 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -74.63 74.02 2.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.431 . . . . 0.0 110.826 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.58 -88.15 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.167 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.6 pt? -62.36 -39.11 92.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 110.739 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.712 HG22 HD12 ' A' ' 29' ' ' LEU . 19.4 t -62.62 -27.06 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.886 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.14 -37.54 82.04 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.292 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.91 -51.28 62.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.482 HD21 HD12 ' A' ' 35' ' ' ILE . 29.5 tp -59.83 -42.37 93.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.72 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.7 mtm -52.92 -37.93 61.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.301 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.22 -46.85 66.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.222 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.58 HG12 HD13 ' A' ' 48' ' ' LEU . 98.5 t -52.09 -41.1 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.62 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 89.1 mmm -63.9 -38.25 90.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.35 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -62.93 -20.48 65.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.703 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -67.71 -57.11 6.93 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.21 0.529 . . . . 0.0 110.941 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.477 ' CZ ' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -69.82 -26.61 64.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.79 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 m -75.83 -38.09 58.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.307 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -102.55 20.11 17.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.061 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.91 164.51 26.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.112 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 96' ' ' ILE . 3.8 tp -84.03 92.86 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 1.4 m-70 69.84 -58.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.507 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.3 t 177.65 80.9 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.792 0.33 . . . . 0.0 110.989 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 89.9 p -68.64 152.52 45.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.853 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -153.87 -46.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.845 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.11 137.76 34.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.66 -170.51 12.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.24 128.83 50.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.852 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -167.74 163.03 14.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -110.82 -75.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.91 102.09 9.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.089 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.382 -1.232 . . . . 0.0 112.534 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.843 0.354 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.25 26.46 8.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -83.65 160.16 21.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.17 162.75 30.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.23 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -127.22 75.11 1.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.691 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.54 119.8 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.251 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.9 p 56.44 -163.2 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -168.21 66.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.265 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' A' ' 50' ' ' TYR . 1.5 t -82.07 99.9 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.347 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.92 57.28 1.27 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.722 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -87.17 153.77 21.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.59 141.44 30.27 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.772 0.32 . . . . 0.0 110.826 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.1 -23.2 12.26 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.713 2.275 . . . . 0.0 112.64 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.42 -34.22 5.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.189 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.39 -25.79 23.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.779 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.97 -150.55 19.6 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.642 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.62 147.78 29.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.955 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -82.85 61.19 5.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.711 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.2 m -48.57 -25.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.205 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -71.16 -21.29 62.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.48 19.63 5.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.571 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.993 HD22 HD11 ' A' ' 26' ' ' LEU . 17.5 mt -70.64 159.28 34.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.975 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -84.26 141.0 39.46 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.026 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.491 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.7 Cg_exo -54.36 -21.03 21.87 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.65 2.234 . . . . 0.0 112.371 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -82.16 -56.3 4.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.308 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.993 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -71.17 -37.43 72.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.25 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.504 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -58.67 -39.67 81.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.38 . . . . 0.0 110.425 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.448 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -63.27 -36.16 82.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.641 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.65 HD12 HG22 ' A' ' 82' ' ' VAL . 14.8 tp -56.38 -43.33 79.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CG ' HD21 ' A' ' 40' ' ' LEU . 18.5 m-85 -66.85 -49.42 65.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.615 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.2 m -60.7 -50.57 72.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.63 ' HB3' HG11 ' A' ' 82' ' ' VAL . 11.9 mtt180 -59.11 -30.23 67.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.521 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.65 4.63 24.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.567 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.86 7.57 88.25 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.986 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.53 HD11 ' HG ' ' A' ' 85' ' ' LEU . 48.7 mt -87.1 122.57 39.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.837 0.351 . . . . 0.0 111.319 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.35 158.28 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.708 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.711 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.38 -29.88 26.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.772 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.22 -38.76 68.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 45' ' ' THR . 37.0 mt-30 -78.02 -32.39 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.502 HD21 ' CG ' ' A' ' 30' ' ' PHE . 57.9 mt -69.61 -24.21 63.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.722 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 37' ' ' GLU . 20.4 p -96.72 -7.45 33.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.528 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 46' ' ' SER . 22.7 t0 -81.41 115.4 20.73 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.826 0.346 . . . . 0.0 110.595 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.22 -35.53 3.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.778 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.22 -59.93 2.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 111.493 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -67.6 -34.89 77.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.487 -178.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -56.19 -41.17 75.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.412 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.58 -56.25 21.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.346 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -63.51 -30.31 71.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.911 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 80.6 mt -68.81 -64.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.023 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 1.7 p90 -55.48 -39.13 70.03 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.117 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 0.9 OUTLIER -52.34 -34.59 48.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.521 179.056 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.47 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 54.7 t80 -64.33 -38.78 92.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.806 178.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 62' ' ' VAL . 48.6 mt -56.62 -30.81 32.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.136 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -69.5 -33.66 73.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.684 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -75.46 -26.0 57.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.729 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 78.4 mm-40 -86.21 11.39 12.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.52 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 99.33 17.14 27.72 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.585 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.84 169.59 45.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.995 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 14.0 tp -48.06 -39.72 20.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.712 0.292 . . . . 0.0 111.145 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 24.6 mm-40 -65.73 -35.44 80.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.327 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 56' ' ' GLN . . . -73.09 -35.96 66.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.768 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.976 HG21 HG23 ' A' ' 53' ' ' ILE . 46.2 t -65.24 -62.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 110.97 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -52.78 -39.03 61.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.186 0.517 . . . . 0.0 110.053 177.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 50.2 mt-30 -63.85 -50.1 70.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.876 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 16.5 pt-20 -69.47 -40.13 77.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.367 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.503 ' HG2' HD11 ' A' ' 81' ' ' LEU . 2.3 mmt -56.77 -41.99 78.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.217 0.532 . . . . 0.0 110.001 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -44.25 21.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.278 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -71.04 -25.7 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.809 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.7 -9.04 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 43.99 -101.58 0.03 OUTLIER Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.91 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.26 118.39 0.49 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.429 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.0 m -63.81 109.93 1.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.835 0.35 . . . . 0.0 110.965 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.19 -27.35 18.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.428 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.25 -134.67 1.68 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.39 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.06 17.21 18.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.641 0.258 . . . . 0.0 111.24 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -75.91 117.38 17.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.842 0.354 . . . . 0.0 111.074 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.0 t -119.01 119.34 33.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.485 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 1.5 p 169.3 -40.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.653 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 105.37 3.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.956 0.408 . . . . 0.0 111.133 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.08 -93.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.502 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.503 HD11 ' HG2' ' A' ' 66' ' ' MET . 2.6 pt? -60.79 -39.65 89.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.0 110.958 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.65 HG22 HD12 ' A' ' 29' ' ' LEU . 22.8 t -63.19 -24.95 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.804 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.82 -36.87 83.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.209 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.36 -52.16 59.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.715 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 35' ' ' ILE . 3.9 tp -51.11 -48.12 61.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.57 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.5 mtt -50.29 -40.85 49.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.706 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -44.08 77.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.237 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.686 HG12 HD13 ' A' ' 48' ' ' LEU . 93.9 t -55.8 -40.28 60.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.527 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 85.7 mmm -62.94 -37.64 87.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.557 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -61.23 -21.33 63.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.522 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -68.59 -57.83 5.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.045 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.54 ' HB2' HD22 ' A' ' 48' ' ' LEU . 2.6 tpt180 -73.32 -15.28 61.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.622 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.9 t -75.67 -36.67 60.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.914 0.387 . . . . 0.0 110.871 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -21.56 35.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.053 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.4 121.13 20.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.932 0.396 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 96' ' ' ILE . 5.5 tp -119.3 102.99 13.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.895 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.4 67.34 9.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.4 p 177.62 37.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.851 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.77 -162.97 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.9 t0 60.35 63.75 1.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -166.64 172.27 10.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.16 122.45 2.09 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.591 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.89 99.92 12.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.885 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.77 -34.92 69.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.89 109.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.911 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.03 147.15 30.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.031 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.369 -1.239 . . . . 0.0 112.559 -179.923 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.818 0.342 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.27 -24.27 32.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.44 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.42 ' O ' ' CD2' ' A' ' 3' ' ' PHE . 17.4 p90 -130.81 102.2 5.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.849 0.357 . . . . 0.0 110.826 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.52 156.35 19.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.089 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -109.68 55.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.741 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -61.41 119.79 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.231 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -91.05 111.04 22.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.752 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -91.37 -24.25 19.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 9' ' ' VAL . 43.7 t 68.36 8.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.743 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.6 25.68 1.5 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.357 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.564 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.59 153.44 20.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.99 0.395 . . . . 0.0 110.301 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.8 OUTLIER -89.3 140.62 28.66 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.712 0.292 . . . . 0.0 110.769 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.45 -36.8 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.743 2.295 . . . . 0.0 112.591 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -91.6 -35.95 13.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 48.0 m-80 -87.7 -30.13 20.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.786 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.29 -144.99 16.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.612 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.748 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.43 152.64 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 111.082 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -88.09 57.9 4.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.845 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.74 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.7 m -49.13 -25.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.28 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.85 -20.11 60.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.125 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -130.32 21.39 5.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.42 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.068 HD22 HD11 ' A' ' 26' ' ' LEU . 17.6 mt -70.37 159.2 34.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.885 0.374 . . . . 0.0 111.053 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -85.25 142.86 38.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.085 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 47.5 Cg_exo -56.4 -18.86 26.44 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.673 2.248 . . . . 0.0 112.456 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -81.2 -58.81 2.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.917 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.068 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -71.76 -40.85 69.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.217 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.458 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -57.26 -34.09 68.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.021 0.439 . . . . 0.0 110.124 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.6 t -64.23 -38.04 89.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.609 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.029 HD13 HD12 ' A' ' 81' ' ' LEU . 1.3 tp -56.68 -58.26 8.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.279 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -51.11 -42.13 60.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.467 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.6 m -62.7 -56.3 18.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.713 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.454 ' CZ ' ' HG3' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -59.32 -25.5 64.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.763 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.98 -19.01 41.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.27 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.73 13.96 53.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.7 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.453 HD12 HD21 ' A' ' 85' ' ' LEU . 60.7 mt -87.26 122.15 38.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.889 0.376 . . . . 0.0 111.152 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -87.73 159.13 18.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.864 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.74 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -53.15 -31.65 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.97 -41.92 68.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.8 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -77.5 -34.59 54.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.683 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.497 HD23 HD13 ' A' ' 49' ' ' ILE . 82.0 mt -70.55 -22.72 62.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.979 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 37' ' ' GLU . 34.8 p -97.03 -5.01 38.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.739 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.37 124.34 29.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.829 0.347 . . . . 0.0 110.78 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.47 -36.71 45.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.635 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -72.08 -59.7 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.815 0.34 . . . . 0.0 111.43 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.42 -32.45 73.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.011 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 91.6 p -58.34 -41.18 84.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.36 . . . . 0.0 110.36 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 4.2 tptm -61.3 -53.02 62.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.473 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.751 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -67.42 -31.46 71.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.25 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.497 HD13 HD23 ' A' ' 40' ' ' LEU . 55.7 mt -68.2 -65.09 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.535 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.564 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.0 OUTLIER -54.89 -36.0 64.68 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.904 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -56.31 -34.05 66.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.389 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.531 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.7 t80 -64.46 -35.09 79.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.158 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.836 HG23 HG21 ' A' ' 62' ' ' VAL . 28.1 mt -62.77 -27.37 42.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.132 178.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.64 -33.34 68.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.53 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -73.27 -26.29 61.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.453 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.42 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 58.6 mm-40 -85.0 3.49 38.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.379 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 103.47 19.62 12.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.431 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 82.86 167.77 41.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.486 ' CD1' HD22 ' A' ' 26' ' ' LEU . 28.2 tp -49.3 -37.54 24.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.47 -34.08 77.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.208 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.422 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.16 -35.43 66.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.379 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.836 HG21 HG23 ' A' ' 53' ' ' ILE . 45.5 t -65.71 -54.75 24.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.366 . . . . 0.0 110.815 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -53.62 -46.75 70.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.077 0.465 . . . . 0.0 110.087 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -63.09 -50.03 72.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.818 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 9.8 pt-20 -69.53 -37.52 77.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.323 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 81' ' ' LEU . 1.7 mmt -57.76 -32.44 67.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.422 . . . . 0.0 110.423 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -77.89 -41.66 35.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.067 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -71.06 -26.59 63.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.07 -21.68 58.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -133.65 96.18 0.29 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.384 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -48.06 139.64 10.48 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.609 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.42 -178.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.68 135.03 12.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.524 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.93 -23.48 29.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.388 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.52 49.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HG3' ' CZ ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -74.57 139.79 43.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.822 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.61 110.27 19.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.44 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 1.7 p -66.81 -12.34 58.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.344 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -71.22 96.18 1.37 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.128 0.489 . . . . 0.0 110.718 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.25 -101.54 0.21 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.003 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.029 HD12 HD13 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -65.22 -34.14 77.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.532 0.206 . . . . 0.0 111.33 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 5.9 t -64.46 -32.58 58.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.822 0.344 . . . . 0.0 111.053 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.63 -43.8 66.4 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.029 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 87' ' ' HIS . . . -65.38 -48.1 74.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.341 . . . . 0.0 110.783 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.453 HD21 HD12 ' A' ' 35' ' ' ILE . 13.2 tp -54.41 -46.04 73.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.33 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -35.39 61.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.276 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 3.3 t60 -68.81 -32.19 71.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.167 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.751 HG12 HD13 ' A' ' 48' ' ' LEU . 58.4 t -69.62 -42.19 80.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.564 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.0 mmt -62.43 -38.78 91.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.11 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -54.44 -21.97 11.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.179 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.64 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 9.8 tptt -70.25 -43.56 70.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.492 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.635 ' HG3' HD21 ' A' ' 48' ' ' LEU . 23.1 mmm-85 -74.82 -31.48 61.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.582 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.0 m -76.96 -30.71 56.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.114 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -105.85 5.14 30.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.782 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -75.82 173.91 10.54 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.248 0.546 . . . . 0.0 111.301 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.643 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -111.93 95.76 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.873 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -56.86 89.69 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.095 0.474 . . . . 0.0 110.179 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -129.25 160.26 33.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.788 -178.003 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.0 m -162.76 -84.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 53.87 91.62 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.877 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 101' ' ' GLU . 10.8 pt-20 -173.52 67.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.076 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 57.07 -113.58 4.55 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.487 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -54.58 118.36 4.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -71.54 66.45 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.66 119.45 39.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.964 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.97 104.41 11.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.025 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 CA-C-O 118.403 -1.22 . . . . 0.0 112.516 -179.929 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.806 0.336 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.71 31.61 4.78 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.419 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -83.73 138.66 33.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.83 157.25 19.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -162.67 62.18 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.05 137.13 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.19 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.3 p -149.04 134.35 18.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.833 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.626 ' O ' HD23 ' A' ' 59' ' ' LEU . 8.9 t60 -109.39 61.17 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 50' ' ' TYR . 2.2 t -71.68 -66.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.939 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.49 44.66 10.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.582 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -87.97 153.88 20.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.342 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -88.36 139.61 30.17 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.775 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.94 -37.16 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.652 2.235 . . . . 0.0 112.568 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -88.94 -41.1 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -87.15 -27.21 23.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.15 -144.26 17.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.459 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.45 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.57 138.92 35.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 110.804 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.69 64.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.123 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.573 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -52.44 -25.62 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.21 -19.56 61.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -130.1 20.52 5.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.466 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.034 HD22 HD11 ' A' ' 26' ' ' LEU . 18.3 mt -70.46 159.21 34.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.369 . . . . 0.0 111.17 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.08 142.05 38.14 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.01 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 46.3 Cg_exo -55.75 -19.74 25.75 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.604 2.203 . . . . 0.0 112.543 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.453 ' CB ' ' HA ' ' A' ' 63' ' ' ARG . 13.8 m-20 -82.17 -57.43 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.034 HD11 HD22 ' A' ' 22' ' ' LEU . 3.8 pp -70.48 -32.75 70.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.235 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.495 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -64.96 -34.85 79.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 0.0 110.203 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -36.25 82.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.518 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.993 HD13 HD12 ' A' ' 81' ' ' LEU . 7.3 tp -56.13 -58.58 7.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.316 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.505 ' CG ' HD21 ' A' ' 40' ' ' LEU . 20.9 m-85 -50.27 -40.83 49.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.739 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m -62.7 -54.97 31.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.789 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.617 ' HB3' HG11 ' A' ' 82' ' ' VAL . 8.6 mtt85 -58.39 -29.38 65.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.792 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.35 -21.05 36.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.184 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.34 17.75 41.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.557 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.438 HD12 HD21 ' A' ' 85' ' ' LEU . 66.5 mt -87.07 118.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.228 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.1 p -88.07 160.58 17.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 41' ' ' THR . 30.4 mp0 -51.9 -28.42 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.067 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.97 -44.56 70.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.662 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.467 ' HB3' HG21 ' A' ' 45' ' ' THR . 53.0 mt-30 -79.15 -31.88 44.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.731 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.505 HD21 ' CG ' ' A' ' 30' ' ' PHE . 91.6 mt -70.24 -27.89 64.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.636 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 37' ' ' GLU . 30.3 p -97.71 -3.41 39.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.512 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -81.62 119.87 24.35 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.83 0.348 . . . . 0.0 110.625 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.08 -35.21 24.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.454 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -72.61 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.454 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.483 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.6 -37.05 81.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.223 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.3 p -55.69 -40.37 72.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 110.286 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -60.46 -55.84 28.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.191 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.512 HD13 HG12 ' A' ' 88' ' ' VAL . 1.4 pp -65.48 -30.79 71.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.521 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 45' ' ' THR . 54.3 mt -67.62 -63.92 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.447 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.5 p90 -52.29 -36.15 52.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.934 0.397 . . . . 0.0 110.376 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.92 -33.28 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.472 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 79.2 t80 -64.63 -41.92 95.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.241 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 62' ' ' VAL . 43.3 mt -55.69 -29.66 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.331 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.91 -36.32 75.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.746 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -71.01 -26.42 63.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.617 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 17.0 mm100 -86.11 9.77 16.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.475 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.42 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.73 17.96 26.74 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.594 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 83.79 169.93 45.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.823 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 8' ' ' HIS . 14.4 tp -48.87 -42.14 35.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.726 0.298 . . . . 0.0 111.016 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -63.6 -35.24 79.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.21 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.42 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -34.25 66.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.484 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 53' ' ' ILE . 21.7 t -66.76 -63.35 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.208 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.453 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -51.85 -41.14 61.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.016 0.436 . . . . 0.0 110.233 178.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -63.14 -52.99 60.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.278 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 20.2 pt-20 -70.78 -29.0 65.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.859 0.361 . . . . 0.0 111.138 -179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.417 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.2 mmt -63.87 -34.37 77.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.695 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.49 -37.16 57.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.614 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -71.14 -23.68 62.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.581 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -87.82 -21.9 24.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.021 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 151.91 -44.3 0.65 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.462 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 66' ' ' MET . . . 69.31 -157.53 53.45 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.61 69.37 2.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 110.972 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.83 131.25 1.45 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.531 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.451 ' O ' ' NE2' ' A' ' 76' ' ' GLN . . . 84.68 -131.46 10.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.532 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.6 m -80.51 64.88 5.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.82 0.343 . . . . 0.0 110.972 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.451 ' NE2' ' O ' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -74.53 110.01 8.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.677 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 t -118.46 120.16 36.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.303 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.624 ' HB2' HG21 ' A' ' 82' ' ' VAL . 60.9 p -78.85 -1.05 33.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.402 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.6 98.6 1.51 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.176 0.512 . . . . 0.0 110.854 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.85 -102.7 0.23 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.019 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.993 HD12 HD13 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -65.21 -34.64 78.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 78' ' ' SER . 6.0 t -64.77 -35.06 74.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.79 0.328 . . . . 0.0 111.378 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.39 -43.9 67.67 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.554 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.41 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.87 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.522 HD22 HD21 ' A' ' 29' ' ' LEU . 15.7 tp -55.97 -47.17 78.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.892 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.4 mtm -53.41 -28.84 31.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -41.88 25.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 48' ' ' LEU . 48.7 t -58.25 -42.36 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 110.318 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 38.8 mmm -63.37 -33.42 75.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.306 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -65.04 -22.88 67.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.814 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -68.34 -57.68 5.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.951 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.96 -23.7 63.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.315 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.9 m -74.43 -25.26 59.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.536 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.48 2.54 36.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.53 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.91 169.68 16.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.214 0.531 . . . . 0.0 111.434 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.7 mt -133.8 82.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.386 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.06 -41.09 2.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 110.335 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.78 25.98 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.255 178.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 p -70.57 176.89 3.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.987 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 59.62 94.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -58.48 -23.12 57.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.029 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 168.33 -93.78 0.11 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.413 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -61.1 134.94 57.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.967 0.413 . . . . 0.0 110.739 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.23 -24.89 62.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -91.86 -171.51 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.859 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.03 130.68 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.152 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.419 -1.212 . . . . 0.0 112.522 -179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.19 137.94 27.58 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.657 0.265 . . . . 0.0 110.747 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.67 -26.48 3.79 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.688 2.259 . . . . 0.0 112.351 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -95.38 -41.39 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -88.87 -26.26 21.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.95 -148.81 19.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.443 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.411 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -81.94 146.84 29.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 110.706 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -81.77 57.32 3.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.987 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.595 HG12 HD13 ' A' ' 40' ' ' LEU . 2.9 m -48.32 -26.02 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.243 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.01 -22.28 61.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.121 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -130.69 21.11 5.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.456 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.925 HD22 HD11 ' A' ' 26' ' ' LEU . 16.7 mt -70.25 159.47 33.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 111.082 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 11.9 t70 -83.47 139.76 41.45 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.816 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.489 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 45.4 Cg_exo -55.97 -18.27 21.93 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.479 2.119 . . . . 0.0 112.62 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 1.2 m-20 -80.87 -58.94 2.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.941 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.925 HD11 HD22 ' A' ' 22' ' ' LEU . 3.9 pp -71.68 -39.06 70.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.248 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.494 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.63 -36.03 79.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.855 0.359 . . . . 0.0 110.499 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.3 t -63.85 -36.27 83.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 82' ' ' VAL . 17.6 tp -57.16 -58.04 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.59 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.625 ' HZ ' HD11 ' A' ' 53' ' ' ILE . 9.8 m-85 -50.27 -41.83 51.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.731 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -49.12 78.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.561 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.507 ' HB3' HG11 ' A' ' 82' ' ' VAL . 8.5 mtt85 -58.25 -32.57 68.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.619 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.66 4.81 23.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.74 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.49 17.08 78.87 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.821 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.533 HD12 HD21 ' A' ' 85' ' ' LEU . 52.8 mt -86.79 120.25 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 111.056 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.8 p -86.92 157.26 19.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -52.99 -34.04 54.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.07 -36.13 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 45' ' ' THR . 1.6 mt-30 -78.58 -35.27 46.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.519 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.595 HD13 HG12 ' A' ' 19' ' ' VAL . 78.1 mt -70.35 -24.46 62.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.734 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 37' ' ' GLU . 44.7 p -96.08 -7.98 34.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.542 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 46' ' ' SER . 5.8 t70 -81.49 123.31 28.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.687 0.28 . . . . 0.0 110.674 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.24 -37.21 45.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.631 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.25 -60.04 2.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.342 . . . . 0.0 111.534 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.638 HG22 HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -66.82 -29.7 69.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.956 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 57.7 p -59.56 -43.66 93.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.441 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 7.4 tptt -60.29 -52.83 63.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.56 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.534 ' C ' HD12 ' A' ' 48' ' ' LEU . 1.9 pp -65.83 -33.04 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.483 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.638 HD11 HG22 ' A' ' 45' ' ' THR . 59.4 mt -68.82 -64.33 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 1.9 p90 -52.53 -36.59 55.79 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.48 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -55.62 -32.51 63.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.519 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.726 ' HD1' HG21 ' A' ' 88' ' ' VAL . 67.3 t80 -64.88 -41.79 95.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.116 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.975 HG23 HG21 ' A' ' 62' ' ' VAL . 22.0 mt -54.72 -27.77 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.365 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.65 -36.16 67.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.592 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.475 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -72.56 -25.45 61.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.609 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.453 ' HG3' ' CE2' ' A' ' 52' ' ' PHE . 83.3 mm-40 -85.54 9.31 16.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.466 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.29 16.46 32.27 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.563 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.37 171.36 47.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.921 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 59' ' ' LEU . 8.3 tp -48.82 -42.29 35.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.805 0.336 . . . . 0.0 110.988 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 15.0 mm-40 -63.62 -34.47 77.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.034 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.28 -32.73 64.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.348 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.975 HG21 HG23 ' A' ' 53' ' ' ILE . 38.6 t -65.75 -63.61 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.917 0.389 . . . . 0.0 110.622 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -54.06 -38.23 65.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.05 0.452 . . . . 0.0 109.986 177.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.415 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 58.1 mt-30 -64.59 -52.63 56.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.768 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -68.05 -31.19 70.68 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.169 -177.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.424 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 1.3 mmt . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 121.094 0.473 . . . . 0.0 109.873 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 29' ' ' LEU . 23.3 t . . . . . 0 CA--C 1.522 -0.127 0 CA-C-O 120.876 0.369 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.88 -39.15 85.62 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.569 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.95 -55.36 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 110.602 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.533 HD21 HD12 ' A' ' 35' ' ' ILE . 20.0 tp -52.83 -39.09 62.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.578 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.9 mtt -53.59 -34.28 57.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.224 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -77.1 -44.59 29.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.359 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.726 HG21 ' HD1' ' A' ' 52' ' ' PHE . 53.4 t -53.85 -38.05 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.635 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 95.7 mmm . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.272 178.856 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.483 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.707 0.289 . . . . 0.0 110.299 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.39 138.59 28.49 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.29 -43.74 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.593 2.195 . . . . 0.0 112.274 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -81.9 -39.86 23.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -87.38 -30.96 20.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.028 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.65 -149.55 18.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.678 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.639 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.69 136.66 35.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.341 . . . . 0.0 110.981 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -77.94 65.65 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.981 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.808 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.7 m -51.85 -23.47 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.237 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -72.3 -22.93 61.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.029 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -128.97 19.34 6.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.529 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.896 HD22 HD11 ' A' ' 26' ' ' LEU . 17.1 mt -70.38 159.7 33.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.881 0.372 . . . . 0.0 111.174 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.18 138.87 42.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.803 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.508 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 48.4 Cg_exo -55.79 -18.35 21.16 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.54 2.16 . . . . 0.0 112.587 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -81.2 -58.11 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.216 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.896 HD11 HD22 ' A' ' 22' ' ' LEU . 3.5 pp -70.64 -42.25 71.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.233 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.508 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -54.96 -38.39 67.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.915 0.388 . . . . 0.0 110.467 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -37.97 89.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.85 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.494 HD12 HG22 ' A' ' 82' ' ' VAL . 22.7 tp -56.03 -55.62 30.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.747 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.679 ' CD2' HD21 ' A' ' 40' ' ' LEU . 10.9 m-30 -50.32 -47.47 55.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.599 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -62.12 -52.58 63.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.472 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.55 ' HB3' HG11 ' A' ' 82' ' ' VAL . 74.4 mtt-85 -53.27 -31.95 46.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.525 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.45 -20.64 39.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.034 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.44 11.2 34.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.938 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.561 HD12 HD21 ' A' ' 85' ' ' LEU . 31.8 mt -86.9 120.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 111.255 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 p -86.91 160.39 18.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.808 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -51.93 -25.8 8.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.709 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.94 -45.17 74.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.458 ' NE2' HG23 ' A' ' 35' ' ' ILE . 22.6 mt-30 -78.39 -29.22 47.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.761 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.679 HD21 ' CD2' ' A' ' 30' ' ' PHE . 88.4 mt -70.39 -26.83 63.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.52 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 37' ' ' GLU . 33.0 p -96.63 -3.93 41.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.531 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 46' ' ' SER . 15.3 t0 -82.73 124.37 30.17 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.776 0.322 . . . . 0.0 110.782 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.52 -40.19 59.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.42 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -72.69 -58.99 2.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.658 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.446 HG22 HD11 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -66.13 -33.62 76.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.337 -178.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 88.1 p -58.71 -39.32 80.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.84 0.352 . . . . 0.0 110.456 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -62.53 -54.96 32.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.555 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.662 HD13 HG12 ' A' ' 88' ' ' VAL . 1.9 pp -63.25 -31.06 72.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.053 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 45' ' ' THR . 57.6 mt -69.7 -64.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.418 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.483 ' CE1' ' CZ2' ' A' ' 11' ' ' TRP . 1.9 p90 -53.99 -39.87 66.44 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.167 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.4 ' OD1' ' CZ ' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -55.86 -33.66 64.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.745 178.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.72 ' HD2' HG21 ' A' ' 88' ' ' VAL . 26.4 t80 -64.65 -31.79 73.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 110.053 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.943 HG23 HG21 ' A' ' 62' ' ' VAL . 31.4 mt -61.72 -29.56 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.118 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -41.3 79.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.301 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 52' ' ' PHE . 1.1 p30 -65.75 -26.84 67.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.442 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 13.3 mm100 -86.2 11.38 12.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.525 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 95.42 18.96 31.47 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.503 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.19 168.24 39.66 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.626 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.516 ' CD1' HD22 ' A' ' 26' ' ' LEU . 34.9 tp -49.18 -38.08 24.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.46 -35.99 82.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 56' ' ' GLN . . . -73.09 -34.61 66.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.497 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.943 HG21 HG23 ' A' ' 53' ' ' ILE . 22.0 t -65.78 -52.37 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.701 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.63 -44.88 69.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.115 0.483 . . . . 0.0 110.046 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -62.52 -50.89 69.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.691 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 22.3 pt-20 -68.89 -30.77 69.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.715 0.293 . . . . 0.0 111.027 -178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.559 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.55 HG11 ' HB3' ' A' ' 32' ' ' ARG . 6.2 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.805 0.336 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.09 -38.76 73.51 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.621 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.22 -51.7 62.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 110.951 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.561 HD21 HD12 ' A' ' 35' ' ' ILE . 45.8 tp -52.47 -46.3 66.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.701 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 39.9 mtm -52.99 -42.34 65.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.327 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.48 73.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.347 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.72 HG21 ' HD2' ' A' ' 52' ' ' PHE . 51.2 t -72.62 -38.29 58.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.587 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.1 mmm . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.532 179.166 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.554 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.312 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -90.19 140.56 27.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.743 0.306 . . . . 0.0 110.604 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.69 -24.73 5.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.683 2.255 . . . . 0.0 112.479 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.31 -40.24 6.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -87.58 -21.14 25.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 95.58 -142.62 16.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.319 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.14 -174.34 5.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 0.0 110.866 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.85 57.22 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.332 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.794 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.5 m -47.87 -25.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.402 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -70.4 -22.07 62.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -134.95 23.61 3.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.596 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.033 HD22 HD11 ' A' ' 26' ' ' LEU . 17.7 mt -69.69 159.94 32.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 111.12 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.51 138.89 44.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.766 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.452 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 46.2 Cg_exo -55.66 -18.08 19.61 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.587 2.192 . . . . 0.0 112.519 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.34 -58.08 3.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.097 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.033 HD11 HD22 ' A' ' 22' ' ' LEU . 2.3 pp -71.45 -41.58 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.299 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -51.9 -40.74 61.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.427 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -64.74 -37.63 88.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.901 HD12 HG22 ' A' ' 82' ' ' VAL . 6.1 tp -56.74 -57.16 13.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.483 ' HZ ' HD11 ' A' ' 53' ' ' ILE . 15.6 m-85 -52.24 -41.88 63.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.8 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -53.97 50.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.623 ' HB3' HG11 ' A' ' 82' ' ' VAL . 12.6 mtt85 -54.11 -32.12 54.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.44 7.72 15.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.836 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.54 8.99 84.62 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.032 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.45 HD11 ' CG ' ' A' ' 89' ' ' MET . 61.0 mt -86.15 112.88 23.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.869 0.366 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.16 166.19 15.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.875 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.794 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -53.38 -29.77 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.09 -42.6 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.75 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -77.91 -29.7 50.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.616 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' CD1' ' CG1' ' A' ' 19' ' ' VAL . 53.9 mt -70.85 -25.3 62.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 37' ' ' GLU . 28.3 p -96.65 -5.72 38.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.706 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.26 119.23 23.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.878 0.371 . . . . 0.0 110.821 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.79 -34.81 28.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.358 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.99 -58.86 3.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.178 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.431 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.2 -30.56 71.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.822 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.8 p -59.36 -43.49 92.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.546 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 1.5 tptm -61.0 -51.71 68.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.593 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.691 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -67.09 -34.45 77.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.678 0.275 . . . . 0.0 111.197 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.56 HD11 ' HE3' ' A' ' 89' ' ' MET . 44.5 mt -68.65 -64.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.843 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.554 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 0.9 OUTLIER -53.72 -35.33 61.07 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.234 -178.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.452 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -54.05 -34.59 60.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.178 178.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.544 ' HD2' HG21 ' A' ' 88' ' ' VAL . 57.0 t80 -64.54 -44.21 91.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.043 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.529 HG23 HG21 ' A' ' 62' ' ' VAL . 23.8 mt -53.31 -25.18 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.336 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.49 -35.94 53.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 52' ' ' PHE . 0.9 OUTLIER -72.23 -25.21 61.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 110.769 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 27.9 mm-40 -86.04 11.58 11.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.494 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.92 19.26 27.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.491 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.32 167.65 38.76 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.648 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.489 ' CD1' HD22 ' A' ' 26' ' ' LEU . 25.4 tp -48.67 -37.01 17.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.088 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -64.99 -37.57 88.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.142 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.432 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.65 -33.32 66.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.49 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 53' ' ' ILE . 60.3 t -65.97 -52.24 51.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.871 0.367 . . . . 0.0 110.581 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -53.89 -44.68 70.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.18 0.515 . . . . 0.0 109.934 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -48.65 78.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.918 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 13.4 pt-20 -69.09 -41.66 77.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.687 0.279 . . . . 0.0 111.307 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.391 . . . . 0.0 110.683 179.866 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.901 HG22 HD12 ' A' ' 29' ' ' LEU . 28.2 t . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 120.786 0.327 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.75 -39.04 86.22 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.959 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.74 -49.66 67.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.591 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -55.93 -45.51 78.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.0 mtm -53.2 -39.57 63.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.15 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -62.92 -41.95 99.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.039 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.691 HG12 HD13 ' A' ' 48' ' ' LEU . 65.8 t -57.55 -36.47 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.488 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.623 ' HE1' HD11 ' A' ' 48' ' ' LEU . 15.8 mmt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.69 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 120.72 0.295 . . . . 0.0 110.256 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -91.96 134.48 28.71 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.626 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.41 -30.16 62.63 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.468 2.112 . . . . 0.0 112.56 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -105.24 -39.53 6.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.73 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -85.67 -9.8 56.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 82.1 -139.06 19.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.405 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -80.94 -169.37 2.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.964 0.411 . . . . 0.0 110.865 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -117.74 52.81 0.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.412 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.769 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.8 m -46.98 -26.36 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.494 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -70.24 -23.23 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -134.75 25.55 3.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.61 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.043 HD22 HD11 ' A' ' 26' ' ' LEU . 17.7 mt -69.99 159.59 33.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 111.271 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.72 139.73 40.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.767 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.491 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 44.3 Cg_exo -55.41 -18.68 19.94 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.506 2.137 . . . . 0.0 112.461 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -81.09 -57.67 3.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.123 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.043 HD11 HD22 ' A' ' 22' ' ' LEU . 3.6 pp -70.63 -41.85 71.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.143 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.491 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -57.11 -37.35 71.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 110.471 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.411 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 34.0 t -63.44 -37.03 85.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.714 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.726 HD12 HG22 ' A' ' 82' ' ' VAL . 38.3 tp -56.92 -53.59 56.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.689 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.469 ' CD2' HD11 ' A' ' 40' ' ' LEU . 17.7 m-85 -51.99 -43.44 63.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.574 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -61.74 -53.59 53.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.769 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.466 ' HB3' HG11 ' A' ' 82' ' ' VAL . 32.8 mtt180 -57.96 -30.57 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.833 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.11 -22.49 36.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.174 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.6 13.02 39.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.806 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.525 HD12 HD21 ' A' ' 85' ' ' LEU . 72.8 mt -86.53 118.67 33.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 111.132 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.19 162.78 17.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.769 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -53.14 -30.04 34.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.86 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.63 -41.15 69.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.845 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -78.03 -30.44 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.72 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.469 HD11 ' CD2' ' A' ' 30' ' ' PHE . 51.5 mt -71.48 -27.79 63.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.729 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 37' ' ' GLU . 10.7 p -97.4 -1.53 44.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.714 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 46' ' ' SER . 14.8 t70 -82.6 124.28 30.01 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.18 -41.44 60.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.55 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -72.53 -57.79 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.641 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.581 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.67 -37.53 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.353 -178.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 91.5 p -56.3 -38.72 71.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 0.0 110.279 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -62.19 -55.46 28.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.391 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.787 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.1 -31.98 73.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.301 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.581 HD11 HG22 ' A' ' 45' ' ' THR . 59.8 mt -67.78 -64.11 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.633 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.504 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 1.5 p90 -54.33 -39.85 67.45 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.387 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -55.49 -32.88 63.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.786 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.635 ' CD1' HG21 ' A' ' 88' ' ' VAL . 85.5 t80 -63.43 -38.42 91.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.911 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.009 HG23 HG21 ' A' ' 62' ' ' VAL . 22.0 mt -58.89 -28.84 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.219 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.43 -38.2 80.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.636 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.482 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -66.01 -25.37 67.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.614 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.477 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -84.15 -8.17 59.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.202 178.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 112.39 21.3 6.24 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.007 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.93 171.6 47.99 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.464 HD13 HD22 ' A' ' 26' ' ' LEU . 8.7 tp -48.24 -40.38 24.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.155 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -65.69 -35.02 79.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.432 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.83 -35.01 67.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.676 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 1.009 HG21 HG23 ' A' ' 53' ' ' ILE . 47.6 t -64.73 -62.1 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 110.74 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -36.2 39.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.208 0.527 . . . . 0.0 109.926 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -65.34 -51.83 57.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.881 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 16.7 pt-20 -68.17 -40.34 82.33 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.718 0.294 . . . . 0.0 111.359 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 C--N 1.326 -0.43 0 CA-C-O 120.962 0.41 . . . . 0.0 110.512 179.4 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.726 HG22 HD12 ' A' ' 29' ' ' LEU . 22.6 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.832 0.348 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.05 -38.46 73.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB3' ' HZ ' ' A' ' 52' ' ' PHE . . . -64.56 -55.44 20.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 111.008 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.525 HD21 HD12 ' A' ' 35' ' ' ILE . 12.4 tp -49.71 -41.17 42.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.791 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.4 mtm -54.19 -44.01 71.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -43.71 90.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.315 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.787 HG12 HD13 ' A' ' 48' ' ' LEU . 59.4 t -55.36 -41.76 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.64 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 84.0 mmm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.714 179.511 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.703 0.287 . . . . 0.0 110.371 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -92.39 135.24 26.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.735 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 20.5 Cg_exo -63.96 -45.89 9.54 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.486 2.124 . . . . 0.0 112.629 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -90.09 -38.24 13.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.839 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -85.71 -21.04 28.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.192 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.55 -149.5 20.62 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.558 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.88 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.01 138.05 34.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.789 0.328 . . . . 0.0 111.028 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -78.2 67.33 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.745 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.783 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.4 m -51.64 -23.59 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.227 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.21 -20.2 60.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -130.29 20.27 5.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.603 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.977 HD22 HD11 ' A' ' 26' ' ' LEU . 18.9 mt -70.19 159.46 33.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 111.158 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.33 140.95 39.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 46.3 Cg_exo -56.12 -19.56 27.39 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.597 2.198 . . . . 0.0 112.512 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -81.4 -56.82 3.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.176 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.977 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -70.0 -42.02 73.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.23 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -54.53 -38.82 67.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.929 0.395 . . . . 0.0 110.123 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 t -63.1 -40.72 98.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.486 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.714 HD12 HG22 ' A' ' 82' ' ' VAL . 13.5 tp -57.11 -52.51 65.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.396 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.467 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 22.9 m-85 -53.45 -47.63 69.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.514 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 m -61.73 -51.51 68.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.831 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.604 ' HB3' HG11 ' A' ' 82' ' ' VAL . 13.8 mtt85 -57.08 -31.93 65.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.406 ' HB2' HG13 ' A' ' 82' ' ' VAL . . . -81.91 -10.91 59.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.477 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.63 13.54 55.07 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.77 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.455 HD12 HD21 ' A' ' 85' ' ' LEU . 64.1 mt -87.08 115.43 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.747 0.308 . . . . 0.0 111.29 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.3 p -87.26 160.76 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.72 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.783 ' HG2' HG21 ' A' ' 19' ' ' VAL . 1.1 mt-10 -52.55 -31.8 37.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.821 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.97 -42.47 72.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.643 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -78.09 -30.64 49.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.749 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 37' ' ' GLU . 73.4 mt -69.81 -26.71 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.547 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 37' ' ' GLU . 61.6 p -96.27 -3.06 44.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.64 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -81.94 116.13 21.43 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 120.786 0.327 . . . . 0.0 110.611 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.49 -35.09 8.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.569 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -72.19 -59.11 2.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.276 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.87 -33.17 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.304 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.0 p -58.42 -42.03 86.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.794 0.33 . . . . 0.0 110.612 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.81 -53.39 56.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.712 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.862 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -64.89 -33.69 76.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.782 0.325 . . . . 0.0 110.908 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.467 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 75.1 mt -67.55 -63.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.23 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.1 p90 -52.26 -40.27 61.49 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.086 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -36.55 64.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.522 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 78.6 t80 -63.46 -29.82 71.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.933 HG23 ' CG2' ' A' ' 62' ' ' VAL . 92.8 mt -66.28 -27.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.088 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -71.46 -39.27 71.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.586 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.4 p30 -64.42 -25.29 67.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.559 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 8.5 mt-30 -84.73 -9.91 57.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.175 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.14 21.37 5.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.134 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.53 168.94 45.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.424 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.1 tp -48.23 -36.23 13.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 111.106 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.12 -37.24 85.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.197 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.61 -34.66 67.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.561 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.933 ' CG2' HG23 ' A' ' 53' ' ' ILE . 61.5 t -65.48 -49.65 77.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 110.615 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -54.51 -48.25 72.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.152 0.501 . . . . 0.0 110.035 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.32 -43.2 95.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.465 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 9.5 pt-20 -67.87 -37.51 81.9 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.721 0.296 . . . . 0.0 111.392 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.425 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 2.1 mmt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.801 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.714 HG22 HD12 ' A' ' 29' ' ' LEU . 16.5 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.858 0.361 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.35 84.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.15 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.03 -43.31 95.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.907 0.384 . . . . 0.0 110.67 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.455 HD21 HD12 ' A' ' 35' ' ' ILE . 8.2 tp -55.74 -49.72 72.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.793 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.4 mtt -49.62 -28.21 5.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.858 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.81 -41.93 20.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.526 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.862 HG12 HD13 ' A' ' 48' ' ' LEU . 70.5 t -63.47 -42.0 94.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.028 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 79.1 mmm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.375 178.216 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.571 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 15' ' ' ASN . 1.3 m-20 -89.42 138.69 28.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.673 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.99 -27.74 3.62 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.611 2.207 . . . . 0.0 112.286 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -97.97 -39.26 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 26.3 m120 -87.92 -25.83 23.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.34 -149.68 19.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.628 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.632 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -82.46 148.17 28.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 110.943 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.95 63.47 8.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.818 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.6 m -50.9 -24.0 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.282 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.14 -21.0 60.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -132.3 23.49 4.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.529 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.003 HD22 HD11 ' A' ' 26' ' ' LEU . 18.4 mt -70.29 159.62 33.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.377 . . . . 0.0 111.029 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 10.5 t70 -83.22 140.33 42.33 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.864 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 45.1 Cg_exo -55.91 -18.3 21.67 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.608 2.205 . . . . 0.0 112.659 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.68 -58.14 3.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.049 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.003 HD11 HD22 ' A' ' 22' ' ' LEU . 3.3 pp -70.45 -40.3 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.094 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -51.99 -38.54 57.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.979 0.418 . . . . 0.0 110.198 179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.441 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -64.54 -34.79 79.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.53 178.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.613 HD12 HG22 ' A' ' 82' ' ' VAL . 59.1 tp -56.76 -59.48 4.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.654 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.509 ' CG ' HD21 ' A' ' 40' ' ' LEU . 8.5 m-85 -51.2 -47.55 62.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.614 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.94 -54.85 36.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.873 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.461 ' HB3' HG11 ' A' ' 82' ' ' VAL . 58.8 mtt-85 -56.54 -29.82 62.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.95 -15.06 55.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.431 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.19 9.25 54.07 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.806 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.482 HD11 ' HG ' ' A' ' 85' ' ' LEU . 42.4 mt -86.7 120.52 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 0.0 111.218 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.2 p -87.14 161.52 18.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.818 ' HG2' HG21 ' A' ' 19' ' ' VAL . 2.7 tt0 -52.96 -31.47 40.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.89 -42.34 71.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -77.9 -30.73 50.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.509 HD21 ' CG ' ' A' ' 30' ' ' PHE . 96.0 mt -70.36 -25.06 63.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.726 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.3 p -96.22 -5.24 40.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.53 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.93 122.43 27.76 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 110.77 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.79 -37.93 45.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.52 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -71.72 -59.56 2.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.665 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -31.63 72.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.765 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.6 p -58.55 -44.22 89.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.357 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 7.8 tptt -59.87 -55.07 38.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.587 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -64.75 -32.91 74.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.504 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 69.7 mt -69.69 -64.17 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.493 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.646 ' HA ' HD12 ' A' ' 53' ' ' ILE . 1.6 p90 -52.75 -37.34 59.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.973 0.416 . . . . 0.0 110.06 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.99 -31.64 61.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.413 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.465 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 66.1 t80 -64.49 -41.52 96.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.095 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.941 HG23 HG21 ' A' ' 62' ' ' VAL . 37.2 mt -54.46 -27.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.29 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -72.7 -38.51 67.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.698 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.465 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -69.05 -25.89 64.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.688 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 18.4 mm100 -85.19 9.09 16.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.402 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.52 19.59 24.79 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.415 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 82.26 168.87 42.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.588 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.1 tp -49.42 -39.63 33.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.691 0.282 . . . . 0.0 111.07 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -63.95 -36.37 83.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.032 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.43 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.05 -32.66 65.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.941 HG21 HG23 ' A' ' 53' ' ' ILE . 22.8 t -66.13 -52.86 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -54.15 -43.79 70.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.124 0.487 . . . . 0.0 110.127 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -63.32 -47.72 81.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.27 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 25.5 pt-20 -68.31 -40.43 81.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.693 0.282 . . . . 0.0 111.299 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.6 mmt . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.137 0.494 . . . . 0.0 110.284 179.131 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.613 HG22 HD12 ' A' ' 29' ' ' LEU . 10.5 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.816 0.341 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.02 -42.15 78.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.318 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.33 -46.2 84.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.373 . . . . 0.0 110.74 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.482 ' HG ' HD11 ' A' ' 35' ' ' ILE . 8.3 tp -52.72 -48.92 66.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.498 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.9 mtt -49.05 -44.05 41.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.659 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.04 -43.51 87.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.361 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.587 HG12 HD13 ' A' ' 48' ' ' LEU . 62.5 t -55.58 -42.94 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.464 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 82.2 mmm . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.448 179.067 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.267 0 CA-C-O 120.802 0.334 . . . . 0.0 110.564 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -92.92 132.51 30.85 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.425 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 24.4 Cg_exo -62.13 -31.59 83.08 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.452 2.101 . . . . 0.0 112.59 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -98.04 -41.22 8.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.668 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -86.44 -14.77 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.694 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 87.22 -140.74 17.07 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.216 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.441 ' HZ ' HD12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -81.79 -169.12 2.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.91 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.3 54.17 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.392 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.678 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.5 m -47.09 -26.33 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.384 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -70.2 -23.68 62.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.046 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -135.52 26.58 3.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.731 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.018 HD22 HD11 ' A' ' 26' ' ' LEU . 17.1 mt -69.65 159.36 33.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.816 0.341 . . . . 0.0 110.996 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.56 140.16 41.3 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 51.6 Cg_exo -54.84 -19.31 18.75 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.621 2.214 . . . . 0.0 112.51 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -81.19 -58.32 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.074 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.018 HD11 HD22 ' A' ' 22' ' ' LEU . 3.8 pp -71.44 -39.14 71.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.245 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.497 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -58.67 -35.57 72.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.383 . . . . 0.0 110.149 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.426 ' O ' ' CD ' ' A' ' 32' ' ' ARG . 25.8 t -63.75 -38.25 90.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.757 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.456 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 8.0 tp -54.86 -53.85 50.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.423 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.441 ' CD2' HD11 ' A' ' 40' ' ' LEU . 22.6 m-85 -51.35 -46.12 62.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.402 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 m -62.39 -48.03 81.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.736 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -62.05 -33.39 74.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.847 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.3 -21.55 36.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.18 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.91 16.77 32.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.703 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.9 mt -86.65 121.76 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.341 . . . . 0.0 111.14 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 p -87.02 159.13 19.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.678 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -53.03 -30.7 37.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.25 68.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.426 ' HB3' HG21 ' A' ' 45' ' ' THR . 33.3 mt-30 -78.47 -31.3 47.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.807 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.441 HD11 ' CD2' ' A' ' 30' ' ' PHE . 81.7 mt -70.71 -24.55 62.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.7 p -97.66 -7.75 30.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.602 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -82.02 116.45 21.63 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.809 0.338 . . . . 0.0 110.819 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.79 -32.05 8.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.4 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.53 -59.96 2.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 111.407 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.477 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.59 -33.79 75.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.969 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.9 m -59.41 -39.48 83.6 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.478 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 5.5 tptt -62.12 -49.17 76.96 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.433 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.507 ' CD1' HG12 ' A' ' 88' ' ' VAL . 1.5 pp -69.96 -34.36 73.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.748 0.309 . . . . 0.0 110.913 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 36.0 mt -67.89 -64.31 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.73 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 0.7 OUTLIER -52.42 -36.13 53.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.913 0.387 . . . . 0.0 110.384 -179.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -33.97 66.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.421 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.622 ' HD1' HG21 ' A' ' 88' ' ' VAL . 65.3 t80 -64.61 -40.12 94.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.327 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.931 HG23 ' CG2' ' A' ' 62' ' ' VAL . 23.2 mt -55.92 -29.92 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.042 0.449 . . . . 0.0 110.181 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -43.21 78.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.631 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.449 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -59.86 -24.39 64.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.934 0.397 . . . . 0.0 110.484 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.548 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 71.3 mm-40 -84.96 -13.91 49.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.159 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.9 24.83 3.81 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.817 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.449 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 83.24 168.79 43.83 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.38 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.457 ' HA ' HG21 ' A' ' 53' ' ' ILE . 10.5 tp -47.35 -33.88 6.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.903 0.383 . . . . 0.0 111.069 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 12.6 mt-10 -68.62 -35.82 77.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.001 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.95 -36.09 67.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.596 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.931 ' CG2' HG23 ' A' ' 53' ' ' ILE . 48.7 t -64.1 -63.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.277 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -30.17 40.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HB2' ' HA ' ' A' ' 61' ' ' ALA . 9.0 mt-30 -63.17 -56.6 15.35 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.088 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 15.7 pt-20 -69.67 -38.36 77.02 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.628 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.401 ' HE3' ' HB3' ' A' ' 28' ' ' SER . 2.1 mmt . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.059 0.457 . . . . 0.0 110.412 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 32' ' ' ARG . 3.3 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.789 0.328 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.39 -43.28 70.59 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.416 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -65.13 -48.55 73.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 14.8 tp -61.31 -40.73 95.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 7.0 mtm -53.28 -37.57 62.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.266 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -72.23 -44.08 63.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.407 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.622 HG21 ' HD1' ' A' ' 52' ' ' PHE . 59.1 t -53.92 -39.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.563 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.914 179.247 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.49 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.1 m-20 -89.42 140.28 28.43 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.749 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.426 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 71.9 Cg_endo -78.16 -18.43 12.76 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.658 2.239 . . . . 0.0 112.584 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -110.93 -38.16 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.024 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -87.25 -21.55 25.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 96.34 -138.29 13.85 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.249 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.409 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -81.71 -169.81 2.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.893 0.378 . . . . 0.0 110.919 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -118.2 53.23 0.97 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.569 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.717 HG11 ' HG3' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -47.01 -26.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.577 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.54 -22.91 61.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.049 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -134.54 25.43 3.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.569 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.056 HD22 HD11 ' A' ' 26' ' ' LEU . 17.5 mt -69.89 159.09 34.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 111.234 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -85.23 140.25 36.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.755 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 50.4 Cg_exo -54.84 -19.61 19.74 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.539 2.159 . . . . 0.0 112.559 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 4.5 m-20 -82.2 -57.12 3.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.328 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.056 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -69.93 -41.36 74.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.069 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.469 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -56.97 -35.46 69.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.933 0.396 . . . . 0.0 110.262 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -39.45 93.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.593 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.756 HD12 HG22 ' A' ' 82' ' ' VAL . 23.3 tp -57.34 -50.86 71.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.801 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 22.8 m-85 -54.65 -48.3 72.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.739 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -61.24 -46.44 90.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.882 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.74 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -58.9 -35.98 73.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.54 0.04 44.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.753 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.74 12.54 77.35 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.912 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.599 HD12 HD21 ' A' ' 85' ' ' LEU . 66.4 mt -86.67 112.91 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.783 0.325 . . . . 0.0 111.129 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.74 164.43 15.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.717 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.35 -29.66 24.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.643 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.83 -44.46 73.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.791 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -78.13 -29.06 48.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.694 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.409 HD21 ' CG ' ' A' ' 30' ' ' PHE . 75.0 mt -70.69 -26.29 63.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.692 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 37' ' ' GLU . 49.0 p -97.28 -7.54 31.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.576 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' SER . 6.1 t0 -81.61 112.59 18.96 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.906 0.384 . . . . 0.0 110.717 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 13' ' ' PRO . . . -46.49 -32.22 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.6 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.23 -58.47 3.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.933 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -68.62 -35.95 77.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.233 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -56.94 -39.74 75.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.854 0.359 . . . . 0.0 110.201 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 1.1 tppm? -60.78 -55.52 32.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.337 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.774 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.03 -33.47 75.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.035 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 60.4 mt -68.44 -63.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.654 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 1.8 p90 -51.09 -38.21 50.34 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.029 0.443 . . . . 0.0 110.018 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.68 -34.21 69.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.523 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 80.9 t80 -63.94 -28.93 70.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.039 0.447 . . . . 0.0 110.259 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.953 HG23 ' CG2' ' A' ' 62' ' ' VAL . 20.1 mt -68.5 -27.8 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.087 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.49 -35.07 70.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.594 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.3 p30 -69.28 -25.46 64.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.585 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.523 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 10.9 mt-30 -84.5 -8.76 58.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.089 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.02 21.39 5.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.064 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.405 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 84.52 168.9 44.95 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.396 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.496 HD13 HD22 ' A' ' 26' ' ' LEU . 11.1 tp -48.45 -38.67 20.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.02 -34.5 78.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.84 -33.91 66.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.607 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.953 ' CG2' HG23 ' A' ' 53' ' ' ILE . 44.5 t -65.32 -63.57 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.333 . . . . 0.0 110.804 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -52.64 -41.42 63.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 110.244 178.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -63.64 -49.15 74.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.644 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -69.44 -33.84 73.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.175 -178.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 110.36 179.532 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.756 HG22 HD12 ' A' ' 29' ' ' LEU . 20.7 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.84 0.352 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.65 -41.3 84.33 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.185 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.54 -49.09 72.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 110.585 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.599 HD21 HD12 ' A' ' 35' ' ' ILE . 9.5 tp -50.89 -52.9 37.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.762 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 12.6 mtm -51.01 -31.37 17.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -79.25 -29.34 42.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.489 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.774 HG12 HD13 ' A' ' 48' ' ' LEU . 64.8 t -72.38 -42.97 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.629 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.425 ' SD ' HD11 ' A' ' 35' ' ' ILE . 83.1 mmm . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.393 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.559 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.42 140.28 28.43 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.674 0.273 . . . . 0.0 110.729 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.98 -37.59 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.686 2.257 . . . . 0.0 112.393 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -90.42 -38.06 13.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.954 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -87.2 -27.73 22.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.41 -149.68 19.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.624 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 11' ' ' TRP . 0.1 OUTLIER -82.65 146.58 29.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 111.003 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.08 67.17 9.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.782 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.8 m -50.53 -29.51 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -70.86 -19.92 62.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.139 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -130.72 20.43 5.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.449 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.939 HD22 HD11 ' A' ' 26' ' ' LEU . 17.3 mt -70.49 159.74 33.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -83.03 139.44 42.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.3 Cg_exo -54.28 -19.61 17.31 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.623 2.215 . . . . 0.0 112.636 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 75.3 m-20 -81.06 -58.16 3.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.061 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.939 HD11 HD22 ' A' ' 22' ' ' LEU . 4.0 pp -70.95 -38.29 72.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.148 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.485 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -61.98 -34.71 76.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.376 . . . . 0.0 110.086 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.415 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 23.1 t -64.21 -36.86 85.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.597 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.448 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 3.4 tp -56.1 -58.12 9.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.302 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.47 ' HD1' HD21 ' A' ' 85' ' ' LEU . 17.7 m-85 -49.59 -38.36 31.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.986 0.422 . . . . 0.0 110.519 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.41 -57.78 10.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.763 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.635 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -60.5 -25.5 66.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.787 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.14 -18.3 43.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.305 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.08 17.99 56.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.604 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.687 HD13 ' HE3' ' A' ' 89' ' ' MET . 60.7 mt -86.24 126.14 40.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.177 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.69 152.79 21.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.782 ' HG2' HG21 ' A' ' 19' ' ' VAL . 1.5 mt-10 -51.9 -25.37 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.737 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.89 -42.76 72.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.875 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -78.37 -30.06 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.796 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.569 HD23 HD13 ' A' ' 49' ' ' ILE . 95.9 mt -70.67 -27.56 64.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.887 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 37' ' ' GLU . 23.4 p -98.33 -2.44 39.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.552 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 46' ' ' SER . 5.4 t70 -82.85 123.77 29.68 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.52 -37.14 47.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.592 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.74 -59.88 2.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.529 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.5 -36.03 80.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.203 -179.066 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 87.3 p -56.5 -37.59 70.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.88 0.372 . . . . 0.0 110.173 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 11.1 tptt -61.92 -55.69 27.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.742 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.86 -28.98 68.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.276 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.569 HD13 HD23 ' A' ' 40' ' ' LEU . 56.0 mt -67.38 -64.8 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.274 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.559 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.8 p90 -55.28 -34.27 63.95 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.75 -35.65 68.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.45 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.519 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 71.2 t80 -63.79 -30.19 71.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.028 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.939 HG23 HG21 ' A' ' 62' ' ' VAL . 17.6 mt -65.43 -27.95 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.033 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.83 -41.77 71.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.571 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.4 p30 -61.4 -25.32 67.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.509 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.519 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 7.7 mt-30 -85.0 -10.61 56.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.252 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.42 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.21 21.73 5.47 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.03 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.445 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 85.28 168.5 44.78 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.657 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.438 ' HA ' HG21 ' A' ' 53' ' ' ILE . 14.9 tp -47.67 -37.13 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 110.969 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.0 -36.96 83.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.611 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.42 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.54 -36.06 68.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.939 HG21 HG23 ' A' ' 53' ' ' ILE . 43.8 t -65.12 -62.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.699 0.285 . . . . 0.0 110.941 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.408 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -49.45 -39.04 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.958 0.409 . . . . 0.0 110.206 178.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -53.96 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.258 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 11.0 pt-20 -70.19 -28.15 65.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.5 mmm . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.833 179.031 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.635 HG11 ' HB3' ' A' ' 32' ' ' ARG . 3.8 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.756 0.312 . . . . 0.0 111.33 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.34 -41.71 77.26 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.561 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.64 -51.08 64.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.598 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.477 HD21 HD12 ' A' ' 35' ' ' ILE . 12.3 tp -58.95 -40.01 83.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.264 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.5 mtm -54.05 -38.57 65.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.198 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -69.89 -44.66 69.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.389 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.742 HG12 HD13 ' A' ' 48' ' ' LEU . 44.8 t -56.11 -38.99 56.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.812 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.687 ' HE3' HD13 ' A' ' 35' ' ' ILE . 28.7 mmt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.048 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 110.901 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.14 140.24 25.81 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.408 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.09 -36.17 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.598 2.199 . . . . 0.0 112.531 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -83.75 -41.35 17.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.129 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -87.62 -28.43 21.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.935 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.95 -146.8 17.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.712 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.8 135.7 35.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.941 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.26 62.85 0.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.563 HG11 ' HG3' ' A' ' 37' ' ' GLU . 2.3 m -53.44 -23.22 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.789 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.85 -20.77 59.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.903 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -128.64 18.31 6.28 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.517 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.925 HD22 HD11 ' A' ' 26' ' ' LEU . 17.4 mt -70.0 159.35 33.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 111.133 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 6.2 t70 -84.54 140.88 38.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.926 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 33.6 Cg_exo -57.24 -17.75 27.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.589 2.193 . . . . 0.0 112.589 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.427 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 0.6 OUTLIER -81.91 -57.94 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.151 -179.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.925 HD11 HD22 ' A' ' 22' ' ' LEU . 4.0 pp -69.57 -41.53 75.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.947 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.508 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -55.58 -35.81 66.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 110.295 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -62.61 -39.24 93.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.719 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.501 HD11 ' HA ' ' A' ' 82' ' ' VAL . 28.9 tp -56.81 -51.28 69.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.587 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.413 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 21.5 m-85 -53.42 -43.46 67.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.577 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.3 m -61.82 -51.55 67.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.89 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.52 ' HB3' HG11 ' A' ' 82' ' ' VAL . 9.9 mtt180 -59.9 -32.73 71.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.813 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HB1' ' HG2' ' A' ' 86' ' ' MET . . . -81.94 -18.28 44.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.34 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.33 8.56 54.83 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.937 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.712 HD12 HD21 ' A' ' 85' ' ' LEU . 72.8 mt -85.98 109.56 18.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.3 p -86.46 167.23 14.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.041 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.563 ' HG3' HG11 ' A' ' 19' ' ' VAL . 1.4 mp0 -53.2 -34.52 57.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.037 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.23 -42.5 66.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -77.68 -35.1 52.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.552 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.523 HD23 HD13 ' A' ' 49' ' ' ILE . 25.2 mt -69.95 -20.7 63.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 37' ' ' GLU . 68.1 p -94.32 -9.53 35.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.402 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -81.07 121.67 26.37 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.754 0.311 . . . . 0.0 110.708 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.72 -34.62 27.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.432 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.35 -59.91 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.59 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.415 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.72 -37.94 82.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.2 p -56.87 -39.52 74.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.818 0.342 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 1.3 tppm? -61.29 -55.79 27.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.348 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.732 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -65.25 -32.08 73.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.328 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.523 HD13 HD23 ' A' ' 40' ' ' LEU . 55.4 mt -66.49 -63.98 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.124 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.565 ' CE1' ' CZ2' ' A' ' 11' ' ' TRP . 2.0 p90 -53.41 -37.96 62.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.97 0.414 . . . . 0.0 110.043 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.9 -35.57 66.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.481 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.493 ' HD2' HG21 ' A' ' 88' ' ' VAL . 37.4 t80 -64.0 -34.55 78.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.097 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.988 HG23 HG21 ' A' ' 62' ' ' VAL . 23.8 mt -60.77 -28.63 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.072 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.36 -38.84 78.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.459 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.83 -25.53 64.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 61.3 mm-40 -87.5 13.38 10.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.455 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 95.21 17.41 37.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.572 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.18 170.55 46.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.879 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 10.2 tp -49.49 -41.56 40.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.713 0.292 . . . . 0.0 111.27 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -65.1 -34.8 79.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.165 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.5 -34.29 65.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.656 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.988 HG21 HG23 ' A' ' 53' ' ' ILE . 61.5 t -64.29 -61.92 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -51.56 -38.6 55.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.082 0.468 . . . . 0.0 110.008 177.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.87 -51.5 64.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.329 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 11.3 pt-20 -68.74 -33.95 74.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.762 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.437 ' CE ' ' CA ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.52 HG11 ' HB3' ' A' ' 32' ' ' ARG . 6.5 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.779 0.323 . . . . 0.0 111.385 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -34.87 78.23 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.298 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -51.28 62.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 110.681 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.712 HD21 HD12 ' A' ' 35' ' ' ILE . 14.5 tp -62.94 -42.5 99.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.477 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.512 ' HG2' ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -53.37 -33.36 53.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.403 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -75.17 -30.31 60.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.349 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.732 HG12 HD13 ' A' ' 48' ' ' LEU . 96.8 t -66.36 -40.24 86.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.626 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.484 ' SD ' HD11 ' A' ' 35' ' ' ILE . 74.1 mmm . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.614 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.809 0.337 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -88.83 140.23 29.38 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.545 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.23 -33.5 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.671 2.247 . . . . 0.0 112.572 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -93.22 -41.11 10.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -87.1 -26.94 23.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.043 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 101.62 -145.11 16.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.386 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.559 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.43 138.9 35.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -76.01 62.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.249 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.583 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.8 m -51.24 -24.69 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.9 -21.39 60.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -128.55 19.91 6.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.383 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.074 HD22 HD11 ' A' ' 26' ' ' LEU . 16.4 mt -71.02 159.06 35.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.793 0.33 . . . . 0.0 111.189 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.88 142.56 39.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.989 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 43.3 Cg_exo -56.01 -20.02 28.51 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.606 2.204 . . . . 0.0 112.529 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.42 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 1.1 m-20 -81.82 -56.97 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.14 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.074 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -71.12 -37.46 72.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.476 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 2.0 ppt_? -59.59 -36.27 75.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.948 0.404 . . . . 0.0 110.214 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.1 t -63.68 -37.2 86.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.652 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 82' ' ' VAL . 25.6 tp -56.71 -57.07 14.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.625 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CG ' HD21 ' A' ' 40' ' ' LEU . 20.3 m-85 -48.35 -43.63 33.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.25 -58.48 7.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.631 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.668 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -55.54 -29.86 59.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.826 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.77 3.52 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.806 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.8 4.28 90.37 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.994 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 36' ' ' SER . 35.2 mt -85.67 162.35 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.893 0.347 . . . . 0.0 110.851 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -145.4 172.77 12.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.033 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 41' ' ' THR . 1.0 OUTLIER -53.45 -37.78 62.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.025 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.71 -46.42 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.71 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -78.54 -34.02 47.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.668 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD21 ' CG ' ' A' ' 30' ' ' PHE . 83.6 mt -70.0 -23.14 63.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 37' ' ' GLU . 46.9 p -94.99 -7.65 39.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.537 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -81.3 119.17 23.32 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.757 0.313 . . . . 0.0 110.715 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.85 -34.48 12.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.493 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -72.75 -59.89 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.415 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.426 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -68.21 -34.41 76.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.409 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.2 p -58.32 -42.3 86.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.847 0.356 . . . . 0.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -60.99 -53.14 60.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.499 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.874 HD13 HG12 ' A' ' 88' ' ' VAL . 1.5 pp -65.04 -32.26 73.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.741 0.305 . . . . 0.0 110.828 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.442 HD13 HD23 ' A' ' 40' ' ' LEU . 49.9 mt -68.42 -64.0 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.384 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.3 p90 -52.08 -40.7 61.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.885 0.374 . . . . 0.0 110.303 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.449 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -53.57 -32.68 51.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 178.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.46 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 69.3 t80 -63.85 -41.74 97.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.122 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.796 HG23 HG21 ' A' ' 62' ' ' VAL . 59.9 mt -55.39 -25.11 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.41 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.83 -35.54 59.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.783 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.46 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -72.93 -25.63 61.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.8 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -87.4 13.98 8.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.552 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.97 14.72 41.7 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.635 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.91 170.19 46.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.127 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.414 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 12.5 tp -48.99 -40.13 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 110.899 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -65.07 -36.19 83.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.302 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.08 -35.76 66.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.899 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.796 HG21 HG23 ' A' ' 53' ' ' ILE . 24.0 t -65.0 -63.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.756 0.312 . . . . 0.0 110.912 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -51.69 -44.53 63.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.071 0.462 . . . . 0.0 110.235 178.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.0 -52.58 62.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.41 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 4.4 pt-20 -70.4 -23.3 62.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.212 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 0.0 110.241 179.037 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 32' ' ' ARG . 16.8 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.824 0.345 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -46.47 60.05 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.037 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.35 -46.49 79.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.948 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.496 HD21 HD12 ' A' ' 35' ' ' ILE . 13.6 tp -55.97 -46.83 78.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.7 mtp -53.62 -29.97 40.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.441 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -80.08 -30.17 39.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.525 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.874 HG12 HD13 ' A' ' 48' ' ' LEU . 59.9 t -69.48 -42.45 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 110.308 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.3 mmm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.138 178.141 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.569 ' CH2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.745 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.09 140.8 29.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.552 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.05 -38.2 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.652 2.235 . . . . 0.0 112.772 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -94.17 -35.6 12.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.19 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.77 -25.29 23.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.112 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.85 -150.19 19.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.393 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.686 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.28 136.36 35.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.332 . . . . 0.0 110.891 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -74.83 62.95 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.277 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.608 HG21 ' HG2' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -52.0 -23.83 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.288 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.43 -21.76 61.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.194 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -132.68 21.89 4.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.487 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.015 HD22 HD11 ' A' ' 26' ' ' LEU . 16.5 mt -70.07 159.03 34.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 111.23 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -85.19 139.84 36.63 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.0 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 52.5 Cg_exo -55.19 -18.94 19.35 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.621 2.214 . . . . 0.0 112.684 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -81.19 -57.97 3.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.228 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.015 HD11 HD22 ' A' ' 22' ' ' LEU . 3.5 pp -69.91 -42.81 72.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.096 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -54.72 -34.22 62.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.956 0.407 . . . . 0.0 110.086 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.33 -39.18 93.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.677 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 82' ' ' VAL . 22.4 tp -56.59 -55.65 31.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.591 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.43 ' CG ' HD21 ' A' ' 40' ' ' LEU . 9.9 m-30 -50.38 -43.61 54.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.617 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 m -62.34 -55.14 30.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.709 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.467 ' HB3' HG11 ' A' ' 82' ' ' VAL . 2.6 mtp180 -56.73 -30.89 63.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.827 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.92 -21.46 37.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 8.68 48.31 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.771 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.569 HD12 HD21 ' A' ' 85' ' ' LEU . 39.3 mt -86.09 112.3 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.83 0.348 . . . . 0.0 111.176 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 p -87.0 167.6 14.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' THR . 3.5 mt-10 -52.17 -28.91 19.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.821 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.5 -46.14 73.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 35' ' ' ILE . 2.7 mt-30 -78.47 -31.38 47.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.688 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.43 HD21 ' CG ' ' A' ' 30' ' ' PHE . 87.4 mt -69.98 -25.48 63.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 37' ' ' GLU . 44.4 p -97.29 -5.33 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.607 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 46' ' ' SER . 20.9 t0 -82.23 113.69 20.22 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.753 0.311 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.6 -32.28 3.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.59 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.94 -59.66 2.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.122 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.413 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.85 -36.5 80.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.295 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -56.39 -38.16 71.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.848 0.356 . . . . 0.0 110.21 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 4.1 tptm -62.07 -54.95 34.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.363 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.693 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -67.04 -30.67 70.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.258 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 48.7 mt -68.02 -64.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.517 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.569 ' CZ ' ' CH2' ' A' ' 11' ' ' TRP . 2.1 p90 -52.77 -40.72 63.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.94 0.4 . . . . 0.0 110.224 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.78 -32.69 60.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.7 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 85' ' ' LEU . 77.0 t80 -64.54 -38.67 91.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.25 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.047 HG23 HG21 ' A' ' 62' ' ' VAL . 44.6 mt -59.18 -28.64 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.238 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.67 -33.95 73.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.342 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.464 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -75.08 -24.66 58.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.476 178.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 97.0 mm-40 -85.9 10.48 13.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.339 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.15 17.08 33.11 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.483 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 82.64 171.21 46.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.809 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.5 tp -49.34 -41.62 39.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 111.281 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -63.87 -34.84 78.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.219 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -35.57 66.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.255 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 1.047 HG21 HG23 ' A' ' 53' ' ' ILE . 22.0 t -66.06 -48.79 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -54.29 -46.55 72.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.112 0.482 . . . . 0.0 109.985 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.53 -49.07 74.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.943 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 20.3 pt-20 -67.56 -24.75 65.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.805 0.336 . . . . 0.0 110.808 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.404 ' CE ' ' N ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.467 HG11 ' HB3' ' A' ' 32' ' ' ARG . 6.0 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.774 0.321 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.2 -38.51 82.56 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.479 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.576 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.94 -48.74 73.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.569 HD21 HD12 ' A' ' 35' ' ' ILE . 30.7 tp -62.03 -45.18 94.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.4 mtm -54.25 -34.48 60.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.499 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -75.74 -24.46 56.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.693 HG12 HD13 ' A' ' 48' ' ' LEU . 48.2 t -78.28 -37.4 22.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.156 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 67.2 mmm . . . . . 0 C--N 1.327 -0.376 0 CA-C-O 121.046 0.451 . . . . 0.0 110.258 179.207 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.556 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 120.772 0.32 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.8 m-20 -90.57 138.41 26.74 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.467 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.23 -23.45 6.33 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.587 2.191 . . . . 0.0 112.598 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -99.1 -41.14 7.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.088 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -88.15 -29.85 20.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.046 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 109.56 -144.79 16.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.467 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.861 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -83.49 147.01 28.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 111.095 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -82.14 58.75 4.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.886 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.473 HG12 HD13 ' A' ' 40' ' ' LEU . 1.6 m -51.38 -24.03 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.069 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -19.77 59.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -131.61 21.34 4.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.401 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.036 HD22 HD11 ' A' ' 26' ' ' LEU . 17.6 mt -70.14 159.63 33.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.933 0.397 . . . . 0.0 111.201 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -83.52 145.85 48.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.06 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 31.4 Cg_exo -58.66 -22.23 59.64 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.634 2.223 . . . . 0.0 112.645 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.92 -56.37 4.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.328 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.036 HD11 HD22 ' A' ' 22' ' ' LEU . 3.6 pp -70.85 -32.77 69.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.333 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -64.17 -35.56 81.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.234 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -35.82 81.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.642 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 9.4 tp -56.4 -60.36 3.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.544 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CG ' HD21 ' A' ' 40' ' ' LEU . 16.7 m-85 -49.0 -45.24 42.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.817 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 m -62.22 -50.38 72.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -59.5 -33.18 71.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.61 -12.79 58.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.378 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.65 11.77 58.9 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.624 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -86.48 114.79 26.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.807 0.336 . . . . 0.0 111.086 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.9 p -87.53 163.49 16.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.815 ' O ' HG23 ' A' ' 41' ' ' THR . 0.4 OUTLIER -53.11 -26.7 17.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.39 -44.77 72.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.405 ' HB3' HG21 ' A' ' 45' ' ' THR . 40.7 mt-30 -78.58 -33.64 47.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.744 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.473 HD13 HG12 ' A' ' 19' ' ' VAL . 76.5 mt -68.79 -22.3 64.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.804 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 37' ' ' GLU . 35.1 p -96.53 -8.75 31.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.555 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.6 t70 -82.22 112.76 19.53 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.783 0.325 . . . . 0.0 110.645 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.96 -31.27 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.7 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -72.37 -59.65 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.882 0.372 . . . . 0.0 110.929 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.71 -33.33 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -58.66 -39.5 80.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.269 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 19.1 tptt -61.74 -53.31 57.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.566 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.937 HD13 HG12 ' A' ' 88' ' ' VAL . 1.9 pp -66.44 -32.41 73.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.356 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 46.3 mt -68.2 -64.59 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.554 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.556 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.3 p90 -53.63 -37.43 63.06 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.981 0.419 . . . . 0.0 110.138 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -55.44 -36.41 66.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.426 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.459 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 64.3 t80 -64.32 -37.56 87.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.043 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.967 HG23 HG21 ' A' ' 62' ' ' VAL . 49.5 mt -58.62 -29.07 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.178 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -40.27 77.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.587 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.459 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -66.37 -26.24 67.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.458 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.46 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 94.6 mm-40 -85.28 1.35 48.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.338 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 104.41 18.82 12.3 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.475 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.45 170.83 46.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.846 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.582 HD13 HD22 ' A' ' 26' ' ' LEU . 12.1 tp -48.52 -40.33 26.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.322 . . . . 0.0 111.093 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.64 -35.07 79.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.247 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -74.05 -34.24 63.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.818 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.967 HG21 HG23 ' A' ' 53' ' ' ILE . 44.0 t -65.02 -63.29 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.699 0.285 . . . . 0.0 110.873 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -52.47 -41.64 63.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.052 0.453 . . . . 0.0 110.13 177.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -63.23 -53.26 55.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.33 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 10.1 pt-20 -69.36 -26.61 64.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.992 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.5 mmt . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.079 0.466 . . . . 0.0 110.238 178.896 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.47 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 3.6 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.24 -48.91 43.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.274 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -65.12 -45.39 85.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.794 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 29' ' ' LEU . 11.4 tp -56.8 -40.99 76.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.625 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.7 mtt -53.0 -41.16 64.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.24 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -45.49 74.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.669 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.937 HG12 HD13 ' A' ' 48' ' ' LEU . 22.5 t -51.25 -40.02 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.709 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 92.9 mmm . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.325 178.699 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.28 137.93 28.98 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.679 0.276 . . . . 0.0 110.795 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.44 -23.36 7.36 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -98.42 -41.4 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -89.45 -25.92 21.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.002 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.74 -142.47 16.1 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.337 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.589 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -83.0 146.4 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 0.0 110.841 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -84.66 61.12 6.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.731 HG11 ' HG3' ' A' ' 37' ' ' GLU . 5.2 m -49.07 -25.36 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.237 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -72.12 -20.88 61.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.086 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -132.23 20.75 4.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.429 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.0 HD22 HD11 ' A' ' 26' ' ' LEU . 17.0 mt -70.28 159.7 33.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.936 0.398 . . . . 0.0 111.163 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -82.44 139.42 44.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.77 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 49.2 Cg_exo -54.86 -19.17 18.36 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.518 2.146 . . . . 0.0 112.464 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' ' HE2' ' A' ' 66' ' ' MET . 7.2 m-20 -81.27 -57.68 3.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.127 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.0 HD11 HD22 ' A' ' 22' ' ' LEU . 3.4 pp -70.64 -40.97 72.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.105 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.5 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.6 OUTLIER -59.04 -39.09 80.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 0.0 110.576 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -64.09 -38.49 91.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.619 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.694 HD12 HG22 ' A' ' 82' ' ' VAL . 15.5 tp -56.11 -51.01 69.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.576 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.444 ' CG ' HD21 ' A' ' 40' ' ' LEU . 21.0 m-85 -52.3 -49.04 64.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.512 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.3 m -62.41 -41.49 98.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.791 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.545 ' HB3' HG11 ' A' ' 82' ' ' VAL . 34.7 mtt180 -62.48 -35.86 80.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.983 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.1 -14.74 57.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.482 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 10.78 45.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.796 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.511 HD11 ' HG ' ' A' ' 85' ' ' LEU . 62.5 mt -86.64 119.62 34.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.842 0.353 . . . . 0.0 110.939 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -86.6 157.45 19.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.998 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.731 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.82 -30.32 32.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.047 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.65 70.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.858 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.432 ' NE2' HG21 ' A' ' 45' ' ' THR . 9.6 mm100 -77.76 -30.14 51.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.712 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.444 HD21 ' CG ' ' A' ' 30' ' ' PHE . 95.2 mt -69.6 -22.8 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.5 p -97.44 -7.68 31.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.606 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' SER . 2.1 t70 -81.45 115.51 20.81 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.818 0.342 . . . . 0.0 110.63 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.96 -34.2 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.682 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -72.44 -59.9 2.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 0.0 111.491 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.442 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.3 -32.89 74.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.172 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 1.4 t -57.86 -42.1 83.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.599 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.469 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.84 -55.2 32.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.358 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.633 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -63.31 -31.61 72.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.723 0.297 . . . . 0.0 110.953 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.431 HD13 HD23 ' A' ' 40' ' ' LEU . 70.4 mt -69.76 -64.02 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.381 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 1.9 p90 -53.35 -38.2 63.06 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.073 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -54.18 -34.32 60.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.638 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.516 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 69.1 t80 -63.93 -30.67 71.73 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.092 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.981 HG23 HG21 ' A' ' 62' ' ' VAL . 40.2 mt -66.29 -28.5 43.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.034 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -71.8 -34.42 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.816 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.478 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.3 p30 -69.96 -25.59 63.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 0.0 110.497 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.516 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 9.0 mt-30 -83.12 -8.97 59.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.094 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 113.64 22.08 5.54 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.886 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.64 171.02 47.21 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.603 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 13.2 tp -47.8 -41.64 24.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 111.055 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 28.5 mt-10 -64.27 -34.51 78.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.4 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -73.16 -35.93 66.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.709 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.981 HG21 HG23 ' A' ' 53' ' ' ILE . 40.3 t -65.14 -63.56 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.667 0.27 . . . . 0.0 110.812 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -53.08 -37.94 62.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.98 0.419 . . . . 0.0 109.94 177.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 43.6 mt-30 -63.17 -50.62 69.67 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.061 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -68.8 -34.88 76.27 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.542 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.415 ' HE2' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 121.087 0.47 . . . . 0.0 110.049 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.694 HG22 HD12 ' A' ' 29' ' ' LEU . 6.2 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.783 0.325 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.33 -36.96 85.65 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.301 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.22 -47.04 81.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.703 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.511 ' HG ' HD11 ' A' ' 35' ' ' ILE . 5.9 tp -54.08 -49.41 69.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.493 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.4 mtm -51.1 -31.63 19.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.473 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -39.92 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.259 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.633 HG12 HD13 ' A' ' 48' ' ' LEU . 57.9 t -56.4 -40.56 67.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.207 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.42 ' CE ' HG22 ' A' ' 45' ' ' THR . 3.3 mmt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.183 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.495 ' CE2' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 120.758 0.313 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.428 ' HB2' ' HB2' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -92.58 136.15 25.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.73 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.15 -58.73 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.494 2.13 . . . . 0.0 112.592 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -81.33 -34.44 31.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.715 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 47.9 m-20 -86.14 -22.76 26.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.651 0.262 . . . . 0.0 111.199 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.65 -150.6 21.83 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.587 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -80.78 142.87 33.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.862 0.363 . . . . 0.0 110.997 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.7 64.96 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.771 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.0 m -54.69 -21.5 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.261 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -72.72 -20.84 61.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.143 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -132.11 20.62 4.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.508 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.867 HD22 HD11 ' A' ' 26' ' ' LEU . 17.7 mt -69.8 159.46 33.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.154 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 9.2 t70 -84.08 137.97 39.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.77 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 44.5 Cg_exo -55.89 -18.53 22.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.558 2.172 . . . . 0.0 112.463 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 68.3 m-20 -80.84 -57.63 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.044 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.867 HD11 HD22 ' A' ' 22' ' ' LEU . 4.1 pp -69.53 -44.81 70.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.148 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.622 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.2 -32.9 62.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.863 0.363 . . . . 0.0 110.534 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.4 t -64.55 -38.06 89.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 82' ' ' VAL . 16.0 tp -56.35 -54.54 44.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.733 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.566 ' CD2' HD11 ' A' ' 40' ' ' LEU . 8.2 m-85 -50.99 -44.32 60.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.769 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -61.8 -49.32 76.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.915 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -34.05 67.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.054 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.94 -18.55 46.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.39 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.15 11.68 41.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.89 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 85' ' ' LEU . 52.4 mt -86.21 117.79 31.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.813 0.34 . . . . 0.0 111.057 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.03 161.46 18.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.771 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -52.73 -26.49 14.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.851 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.09 -43.2 73.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HG2' HG21 ' A' ' 45' ' ' THR . 0.5 OUTLIER -78.57 -28.73 45.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.742 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 30' ' ' PHE . 33.1 mt -71.19 -23.58 62.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.856 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 37' ' ' GLU . 45.6 p -98.05 -7.55 29.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.696 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 46' ' ' SER . 29.1 t0 -81.96 122.55 27.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.799 0.333 . . . . 0.0 110.744 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.07 -38.22 37.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.556 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -73.18 -59.81 2.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.672 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.487 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.75 -35.96 81.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.126 -178.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 70.4 m -58.8 -41.98 88.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.855 0.36 . . . . 0.0 110.438 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -60.11 -55.23 36.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.43 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.824 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -64.4 -31.99 73.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.383 -178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 45' ' ' THR . 60.4 mt -67.5 -63.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.203 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.495 ' CE2' ' CE2' ' A' ' 11' ' ' TRP . 2.0 p90 -52.36 -35.84 52.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.925 0.393 . . . . 0.0 110.303 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.8 -32.76 63.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.476 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 74.0 t80 -64.67 -41.03 96.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.167 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.927 HG23 HG21 ' A' ' 62' ' ' VAL . 30.8 mt -55.95 -28.23 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.213 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -71.21 -36.13 71.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.589 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -73.49 -25.92 60.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.568 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 89.2 mm-40 -86.22 12.5 9.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.639 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.49 15.04 36.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.607 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.1 170.63 45.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.784 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.4 tp -48.95 -37.95 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 111.112 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.01 -35.69 82.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.317 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.21 -35.8 66.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.668 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.927 HG21 HG23 ' A' ' 53' ' ' ILE . 31.3 t -65.32 -63.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.707 0.289 . . . . 0.0 110.768 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.425 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -52.1 -37.47 54.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.06 0.457 . . . . 0.0 110.138 178.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -63.09 -52.07 64.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.53 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.403 ' OE2' ' N ' ' A' ' 66' ' ' MET . 0.1 OUTLIER -69.5 -36.32 76.37 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.803 0.335 . . . . 0.0 110.982 -178.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.403 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 2.8 mmt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.596 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 29' ' ' LEU . 9.2 t . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.892 0.377 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.29 -41.1 80.09 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.26 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.49 -39.46 93.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 35' ' ' ILE . 10.3 tp -64.0 -41.08 97.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.37 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -42.5 67.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.18 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -44.89 92.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.824 HG12 HD13 ' A' ' 48' ' ' LEU . 44.7 t -52.33 -41.79 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.56 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 74.5 mmm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.793 179.289 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.486 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.772 0.32 . . . . 0.0 110.318 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.96 138.58 27.61 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.615 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -78.61 -33.89 1.58 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -92.33 -41.0 10.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.946 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.15 -25.1 24.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.012 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.34 -146.28 18.19 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.505 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.59 140.21 34.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.882 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -74.86 60.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.772 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -50.52 -24.64 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -73.48 -22.25 60.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -128.7 20.03 6.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.433 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.825 HD22 HD11 ' A' ' 26' ' ' LEU . 17.1 mt -70.64 159.49 34.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 111.051 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 2.6 t70 -84.58 139.3 38.11 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.095 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 48.3 Cg_exo -55.67 -19.0 22.49 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.56 2.173 . . . . 0.0 112.399 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -81.34 -57.16 3.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.929 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.825 HD11 HD22 ' A' ' 22' ' ' LEU . 4.2 pp -70.14 -44.37 69.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.041 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.707 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -54.39 -35.9 63.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.917 0.389 . . . . 0.0 110.46 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.06 -38.92 93.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.708 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.633 HD12 HG22 ' A' ' 82' ' ' VAL . 27.8 tp -56.65 -54.23 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.572 ' HD1' HD21 ' A' ' 85' ' ' LEU . 21.7 m-85 -51.93 -46.77 64.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.491 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -62.21 -50.72 70.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.714 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.554 ' HB3' HG11 ' A' ' 82' ' ' VAL . 43.9 mtt180 -54.73 -32.25 59.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.555 ' HB1' ' HG2' ' A' ' 86' ' ' MET . . . -82.5 -14.24 55.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.469 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.05 13.12 50.58 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.677 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.476 HD12 HD21 ' A' ' 85' ' ' LEU . 58.2 mt -86.52 118.9 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 111.047 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.74 163.57 17.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.881 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.772 ' HG2' HG21 ' A' ' 19' ' ' VAL . 2.4 mt-10 -53.78 -30.3 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.876 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.91 72.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.074 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -78.27 -31.32 48.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.805 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.485 HD21 ' CG ' ' A' ' 30' ' ' PHE . 96.0 mt -70.97 -27.59 63.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.463 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 37' ' ' GLU . 31.5 p -97.75 -3.64 38.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.555 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.72 121.46 26.42 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.9 -37.23 30.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.479 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.86 -59.89 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.595 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.71 -35.52 78.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.394 -178.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.5 p -57.42 -37.57 72.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.822 0.344 . . . . 0.0 110.147 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 18.0 tptt -61.55 -56.07 24.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.146 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.82 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -65.72 -30.72 71.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.287 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.455 HD13 HD23 ' A' ' 40' ' ' LEU . 39.5 mt -68.03 -64.21 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.532 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.3 p90 -52.57 -38.66 60.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.929 0.395 . . . . 0.0 110.203 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.11 -33.54 65.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.674 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 49' ' ' ILE . 53.1 t80 -64.62 -39.63 94.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.303 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.951 HG23 HG21 ' A' ' 62' ' ' VAL . 21.6 mt -57.39 -29.87 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.241 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.34 -36.41 79.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.433 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.69 -25.12 61.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.558 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 16.9 mm100 -86.51 12.13 11.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.44 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.23 17.86 33.09 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.572 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.76 166.84 39.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.696 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.49 HD11 ' CD2' ' A' ' 26' ' ' LEU . 32.1 tp -49.08 -37.33 20.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 0.0 111.119 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.9 -34.55 78.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.2 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.78 -35.53 67.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.267 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.951 HG21 HG23 ' A' ' 53' ' ' ILE . 18.5 t -66.09 -48.61 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.925 0.393 . . . . 0.0 110.737 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -53.76 -46.23 70.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.175 0.512 . . . . 0.0 109.956 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.22 -48.68 74.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.135 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 8.0 pt-20 -68.6 -20.73 64.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.612 0.244 . . . . 0.0 111.643 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.525 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 2.2 mmt . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.633 HG22 HD12 ' A' ' 29' ' ' LEU . 8.5 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.834 0.35 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.75 -41.05 75.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.32 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.2 -45.66 87.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.815 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.572 HD21 ' HD1' ' A' ' 30' ' ' PHE . 13.4 tp -60.91 -44.85 96.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.481 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.555 ' HG2' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -53.56 -42.6 67.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.373 178.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -36.07 82.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.542 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.82 HG12 HD13 ' A' ' 48' ' ' LEU . 65.4 t -65.91 -40.18 86.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.766 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 48.5 mmm . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 179.851 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.699 0.285 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.8 m-20 -89.52 140.15 28.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.717 0.294 . . . . 0.0 110.54 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.73 -28.39 5.27 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.662 2.241 . . . . 0.0 112.483 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -98.0 -38.83 9.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -87.48 -21.62 25.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 95.6 -138.2 13.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.206 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.58 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -81.94 -169.08 2.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.942 0.401 . . . . 0.0 110.755 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -123.99 54.15 1.35 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.499 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.798 HG11 ' HG3' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -46.15 -26.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.641 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -68.56 -23.94 64.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.031 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -134.78 25.21 3.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.642 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.892 HD22 HD11 ' A' ' 26' ' ' LEU . 17.6 mt -70.2 159.5 33.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.927 0.394 . . . . 0.0 111.167 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.91 137.97 40.47 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.707 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.6 Cg_exo -54.76 -19.22 18.15 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.584 2.189 . . . . 0.0 112.654 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 52.2 m-20 -81.64 -57.71 3.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.291 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.892 HD11 HD22 ' A' ' 22' ' ' LEU . 4.0 pp -70.91 -38.1 72.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.158 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.604 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -62.22 -35.51 79.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.489 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 t -63.24 -36.32 83.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.633 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 82' ' ' VAL . 25.2 tp -56.6 -50.72 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.644 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 24.4 m-85 -55.47 -43.99 76.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.569 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -50.11 74.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.81 -29.3 69.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.16 -21.2 36.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.173 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.36 14.51 38.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.643 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.482 HD12 HD21 ' A' ' 85' ' ' LEU . 64.8 mt -86.75 121.54 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.0 111.059 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 p -86.97 158.23 19.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.798 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -52.07 -27.12 12.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.842 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.17 -42.17 72.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -78.1 -30.17 49.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.432 HD23 HD13 ' A' ' 49' ' ' ILE . 70.6 mt -70.33 -24.77 63.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 37' ' ' GLU . 31.6 p -98.45 -5.98 31.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.705 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.89 121.14 26.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.84 0.353 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.08 -35.54 25.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.276 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -72.53 -59.9 2.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.685 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -67.16 -33.74 76.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.987 -179.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.4 p -57.6 -40.07 78.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.726 0.298 . . . . 0.0 110.345 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -61.77 -53.93 49.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.356 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.58 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.64 -31.44 72.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.19 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.432 HD13 HD23 ' A' ' 40' ' ' LEU . 54.1 mt -69.95 -64.78 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.749 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.504 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -54.18 -36.94 63.94 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.361 -178.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -55.0 -33.17 62.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.446 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.443 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 60.7 t80 -64.87 -39.57 93.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.188 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 62' ' ' VAL . 22.6 mt -56.39 -29.98 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.274 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.75 -36.37 75.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -71.14 -26.51 63.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.636 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 97.1 mm-40 -86.05 11.14 12.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.503 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.33 18.21 29.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.496 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.47 172.33 48.63 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.007 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 59' ' ' LEU . 8.2 tp -48.43 -44.86 35.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 0.0 111.196 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.5 -35.19 79.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.392 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -33.73 65.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.572 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.976 HG21 HG23 ' A' ' 53' ' ' ILE . 48.6 t -64.9 -63.48 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.43 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 1.4 ptp180 -52.29 -38.54 58.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 110.088 177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -64.14 -48.96 74.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.909 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 66' ' ' MET . 10.7 pt-20 -68.52 -43.59 76.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.517 -177.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.445 ' N ' ' HG3' ' A' ' 65' ' ' GLU . 4.9 mmm . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 121.053 0.454 . . . . 0.0 110.57 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.712 HG22 HD12 ' A' ' 29' ' ' LEU . 19.4 t . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.87 0.367 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.14 -37.54 82.04 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.292 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.91 -51.28 62.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.482 HD21 HD12 ' A' ' 35' ' ' ILE . 29.5 tp -59.83 -42.37 93.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.72 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.7 mtm -52.92 -37.93 61.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.301 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -69.22 -46.85 66.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.222 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.58 HG12 HD13 ' A' ' 48' ' ' LEU . 98.5 t -52.09 -41.1 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.62 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 89.1 mmm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.35 179.29 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.25 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.59 141.44 30.27 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.772 0.32 . . . . 0.0 110.826 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.1 -23.2 12.26 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.713 2.275 . . . . 0.0 112.64 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.42 -34.22 5.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.189 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.39 -25.79 23.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.779 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.97 -150.55 19.6 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.642 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.62 147.78 29.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.955 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -82.85 61.19 5.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.711 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.2 m -48.57 -25.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.205 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -71.16 -21.29 62.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.48 19.63 5.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.571 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.993 HD22 HD11 ' A' ' 26' ' ' LEU . 17.5 mt -70.64 159.28 34.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.975 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -84.26 141.0 39.46 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.026 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.491 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.7 Cg_exo -54.36 -21.03 21.87 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.65 2.234 . . . . 0.0 112.371 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -82.16 -56.3 4.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.308 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.993 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -71.17 -37.43 72.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.25 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.504 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -58.67 -39.67 81.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.38 . . . . 0.0 110.425 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.448 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -63.27 -36.16 82.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.641 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.65 HD12 HG22 ' A' ' 82' ' ' VAL . 14.8 tp -56.38 -43.33 79.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CG ' HD21 ' A' ' 40' ' ' LEU . 18.5 m-85 -66.85 -49.42 65.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.615 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.2 m -60.7 -50.57 72.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.63 ' HB3' HG11 ' A' ' 82' ' ' VAL . 11.9 mtt180 -59.11 -30.23 67.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.521 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.65 4.63 24.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.567 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.86 7.57 88.25 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.986 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.53 HD11 ' HG ' ' A' ' 85' ' ' LEU . 48.7 mt -87.1 122.57 39.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.837 0.351 . . . . 0.0 111.319 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.35 158.28 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.708 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.711 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.38 -29.88 26.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.772 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.22 -38.76 68.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 45' ' ' THR . 37.0 mt-30 -78.02 -32.39 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD21 ' CG ' ' A' ' 30' ' ' PHE . 57.9 mt -69.61 -24.21 63.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.722 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 37' ' ' GLU . 20.4 p -96.72 -7.45 33.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.528 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 46' ' ' SER . 22.7 t0 -81.41 115.4 20.73 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.826 0.346 . . . . 0.0 110.595 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.22 -35.53 3.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.778 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.22 -59.93 2.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 111.493 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -67.6 -34.89 77.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.487 -178.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -56.19 -41.17 75.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.412 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.58 -56.25 21.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.346 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -63.51 -30.31 71.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.911 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 80.6 mt -68.81 -64.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.023 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 1.7 p90 -55.48 -39.13 70.03 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.117 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 0.9 OUTLIER -52.34 -34.59 48.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.521 179.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.47 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 54.7 t80 -64.33 -38.78 92.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.806 178.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 62' ' ' VAL . 48.6 mt -56.62 -30.81 32.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.136 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -69.5 -33.66 73.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.684 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -75.46 -26.0 57.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.729 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 78.4 mm-40 -86.21 11.39 12.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.52 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 99.33 17.14 27.72 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.585 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.84 169.59 45.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.995 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 14.0 tp -48.06 -39.72 20.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.712 0.292 . . . . 0.0 111.145 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 24.6 mm-40 -65.73 -35.44 80.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.327 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 56' ' ' GLN . . . -73.09 -35.96 66.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.768 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.976 HG21 HG23 ' A' ' 53' ' ' ILE . 46.2 t -65.24 -62.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 110.97 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -52.78 -39.03 61.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.186 0.517 . . . . 0.0 110.053 177.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 50.2 mt-30 -63.85 -50.1 70.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.876 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 16.5 pt-20 -69.47 -40.13 77.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.367 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.217 0.532 . . . . 0.0 110.001 179.146 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.65 HG22 HD12 ' A' ' 29' ' ' LEU . 22.8 t . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.854 0.359 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.82 -36.87 83.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.209 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.36 -52.16 59.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.715 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 35' ' ' ILE . 3.9 tp -51.11 -48.12 61.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.57 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.5 mtt -50.29 -40.85 49.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.706 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -44.08 77.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.237 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.686 HG12 HD13 ' A' ' 48' ' ' LEU . 93.9 t -55.8 -40.28 60.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.527 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 85.7 mmm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.557 179.214 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.564 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 CA-C-O 120.706 0.289 . . . . 0.0 110.301 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.8 OUTLIER -89.3 140.62 28.66 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.712 0.292 . . . . 0.0 110.769 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.45 -36.8 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.743 2.295 . . . . 0.0 112.591 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -91.6 -35.95 13.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 48.0 m-80 -87.7 -30.13 20.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.786 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.29 -144.99 16.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.612 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.748 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.43 152.64 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 111.082 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -88.09 57.9 4.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.845 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.74 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.7 m -49.13 -25.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.28 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.85 -20.11 60.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.125 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -130.32 21.39 5.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.42 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.068 HD22 HD11 ' A' ' 26' ' ' LEU . 17.6 mt -70.37 159.2 34.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.885 0.374 . . . . 0.0 111.053 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -85.25 142.86 38.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.085 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 47.5 Cg_exo -56.4 -18.86 26.44 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.673 2.248 . . . . 0.0 112.456 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -81.2 -58.81 2.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.917 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.068 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -71.76 -40.85 69.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.217 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.458 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -57.26 -34.09 68.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.021 0.439 . . . . 0.0 110.124 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.6 t -64.23 -38.04 89.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.609 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 82' ' ' VAL . 1.3 tp -56.68 -58.26 8.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.279 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -51.11 -42.13 60.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.467 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.6 m -62.7 -56.3 18.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.713 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -25.5 64.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.763 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.98 -19.01 41.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.27 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.73 13.96 53.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.7 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.453 HD12 HD21 ' A' ' 85' ' ' LEU . 60.7 mt -87.26 122.15 38.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.889 0.376 . . . . 0.0 111.152 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -87.73 159.13 18.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.864 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.74 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -53.15 -31.65 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.97 -41.92 68.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.8 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -77.5 -34.59 54.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.683 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.497 HD23 HD13 ' A' ' 49' ' ' ILE . 82.0 mt -70.55 -22.72 62.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.979 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 37' ' ' GLU . 34.8 p -97.03 -5.01 38.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.739 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.37 124.34 29.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.829 0.347 . . . . 0.0 110.78 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.47 -36.71 45.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.635 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -72.08 -59.7 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.815 0.34 . . . . 0.0 111.43 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.42 -32.45 73.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.011 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 91.6 p -58.34 -41.18 84.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.36 . . . . 0.0 110.36 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 4.2 tptm -61.3 -53.02 62.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.473 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.751 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -67.42 -31.46 71.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.25 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.497 HD13 HD23 ' A' ' 40' ' ' LEU . 55.7 mt -68.2 -65.09 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.535 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.564 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.0 OUTLIER -54.89 -36.0 64.68 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.904 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -56.31 -34.05 66.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.389 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.531 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.7 t80 -64.46 -35.09 79.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.158 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.836 HG23 HG21 ' A' ' 62' ' ' VAL . 28.1 mt -62.77 -27.37 42.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.132 178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.64 -33.34 68.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.53 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -73.27 -26.29 61.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.453 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.42 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 12.6 mm100 -85.0 3.49 38.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.379 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 103.47 19.62 12.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.431 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.407 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 82.86 167.77 41.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.486 ' CD1' HD22 ' A' ' 26' ' ' LEU . 28.2 tp -49.3 -37.54 24.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.47 -34.08 77.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.208 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.422 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.16 -35.43 66.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.379 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.836 HG21 HG23 ' A' ' 53' ' ' ILE . 45.5 t -65.71 -54.75 24.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.366 . . . . 0.0 110.815 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -53.62 -46.75 70.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.077 0.465 . . . . 0.0 110.087 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -63.09 -50.03 72.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.818 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 9.8 pt-20 -69.53 -37.52 77.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.323 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.422 . . . . 0.0 110.423 179.156 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 5.9 t . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.822 0.344 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.63 -43.8 66.4 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.029 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 87' ' ' HIS . . . -65.38 -48.1 74.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.341 . . . . 0.0 110.783 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.453 HD21 HD12 ' A' ' 35' ' ' ILE . 13.2 tp -54.41 -46.04 73.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.33 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -35.39 61.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.276 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 3.3 t60 -68.81 -32.19 71.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.167 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.751 HG12 HD13 ' A' ' 48' ' ' LEU . 58.4 t -69.62 -42.19 80.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.564 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.0 mmt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.11 178.611 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.762 0.315 . . . . 0.0 110.342 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -88.36 139.61 30.17 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.775 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.94 -37.16 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.652 2.235 . . . . 0.0 112.568 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -88.94 -41.1 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -87.15 -27.21 23.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.15 -144.26 17.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.459 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.45 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.57 138.92 35.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 110.804 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.69 64.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.123 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.573 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -52.44 -25.62 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.21 -19.56 61.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -130.1 20.52 5.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.466 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.034 HD22 HD11 ' A' ' 26' ' ' LEU . 18.3 mt -70.46 159.21 34.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.369 . . . . 0.0 111.17 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.08 142.05 38.14 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.01 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 46.3 Cg_exo -55.75 -19.74 25.75 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.604 2.203 . . . . 0.0 112.543 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.453 ' CB ' ' HA ' ' A' ' 63' ' ' ARG . 13.8 m-20 -82.17 -57.43 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.034 HD11 HD22 ' A' ' 22' ' ' LEU . 3.8 pp -70.48 -32.75 70.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.235 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.495 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -64.96 -34.85 79.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 0.0 110.203 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -36.25 82.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.518 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.522 HD21 HD22 ' A' ' 85' ' ' LEU . 7.3 tp -56.13 -58.58 7.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.316 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.505 ' CG ' HD21 ' A' ' 40' ' ' LEU . 20.9 m-85 -50.27 -40.83 49.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.739 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m -62.7 -54.97 31.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.789 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.617 ' HB3' HG11 ' A' ' 82' ' ' VAL . 8.6 mtt85 -58.39 -29.38 65.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.792 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.35 -21.05 36.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.184 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.34 17.75 41.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.557 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.438 HD12 HD21 ' A' ' 85' ' ' LEU . 66.5 mt -87.07 118.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.228 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.1 p -88.07 160.58 17.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 41' ' ' THR . 30.4 mp0 -51.9 -28.42 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.067 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.97 -44.56 70.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.662 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.467 ' HB3' HG21 ' A' ' 45' ' ' THR . 53.0 mt-30 -79.15 -31.88 44.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.731 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.505 HD21 ' CG ' ' A' ' 30' ' ' PHE . 91.6 mt -70.24 -27.89 64.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.636 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 37' ' ' GLU . 30.3 p -97.71 -3.41 39.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.512 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -81.62 119.87 24.35 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.83 0.348 . . . . 0.0 110.625 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.08 -35.21 24.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.454 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -72.61 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.454 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.483 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.6 -37.05 81.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.223 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.3 p -55.69 -40.37 72.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 110.286 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -60.46 -55.84 28.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.191 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.512 HD13 HG12 ' A' ' 88' ' ' VAL . 1.4 pp -65.48 -30.79 71.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.521 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 45' ' ' THR . 54.3 mt -67.62 -63.92 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.447 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.5 p90 -52.29 -36.15 52.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.934 0.397 . . . . 0.0 110.376 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.92 -33.28 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.472 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 79.2 t80 -64.63 -41.92 95.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.241 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 62' ' ' VAL . 43.3 mt -55.69 -29.66 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.331 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.91 -36.32 75.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.746 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -71.01 -26.42 63.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.617 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 17.0 mm100 -86.11 9.77 16.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.475 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.42 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.73 17.96 26.74 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.594 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 83.79 169.93 45.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.823 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 14.4 tp -48.87 -42.14 35.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.726 0.298 . . . . 0.0 111.016 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -63.6 -35.24 79.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.21 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.42 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -34.25 66.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.484 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 53' ' ' ILE . 21.7 t -66.76 -63.35 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.208 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.453 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -51.85 -41.14 61.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.016 0.436 . . . . 0.0 110.233 178.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -63.14 -52.99 60.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.278 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 20.2 pt-20 -70.78 -29.0 65.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.859 0.361 . . . . 0.0 111.138 -179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.404 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 1.2 mmt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.695 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.617 HG11 ' HB3' ' A' ' 32' ' ' ARG . 6.0 t . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 120.79 0.328 . . . . 0.0 111.378 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.39 -43.9 67.67 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.554 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.41 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.87 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.522 HD22 HD21 ' A' ' 29' ' ' LEU . 15.7 tp -55.97 -47.17 78.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.892 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.4 mtm -53.41 -28.84 31.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -41.88 25.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 48' ' ' LEU . 48.7 t -58.25 -42.36 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 110.318 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 38.8 mmm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.306 178.653 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.858 0.361 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.7 31.26 45.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.491 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.442 ' CD1' ' O ' ' A' ' 3' ' ' PHE . 9.3 p90 -87.21 141.98 28.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.344 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' HE2' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -87.54 153.17 21.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.902 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.463 ' CD2' ' N ' ' A' ' 5' ' ' HIS . 1.6 p80 -128.07 123.74 35.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.441 HG22 ' HE2' ' A' ' 4' ' ' LYS . 4.0 t -105.17 131.53 54.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.168 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -90.28 130.14 36.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.716 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.616 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.2 t-80 -74.05 78.73 1.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.66 -48.08 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.582 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.07 36.19 72.01 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.038 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -88.74 153.43 21.1 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.19 137.94 27.58 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.657 0.265 . . . . 0.0 110.747 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.67 -26.48 3.79 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.688 2.259 . . . . 0.0 112.351 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -95.38 -41.39 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -88.87 -26.26 21.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.902 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.95 -148.81 19.03 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.443 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.411 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -81.94 146.84 29.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 110.706 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -81.77 57.32 3.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.987 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.595 HG12 HD13 ' A' ' 40' ' ' LEU . 2.9 m -48.32 -26.02 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.243 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -72.01 -22.28 61.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.121 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -130.69 21.11 5.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.456 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.925 HD22 HD11 ' A' ' 26' ' ' LEU . 16.7 mt -70.25 159.47 33.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.83 0.348 . . . . 0.0 111.082 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 11.9 t70 -83.47 139.76 41.45 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.816 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.489 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 45.4 Cg_exo -55.97 -18.27 21.93 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.479 2.119 . . . . 0.0 112.62 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 1.2 m-20 -80.87 -58.94 2.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.941 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.925 HD11 HD22 ' A' ' 22' ' ' LEU . 3.9 pp -71.68 -39.06 70.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.248 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.494 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -61.63 -36.03 79.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.855 0.359 . . . . 0.0 110.499 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.3 t -63.85 -36.27 83.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.587 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 82' ' ' VAL . 17.6 tp -57.16 -58.04 9.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.59 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.625 ' HZ ' HD11 ' A' ' 53' ' ' ILE . 9.8 m-85 -50.27 -41.83 51.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.731 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.53 -49.12 78.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.561 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.507 ' HB3' HG11 ' A' ' 82' ' ' VAL . 8.5 mtt85 -58.25 -32.57 68.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.619 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.66 4.81 23.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.74 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.49 17.08 78.87 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.821 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.533 HD12 HD21 ' A' ' 85' ' ' LEU . 52.8 mt -86.79 120.25 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.804 0.335 . . . . 0.0 111.056 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.8 p -86.92 157.26 19.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.988 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.514 ' O ' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -52.99 -34.04 54.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.07 -36.13 62.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.713 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 45' ' ' THR . 1.6 mt-30 -78.58 -35.27 46.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.519 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.595 HD13 HG12 ' A' ' 19' ' ' VAL . 78.1 mt -70.35 -24.46 62.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.734 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 37' ' ' GLU . 44.7 p -96.08 -7.98 34.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.542 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' CB ' ' A' ' 46' ' ' SER . 5.8 t70 -81.49 123.31 28.51 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.687 0.28 . . . . 0.0 110.674 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.24 -37.21 45.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.631 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.25 -60.04 2.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.817 0.342 . . . . 0.0 111.534 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.638 HG22 HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -66.82 -29.7 69.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.956 -179.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 57.7 p -59.56 -43.66 93.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.441 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 7.4 tptt -60.29 -52.83 63.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.56 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.534 ' C ' HD12 ' A' ' 48' ' ' LEU . 1.9 pp -65.83 -33.04 74.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.483 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.638 HD11 HG22 ' A' ' 45' ' ' THR . 59.4 mt -68.82 -64.33 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 1.9 p90 -52.53 -36.59 55.79 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.48 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -55.62 -32.51 63.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.519 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.726 ' HD1' HG21 ' A' ' 88' ' ' VAL . 67.3 t80 -64.88 -41.79 95.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.116 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.975 HG23 HG21 ' A' ' 62' ' ' VAL . 22.0 mt -54.72 -27.77 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.365 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -72.65 -36.16 67.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.592 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.475 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -72.56 -25.45 61.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.609 179.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.453 ' HG3' ' CE2' ' A' ' 52' ' ' PHE . 83.3 mm-40 -85.54 9.31 16.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.466 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.29 16.46 32.27 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.563 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.37 171.36 47.47 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.921 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 8' ' ' HIS . 8.3 tp -48.82 -42.29 35.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.805 0.336 . . . . 0.0 110.988 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 15.0 mm-40 -63.62 -34.47 77.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.034 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.28 -32.73 64.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.348 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.975 HG21 HG23 ' A' ' 53' ' ' ILE . 38.6 t -65.75 -63.61 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.917 0.389 . . . . 0.0 110.622 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -54.06 -38.23 65.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.05 0.452 . . . . 0.0 109.986 177.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.415 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 58.1 mt-30 -64.59 -52.63 56.57 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.768 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.767 ' CD ' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -68.05 -31.19 70.68 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.169 -177.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.424 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 1.3 mmt -58.65 -33.13 69.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.094 0.473 . . . . 0.0 109.873 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -40.78 40.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.592 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -72.79 -25.67 61.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.11 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.418 ' NE2' ' OE1' ' A' ' 65' ' ' GLU . 36.6 mt-30 -90.58 18.24 6.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.357 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -115.93 18.53 14.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.409 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.71 -52.73 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.448 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 39.9 t -68.26 129.07 38.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 0.0 110.754 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.04 125.22 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.261 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.24 -108.65 1.05 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.272 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.7 t 179.23 -36.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.917 0.389 . . . . 0.0 110.714 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.402 ' O ' ' NE2' ' A' ' 76' ' ' GLN . 1.9 pm0 -74.74 134.95 41.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.189 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.5 122.53 32.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.483 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.424 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 11.0 p 168.88 -40.31 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.282 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -71.24 83.7 0.75 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.173 0.511 . . . . 0.0 110.542 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.25 -99.47 0.15 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.619 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.767 HD13 ' CD ' ' A' ' 65' ' ' GLU . 2.1 pt? -58.1 -34.22 69.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.776 0.322 . . . . 0.0 111.221 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 29' ' ' LEU . 23.3 t -60.52 -30.56 46.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.631 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.88 -39.15 85.62 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.569 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.95 -55.36 17.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.0 110.602 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.533 HD21 HD12 ' A' ' 35' ' ' ILE . 20.0 tp -52.83 -39.09 62.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.578 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 25.9 mtt -53.59 -34.28 57.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.224 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -77.1 -44.59 29.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.359 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.726 HG21 ' HD1' ' A' ' 52' ' ' PHE . 53.4 t -53.85 -38.05 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.635 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 95.7 mmm -63.01 -28.91 70.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.272 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -77.03 -5.53 49.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.393 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -70.39 -11.69 61.08 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.475 0.178 . . . . 0.0 111.241 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.688 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 12.0 mmm180 -74.75 -24.94 58.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.651 0.262 . . . . 0.0 110.742 178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' A' ' 92' ' ' ARG . 0.3 OUTLIER 82.1 -41.01 0.12 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.352 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -151.33 20.69 0.74 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 92' ' ' ARG . . . -70.76 114.35 8.75 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.269 0.557 . . . . 0.0 111.246 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 96' ' ' ILE . 10.3 tt -132.58 112.32 18.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.086 177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.423 ' O ' ' CG ' ' A' ' 97' ' ' HIS . 56.4 p-80 -67.72 72.0 0.15 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.192 0.52 . . . . 0.0 110.416 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' ILE . 1.1 t -123.35 170.97 9.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.655 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.3 p -122.46 127.46 49.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.004 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.52 99.17 11.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -20.01 20.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.188 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 172.37 47.95 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.411 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.42 172.5 6.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.827 0.346 . . . . 0.0 110.784 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -168.03 104.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -40.63 89.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.977 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.1 141.4 34.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.024 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.469 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.785 0.326 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.45 -22.17 29.24 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.545 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -117.9 132.57 56.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.316 . . . . 0.0 110.884 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 121.7 29.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.941 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -120.33 103.36 9.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.795 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.8 t -80.15 115.8 23.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.271 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.1 m -91.26 152.6 20.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.628 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -106.0 93.54 4.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.125 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.0 t -68.39 -50.5 56.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.673 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.08 32.49 35.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.981 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.483 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -88.75 153.43 21.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.707 0.289 . . . . 0.0 110.299 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.39 138.59 28.49 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.558 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.29 -43.74 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.593 2.195 . . . . 0.0 112.274 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -81.9 -39.86 23.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.916 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -87.38 -30.96 20.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.028 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.65 -149.55 18.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.678 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.639 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.69 136.66 35.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.815 0.341 . . . . 0.0 110.981 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -77.94 65.65 3.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.981 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.808 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.7 m -51.85 -23.47 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.237 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -72.3 -22.93 61.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.029 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -128.97 19.34 6.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.529 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.896 HD22 HD11 ' A' ' 26' ' ' LEU . 17.1 mt -70.38 159.7 33.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.881 0.372 . . . . 0.0 111.174 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -83.18 138.87 42.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.803 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.508 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 48.4 Cg_exo -55.79 -18.35 21.16 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.54 2.16 . . . . 0.0 112.587 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -81.2 -58.11 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.216 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.896 HD11 HD22 ' A' ' 22' ' ' LEU . 3.5 pp -70.64 -42.25 71.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.233 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.508 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -54.96 -38.39 67.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.915 0.388 . . . . 0.0 110.467 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -37.97 89.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.85 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.494 HD12 HG22 ' A' ' 82' ' ' VAL . 22.7 tp -56.03 -55.62 30.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.747 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.679 ' CD2' HD21 ' A' ' 40' ' ' LEU . 10.9 m-30 -50.32 -47.47 55.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.599 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -62.12 -52.58 63.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.472 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.55 ' HB3' HG11 ' A' ' 82' ' ' VAL . 74.4 mtt-85 -53.27 -31.95 46.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.525 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.45 -20.64 39.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.034 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.44 11.2 34.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.938 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.561 HD12 HD21 ' A' ' 85' ' ' LEU . 31.8 mt -86.9 120.0 35.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.793 0.33 . . . . 0.0 111.255 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 p -86.91 160.39 18.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.658 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.808 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -51.93 -25.8 8.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.709 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.94 -45.17 74.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.458 ' NE2' HG23 ' A' ' 35' ' ' ILE . 22.6 mt-30 -78.39 -29.22 47.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.761 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.679 HD21 ' CD2' ' A' ' 30' ' ' PHE . 88.4 mt -70.39 -26.83 63.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.52 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 37' ' ' GLU . 33.0 p -96.63 -3.93 41.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.531 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' O ' ' CB ' ' A' ' 46' ' ' SER . 15.3 t0 -82.73 124.37 30.17 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 120.776 0.322 . . . . 0.0 110.782 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.52 -40.19 59.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.42 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -72.69 -58.99 2.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.658 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.446 HG22 HD11 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -66.13 -33.62 76.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.337 -178.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 88.1 p -58.71 -39.32 80.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.84 0.352 . . . . 0.0 110.456 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.478 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -62.53 -54.96 32.09 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.555 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.662 HD13 HG12 ' A' ' 88' ' ' VAL . 1.9 pp -63.25 -31.06 72.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.053 -178.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 45' ' ' THR . 57.6 mt -69.7 -64.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.418 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.483 ' CE1' ' CZ2' ' A' ' 11' ' ' TRP . 1.9 p90 -53.99 -39.87 66.44 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.167 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.4 ' OD1' ' CZ ' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -55.86 -33.66 64.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.745 178.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.72 ' HD2' HG21 ' A' ' 88' ' ' VAL . 26.4 t80 -64.65 -31.79 73.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 110.053 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.943 HG23 HG21 ' A' ' 62' ' ' VAL . 31.4 mt -61.72 -29.56 46.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.118 178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -41.3 79.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.301 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 52' ' ' PHE . 1.1 p30 -65.75 -26.84 67.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.442 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 13.3 mm100 -86.2 11.38 12.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.525 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 95.42 18.96 31.47 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.503 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.19 168.24 39.66 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.626 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.516 ' CD1' HD22 ' A' ' 26' ' ' LEU . 34.9 tp -49.18 -38.08 24.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -64.46 -35.99 82.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.076 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 56' ' ' GLN . . . -73.09 -34.61 66.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.497 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.943 HG21 HG23 ' A' ' 53' ' ' ILE . 22.0 t -65.78 -52.37 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.701 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -53.63 -44.88 69.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.115 0.483 . . . . 0.0 110.046 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -62.52 -50.89 69.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.691 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 22.3 pt-20 -68.89 -30.77 69.33 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.715 0.293 . . . . 0.0 111.027 -178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.624 ' HE3' HD11 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -68.4 -27.6 66.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.559 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.22 -43.46 33.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -32.58 68.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.845 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 77' ' ' SER . 0.5 OUTLIER -86.4 -21.7 26.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.05 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -137.96 67.88 0.52 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.446 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.47 -83.18 1.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.569 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 67.4 m -51.71 166.62 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 111.001 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.42 111.22 4.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.442 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 120.41 -43.93 1.46 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.401 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.0 m -84.37 61.71 6.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.813 0.339 . . . . 0.0 110.863 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -74.48 145.05 43.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.419 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 13.7 m -122.35 90.51 3.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.414 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -89.18 -18.02 27.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.881 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -73.59 95.96 2.38 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.057 0.456 . . . . 0.0 110.785 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.21 -94.71 0.15 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.856 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.624 HD11 ' HE3' ' A' ' 66' ' ' MET . 2.7 pt? -63.37 -41.31 98.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.798 0.332 . . . . 0.0 111.203 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.55 HG11 ' HB3' ' A' ' 32' ' ' ARG . 6.2 t -64.47 -31.28 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.203 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.09 -38.76 73.51 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.621 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.22 -51.7 62.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 110.951 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.561 HD21 HD12 ' A' ' 35' ' ' ILE . 45.8 tp -52.47 -46.3 66.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.701 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 39.9 mtm -52.99 -42.34 65.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.327 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -32.48 73.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.347 178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.72 HG21 ' HD2' ' A' ' 52' ' ' PHE . 51.2 t -72.62 -38.29 58.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.587 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 49.1 mmm -63.49 -32.79 74.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.532 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -57.39 -17.36 12.34 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.973 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.75 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 2.2 tptp -68.98 -33.04 73.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.045 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.441 ' HG2' ' CD2' ' A' ' 48' ' ' LEU . 15.2 mmm-85 -71.82 -20.16 61.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.003 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.456 ' CB ' ' HD2' ' A' ' 94' ' ' ARG . 49.9 m -75.95 -31.2 58.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.107 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.456 ' HD2' ' CB ' ' A' ' 93' ' ' SER . 5.7 mpt_? -133.75 28.54 3.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.75 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -73.46 173.76 9.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.424 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.514 HG22 ' HB3' ' A' ' 98' ' ' SER . 15.5 mm -76.23 106.83 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.237 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -47.1 -39.04 12.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.83 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.514 ' HB3' HG22 ' A' ' 96' ' ' ILE . 1.5 p 44.14 38.57 2.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.159 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 m -170.03 95.32 0.26 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.795 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.87 -177.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -144.41 -43.37 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.017 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.21 103.64 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.679 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.92 124.17 24.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.746 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 40.44 95.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.632 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -46.66 108.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.313 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.24 125.67 30.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.039 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.401 -1.222 . . . . 0.0 112.475 -179.921 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.872 0.368 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.39 -22.16 38.67 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.507 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -118.59 143.66 46.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.765 0.317 . . . . 0.0 110.96 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -87.58 152.98 21.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.958 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -88.3 69.86 9.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.937 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.7 t -111.69 140.32 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.51 141.54 28.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.598 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -134.75 96.53 3.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.364 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG11 ' HB2' ' A' ' 50' ' ' TYR . 4.8 t -66.3 -38.93 82.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.001 0.429 . . . . 0.0 110.536 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.59 29.37 72.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.959 -0.639 . . . . 0.0 113.121 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.554 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.48 153.26 20.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.715 0.293 . . . . 0.0 110.312 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -90.19 140.56 27.29 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.743 0.306 . . . . 0.0 110.604 179.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -79.69 -24.73 5.91 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.683 2.255 . . . . 0.0 112.479 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -102.31 -40.24 6.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.055 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -87.58 -21.14 25.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.155 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 95.58 -142.62 16.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.319 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -82.14 -174.34 5.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 0.0 110.866 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.85 57.22 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.332 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.794 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.5 m -47.87 -25.8 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.402 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -70.4 -22.07 62.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.031 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -134.95 23.61 3.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.596 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.033 HD22 HD11 ' A' ' 26' ' ' LEU . 17.7 mt -69.69 159.94 32.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.933 0.397 . . . . 0.0 111.12 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.51 138.89 44.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.766 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.452 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 46.2 Cg_exo -55.66 -18.08 19.61 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.587 2.192 . . . . 0.0 112.519 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -80.34 -58.08 3.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.097 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.033 HD11 HD22 ' A' ' 22' ' ' LEU . 2.3 pp -71.45 -41.58 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.299 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.452 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -51.9 -40.74 61.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 -179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.427 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -64.74 -37.63 88.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.901 HD12 HG22 ' A' ' 82' ' ' VAL . 6.1 tp -56.74 -57.16 13.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.979 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.483 ' HZ ' HD11 ' A' ' 53' ' ' ILE . 15.6 m-85 -52.24 -41.88 63.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.8 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -53.97 50.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.903 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.623 ' HB3' HG11 ' A' ' 82' ' ' VAL . 12.6 mtt85 -54.11 -32.12 54.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.44 7.72 15.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.836 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.54 8.99 84.62 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.554 -0.831 . . . . 0.0 113.032 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.45 HD11 ' CG ' ' A' ' 89' ' ' MET . 61.0 mt -86.15 112.88 23.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.869 0.366 . . . . 0.0 111.1 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.16 166.19 15.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.875 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.794 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -53.38 -29.77 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.09 -42.6 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.75 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -77.91 -29.7 50.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.616 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' CD1' ' CG1' ' A' ' 19' ' ' VAL . 53.9 mt -70.85 -25.3 62.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 37' ' ' GLU . 28.3 p -96.65 -5.72 38.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.706 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.26 119.23 23.84 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.878 0.371 . . . . 0.0 110.821 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.79 -34.81 28.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.358 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -71.99 -58.86 3.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.178 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.431 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.2 -30.56 71.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.822 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.8 p -59.36 -43.49 92.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.546 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 1.5 tptm -61.0 -51.71 68.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.593 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.691 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -67.09 -34.45 77.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.678 0.275 . . . . 0.0 111.197 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.56 HD11 ' HE3' ' A' ' 89' ' ' MET . 44.5 mt -68.65 -64.36 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.843 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.554 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 0.9 OUTLIER -53.72 -35.33 61.07 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.234 -178.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 1.0 OUTLIER -54.05 -34.59 60.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.178 178.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.544 ' HD2' HG21 ' A' ' 88' ' ' VAL . 57.0 t80 -64.54 -44.21 91.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.043 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.529 HG23 HG21 ' A' ' 62' ' ' VAL . 23.8 mt -53.31 -25.18 9.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.336 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.49 -35.94 53.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.877 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 52' ' ' PHE . 0.9 OUTLIER -72.23 -25.21 61.55 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.944 0.402 . . . . 0.0 110.769 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 27.9 mm-40 -86.04 11.58 11.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.494 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.92 19.26 27.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.491 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.32 167.65 38.76 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.648 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.489 ' CD1' HD22 ' A' ' 26' ' ' LEU . 25.4 tp -48.67 -37.01 17.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.835 0.35 . . . . 0.0 111.088 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -64.99 -37.57 88.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.142 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.432 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.65 -33.32 66.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.49 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 53' ' ' ILE . 60.3 t -65.97 -52.24 51.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.871 0.367 . . . . 0.0 110.581 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.41 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 25.7 mtp180 -53.89 -44.68 70.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.18 0.515 . . . . 0.0 109.934 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -48.65 78.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.918 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 13.4 pt-20 -69.09 -41.66 77.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.687 0.279 . . . . 0.0 111.307 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.3 mmt -61.98 -30.46 70.95 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.922 0.391 . . . . 0.0 110.683 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.41 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 4.2 mmt180 -77.73 -41.41 37.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.448 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 mtp85 -69.69 -31.29 69.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.953 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.416 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -71.05 -6.58 40.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.808 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -89.69 82.02 1.43 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.403 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -143.97 18.81 2.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.661 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.2 p 51.8 176.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.897 0.38 . . . . 0.0 111.045 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 73.27 -159.41 53.35 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.719 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.42 151.92 31.06 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.582 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.8 t 53.3 48.46 21.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.369 . . . . 0.0 110.888 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.13 162.43 28.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.08 162.93 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.036 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.409 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.9 m 77.85 -57.32 0.49 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.998 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -74.44 87.85 2.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.915 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.36 -89.69 0.11 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.39 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.556 ' CD1' HD13 ' A' ' 29' ' ' LEU . 2.6 pt? -61.09 -39.32 89.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.849 0.357 . . . . 0.0 110.812 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.901 HG22 HD12 ' A' ' 29' ' ' LEU . 28.2 t -62.52 -25.35 37.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.878 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.75 -39.04 86.22 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.483 -0.865 . . . . 0.0 111.959 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.74 -49.66 67.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.96 0.409 . . . . 0.0 110.591 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.7 tp -55.93 -45.51 78.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.537 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.0 mtm -53.2 -39.57 63.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.15 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -62.92 -41.95 99.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.039 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.691 HG12 HD13 ' A' ' 48' ' ' LEU . 65.8 t -57.55 -36.47 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.488 178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.623 ' HE1' HD11 ' A' ' 48' ' ' LEU . 15.8 mmt -65.26 -27.03 68.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.69 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -69.88 -11.89 61.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.668 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -70.31 -36.8 74.52 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.939 0.399 . . . . 0.0 110.689 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.465 ' HG2' HD22 ' A' ' 48' ' ' LEU . 5.3 mmp_? -74.43 -22.07 59.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.78 178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.0 t -75.68 -31.3 59.67 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.074 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -92.74 -5.49 51.12 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.665 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.6 174.36 9.15 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.05 0.453 . . . . 0.0 111.297 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 98' ' ' SER . 39.3 mm -70.42 107.91 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.221 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -67.04 66.81 0.06 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.925 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -96.19 150.12 20.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.185 -177.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.3 t 61.03 -82.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.015 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -154.42 116.14 4.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.93 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.4 pm0 -62.24 -22.27 65.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.042 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 152.86 122.67 0.93 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.502 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -96.43 135.16 38.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.895 0.379 . . . . 0.0 110.836 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -167.75 133.15 1.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.834 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -101.43 160.94 14.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.807 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.27 132.39 35.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.154 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.356 -1.247 . . . . 0.0 112.472 179.893 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.803 0.335 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.82 20.73 23.26 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.536 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 3' ' ' PHE . 27.5 p90 -122.89 128.08 49.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.862 0.363 . . . . 0.0 110.843 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.4 164.89 15.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.042 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -143.8 68.03 1.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.874 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 t -75.55 145.52 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.191 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.6 m 59.88 176.53 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -145.4 62.47 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.224 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 9' ' ' VAL . 1.9 t -72.14 -46.68 57.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.075 0.464 . . . . 0.0 110.378 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 43.3 57.49 4.29 Favored Glycine 0 CA--C 1.518 0.233 0 CA-C-N 115.693 -0.685 . . . . 0.0 113.395 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.37 152.73 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 0.0 110.256 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -91.96 134.48 28.71 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.626 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.41 -30.16 62.63 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.468 2.112 . . . . 0.0 112.56 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -105.24 -39.53 6.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.73 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -85.67 -9.8 56.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 82.1 -139.06 19.46 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.405 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 50' ' ' TYR . 0.3 OUTLIER -80.94 -169.37 2.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.964 0.411 . . . . 0.0 110.865 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -117.74 52.81 0.97 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.412 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.769 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.8 m -46.98 -26.36 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.494 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -70.24 -23.23 62.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.085 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -134.75 25.55 3.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.61 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.043 HD22 HD11 ' A' ' 26' ' ' LEU . 17.7 mt -69.99 159.59 33.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.911 0.386 . . . . 0.0 111.271 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -83.72 139.73 40.71 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.767 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.491 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 44.3 Cg_exo -55.41 -18.68 19.94 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.506 2.137 . . . . 0.0 112.461 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -81.09 -57.67 3.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.123 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.043 HD11 HD22 ' A' ' 22' ' ' LEU . 3.6 pp -70.63 -41.85 71.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.143 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.491 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -57.11 -37.35 71.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 110.471 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.411 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 34.0 t -63.44 -37.03 85.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.714 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.726 HD12 HG22 ' A' ' 82' ' ' VAL . 38.3 tp -56.92 -53.59 56.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.689 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.469 ' CD2' HD11 ' A' ' 40' ' ' LEU . 17.7 m-85 -51.99 -43.44 63.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.574 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -61.74 -53.59 53.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.769 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.466 ' HB3' HG11 ' A' ' 82' ' ' VAL . 32.8 mtt180 -57.96 -30.57 66.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.833 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.11 -22.49 36.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.174 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.6 13.02 39.29 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.806 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.525 HD12 HD21 ' A' ' 85' ' ' LEU . 72.8 mt -86.53 118.67 33.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.803 0.335 . . . . 0.0 111.132 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -87.19 162.78 17.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.87 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.769 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -53.14 -30.04 34.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.86 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.63 -41.15 69.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.845 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -78.03 -30.44 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.72 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.469 HD11 ' CD2' ' A' ' 30' ' ' PHE . 51.5 mt -71.48 -27.79 63.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.729 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 37' ' ' GLU . 10.7 p -97.4 -1.53 44.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.714 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 46' ' ' SER . 14.8 t70 -82.6 124.28 30.01 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.786 0.327 . . . . 0.0 110.905 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.18 -41.44 60.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.55 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -72.53 -57.79 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.641 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.581 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.67 -37.53 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.353 -178.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 91.5 p -56.3 -38.72 71.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.914 0.388 . . . . 0.0 110.279 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -62.19 -55.46 28.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.391 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.787 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.1 -31.98 73.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.301 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.581 HD11 HG22 ' A' ' 45' ' ' THR . 59.8 mt -67.78 -64.11 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.633 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.504 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 1.5 p90 -54.33 -39.85 67.45 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.387 -178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -55.49 -32.88 63.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.786 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.635 ' CD1' HG21 ' A' ' 88' ' ' VAL . 85.5 t80 -63.43 -38.42 91.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.911 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.009 HG23 HG21 ' A' ' 62' ' ' VAL . 22.0 mt -58.89 -28.84 39.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.219 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.43 -38.2 80.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.636 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.482 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -66.01 -25.37 67.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.614 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.477 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -84.15 -8.17 59.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.202 178.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 112.39 21.3 6.24 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.007 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.93 171.6 47.99 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.826 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.464 HD13 HD22 ' A' ' 26' ' ' LEU . 8.7 tp -48.24 -40.38 24.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.824 0.345 . . . . 0.0 111.155 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -65.69 -35.02 79.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.432 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.83 -35.01 67.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.676 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 1.009 HG21 HG23 ' A' ' 53' ' ' ILE . 47.6 t -64.73 -62.1 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.769 0.319 . . . . 0.0 110.74 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.17 -36.2 39.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.208 0.527 . . . . 0.0 109.926 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -65.34 -51.83 57.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.881 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.463 ' HA ' ' CD ' ' A' ' 68' ' ' ARG . 16.7 pt-20 -68.17 -40.34 82.33 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.718 0.294 . . . . 0.0 111.359 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mmt -56.99 -27.3 61.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.962 0.41 . . . . 0.0 110.512 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -77.98 -43.37 29.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.577 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' CD ' ' HA ' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -68.54 -24.88 64.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.79 0.328 . . . . 0.0 110.706 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.498 ' OE1' HD22 ' A' ' 81' ' ' LEU . 14.7 mt-30 -82.78 -2.54 54.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.415 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -53.96 96.77 0.03 OUTLIER Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.492 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.5 -179.27 22.35 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 p -120.96 -41.53 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.329 . . . . 0.0 110.967 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 75' ' ' SER . . . -139.98 146.85 18.52 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.597 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.32 -82.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.607 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 73' ' ' GLY . 2.1 p -78.68 57.73 2.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.402 ' HG3' ' OG ' ' A' ' 78' ' ' SER . 4.9 pt20 -75.9 163.07 27.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.981 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 77.8 p -68.72 95.88 0.69 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.934 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.402 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 0.3 OUTLIER 166.97 -41.8 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.923 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.69 80.25 1.54 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.974 0.416 . . . . 0.0 110.666 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.96 -90.84 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.108 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.498 HD22 ' OE1' ' A' ' 69' ' ' GLN . 2.7 pt? -62.46 -38.79 91.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.78 0.324 . . . . 0.0 111.008 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.726 HG22 HD12 ' A' ' 29' ' ' LEU . 22.6 t -61.61 -28.07 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.05 -38.46 73.73 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.503 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB3' ' HZ ' ' A' ' 52' ' ' PHE . . . -64.56 -55.44 20.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.734 0.302 . . . . 0.0 111.008 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.525 HD21 HD12 ' A' ' 35' ' ' ILE . 12.4 tp -49.71 -41.17 42.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.791 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.4 mtm -54.19 -44.01 71.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -43.71 90.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.315 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.787 HG12 HD13 ' A' ' 48' ' ' LEU . 59.4 t -55.36 -41.76 63.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.64 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 84.0 mmm -63.79 -32.02 73.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.714 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -65.85 -13.29 59.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.367 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.0 tptt -70.5 -31.5 68.63 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.905 0.383 . . . . 0.0 110.652 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.458 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 14.1 mmm-85 -74.71 -21.81 59.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.842 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.4 t -74.92 -25.43 58.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.826 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -108.37 -17.56 13.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.316 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.28 117.41 16.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.998 0.427 . . . . 0.0 111.111 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.525 ' O ' HG23 ' A' ' 96' ' ' ILE . 1.8 tp -123.01 106.58 17.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.667 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -42.47 -29.61 0.29 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.476 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.8 p -96.47 -162.93 1.0 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.749 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.3 t 60.58 123.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.055 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.3 t0 59.72 98.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -166.57 166.04 16.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -178.19 -169.23 38.76 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.576 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.45 175.95 5.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.787 0.327 . . . . 0.0 110.844 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.6 t70 42.13 95.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.63 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -102.57 19.65 18.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.224 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.87 101.68 10.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.792 0.329 . . . . 0.0 111.043 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.425 -1.208 . . . . 0.0 112.523 179.919 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.772 0.32 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.78 24.68 76.35 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.467 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -51.15 156.42 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.357 . . . . 0.0 110.911 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -87.41 145.1 26.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.127 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.41 71.84 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.749 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.7 t -82.51 138.4 19.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.2 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.9 m -90.66 -51.79 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 79.21 -53.36 0.44 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.567 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.1 t 70.23 -63.47 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.798 0.332 . . . . 0.0 110.737 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.74 27.1 5.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.113 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.38 152.76 21.33 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.878 0.339 . . . . 0.0 110.371 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 0.7 OUTLIER -92.39 135.24 26.95 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.735 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 20.5 Cg_exo -63.96 -45.89 9.54 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.486 2.124 . . . . 0.0 112.629 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -90.09 -38.24 13.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.839 -177.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -85.71 -21.04 28.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.192 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.55 -149.5 20.62 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.558 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.88 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.01 138.05 34.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.789 0.328 . . . . 0.0 111.028 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -78.2 67.33 3.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.745 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.783 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.4 m -51.64 -23.59 3.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.227 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.21 -20.2 60.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.122 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -130.29 20.27 5.29 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.603 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.977 HD22 HD11 ' A' ' 26' ' ' LEU . 18.9 mt -70.19 159.46 33.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 0.0 111.158 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.33 140.95 39.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.084 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 46.3 Cg_exo -56.12 -19.56 27.39 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.597 2.198 . . . . 0.0 112.512 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -81.4 -56.82 3.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.176 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.977 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -70.0 -42.02 73.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.23 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -54.53 -38.82 67.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.929 0.395 . . . . 0.0 110.123 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.5 t -63.1 -40.72 98.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.486 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.714 HD12 HG22 ' A' ' 82' ' ' VAL . 13.5 tp -57.11 -52.51 65.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.396 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.467 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 22.9 m-85 -53.45 -47.63 69.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.514 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.3 m -61.73 -51.51 68.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.831 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.604 ' HB3' HG11 ' A' ' 82' ' ' VAL . 13.8 mtt85 -57.08 -31.93 65.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.406 ' HB2' HG13 ' A' ' 82' ' ' VAL . . . -81.91 -10.91 59.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.477 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.63 13.54 55.07 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.77 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.455 HD12 HD21 ' A' ' 85' ' ' LEU . 64.1 mt -87.08 115.43 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.747 0.308 . . . . 0.0 111.29 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.3 p -87.26 160.76 18.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.72 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.783 ' HG2' HG21 ' A' ' 19' ' ' VAL . 1.1 mt-10 -52.55 -31.8 37.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.821 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.97 -42.47 72.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.643 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -78.09 -30.64 49.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.749 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 37' ' ' GLU . 73.4 mt -69.81 -26.71 64.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.547 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 37' ' ' GLU . 61.6 p -96.27 -3.06 44.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.64 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -81.94 116.13 21.43 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-O 120.786 0.327 . . . . 0.0 110.611 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.49 -35.09 8.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.569 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 66.1 tt0 -72.19 -59.11 2.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.276 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.405 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.87 -33.17 75.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.304 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.0 p -58.42 -42.03 86.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.794 0.33 . . . . 0.0 110.612 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.81 -53.39 56.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.712 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.862 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -64.89 -33.69 76.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.782 0.325 . . . . 0.0 110.908 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.467 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 75.1 mt -67.55 -63.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.23 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.1 p90 -52.26 -40.27 61.49 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.086 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.4 -36.55 64.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.821 178.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.522 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 78.6 t80 -63.46 -29.82 71.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.024 0.44 . . . . 0.0 110.33 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.933 HG23 ' CG2' ' A' ' 62' ' ' VAL . 92.8 mt -66.28 -27.26 40.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.088 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -71.46 -39.27 71.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.586 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.4 p30 -64.42 -25.29 67.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.559 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 8.5 mt-30 -84.73 -9.91 57.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.175 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.14 21.37 5.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.134 -179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.53 168.94 45.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.424 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.1 tp -48.23 -36.23 13.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.821 0.343 . . . . 0.0 111.106 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.12 -37.24 85.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.197 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.61 -34.66 67.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.561 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.933 ' CG2' HG23 ' A' ' 53' ' ' ILE . 61.5 t -65.48 -49.65 77.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.911 0.386 . . . . 0.0 110.615 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -54.51 -48.25 72.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.152 0.501 . . . . 0.0 110.035 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -64.32 -43.2 95.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.465 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 9.5 pt-20 -67.87 -37.51 81.9 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.721 0.296 . . . . 0.0 111.392 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.425 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 2.1 mmt -64.19 -24.12 67.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.801 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -55.95 4.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.665 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' HD3' ' HA ' ' A' ' 65' ' ' GLU . 1.1 ptm180 -70.53 -36.17 73.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.667 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.4 ' OE1' HD22 ' A' ' 81' ' ' LEU . 48.1 mt-30 -67.99 -9.86 48.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.472 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.418 ' CA ' ' HB2' ' A' ' 77' ' ' SER . . . -100.24 62.9 0.64 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.452 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -134.44 -176.44 14.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.633 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.7 t 64.09 125.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.796 0.332 . . . . 0.0 110.914 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.46 -110.95 3.6 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.395 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.72 34.8 5.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.387 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.06 55.08 10.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.97 0.414 . . . . 0.0 110.643 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -74.87 102.64 4.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.157 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.418 ' HB2' ' CA ' ' A' ' 70' ' ' GLY . 9.1 t -110.46 98.12 7.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.559 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.43 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 0.0 OUTLIER 175.11 -44.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.547 -179.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -71.87 67.51 0.61 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.155 0.503 . . . . 0.0 110.684 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.39 -91.01 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.966 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.536 ' HG ' HD13 ' A' ' 29' ' ' LEU . 2.7 pt? -62.18 -38.91 90.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 110.566 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.714 HG22 HD12 ' A' ' 29' ' ' LEU . 16.5 t -61.95 -26.15 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.682 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.94 -40.35 84.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.15 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.03 -43.31 95.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.907 0.384 . . . . 0.0 110.67 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.455 HD21 HD12 ' A' ' 35' ' ' ILE . 8.2 tp -55.74 -49.72 72.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.793 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.4 mtt -49.62 -28.21 5.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.858 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.81 -41.93 20.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.526 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.862 HG12 HD13 ' A' ' 48' ' ' LEU . 70.5 t -63.47 -42.0 94.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.028 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 79.1 mmm -64.94 -31.44 72.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.375 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -62.51 -18.57 62.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.475 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 5.9 tptt -69.97 -49.91 46.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.205 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.421 ' HG2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -72.06 -18.61 61.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.472 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.2 m -76.09 -30.18 58.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 0.0 110.991 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -121.46 4.13 10.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.887 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -74.77 147.7 41.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 111.074 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -59.65 102.09 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.138 0.494 . . . . 0.0 110.81 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.422 ' O ' HD13 ' A' ' 96' ' ' ILE . 65.8 m80 -51.83 123.6 10.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.866 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 97' ' ' HIS . 1.9 m 76.53 56.62 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.596 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 11.8 p -67.74 -173.94 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.823 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -154.36 150.58 28.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.797 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -124.09 32.24 5.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.73 18.48 78.89 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.637 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.02 108.03 17.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.831 0.348 . . . . 0.0 110.869 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 40.86 -164.71 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.639 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 69.47 114.71 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.905 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.23 126.9 32.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.039 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.345 -1.253 . . . . 0.0 112.432 -179.855 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.84 0.352 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.99 -20.16 39.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.607 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -129.33 123.31 31.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 0.0 110.96 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.78 101.0 13.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -104.64 100.06 9.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.56 113.96 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.984 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.4 p 59.81 176.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -166.8 59.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -72.74 -44.26 59.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.633 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.85 41.9 36.89 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.069 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.571 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -88.33 153.51 21.14 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 15' ' ' ASN . 1.3 m-20 -89.42 138.69 28.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.673 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.99 -27.74 3.62 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.611 2.207 . . . . 0.0 112.286 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -97.97 -39.26 9.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 26.3 m120 -87.92 -25.83 23.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.876 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.34 -149.68 19.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.628 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.632 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -82.46 148.17 28.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.0 110.943 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.95 63.47 8.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.818 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.6 m -50.9 -24.0 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.282 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.14 -21.0 60.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -132.3 23.49 4.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.529 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.003 HD22 HD11 ' A' ' 26' ' ' LEU . 18.4 mt -70.29 159.62 33.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.891 0.377 . . . . 0.0 111.029 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 10.5 t70 -83.22 140.33 42.33 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.864 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 45.1 Cg_exo -55.91 -18.3 21.67 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.608 2.205 . . . . 0.0 112.659 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.68 -58.14 3.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.049 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.003 HD11 HD22 ' A' ' 22' ' ' LEU . 3.3 pp -70.45 -40.3 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.094 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -51.99 -38.54 57.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.979 0.418 . . . . 0.0 110.198 179.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.441 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -64.54 -34.79 79.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.53 178.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.613 HD12 HG22 ' A' ' 82' ' ' VAL . 59.1 tp -56.76 -59.48 4.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.654 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.509 ' CG ' HD21 ' A' ' 40' ' ' LEU . 8.5 m-85 -51.2 -47.55 62.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.614 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.94 -54.85 36.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.873 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.461 ' HB3' HG11 ' A' ' 82' ' ' VAL . 58.8 mtt-85 -56.54 -29.82 62.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.95 -15.06 55.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.431 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.19 9.25 54.07 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.806 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.482 HD11 ' HG ' ' A' ' 85' ' ' LEU . 42.4 mt -86.7 120.52 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 0.0 111.218 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.2 p -87.14 161.52 18.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.821 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.818 ' HG2' HG21 ' A' ' 19' ' ' VAL . 2.7 tt0 -52.96 -31.47 40.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.847 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.89 -42.34 71.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.022 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -77.9 -30.73 50.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.509 HD21 ' CG ' ' A' ' 30' ' ' PHE . 96.0 mt -70.36 -25.06 63.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.726 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.3 p -96.22 -5.24 40.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.53 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.93 122.43 27.76 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 110.77 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.79 -37.93 45.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.52 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.471 ' CG ' ' CZ ' ' A' ' 92' ' ' ARG . 15.6 tp10 -71.72 -59.56 2.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.665 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -31.63 72.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.765 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 89.6 p -58.55 -44.22 89.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.357 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 7.8 tptt -59.87 -55.07 38.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.444 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.587 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -64.75 -32.91 74.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.504 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 69.7 mt -69.69 -64.17 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.493 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.646 ' HA ' HD12 ' A' ' 53' ' ' ILE . 1.6 p90 -52.75 -37.34 59.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.973 0.416 . . . . 0.0 110.06 -178.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.99 -31.64 61.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.413 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.465 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 66.1 t80 -64.49 -41.52 96.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.095 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.941 HG23 HG21 ' A' ' 62' ' ' VAL . 37.2 mt -54.46 -27.92 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.29 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -72.7 -38.51 67.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.698 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.465 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -69.05 -25.89 64.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.688 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 18.4 mm100 -85.19 9.09 16.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.402 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.52 19.59 24.79 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.415 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 82.26 168.87 42.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.818 -0.705 . . . . 0.0 112.588 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.1 tp -49.42 -39.63 33.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.691 0.282 . . . . 0.0 111.07 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -63.95 -36.37 83.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.032 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.43 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.05 -32.66 65.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.941 HG21 HG23 ' A' ' 53' ' ' ILE . 22.8 t -66.13 -52.86 43.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -54.15 -43.79 70.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.124 0.487 . . . . 0.0 110.127 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -63.32 -47.72 81.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.27 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 25.5 pt-20 -68.31 -40.43 81.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.693 0.282 . . . . 0.0 111.299 -177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.6 mmt -57.91 -34.27 69.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.137 0.494 . . . . 0.0 110.284 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -78.79 -33.49 46.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.282 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -69.64 -21.55 63.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.52 HE22 HD22 ' A' ' 81' ' ' LEU . 34.4 mt-30 -96.54 -0.88 48.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.803 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.14 92.41 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.324 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . -107.48 -20.31 8.68 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.672 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.88 -83.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.626 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . -93.4 100.96 2.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.183 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.21 128.92 1.16 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.001 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.19 52.92 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.99 0.424 . . . . 0.0 110.37 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -73.82 161.86 29.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.274 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 t -68.7 99.92 1.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.733 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.428 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.5 t 179.35 -48.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.158 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -73.94 84.64 1.74 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.08 0.467 . . . . 0.0 110.726 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.52 -91.46 0.1 Allowed Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.902 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.604 ' CD1' HD13 ' A' ' 29' ' ' LEU . 2.7 pt? -62.92 -40.02 96.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.907 0.384 . . . . 0.0 110.707 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.613 HG22 HD12 ' A' ' 29' ' ' LEU . 10.5 t -63.77 -26.43 40.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.097 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.02 -42.15 78.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.318 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.434 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.33 -46.2 84.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.373 . . . . 0.0 110.74 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.482 ' HG ' HD11 ' A' ' 35' ' ' ILE . 8.3 tp -52.72 -48.92 66.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.498 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 16.9 mtt -49.05 -44.05 41.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.659 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.04 -43.51 87.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.361 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.587 HG12 HD13 ' A' ' 48' ' ' LEU . 62.5 t -55.58 -42.94 70.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.464 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 82.2 mmm -63.79 -31.71 72.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.448 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -68.67 -15.73 63.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.008 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 3.3 tptp -70.3 -25.87 63.52 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.734 0.302 . . . . 0.0 110.646 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.514 ' HG2' HD22 ' A' ' 48' ' ' LEU . 9.3 mmm180 -73.92 -33.29 63.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.126 0.489 . . . . 0.0 110.112 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 t -75.15 -28.84 60.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.117 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -116.89 26.13 10.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.676 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -74.35 153.05 39.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.892 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 96' ' ' ILE . 2.0 tp -86.59 98.44 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.876 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.0 p-80 -46.24 92.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.044 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ILE . 1.2 p -125.57 26.16 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.006 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.56 173.7 11.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -154.7 -175.52 5.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.012 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 178.86 -36.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.53 168.51 21.05 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.527 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -95.85 107.91 20.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.754 0.312 . . . . 0.0 110.923 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t0 39.76 38.26 0.42 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.73 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -153.69 161.39 42.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.965 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.81 151.5 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.073 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.362 -1.244 . . . . 0.0 112.52 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.826 0.346 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.2 -24.14 23.49 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.477 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -118.46 158.51 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.969 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -87.11 111.45 20.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.802 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -88.42 75.65 8.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.111 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.6 HG11 ' HG2' ' A' ' 60' ' ' GLU . 21.5 t -79.94 139.18 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.825 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.8 m -91.61 173.12 8.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.434 0.635 . . . . 0.0 111.806 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.556 ' O ' HG22 ' A' ' 9' ' ' VAL . 2.8 t60 -93.45 -26.07 17.36 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.918 174.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.626 HG11 ' HB2' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -163.87 -70.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.437 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.92 28.89 12.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.848 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.95 152.38 21.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.802 0.334 . . . . 0.0 110.564 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -92.92 132.51 30.85 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.425 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 12' ' ' ASP . 24.4 Cg_exo -62.13 -31.59 83.08 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.452 2.101 . . . . 0.0 112.59 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -98.04 -41.22 8.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.668 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -86.44 -14.77 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.694 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 87.22 -140.74 17.07 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.216 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.441 ' HZ ' HD12 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -81.79 -169.12 2.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.984 0.421 . . . . 0.0 110.91 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -124.3 54.17 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.392 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.678 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.5 m -47.09 -26.33 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.384 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -70.2 -23.68 62.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.046 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -135.52 26.58 3.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.731 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.018 HD22 HD11 ' A' ' 26' ' ' LEU . 17.1 mt -69.65 159.36 33.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.816 0.341 . . . . 0.0 110.996 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -83.56 140.16 41.3 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.946 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.497 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 51.6 Cg_exo -54.84 -19.31 18.75 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.621 2.214 . . . . 0.0 112.51 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -81.19 -58.32 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.074 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.018 HD11 HD22 ' A' ' 22' ' ' LEU . 3.8 pp -71.44 -39.14 71.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.245 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.497 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -58.67 -35.57 72.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.383 . . . . 0.0 110.149 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.426 ' O ' ' CD ' ' A' ' 32' ' ' ARG . 25.8 t -63.75 -38.25 90.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.757 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.969 HD13 HD12 ' A' ' 81' ' ' LEU . 8.0 tp -54.86 -53.85 50.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.423 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.441 ' CD2' HD11 ' A' ' 40' ' ' LEU . 22.6 m-85 -51.35 -46.12 62.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.402 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 m -62.39 -48.03 81.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.736 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.693 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -62.05 -33.39 74.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.847 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.3 -21.55 36.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.18 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.91 16.77 32.25 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.703 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.9 mt -86.65 121.76 38.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.341 . . . . 0.0 111.14 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.4 p -87.02 159.13 19.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.678 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -53.03 -30.7 37.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.25 68.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.426 ' HB3' HG21 ' A' ' 45' ' ' THR . 33.3 mt-30 -78.47 -31.3 47.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.807 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.441 HD11 ' CD2' ' A' ' 30' ' ' PHE . 81.7 mt -70.71 -24.55 62.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.7 p -97.66 -7.75 30.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.602 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -82.02 116.45 21.63 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 120.809 0.338 . . . . 0.0 110.819 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.79 -32.05 8.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.4 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.53 -59.96 2.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 111.407 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.477 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.59 -33.79 75.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.969 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.9 m -59.41 -39.48 83.6 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.478 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 5.5 tptt -62.12 -49.17 76.96 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.433 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.507 ' CD1' HG12 ' A' ' 88' ' ' VAL . 1.5 pp -69.96 -34.36 73.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.748 0.309 . . . . 0.0 110.913 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 36.0 mt -67.89 -64.31 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.73 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.626 ' HB2' HG11 ' A' ' 9' ' ' VAL . 0.7 OUTLIER -52.42 -36.13 53.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.913 0.387 . . . . 0.0 110.384 -179.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -33.97 66.03 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.421 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.622 ' HD1' HG21 ' A' ' 88' ' ' VAL . 65.3 t80 -64.61 -40.12 94.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.327 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.931 HG23 ' CG2' ' A' ' 62' ' ' VAL . 23.2 mt -55.92 -29.92 27.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.042 0.449 . . . . 0.0 110.181 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.32 -43.21 78.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.631 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.449 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -59.86 -24.39 64.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.934 0.397 . . . . 0.0 110.484 179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.548 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 71.3 mm-40 -84.96 -13.91 49.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.159 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.9 24.83 3.81 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.817 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.449 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 83.24 168.79 43.83 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.38 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.457 ' HA ' HG21 ' A' ' 53' ' ' ILE . 10.5 tp -47.35 -33.88 6.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.903 0.383 . . . . 0.0 111.069 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.6 ' HG2' HG11 ' A' ' 6' ' ' VAL . 12.6 mt-10 -68.62 -35.82 77.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.001 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.548 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.95 -36.09 67.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.596 -178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.931 ' CG2' HG23 ' A' ' 53' ' ' ILE . 48.7 t -64.1 -63.92 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.277 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -30.17 40.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.526 ' HB2' ' HA ' ' A' ' 61' ' ' ALA . 9.0 mt-30 -63.17 -56.6 15.35 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.088 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 15.7 pt-20 -69.67 -38.36 77.02 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.628 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.401 ' HE3' ' HB3' ' A' ' 28' ' ' SER . 2.1 mmt -57.19 -37.38 72.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.059 0.457 . . . . 0.0 110.412 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -77.88 -37.0 49.12 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.081 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.9 mtm-85 -69.92 -22.83 63.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.125 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.604 HE22 HD23 ' A' ' 81' ' ' LEU . 14.8 pt20 -108.97 -16.94 14.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.536 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -51.81 -44.08 54.97 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.474 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 66.73 -146.16 47.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.345 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.78 179.24 9.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 0.0 110.932 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 54.79 40.33 71.3 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.429 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.52 46.81 83.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.448 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.5 m -109.03 44.68 1.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.302 . . . . 0.0 111.066 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.33 123.98 25.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.607 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 53.1 p -118.89 112.28 19.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.975 0.417 . . . . 0.0 111.442 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.725 ' HB2' HG21 ' A' ' 82' ' ' VAL . 57.0 p -89.0 -11.38 44.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.117 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' N ' ' OE1' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -70.94 63.57 0.31 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.187 0.518 . . . . 0.0 111.158 -178.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.86 -101.26 0.16 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.705 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.969 HD12 HD13 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -64.77 -30.72 71.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.766 0.317 . . . . 0.0 110.847 178.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.725 HG21 ' HB2' ' A' ' 78' ' ' SER . 3.3 t -65.76 -37.57 80.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.399 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.39 -43.28 70.59 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.416 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -65.13 -48.55 73.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.804 0.335 . . . . 0.0 110.906 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 14.8 tp -61.31 -40.73 95.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 7.0 mtm -53.28 -37.57 62.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.266 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -72.23 -44.08 63.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.407 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.622 HG21 ' HD1' ' A' ' 52' ' ' PHE . 59.1 t -53.92 -39.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.563 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 96.4 mmm -65.51 -29.44 70.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.914 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 86.0 mt-30 -66.05 -10.56 41.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.715 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 4.4 mptt -69.79 -38.39 76.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.947 0.403 . . . . 0.0 110.454 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.418 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 30.4 mmm180 -74.71 -26.72 60.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.537 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.35 -37.35 57.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.036 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 90' ' ' GLN . 12.3 mmt85 -90.84 -5.42 55.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.842 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.83 120.85 20.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 110.643 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.662 ' O ' HG23 ' A' ' 96' ' ' ILE . 3.2 tp -107.17 101.27 12.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.176 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.9 88.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.553 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -115.91 41.46 2.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.111 -178.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.7 p -116.34 74.33 0.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.893 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -155.02 -46.09 0.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.975 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -58.79 156.06 11.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.905 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.26 -19.24 4.61 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.639 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -91.83 131.35 37.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 111.094 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.33 151.0 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.893 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.49 172.83 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.01 93.46 6.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.538 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.843 0.354 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.76 -17.6 45.38 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.675 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -114.66 176.22 5.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.35 . . . . 0.0 110.97 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HB3' HG23 ' A' ' 6' ' ' VAL . 3.1 mtpt -133.05 175.91 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.941 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -111.68 44.69 1.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.535 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 4' ' ' LYS . 2.4 t -86.77 144.87 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.85 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.7 m 66.82 -64.41 0.24 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.937 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.442 ' O ' HD23 ' A' ' 59' ' ' LEU . 3.1 t60 75.47 51.06 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.524 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.18 -41.76 26.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.106 0.479 . . . . 0.0 110.134 178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 44.0 47.61 7.95 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.302 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.49 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.28 153.15 21.12 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.1 m-20 -89.42 140.28 28.43 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.749 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.426 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 71.9 Cg_endo -78.16 -18.43 12.76 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.658 2.239 . . . . 0.0 112.584 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -110.93 -38.16 5.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.024 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -87.25 -21.55 25.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.218 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 96.34 -138.29 13.85 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.249 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.409 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -81.71 -169.81 2.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.893 0.378 . . . . 0.0 110.919 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -118.2 53.23 0.97 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.569 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.717 HG11 ' HG3' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -47.01 -26.08 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.577 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.54 -22.91 61.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.049 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -134.54 25.43 3.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.569 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.056 HD22 HD11 ' A' ' 26' ' ' LEU . 17.5 mt -69.89 159.09 34.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 111.234 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -85.23 140.25 36.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.755 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.469 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 50.4 Cg_exo -54.84 -19.61 19.74 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.539 2.159 . . . . 0.0 112.559 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.441 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 4.5 m-20 -82.2 -57.12 3.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.328 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.056 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -69.93 -41.36 74.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.069 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.9 OUTLIER -56.97 -35.46 69.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.933 0.396 . . . . 0.0 110.262 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.43 -39.45 93.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.593 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.756 HD12 HG22 ' A' ' 82' ' ' VAL . 23.3 tp -57.34 -50.86 71.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.801 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 22.8 m-85 -54.65 -48.3 72.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.739 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -61.24 -46.44 90.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.882 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.74 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -58.9 -35.98 73.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.54 0.04 44.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.753 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.74 12.54 77.35 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.912 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.599 HD12 HD21 ' A' ' 85' ' ' LEU . 66.4 mt -86.67 112.91 23.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.783 0.325 . . . . 0.0 111.129 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.74 164.43 15.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.717 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.35 -29.66 24.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.643 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.83 -44.46 73.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.791 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -78.13 -29.06 48.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.694 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.409 HD21 ' CG ' ' A' ' 30' ' ' PHE . 75.0 mt -70.69 -26.29 63.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.692 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 37' ' ' GLU . 49.0 p -97.28 -7.54 31.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.576 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' SER . 6.1 t0 -81.61 112.59 18.96 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.906 0.384 . . . . 0.0 110.717 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 13' ' ' PRO . . . -46.49 -32.22 3.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.6 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.23 -58.47 3.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.933 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -68.62 -35.95 77.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.233 -179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -56.94 -39.74 75.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.854 0.359 . . . . 0.0 110.201 179.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 1.1 tppm? -60.78 -55.52 32.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.337 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.774 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.03 -33.47 75.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.035 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 60.4 mt -68.44 -63.64 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.654 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 1.8 p90 -51.09 -38.21 50.34 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.029 0.443 . . . . 0.0 110.018 -177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.68 -34.21 69.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.523 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 80.9 t80 -63.94 -28.93 70.16 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.039 0.447 . . . . 0.0 110.259 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.953 HG23 ' CG2' ' A' ' 62' ' ' VAL . 20.1 mt -68.5 -27.8 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.087 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.49 -35.07 70.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.594 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.3 p30 -69.28 -25.46 64.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.585 179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.523 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 10.9 mt-30 -84.5 -8.76 58.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.089 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.02 21.39 5.65 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.064 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 84.52 168.9 44.95 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.396 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.496 HD13 HD22 ' A' ' 26' ' ' LEU . 11.1 tp -48.45 -38.67 20.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -65.02 -34.5 78.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -72.84 -33.91 66.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.607 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.953 ' CG2' HG23 ' A' ' 53' ' ' ILE . 44.5 t -65.32 -63.57 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.333 . . . . 0.0 110.804 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.9 OUTLIER -52.64 -41.42 63.74 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 110.244 178.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -63.64 -49.15 74.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.644 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.883 ' CD ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -69.44 -33.84 73.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.175 -178.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.3 mmt -60.5 -31.47 70.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.01 0.433 . . . . 0.0 110.36 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -76.75 -38.99 53.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.49 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 -69.66 -29.04 66.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.931 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.423 ' NE2' ' OE1' ' A' ' 65' ' ' GLU . 41.7 mt-30 -90.65 16.17 9.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.856 178.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -94.33 -23.98 20.34 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.448 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -158.3 120.9 1.01 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.439 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.0 t -175.78 -68.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 110.816 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.95 -81.39 1.47 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.331 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 75' ' ' SER . . . -78.89 -19.89 71.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 74' ' ' GLY . 0.2 OUTLIER 88.18 -23.8 0.11 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.956 0.503 . . . . 0.0 111.612 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 pm0 -75.83 144.27 41.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.879 0.371 . . . . 0.0 111.051 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.8 OUTLIER -108.15 109.47 20.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.693 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.427 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.7 OUTLIER 164.74 -37.11 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.497 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.2 101.8 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.087 0.47 . . . . 0.0 110.795 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.31 -97.3 0.19 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.998 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.883 HD13 ' CD ' ' A' ' 65' ' ' GLU . 2.4 pt? -59.72 -38.79 82.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.654 0.264 . . . . 0.0 111.365 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.756 HG22 HD12 ' A' ' 29' ' ' LEU . 20.7 t -62.68 -25.66 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.352 . . . . 0.0 110.712 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.65 -41.3 84.33 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.185 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.438 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.54 -49.09 72.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 110.585 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.599 HD21 HD12 ' A' ' 35' ' ' ILE . 9.5 tp -50.89 -52.9 37.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.762 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 12.6 mtm -51.01 -31.37 17.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -79.25 -29.34 42.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.489 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.774 HG12 HD13 ' A' ' 48' ' ' LEU . 64.8 t -72.38 -42.97 64.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.629 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.425 ' SD ' HD11 ' A' ' 35' ' ' ILE . 83.1 mmm -62.71 -35.49 79.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.393 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -54.14 -21.55 8.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.261 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 95' ' ' ALA . 11.1 tptt -70.66 -56.59 6.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.31 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -24.48 60.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.29 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.43 -29.34 52.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.42 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -108.92 -15.46 14.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.867 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 91' ' ' LYS . . . -74.73 172.6 11.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.171 0.51 . . . . 0.0 111.667 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 19.5 mm -61.01 107.89 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.633 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.422 ' O ' ' CB ' ' A' ' 98' ' ' SER . 95.7 m-70 -55.38 144.39 25.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.389 178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 97' ' ' HIS . 1.4 t 80.34 -57.29 0.34 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.338 -178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.5 171.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.462 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -154.97 126.55 7.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.708 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -56.86 -25.73 57.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 176.43 133.82 1.86 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.394 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -110.34 149.07 30.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.46 -179.06 4.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.832 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.18 99.42 2.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.003 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.95 122.39 27.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.418 -1.212 . . . . 0.0 112.469 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.77 0.319 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.9 29.99 40.33 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.393 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -71.39 141.93 50.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.73 174.16 8.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.79 94.24 2.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.772 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.3 t -112.41 143.46 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.344 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.1 -161.33 0.8 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.595 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -140.55 -56.51 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.196 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.505 HG11 ' HB2' ' A' ' 50' ' ' TYR . 2.2 t 41.18 95.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 111.518 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.33 50.83 4.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.967 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.559 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -87.74 153.63 21.2 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -89.42 140.28 28.43 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.674 0.273 . . . . 0.0 110.729 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.98 -37.59 0.55 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.686 2.257 . . . . 0.0 112.393 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -90.42 -38.06 13.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.954 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -87.2 -27.73 22.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.863 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.41 -149.68 19.2 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.624 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 11' ' ' TRP . 0.1 OUTLIER -82.65 146.58 29.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 111.003 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.08 67.17 9.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.019 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.782 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.8 m -50.53 -29.51 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -70.86 -19.92 62.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.139 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -130.72 20.43 5.07 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.449 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.939 HD22 HD11 ' A' ' 26' ' ' LEU . 17.3 mt -70.49 159.74 33.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.868 0.366 . . . . 0.0 110.889 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -83.03 139.44 42.65 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.3 Cg_exo -54.28 -19.61 17.31 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.623 2.215 . . . . 0.0 112.636 -179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 75.3 m-20 -81.06 -58.16 3.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.061 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.939 HD11 HD22 ' A' ' 22' ' ' LEU . 4.0 pp -70.95 -38.29 72.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.148 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.485 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -61.98 -34.71 76.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.889 0.376 . . . . 0.0 110.086 179.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.415 ' OG ' ' NE ' ' A' ' 32' ' ' ARG . 23.1 t -64.21 -36.86 85.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.597 178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.075 HD13 HD12 ' A' ' 81' ' ' LEU . 3.4 tp -56.1 -58.12 9.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.302 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.47 ' HD1' HD21 ' A' ' 85' ' ' LEU . 17.7 m-85 -49.59 -38.36 31.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.986 0.422 . . . . 0.0 110.519 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.41 -57.78 10.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.763 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.635 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -60.5 -25.5 66.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.787 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.14 -18.3 43.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.305 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.08 17.99 56.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.604 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.687 HD13 ' HE3' ' A' ' 89' ' ' MET . 60.7 mt -86.24 126.14 40.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.177 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.69 152.79 21.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.782 ' HG2' HG21 ' A' ' 19' ' ' VAL . 1.5 mt-10 -51.9 -25.37 7.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.737 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.89 -42.76 72.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.875 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -78.37 -30.06 47.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.796 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.569 HD23 HD13 ' A' ' 49' ' ' ILE . 95.9 mt -70.67 -27.56 64.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.887 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 37' ' ' GLU . 23.4 p -98.33 -2.44 39.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.552 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 46' ' ' SER . 5.4 t70 -82.85 123.77 29.68 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.749 0.309 . . . . 0.0 110.818 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.52 -37.14 47.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.592 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.74 -59.88 2.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.529 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.416 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.5 -36.03 80.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.203 -179.066 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 87.3 p -56.5 -37.59 70.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.88 0.372 . . . . 0.0 110.173 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 11.1 tptt -61.92 -55.69 27.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.168 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.742 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.86 -28.98 68.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.276 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.569 HD13 HD23 ' A' ' 40' ' ' LEU . 56.0 mt -67.38 -64.8 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.274 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.559 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.8 p90 -55.28 -34.27 63.95 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.75 -35.65 68.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.45 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.519 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 71.2 t80 -63.79 -30.19 71.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.028 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.939 HG23 HG21 ' A' ' 62' ' ' VAL . 17.6 mt -65.43 -27.95 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.033 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.83 -41.77 71.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.571 178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.477 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.4 p30 -61.4 -25.32 67.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.509 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.519 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 7.7 mt-30 -85.0 -10.61 56.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.252 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.42 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 114.21 21.73 5.47 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.03 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.445 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 85.28 168.5 44.78 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.657 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.438 ' HA ' HG21 ' A' ' 53' ' ' ILE . 14.9 tp -47.67 -37.13 12.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.895 0.379 . . . . 0.0 110.969 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -67.0 -36.96 83.32 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.611 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.42 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.54 -36.06 68.19 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.939 HG21 HG23 ' A' ' 53' ' ' ILE . 43.8 t -65.12 -62.92 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.699 0.285 . . . . 0.0 110.941 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.408 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -49.45 -39.04 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.958 0.409 . . . . 0.0 110.206 178.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.09 -53.96 45.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.258 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.444 ' HA ' ' CD ' ' A' ' 68' ' ' ARG . 11.0 pt-20 -70.19 -28.15 65.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 110.922 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.689 ' SD ' HD21 ' A' ' 81' ' ' LEU . 5.5 mmm -71.74 -22.72 61.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.833 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -76.08 -49.39 17.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.155 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' CD ' ' HA ' ' A' ' 65' ' ' GLU . 0.2 OUTLIER -70.74 -29.35 65.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.064 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.16 -20.87 60.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.173 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 76' ' ' GLN . . . -108.41 -41.79 1.45 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.637 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 70.14 103.0 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.398 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 68.94 -63.97 0.34 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.843 0.354 . . . . 0.0 110.904 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 155.43 153.25 6.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.495 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.78 145.99 0.25 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.433 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.88 33.13 22.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.413 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 6.7 pt20 -74.63 163.6 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.857 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.8 m -95.4 103.81 15.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.224 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.464 ' CB ' HG21 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -71.51 -10.33 59.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.365 179.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -71.6 88.91 0.96 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.135 0.493 . . . . 0.0 110.818 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.49 -100.89 0.18 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.811 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.075 HD12 HD13 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -65.07 -34.09 77.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.62 0.247 . . . . 0.0 111.148 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.635 HG11 ' HB3' ' A' ' 32' ' ' ARG . 3.8 t -64.99 -37.48 80.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.756 0.312 . . . . 0.0 111.33 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.34 -41.71 77.26 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.561 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.64 -51.08 64.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 0.0 110.598 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.477 HD21 HD12 ' A' ' 35' ' ' ILE . 12.3 tp -58.95 -40.01 83.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.264 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.5 mtm -54.05 -38.57 65.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.198 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -69.89 -44.66 69.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.389 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.742 HG12 HD13 ' A' ' 48' ' ' LEU . 44.8 t -56.11 -38.99 56.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.812 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.687 ' HE3' HD13 ' A' ' 35' ' ' ILE . 28.7 mmt -61.39 -37.62 84.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.048 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -74.41 -16.98 60.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.276 176.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptp -68.64 -56.96 6.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.058 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.47 ' HB2' HD22 ' A' ' 48' ' ' LEU . 2.6 tpt180 -73.31 -17.24 61.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.436 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.92 -34.23 59.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.808 0.337 . . . . 0.0 110.934 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -96.71 -15.37 21.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.461 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.08 119.04 17.74 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.07 0.462 . . . . 0.0 111.442 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.658 ' O ' HG23 ' A' ' 96' ' ' ILE . 4.5 tt -128.85 108.3 17.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.351 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.83 78.87 0.08 Allowed 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.386 -0.525 . . . . 0.0 110.527 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -110.71 -168.61 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.759 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 101' ' ' GLU . 0.3 OUTLIER -100.97 177.39 4.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.932 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 66.98 -68.78 0.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 99' ' ' SER . 2.1 pt-20 -137.63 83.74 2.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.982 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -158.1 62.77 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.457 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.62 174.5 5.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.826 0.346 . . . . 0.0 110.917 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.03 178.65 3.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -129.94 36.31 4.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.969 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.88 143.07 32.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.055 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 CA-C-O 118.384 -1.231 . . . . 0.0 112.58 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.829 0.347 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.48 -23.5 22.3 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -139.92 115.65 10.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -87.1 152.03 22.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.41 73.79 2.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 8' ' ' HIS . 48.1 t -103.43 145.72 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.234 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.584 ' CB ' HD23 ' A' ' 59' ' ' LEU . 0.6 OUTLIER 48.13 -89.2 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.633 178.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.441 ' N ' ' O ' ' A' ' 6' ' ' VAL . 25.6 t60 45.94 45.43 11.97 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.707 HG11 ' HB2' ' A' ' 50' ' ' TYR . 2.1 t 32.18 101.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.78 58.4 0.52 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.249 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.565 ' CZ2' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.8 153.79 20.4 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.799 0.333 . . . . 0.0 110.901 -178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.14 140.24 25.81 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.408 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -78.09 -36.17 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.598 2.199 . . . . 0.0 112.531 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -83.75 -41.35 17.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.129 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -87.62 -28.43 21.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.935 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.95 -146.8 17.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.712 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.8 135.7 35.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.894 0.378 . . . . 0.0 110.941 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.26 62.85 0.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.563 HG11 ' HG3' ' A' ' 37' ' ' GLU . 2.3 m -53.44 -23.22 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.789 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.85 -20.77 59.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.903 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -128.64 18.31 6.28 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.517 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.925 HD22 HD11 ' A' ' 26' ' ' LEU . 17.4 mt -70.0 159.35 33.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 111.133 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 6.2 t70 -84.54 140.88 38.63 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.926 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 33.6 Cg_exo -57.24 -17.75 27.26 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.589 2.193 . . . . 0.0 112.589 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.427 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 0.6 OUTLIER -81.91 -57.94 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.151 -179.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.925 HD11 HD22 ' A' ' 22' ' ' LEU . 4.0 pp -69.57 -41.53 75.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.947 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.508 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -55.58 -35.81 66.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.925 0.393 . . . . 0.0 110.295 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.419 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -62.61 -39.24 93.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.719 179.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.501 HD11 ' HA ' ' A' ' 82' ' ' VAL . 28.9 tp -56.81 -51.28 69.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.587 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.413 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 21.5 m-85 -53.42 -43.46 67.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.577 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.3 m -61.82 -51.55 67.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.89 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.52 ' HB3' HG11 ' A' ' 82' ' ' VAL . 9.9 mtt180 -59.9 -32.73 71.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.813 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.512 ' HB1' ' HG2' ' A' ' 86' ' ' MET . . . -81.94 -18.28 44.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.34 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.33 8.56 54.83 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.937 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.712 HD12 HD21 ' A' ' 85' ' ' LEU . 72.8 mt -85.98 109.56 18.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 35.3 p -86.46 167.23 14.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.041 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.563 ' HG3' HG11 ' A' ' 19' ' ' VAL . 1.4 mp0 -53.2 -34.52 57.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.037 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.23 -42.5 66.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.849 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -77.68 -35.1 52.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.552 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.523 HD23 HD13 ' A' ' 49' ' ' ILE . 25.2 mt -69.95 -20.7 63.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 37' ' ' GLU . 68.1 p -94.32 -9.53 35.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.402 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -81.07 121.67 26.37 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.754 0.311 . . . . 0.0 110.708 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.72 -34.62 27.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.432 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.35 -59.91 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.59 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.415 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.72 -37.94 82.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 -179.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 87.2 p -56.87 -39.52 74.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.818 0.342 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 1.3 tppm? -61.29 -55.79 27.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.348 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.732 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -65.25 -32.08 73.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.328 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.523 HD13 HD23 ' A' ' 40' ' ' LEU . 55.4 mt -66.49 -63.98 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.124 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.707 ' HB2' HG11 ' A' ' 9' ' ' VAL . 2.0 p90 -53.41 -37.96 62.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.97 0.414 . . . . 0.0 110.043 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -55.9 -35.57 66.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.481 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.493 ' HD2' HG21 ' A' ' 88' ' ' VAL . 37.4 t80 -64.0 -34.55 78.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.097 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.988 HG23 HG21 ' A' ' 62' ' ' VAL . 23.8 mt -60.77 -28.63 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.072 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.36 -38.84 78.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.459 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -68.83 -25.53 64.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.675 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 61.3 mm-40 -87.5 13.38 10.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.455 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 95.21 17.41 37.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.572 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.18 170.55 46.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.879 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.584 HD23 ' CB ' ' A' ' 7' ' ' SER . 10.2 tp -49.49 -41.56 40.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.713 0.292 . . . . 0.0 111.27 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.444 ' CG ' ' HB2' ' A' ' 7' ' ' SER . 29.1 mt-10 -65.1 -34.8 79.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.165 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.5 -34.29 65.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.656 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.988 HG21 HG23 ' A' ' 53' ' ' ILE . 61.5 t -64.29 -61.92 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.866 0.365 . . . . 0.0 110.521 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.4 OUTLIER -51.56 -38.6 55.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.082 0.468 . . . . 0.0 110.008 177.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -63.87 -51.5 64.29 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.329 178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB2' ' NE2' ' A' ' 69' ' ' GLN . 11.3 pt-20 -68.74 -33.95 74.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.762 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.437 ' CE ' ' CA ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -64.63 -23.77 67.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.569 178.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.5 -47.38 27.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.475 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.3 mtt180 -70.56 -40.33 73.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.419 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.435 ' NE2' ' HB2' ' A' ' 65' ' ' GLU . 31.6 mt-30 -88.9 9.96 23.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.653 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -114.93 -26.95 3.38 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.496 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.43 47.56 50.12 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.442 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.2 m 50.84 29.28 4.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.33 171.77 38.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.561 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.75 -97.5 1.11 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.53 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.7 p -75.37 65.39 1.66 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.808 0.337 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.1 146.72 43.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.811 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.46 85.49 2.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.218 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.563 ' HB2' HG21 ' A' ' 82' ' ' VAL . 80.3 p -68.25 -16.24 63.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.104 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.02 93.68 1.79 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.125 0.488 . . . . 0.0 110.805 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.44 -94.92 0.15 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.984 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.7 pt? -63.39 -39.91 95.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.799 0.333 . . . . 0.0 111.232 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.563 HG21 ' HB2' ' A' ' 78' ' ' SER . 6.5 t -62.92 -33.29 59.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.385 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -34.87 78.23 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.298 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.04 -51.28 62.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 110.681 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.712 HD21 HD12 ' A' ' 35' ' ' ILE . 14.5 tp -62.94 -42.5 99.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.477 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.512 ' HG2' ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -53.37 -33.36 53.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.403 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -75.17 -30.31 60.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.349 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.732 HG12 HD13 ' A' ' 48' ' ' LEU . 96.8 t -66.36 -40.24 86.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.626 179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.484 ' SD ' HD11 ' A' ' 35' ' ' ILE . 74.1 mmm -62.38 -26.77 68.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.614 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -73.98 -16.62 61.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.236 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -70.57 -35.26 72.97 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.811 0.338 . . . . 0.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.461 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.21 -24.05 59.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.844 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 m -73.18 -24.2 60.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.871 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -107.97 -21.08 12.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.005 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.65 129.82 38.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.258 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.701 ' O ' HG23 ' A' ' 96' ' ' ILE . 20.2 tt -106.13 99.6 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.801 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -89.96 -23.59 21.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.26 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.1 t -66.55 -22.04 66.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.053 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.62 -26.17 61.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 0.0 111.014 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.02 90.38 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.973 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -132.98 49.04 2.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.974 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.46 142.21 0.14 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.446 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -82.88 130.52 35.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.38 . . . . 0.0 110.843 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -167.65 147.55 5.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.968 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -100.13 144.4 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.02 93.58 6.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.022 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.387 -1.23 . . . . 0.0 112.518 -179.909 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.847 0.356 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.57 25.62 8.07 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.508 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -112.8 145.07 41.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.754 0.312 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.13 157.55 19.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.977 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -112.5 71.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.54 130.88 59.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.188 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.419 ' HB3' ' HA3' ' A' ' 58' ' ' GLY . 1.4 p -90.72 164.39 14.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.503 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.426 ' O ' ' N ' ' A' ' 10' ' ' GLY . 12.4 t60 -116.48 -38.95 3.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.064 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.2 t 67.22 -66.01 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.818 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 8' ' ' HIS . . . 90.79 36.35 6.84 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.976 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.489 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.29 153.55 20.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.337 . . . . 0.0 110.25 179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 16' ' ' GLY . 0.7 OUTLIER -88.83 140.23 29.38 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.545 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.23 -33.5 1.39 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.671 2.247 . . . . 0.0 112.572 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -93.22 -41.11 10.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.164 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -87.1 -26.94 23.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.043 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.414 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 101.62 -145.11 16.67 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.386 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.559 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.43 138.9 35.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.926 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -76.01 62.14 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.249 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.583 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.8 m -51.24 -24.69 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -73.9 -21.39 60.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -128.55 19.91 6.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.383 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.074 HD22 HD11 ' A' ' 26' ' ' LEU . 16.4 mt -71.02 159.06 35.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.793 0.33 . . . . 0.0 111.189 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -84.88 142.56 39.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.989 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 43.3 Cg_exo -56.01 -20.02 28.51 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.606 2.204 . . . . 0.0 112.529 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.42 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 1.1 m-20 -81.82 -56.97 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.14 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.074 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -71.12 -37.46 72.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.294 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.476 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 2.0 ppt_? -59.59 -36.27 75.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.948 0.404 . . . . 0.0 110.214 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.1 t -63.68 -37.2 86.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.652 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.035 HD13 HD12 ' A' ' 81' ' ' LEU . 25.6 tp -56.71 -57.07 14.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.625 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CG ' HD21 ' A' ' 40' ' ' LEU . 20.3 m-85 -48.35 -43.63 33.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.25 -58.48 7.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.631 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.668 ' HB3' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -55.54 -29.86 59.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.826 179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.77 3.52 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.806 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.8 4.28 90.37 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.994 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 36' ' ' SER . 35.2 mt -85.67 162.35 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.893 0.347 . . . . 0.0 110.851 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 35' ' ' ILE . 0.9 OUTLIER -145.4 172.77 12.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.033 -179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.82 ' O ' HG23 ' A' ' 41' ' ' THR . 1.0 OUTLIER -53.45 -37.78 62.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.025 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.71 -46.42 70.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.71 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -78.54 -34.02 47.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.668 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.502 HD21 ' CG ' ' A' ' 30' ' ' PHE . 83.6 mt -70.0 -23.14 63.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.851 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.82 HG23 ' O ' ' A' ' 37' ' ' GLU . 46.9 p -94.99 -7.65 39.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.537 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -81.3 119.17 23.32 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.757 0.313 . . . . 0.0 110.715 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.85 -34.48 12.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.493 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' OE1' ' NH2' ' A' ' 92' ' ' ARG . 36.5 tt0 -72.75 -59.89 2.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.415 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.426 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -68.21 -34.41 76.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.409 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.2 p -58.32 -42.3 86.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.847 0.356 . . . . 0.0 110.559 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -60.99 -53.14 60.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.499 -179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.874 HD13 HG12 ' A' ' 88' ' ' VAL . 1.5 pp -65.04 -32.26 73.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.741 0.305 . . . . 0.0 110.828 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.442 HD13 HD23 ' A' ' 40' ' ' LEU . 49.9 mt -68.42 -64.0 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.384 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.466 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.3 p90 -52.08 -40.7 61.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.885 0.374 . . . . 0.0 110.303 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.449 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -53.57 -32.68 51.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 178.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.46 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 69.3 t80 -63.85 -41.74 97.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.871 0.367 . . . . 0.0 110.122 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.796 HG23 HG21 ' A' ' 62' ' ' VAL . 59.9 mt -55.39 -25.11 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.41 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -75.83 -35.54 59.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.783 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.46 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -72.93 -25.63 61.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.8 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -87.4 13.98 8.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.552 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.97 14.72 41.7 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.635 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 7' ' ' SER . . . 84.91 170.19 46.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.127 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.414 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 12.5 tp -48.99 -40.13 29.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.377 . . . . 0.0 110.899 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -65.07 -36.19 83.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.302 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.08 -35.76 66.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.899 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.796 HG21 HG23 ' A' ' 53' ' ' ILE . 24.0 t -65.0 -63.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.756 0.312 . . . . 0.0 110.912 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.2 OUTLIER -51.69 -44.53 63.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.071 0.462 . . . . 0.0 110.235 178.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -63.0 -52.58 62.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.41 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 4.4 pt-20 -70.4 -23.3 62.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.212 -178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.7 mmt -69.01 -35.15 76.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.095 0.474 . . . . 0.0 110.241 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -77.36 -33.43 55.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.667 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.82 -22.01 62.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.882 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 77' ' ' SER . 15.3 mt-30 -88.2 -18.67 28.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.311 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.68 108.65 2.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.516 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.67 -157.39 19.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.573 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 66.69 146.04 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.798 0.333 . . . . 0.0 110.949 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.13 101.08 2.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.533 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.87 -29.98 7.74 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.473 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.72 50.37 0.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.859 0.361 . . . . 0.0 110.845 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -74.58 151.95 39.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.032 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.413 ' HA ' ' HB3' ' A' ' 69' ' ' GLN . 0.2 OUTLIER -53.03 154.95 2.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.804 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.423 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 0.1 OUTLIER 82.97 -48.22 0.15 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.341 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.99 70.57 1.04 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.092 0.472 . . . . 0.0 110.762 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.31 -93.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.009 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.035 HD12 HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -62.46 -29.81 70.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.76 179.127 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.668 HG11 ' HB3' ' A' ' 32' ' ' ARG . 16.8 t -64.58 -30.04 49.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.768 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.86 -46.47 60.05 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.037 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.35 -46.49 79.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.948 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.496 HD21 HD12 ' A' ' 35' ' ' ILE . 13.6 tp -55.97 -46.83 78.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 33.7 mtp -53.62 -29.97 40.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.441 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.401 ' O ' ' HB2' ' A' ' 90' ' ' GLN . 79.0 t60 -80.08 -30.17 39.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.525 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.874 HG12 HD13 ' A' ' 48' ' ' LEU . 59.9 t -69.48 -42.45 80.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 0.0 110.308 178.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 55.3 mmm -63.51 -28.39 69.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.138 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 87' ' ' HIS . 1.0 OUTLIER -63.13 -18.75 63.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.343 179.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.771 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 9.8 tptt -69.75 -36.46 75.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.994 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.426 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 14.5 mmm-85 -73.66 -19.45 60.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.99 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.421 ' HB2' ' HD3' ' A' ' 94' ' ' ARG . 41.0 m -75.01 -31.54 61.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.124 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.421 ' HD3' ' HB2' ' A' ' 93' ' ' SER . 1.4 mpp_? -130.84 25.74 4.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.28 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.771 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -74.09 136.05 42.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.935 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.588 ' O ' HG23 ' A' ' 96' ' ' ILE . 5.7 tp -132.45 82.53 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.119 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -136.45 73.65 1.46 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.299 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m 75.6 25.83 1.17 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.234 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.14 -26.18 14.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.927 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 54.07 179.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -61.58 -27.57 68.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.33 -130.96 11.69 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.477 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.51 157.68 15.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.917 0.389 . . . . 0.0 110.747 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.89 169.34 11.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.041 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 64.17 33.21 12.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.03 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.7 114.65 19.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.946 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 CA-C-O 118.365 -1.242 . . . . 0.0 112.509 -179.746 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.821 0.343 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.89 18.35 47.77 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.6 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -147.1 162.8 38.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.344 . . . . 0.0 110.861 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.76 126.86 35.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.054 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -145.07 100.32 3.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.898 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.5 t -83.5 139.98 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.219 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.93 -27.79 18.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 68.44 114.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.036 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.9 t -81.83 -55.12 8.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.956 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.13 18.82 8.44 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.785 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.569 ' CH2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.4 153.81 20.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.823 0.344 . . . . 0.0 110.745 -179.596 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.09 140.8 29.01 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.552 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.05 -38.2 0.88 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.652 2.235 . . . . 0.0 112.772 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -94.17 -35.6 12.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.19 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.77 -25.29 23.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.112 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.85 -150.19 19.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.393 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.686 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.28 136.36 35.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.332 . . . . 0.0 110.891 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -74.83 62.95 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.277 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.608 HG21 ' HG2' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -52.0 -23.83 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.288 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -72.43 -21.76 61.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.194 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -132.68 21.89 4.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.487 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.015 HD22 HD11 ' A' ' 26' ' ' LEU . 16.5 mt -70.07 159.03 34.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.912 0.387 . . . . 0.0 111.23 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -85.19 139.84 36.63 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.0 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.457 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 52.5 Cg_exo -55.19 -18.94 19.35 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.621 2.214 . . . . 0.0 112.684 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -81.19 -57.97 3.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.228 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.015 HD11 HD22 ' A' ' 22' ' ' LEU . 3.5 pp -69.91 -42.81 72.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.096 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -54.72 -34.22 62.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.956 0.407 . . . . 0.0 110.086 179.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.33 -39.18 93.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.677 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 82' ' ' VAL . 22.4 tp -56.59 -55.65 31.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.591 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.43 ' CG ' HD21 ' A' ' 40' ' ' LEU . 9.9 m-30 -50.38 -43.61 54.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.617 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 m -62.34 -55.14 30.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.709 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.467 ' HB3' HG11 ' A' ' 82' ' ' VAL . 2.6 mtp180 -56.73 -30.89 63.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.827 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.92 -21.46 37.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.159 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.69 8.68 48.31 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.771 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.569 HD12 HD21 ' A' ' 85' ' ' LEU . 39.3 mt -86.09 112.3 22.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.83 0.348 . . . . 0.0 111.176 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.9 p -87.0 167.6 14.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.648 ' O ' HG23 ' A' ' 41' ' ' THR . 3.5 mt-10 -52.17 -28.91 19.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.821 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.5 -46.14 73.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.724 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 35' ' ' ILE . 2.7 mt-30 -78.47 -31.38 47.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.688 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.43 HD21 ' CG ' ' A' ' 30' ' ' PHE . 87.4 mt -69.98 -25.48 63.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.663 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 37' ' ' GLU . 44.4 p -97.29 -5.33 36.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.607 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 46' ' ' SER . 20.9 t0 -82.23 113.69 20.22 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.753 0.311 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -46.6 -32.28 3.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.59 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.94 -59.66 2.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.122 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.413 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.85 -36.5 80.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.295 -179.272 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.3 OUTLIER -56.39 -38.16 71.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.848 0.356 . . . . 0.0 110.21 179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 4.1 tptm -62.07 -54.95 34.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.363 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.693 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -67.04 -30.67 70.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.258 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 48.7 mt -68.02 -64.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.517 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.569 ' CZ ' ' CH2' ' A' ' 11' ' ' TRP . 2.1 p90 -52.77 -40.72 63.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.94 0.4 . . . . 0.0 110.224 -178.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -54.78 -32.69 60.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.7 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 85' ' ' LEU . 77.0 t80 -64.54 -38.67 91.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.25 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.047 HG23 HG21 ' A' ' 62' ' ' VAL . 44.6 mt -59.18 -28.64 39.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.238 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -69.67 -33.95 73.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.342 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.464 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -75.08 -24.66 58.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.476 178.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 97.0 mm-40 -85.9 10.48 13.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.339 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.15 17.08 33.11 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.483 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.433 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 82.64 171.21 46.64 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.809 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.5 tp -49.34 -41.62 39.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.768 0.318 . . . . 0.0 111.281 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -63.87 -34.84 78.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.219 -178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.437 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -35.57 66.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.255 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 1.047 HG21 HG23 ' A' ' 53' ' ' ILE . 22.0 t -66.06 -48.79 80.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.705 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -54.29 -46.55 72.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.112 0.482 . . . . 0.0 109.985 177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -63.53 -49.07 74.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.943 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 20.3 pt-20 -67.56 -24.75 65.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.805 0.336 . . . . 0.0 110.808 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.404 ' CE ' ' N ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -72.93 -22.53 60.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.778 178.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.2 mmt-85 -75.93 -51.7 11.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.909 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -32.42 69.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.849 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.625 ' OE1' HD22 ' A' ' 81' ' ' LEU . 32.6 mt-30 -91.03 -6.88 53.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.582 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -121.51 104.8 0.96 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.499 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.19 -70.32 1.02 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.524 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.68 -71.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 0.0 110.995 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.52 66.73 0.5 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 136.57 -22.23 3.36 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.446 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.68 29.98 4.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -74.7 129.64 38.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.876 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.93 94.33 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.987 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.566 ' CB ' HG21 ' A' ' 82' ' ' VAL . 2.1 p -79.7 -5.72 55.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.557 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.75 102.08 3.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.965 0.412 . . . . 0.0 110.969 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.29 -94.38 0.18 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.356 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.625 HD22 ' OE1' ' A' ' 69' ' ' GLN . 2.7 pt? -63.71 -41.11 98.15 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.684 0.278 . . . . 0.0 111.48 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.566 HG21 ' CB ' ' A' ' 78' ' ' SER . 6.0 t -63.61 -37.13 78.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.774 0.321 . . . . 0.0 111.272 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.2 -38.51 82.56 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.479 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.576 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.94 -48.74 73.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 0.0 110.766 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.569 HD21 HD12 ' A' ' 35' ' ' ILE . 30.7 tp -62.03 -45.18 94.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 6.4 mtm -54.25 -34.48 60.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.499 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -75.74 -24.46 56.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.834 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.693 HG12 HD13 ' A' ' 48' ' ' LEU . 48.2 t -78.28 -37.4 22.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.156 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 67.2 mmm -62.49 -37.11 84.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.046 0.451 . . . . 0.0 110.258 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -68.14 -11.25 58.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.229 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 1.4 tptp -69.26 -27.94 65.88 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.678 0.275 . . . . 0.0 111.257 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.489 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 21.3 mmm180 -73.07 -22.24 60.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 0.0 110.963 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.423 ' HB2' ' HD2' ' A' ' 94' ' ' ARG . 64.5 m -76.06 -24.84 55.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.441 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.423 ' HD2' ' HB2' ' A' ' 93' ' ' SER . 1.3 mpt_? -130.7 11.02 5.19 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -74.37 173.63 9.99 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-O 121.084 0.469 . . . . 0.0 111.377 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 98' ' ' SER . 16.3 mm -75.7 106.79 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.014 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.88 90.71 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.548 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.5 OUTLIER -147.52 111.4 5.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.068 -178.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.7 m -146.55 -44.73 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.051 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 58.43 73.34 0.48 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.98 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -108.04 173.42 6.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.74 86.02 0.11 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.37 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 104' ' ' ASP . 2.5 tt0 -76.7 169.98 17.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.874 0.368 . . . . 0.0 110.789 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER 80.36 151.8 0.11 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.612 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.37 110.53 0.46 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.851 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.68 133.01 35.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.988 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.357 -1.246 . . . . 0.0 112.506 -179.913 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.836 0.351 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.27 -20.83 48.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.535 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -124.39 136.61 54.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 0.0 110.858 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -86.94 141.61 28.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.927 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -124.85 52.38 1.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.1 t -72.92 145.15 12.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.078 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.5 -49.53 6.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.75 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.6 t60 69.72 80.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.147 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' A' ' 50' ' ' TYR . 4.0 t -60.32 -54.87 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.743 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.27 19.56 16.14 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.806 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.556 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.16 153.44 20.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 0.0 110.383 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.8 m-20 -90.57 138.41 26.74 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.467 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.23 -23.45 6.33 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.587 2.191 . . . . 0.0 112.598 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -99.1 -41.14 7.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.088 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -88.15 -29.85 20.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.046 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 109.56 -144.79 16.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.467 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.861 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.2 OUTLIER -83.49 147.01 28.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 111.095 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -82.14 58.75 4.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.886 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG12 HD13 ' A' ' 40' ' ' LEU . 1.6 m -51.38 -24.03 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.069 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -74.99 -19.77 59.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.3 m-20 -131.61 21.34 4.68 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.401 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.036 HD22 HD11 ' A' ' 26' ' ' LEU . 17.6 mt -70.14 159.63 33.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.933 0.397 . . . . 0.0 111.201 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -83.52 145.85 48.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.06 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.471 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 31.4 Cg_exo -58.66 -22.23 59.64 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.634 2.223 . . . . 0.0 112.645 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -81.92 -56.37 4.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.328 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.036 HD11 HD22 ' A' ' 22' ' ' LEU . 3.6 pp -70.85 -32.77 69.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.333 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HG2' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -64.17 -35.56 81.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.234 179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -35.82 81.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.642 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.047 HD13 HD12 ' A' ' 81' ' ' LEU . 9.4 tp -56.4 -60.36 3.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.544 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.452 ' CG ' HD21 ' A' ' 40' ' ' LEU . 16.7 m-85 -49.0 -45.24 42.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.817 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.7 m -62.22 -50.38 72.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -59.5 -33.18 71.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.61 -12.79 58.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.378 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.65 11.77 58.9 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.624 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -86.48 114.79 26.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.807 0.336 . . . . 0.0 111.086 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.9 p -87.53 163.49 16.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.815 ' O ' HG23 ' A' ' 41' ' ' THR . 0.4 OUTLIER -53.11 -26.7 17.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.901 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.39 -44.77 72.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.878 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.405 ' HB3' HG21 ' A' ' 45' ' ' THR . 40.7 mt-30 -78.58 -33.64 47.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.744 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.473 HD13 HG12 ' A' ' 19' ' ' VAL . 76.5 mt -68.79 -22.3 64.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.804 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 37' ' ' GLU . 35.1 p -96.53 -8.75 31.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.555 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.6 t70 -82.22 112.76 19.53 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-O 120.783 0.325 . . . . 0.0 110.645 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.96 -31.27 2.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.7 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -72.37 -59.65 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.882 0.372 . . . . 0.0 110.929 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.71 -33.33 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -58.66 -39.5 80.8 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.269 179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 19.1 tptt -61.74 -53.31 57.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.566 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.937 HD13 HG12 ' A' ' 88' ' ' VAL . 1.9 pp -66.44 -32.41 73.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.356 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.41 ' O ' ' HB3' ' A' ' 52' ' ' PHE . 46.3 mt -68.2 -64.59 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.554 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.556 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.3 p90 -53.63 -37.43 63.06 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.981 0.419 . . . . 0.0 110.138 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -55.44 -36.41 66.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.426 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.459 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 64.3 t80 -64.32 -37.56 87.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.043 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.967 HG23 HG21 ' A' ' 62' ' ' VAL . 49.5 mt -58.62 -29.07 38.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.178 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -40.27 77.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.587 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.459 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -66.37 -26.24 67.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.458 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.46 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 94.6 mm-40 -85.28 1.35 48.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.338 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 104.41 18.82 12.3 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.475 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.45 170.83 46.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.846 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD13 HD22 ' A' ' 26' ' ' LEU . 12.1 tp -48.52 -40.33 26.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.322 . . . . 0.0 111.093 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -64.64 -35.07 79.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.247 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -74.05 -34.24 63.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.818 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.967 HG21 HG23 ' A' ' 53' ' ' ILE . 44.0 t -65.02 -63.29 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.699 0.285 . . . . 0.0 110.873 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -52.47 -41.64 63.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.052 0.453 . . . . 0.0 110.13 177.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -63.23 -53.26 55.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.33 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 10.1 pt-20 -69.36 -26.61 64.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.992 -178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.557 ' SD ' HD11 ' A' ' 81' ' ' LEU . 1.5 mmt -67.29 -29.5 69.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.079 0.466 . . . . 0.0 110.238 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -77.64 -44.8 27.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.0 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.0 mtt-85 -71.91 -29.49 64.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.006 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.54 -18.09 62.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.323 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.71 -20.59 59.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.531 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -131.83 96.16 0.32 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.706 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.9 t -163.45 72.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.945 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.97 -43.01 1.78 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.571 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.29 -99.95 0.17 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.525 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 46.0 t -154.5 38.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.844 0.354 . . . . 0.0 111.018 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -74.94 106.65 6.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.976 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.4 OUTLIER -115.61 141.6 47.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.674 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.524 ' OG ' HG21 ' A' ' 82' ' ' VAL . 8.3 t 88.22 -27.19 0.07 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.617 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.7 84.04 1.17 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.047 0.451 . . . . 0.0 110.765 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.49 -98.36 0.14 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.958 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.047 HD12 HD13 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -64.41 -33.66 76.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.68 0.276 . . . . 0.0 110.926 179.219 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG21 ' OG ' ' A' ' 78' ' ' SER . 3.6 t -65.32 -32.29 57.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.807 0.337 . . . . 0.0 111.165 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.24 -48.91 43.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.451 -0.88 . . . . 0.0 112.274 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.428 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -65.12 -45.39 85.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.794 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 29' ' ' LEU . 11.4 tp -56.8 -40.99 76.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.625 179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.411 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 4.7 mtt -53.0 -41.16 64.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.24 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -45.49 74.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.669 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.937 HG12 HD13 ' A' ' 48' ' ' LEU . 22.5 t -51.25 -40.02 22.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.709 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 92.9 mmm -63.0 -28.53 70.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.325 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 86' ' ' MET . 42.8 mt-30 -69.26 -17.13 63.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.171 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -67.85 -53.64 25.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.301 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -18.23 62.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.413 -179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.0 m -76.35 -28.77 56.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.8 0.334 . . . . 0.0 111.082 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -110.66 -14.19 14.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.616 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.8 118.17 17.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.961 0.41 . . . . 0.0 111.236 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -105.3 105.08 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.262 0.553 . . . . 0.0 110.871 179.586 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -43.5 102.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.493 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.99 142.86 23.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.894 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.21 175.3 5.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.002 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.3 t0 60.16 178.48 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.997 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -140.6 76.34 1.55 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.937 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -118.42 -136.97 5.57 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.653 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.98 122.46 8.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.35 . . . . 0.0 111.085 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -168.43 82.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.859 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -169.61 -176.44 2.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.01 97.85 7.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.068 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.41 -1.216 . . . . 0.0 112.474 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.8 0.333 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.17 29.62 4.21 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -121.43 154.83 36.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.938 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.35 147.77 25.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -123.12 48.67 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 t -117.94 141.73 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.025 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.4 t 58.76 176.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.723 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -174.85 63.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.344 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 50' ' ' TYR . 3.0 t -59.92 -48.68 86.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.005 0.431 . . . . 0.0 110.529 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.09 40.92 97.76 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.036 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -88.5 153.44 21.15 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.28 137.93 28.98 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.679 0.276 . . . . 0.0 110.795 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.44 -23.36 7.36 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.69 2.26 . . . . 0.0 112.358 -179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -98.42 -41.4 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -89.45 -25.92 21.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.002 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.74 -142.47 16.1 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.337 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.589 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -83.0 146.4 28.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 0.0 110.841 179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -84.66 61.12 6.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.731 HG11 ' HG3' ' A' ' 37' ' ' GLU . 5.2 m -49.07 -25.36 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.237 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -72.12 -20.88 61.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.086 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -132.23 20.75 4.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.429 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.0 HD22 HD11 ' A' ' 26' ' ' LEU . 17.0 mt -70.28 159.7 33.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.936 0.398 . . . . 0.0 111.163 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -82.44 139.42 44.65 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.77 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 49.2 Cg_exo -54.86 -19.17 18.36 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.518 2.146 . . . . 0.0 112.464 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' ' HE2' ' A' ' 66' ' ' MET . 7.2 m-20 -81.27 -57.68 3.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.127 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.0 HD11 HD22 ' A' ' 22' ' ' LEU . 3.4 pp -70.64 -40.97 72.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.105 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.5 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.6 OUTLIER -59.04 -39.09 80.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.854 0.359 . . . . 0.0 110.576 179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -64.09 -38.49 91.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.619 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.694 HD12 HG22 ' A' ' 82' ' ' VAL . 15.5 tp -56.11 -51.01 69.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.576 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.444 ' CG ' HD21 ' A' ' 40' ' ' LEU . 21.0 m-85 -52.3 -49.04 64.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.512 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.3 m -62.41 -41.49 98.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.791 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.545 ' HB3' HG11 ' A' ' 82' ' ' VAL . 34.7 mtt180 -62.48 -35.86 80.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.983 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.1 -14.74 57.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.482 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 10.78 45.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.796 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.511 HD11 ' HG ' ' A' ' 85' ' ' LEU . 62.5 mt -86.64 119.62 34.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.842 0.353 . . . . 0.0 110.939 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -86.6 157.45 19.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.998 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.731 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.82 -30.32 32.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.047 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.65 70.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.858 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.432 ' NE2' HG21 ' A' ' 45' ' ' THR . 9.6 mm100 -77.76 -30.14 51.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.712 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.444 HD21 ' CG ' ' A' ' 30' ' ' PHE . 95.2 mt -69.6 -22.8 63.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.5 p -97.44 -7.68 31.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.606 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' SER . 2.1 t70 -81.45 115.51 20.81 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.818 0.342 . . . . 0.0 110.63 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.96 -34.2 3.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.682 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.482 ' CG ' ' CZ ' ' A' ' 92' ' ' ARG . 5.6 tp10 -72.44 -59.9 2.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.824 0.345 . . . . 0.0 111.491 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.442 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.3 -32.89 74.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.172 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 1.4 t -57.86 -42.1 83.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.599 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.469 ' HA ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.84 -55.2 32.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.358 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.633 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -63.31 -31.61 72.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.723 0.297 . . . . 0.0 110.953 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.431 HD13 HD23 ' A' ' 40' ' ' LEU . 70.4 mt -69.76 -64.02 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.381 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.469 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 1.9 p90 -53.35 -38.2 63.06 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.073 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -54.18 -34.32 60.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.638 178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.516 ' CE2' ' NE2' ' A' ' 56' ' ' GLN . 69.1 t80 -63.93 -30.67 71.73 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.092 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.981 HG23 HG21 ' A' ' 62' ' ' VAL . 40.2 mt -66.29 -28.5 43.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.034 177.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -71.8 -34.42 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.816 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.478 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.3 p30 -69.96 -25.59 63.7 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 0.0 110.497 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.516 ' NE2' ' CE2' ' A' ' 52' ' ' PHE . 9.0 mt-30 -83.12 -8.97 59.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.094 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 113.64 22.08 5.54 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.886 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.64 171.02 47.21 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.603 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 63' ' ' ARG . 13.2 tp -47.8 -41.64 24.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.801 0.334 . . . . 0.0 111.055 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 28.5 mt-10 -64.27 -34.51 78.28 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.4 -178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 56' ' ' GLN . . . -73.16 -35.93 66.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.709 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.981 HG21 HG23 ' A' ' 53' ' ' ILE . 40.3 t -65.14 -63.56 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.667 0.27 . . . . 0.0 110.812 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 59' ' ' LEU . 1.0 OUTLIER -53.08 -37.94 62.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.98 0.419 . . . . 0.0 109.94 177.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.416 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 43.6 mt-30 -63.17 -50.62 69.67 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.061 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.879 ' CD ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -68.8 -34.88 76.27 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.542 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.415 ' HE2' ' O ' ' A' ' 25' ' ' ASP . 1.0 OUTLIER -60.51 -29.32 69.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.087 0.47 . . . . 0.0 110.049 178.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -76.56 -41.4 46.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.388 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -72.19 -32.49 66.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.485 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.414 ' NE2' ' O ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -82.43 -20.49 36.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.983 179.199 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -103.7 109.46 3.43 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.132 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -41.69 -95.87 0.01 OUTLIER Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.172 -0.537 . . . . 0.0 113.213 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.1 t -148.8 79.22 1.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 59.35 116.65 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.577 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.63 -34.26 4.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.521 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.21 40.23 1.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.911 0.386 . . . . 0.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -74.79 131.9 41.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.831 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.414 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 63.5 m -113.77 122.81 48.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.121 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.649 ' HB2' HG21 ' A' ' 82' ' ' VAL . 88.4 p -95.02 -6.26 42.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.367 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.45 102.37 3.18 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.01 0.433 . . . . 0.0 110.932 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.63 -95.24 0.18 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.376 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.879 HD13 ' CD ' ' A' ' 65' ' ' GLU . 2.7 pt? -62.85 -41.15 99.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.625 0.25 . . . . 0.0 111.361 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.694 HG22 HD12 ' A' ' 29' ' ' LEU . 6.2 t -63.8 -28.51 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.783 0.325 . . . . 0.0 111.078 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.33 -36.96 85.65 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.301 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.426 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.22 -47.04 81.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.896 0.379 . . . . 0.0 110.703 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.511 ' HG ' HD11 ' A' ' 35' ' ' ILE . 5.9 tp -54.08 -49.41 69.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.493 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.4 mtm -51.1 -31.63 19.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.473 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -39.92 36.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.259 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.633 HG12 HD13 ' A' ' 48' ' ' LEU . 57.9 t -56.4 -40.56 67.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.207 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.42 ' CE ' HG22 ' A' ' 45' ' ' THR . 3.3 mmt -63.99 -39.22 93.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.183 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -58.38 -21.83 51.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.863 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -68.32 -56.82 7.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.076 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.482 ' CZ ' ' CG ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -69.54 -25.22 63.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.778 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.7 m -73.73 -30.71 62.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.07 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.73 23.9 11.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.606 178.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 92' ' ' ARG . . . -74.12 143.11 45.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.234 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.541 ' O ' HG23 ' A' ' 96' ' ' ILE . 1.2 tp -105.92 99.22 8.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.46 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -40.21 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.639 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 96' ' ' ILE . 4.8 p -86.79 106.35 17.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.061 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.28 -161.22 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.25 31.33 8.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.892 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 101' ' ' GLU . 4.0 pt-20 -155.4 105.3 2.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -146.44 -103.95 0.38 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.588 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -95.87 97.21 9.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.855 0.36 . . . . 0.0 111.019 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -167.74 54.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.411 ' CG ' ' O ' ' A' ' 105' ' ' GLN . 0.3 OUTLIER -76.68 82.84 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.97 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.05 98.55 8.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.03 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.415 -1.214 . . . . 0.0 112.419 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.784 0.326 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.58 29.51 39.4 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.621 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -101.37 178.08 4.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.803 0.335 . . . . 0.0 110.944 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -86.89 110.59 20.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.847 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -112.81 87.65 2.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.897 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.19 140.88 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.104 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.405 ' CB ' ' HA3' ' A' ' 58' ' ' GLY . 0.7 OUTLIER -90.2 137.79 32.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.683 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -107.99 114.22 27.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.204 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 50' ' ' TYR . 7.0 t -71.82 -62.82 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.541 178.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.54 34.91 5.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.93 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.495 ' CE2' ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -88.7 152.61 21.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.758 0.313 . . . . 0.0 110.214 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.428 ' HB2' ' HB2' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -92.58 136.15 25.61 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.73 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -63.15 -58.73 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.494 2.13 . . . . 0.0 112.592 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -81.33 -34.44 31.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.715 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 47.9 m-20 -86.14 -22.76 26.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.651 0.262 . . . . 0.0 111.199 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.65 -150.6 21.83 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.587 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -80.78 142.87 33.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.862 0.363 . . . . 0.0 110.997 -179.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -81.7 64.96 6.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.771 HG21 ' HG2' ' A' ' 37' ' ' GLU . 2.0 m -54.69 -21.5 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.261 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -72.72 -20.84 61.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.143 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -132.11 20.62 4.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.508 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.867 HD22 HD11 ' A' ' 26' ' ' LEU . 17.7 mt -69.8 159.46 33.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.154 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 9.2 t70 -84.08 137.97 39.98 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.77 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 44.5 Cg_exo -55.89 -18.53 22.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.558 2.172 . . . . 0.0 112.463 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.425 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 68.3 m-20 -80.84 -57.63 3.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.044 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.867 HD11 HD22 ' A' ' 22' ' ' LEU . 4.1 pp -69.53 -44.81 70.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.148 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.622 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -55.2 -32.9 62.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.863 0.363 . . . . 0.0 110.534 179.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.4 t -64.55 -38.06 89.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 82' ' ' VAL . 16.0 tp -56.35 -54.54 44.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.733 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.566 ' CD2' HD11 ' A' ' 40' ' ' LEU . 8.2 m-85 -50.99 -44.32 60.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.769 179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -61.8 -49.32 76.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.915 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -34.05 67.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.054 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.94 -18.55 46.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.39 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.15 11.68 41.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.89 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 85' ' ' LEU . 52.4 mt -86.21 117.79 31.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.813 0.34 . . . . 0.0 111.057 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.03 161.46 18.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.771 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -52.73 -26.49 14.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.851 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.09 -43.2 73.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HG2' HG21 ' A' ' 45' ' ' THR . 0.5 OUTLIER -78.57 -28.73 45.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.742 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 30' ' ' PHE . 33.1 mt -71.19 -23.58 62.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.856 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 37' ' ' GLU . 45.6 p -98.05 -7.55 29.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.696 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 46' ' ' SER . 29.1 t0 -81.96 122.55 27.91 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.799 0.333 . . . . 0.0 110.744 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.07 -38.22 37.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.556 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' OE2' ' CZ ' ' A' ' 92' ' ' ARG . 18.3 tt0 -73.18 -59.81 2.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.672 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.487 HG22 HD11 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -66.75 -35.96 81.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.126 -178.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 42' ' ' ASP . 70.4 m -58.8 -41.98 88.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.855 0.36 . . . . 0.0 110.438 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -60.11 -55.23 36.38 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.43 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.824 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -64.4 -31.99 73.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.383 -178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 45' ' ' THR . 60.4 mt -67.5 -63.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.203 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.495 ' CE2' ' CE2' ' A' ' 11' ' ' TRP . 2.0 p90 -52.36 -35.84 52.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.925 0.393 . . . . 0.0 110.303 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -55.8 -32.76 63.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.477 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.476 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 74.0 t80 -64.67 -41.03 96.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.167 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.927 HG23 HG21 ' A' ' 62' ' ' VAL . 30.8 mt -55.95 -28.23 24.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.213 178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -71.21 -36.13 71.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.589 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.476 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -73.49 -25.92 60.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.568 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 89.2 mm-40 -86.22 12.5 9.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.639 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.49 15.04 36.07 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.607 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' HA3' ' CB ' ' A' ' 7' ' ' SER . . . 82.1 170.63 45.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.784 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.4 tp -48.95 -37.95 21.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.764 0.316 . . . . 0.0 111.112 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.01 -35.69 82.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.317 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.21 -35.8 66.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.668 -179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.927 HG21 HG23 ' A' ' 53' ' ' ILE . 31.3 t -65.32 -63.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.707 0.289 . . . . 0.0 110.768 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.425 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -52.1 -37.47 54.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.06 0.457 . . . . 0.0 110.138 178.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -63.09 -52.07 64.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.53 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.688 ' CD ' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -69.5 -36.32 76.37 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.803 0.335 . . . . 0.0 110.982 -178.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.411 ' O ' ' HG3' ' A' ' 69' ' ' GLN . 2.8 mmt -66.66 -28.81 68.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.596 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.421 ' CG ' ' O ' ' A' ' 63' ' ' ARG . 11.5 mmt180 -77.92 -35.84 50.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.067 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -18.32 62.14 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.819 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 66' ' ' MET . 4.8 pt20 -90.41 -14.45 32.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.716 -0.22 . . . . 0.0 111.542 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.97 -60.87 7.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.604 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -107.18 -118.05 4.29 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.629 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.3 p -57.93 148.85 24.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.877 0.37 . . . . 0.0 111.014 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.17 -70.96 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.39 -175.15 36.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.437 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 72.9 m -99.88 1.08 42.53 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -74.91 119.37 18.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.838 0.352 . . . . 0.0 110.951 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -122.18 90.47 3.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.683 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.568 ' HB2' HG21 ' A' ' 82' ' ' VAL . 4.6 p 88.33 -22.74 0.13 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.491 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -74.35 88.18 2.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.012 0.434 . . . . 0.0 110.842 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.17 -92.45 0.11 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.096 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.688 HD13 ' CD ' ' A' ' 65' ' ' GLU . 2.6 pt? -63.39 -39.12 93.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.956 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 29' ' ' LEU . 9.2 t -62.67 -27.41 42.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.29 -41.1 80.09 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.26 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.49 -39.46 93.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.337 . . . . 0.0 110.785 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 35' ' ' ILE . 10.3 tp -64.0 -41.08 97.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.37 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.41 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -53.58 -42.5 67.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.18 178.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -44.89 92.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.442 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.824 HG12 HD13 ' A' ' 48' ' ' LEU . 44.7 t -52.33 -41.79 35.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.56 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 74.5 mmm -65.17 -33.59 76.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.793 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 86' ' ' MET . 37.2 mt-30 -59.53 -19.46 48.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.538 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.585 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 1.5 tptp -68.26 -35.56 78.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.843 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.453 ' CG ' ' CD2' ' A' ' 48' ' ' LEU . 30.5 mmm-85 -74.74 -26.51 59.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.564 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 24.5 t -77.34 -31.71 54.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.023 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 45.9 mmm-85 -113.66 18.29 17.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.61 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -75.61 116.79 16.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.99 0.424 . . . . 0.0 111.059 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.588 ' O ' HG23 ' A' ' 96' ' ' ILE . 2.2 tp -132.55 104.64 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.976 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -48.77 92.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 96' ' ' ILE . 2.2 t -130.29 159.45 36.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.954 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.8 m -117.21 33.33 5.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.64 72.81 0.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.944 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -166.45 -174.52 2.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.09 75.41 0.39 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.406 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -111.44 162.39 15.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.941 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.3 t70 39.44 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.756 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -129.71 129.35 44.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.16 128.6 33.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.526 179.937 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.833 0.349 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.39 -24.28 29.85 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.615 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -143.17 152.61 41.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 110.931 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -87.2 148.3 25.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.916 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -154.3 57.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.738 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.6 t -102.91 141.4 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.14 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.29 113.04 24.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.728 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -100.43 112.79 25.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.155 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.477 HG11 ' CZ ' ' A' ' 17' ' ' PHE . 12.6 t -75.92 -34.55 27.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.029 0.442 . . . . 0.0 110.685 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.05 32.59 63.1 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.984 -0.626 . . . . 0.0 113.131 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.486 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.06 153.45 20.98 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.851 0.325 . . . . 0.0 110.318 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.96 138.58 27.61 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.615 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -78.61 -33.89 1.58 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.672 2.248 . . . . 0.0 112.33 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -92.33 -41.0 10.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.946 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.15 -25.1 24.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.012 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.34 -146.28 18.19 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.505 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' CZ ' HG11 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -81.59 140.21 34.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.347 . . . . 0.0 110.882 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -74.86 60.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.174 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.772 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -50.52 -24.64 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -73.48 -22.25 60.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.1 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -128.7 20.03 6.09 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.433 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.825 HD22 HD11 ' A' ' 26' ' ' LEU . 17.1 mt -70.64 159.49 34.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 111.051 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 2.6 t70 -84.58 139.3 38.11 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.095 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' HA ' ' HG2' ' A' ' 27' ' ' ARG . 48.3 Cg_exo -55.67 -19.0 22.49 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.56 2.173 . . . . 0.0 112.399 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -81.34 -57.16 3.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.929 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.825 HD11 HD22 ' A' ' 22' ' ' LEU . 4.2 pp -70.14 -44.37 69.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.041 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.707 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -54.39 -35.9 63.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.917 0.389 . . . . 0.0 110.46 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.06 -38.92 93.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.708 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.633 HD12 HG22 ' A' ' 82' ' ' VAL . 27.8 tp -56.65 -54.23 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.572 ' HD1' HD21 ' A' ' 85' ' ' LEU . 21.7 m-85 -51.93 -46.77 64.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.491 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -62.21 -50.72 70.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.714 178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.554 ' HB3' HG11 ' A' ' 82' ' ' VAL . 43.9 mtt180 -54.73 -32.25 59.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.812 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.555 ' HB1' ' HG2' ' A' ' 86' ' ' MET . . . -82.5 -14.24 55.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.469 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.05 13.12 50.58 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.677 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.476 HD12 HD21 ' A' ' 85' ' ' LEU . 58.2 mt -86.52 118.9 33.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 111.047 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.74 163.57 17.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.881 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.772 ' HG2' HG21 ' A' ' 19' ' ' VAL . 2.4 mt-10 -53.78 -30.3 44.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.876 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.1 -41.91 72.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.074 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -78.27 -31.32 48.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.805 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.485 HD21 ' CG ' ' A' ' 30' ' ' PHE . 96.0 mt -70.97 -27.59 63.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.463 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 37' ' ' GLU . 31.5 p -97.75 -3.64 38.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.555 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.72 121.46 26.42 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.9 -37.23 30.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.479 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -72.86 -59.89 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.595 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.71 -35.52 78.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.394 -178.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.5 p -57.42 -37.57 72.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.822 0.344 . . . . 0.0 110.147 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 18.0 tptt -61.55 -56.07 24.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.146 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.82 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -65.72 -30.72 71.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.287 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.455 HD13 HD23 ' A' ' 40' ' ' LEU . 39.5 mt -68.03 -64.21 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.532 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.3 p90 -52.57 -38.66 60.36 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.929 0.395 . . . . 0.0 110.203 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.11 -33.54 65.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.674 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 49' ' ' ILE . 53.1 t80 -64.62 -39.63 94.06 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.303 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.951 HG23 HG21 ' A' ' 62' ' ' VAL . 21.6 mt -57.39 -29.87 34.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.241 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.34 -36.41 79.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.433 178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.69 -25.12 61.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.558 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.406 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 16.9 mm100 -86.51 12.13 11.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.44 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 96.23 17.86 33.09 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.572 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.76 166.84 39.8 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.696 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.49 HD11 ' CD2' ' A' ' 26' ' ' LEU . 32.1 tp -49.08 -37.33 20.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 0.0 111.119 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.9 -34.55 78.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.2 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -72.78 -35.53 67.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.267 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.951 HG21 HG23 ' A' ' 53' ' ' ILE . 18.5 t -66.09 -48.61 80.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.925 0.393 . . . . 0.0 110.737 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -53.76 -46.23 70.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.175 0.512 . . . . 0.0 109.956 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -64.22 -48.68 74.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.135 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 8.0 pt-20 -68.6 -20.73 64.51 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.612 0.244 . . . . 0.0 111.643 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.525 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 2.2 mmt -85.85 -33.71 21.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -78.73 -37.88 40.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.427 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -71.58 -20.91 61.94 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.868 -179.017 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 66' ' ' MET . 1.8 pt20 -82.12 -8.15 59.64 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.57 -42.64 39.58 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.595 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.55 34.32 4.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.533 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 m -70.85 170.22 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.771 0.32 . . . . 0.0 110.925 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.46 -65.34 3.57 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.37 178.06 53.14 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.528 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.2 m -98.99 29.34 3.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -74.75 106.31 6.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.447 ' O ' ' CB ' ' A' ' 78' ' ' SER . 88.5 p -122.04 115.2 22.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.447 ' CB ' ' O ' ' A' ' 77' ' ' SER . 1.5 m 87.76 -25.94 0.08 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.675 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.72 91.68 2.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 110.783 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.32 -91.91 0.12 Allowed Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.087 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.537 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.4 pt? -64.0 -39.59 94.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.359 . . . . 0.0 111.055 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.633 HG22 HD12 ' A' ' 29' ' ' LEU . 8.5 t -63.54 -30.58 50.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.106 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.75 -41.05 75.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.32 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 88' ' ' VAL . . . -64.2 -45.66 87.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 110.815 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.572 HD21 ' HD1' ' A' ' 30' ' ' PHE . 13.4 tp -60.91 -44.85 96.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.481 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.555 ' HG2' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -53.56 -42.6 67.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.373 178.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -36.07 82.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.542 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.82 HG12 HD13 ' A' ' 48' ' ' LEU . 65.4 t -65.91 -40.18 86.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.766 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 48.5 mmm -62.11 -39.03 91.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.659 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.409 ' NE2' ' HA ' ' A' ' 90' ' ' GLN . 14.7 mm100 -62.83 -14.24 43.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.967 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 2.2 tptp -70.7 -48.88 52.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.384 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.417 ' HG2' ' CD2' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -71.16 -20.62 62.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.717 -178.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.9 t -77.03 -24.25 52.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.942 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.421 ' HD3' ' N ' ' A' ' 94' ' ' ARG . 1.1 mpp_? -135.09 14.32 3.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.047 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -72.91 174.26 8.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.98 0.419 . . . . 0.0 111.233 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.652 ' H ' HD12 ' A' ' 96' ' ' ILE . 5.3 mp -58.33 110.57 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.176 179.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.42 66.65 0.08 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.829 177.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.6 OUTLIER -92.71 -34.46 13.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.953 -177.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -159.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.757 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.77 135.16 34.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.95 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -48.7 101.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.068 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -160.08 57.4 0.32 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.491 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -93.6 112.86 24.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.785 0.326 . . . . 0.0 110.975 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 103' ' ' GLU . 3.3 t0 81.39 -61.53 0.2 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.23 158.22 23.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.989 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.22 107.1 13.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.065 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.354 -1.248 . . . . 0.0 112.537 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.853 0.359 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.65 -24.07 33.64 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -140.65 170.7 15.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.788 0.327 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.23 112.94 22.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.959 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -99.63 111.88 24.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.703 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.57 139.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.366 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.9 m 59.19 -177.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -150.53 74.13 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.259 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.7 t -72.87 -35.55 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.468 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.89 39.61 8.86 Favored Glycine 0 C--N 1.33 0.234 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.071 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -89.11 153.35 21.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.699 0.285 . . . . 0.0 110.264 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 16' ' ' GLY . 1.8 m-20 -89.52 140.15 28.26 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 120.717 0.294 . . . . 0.0 110.54 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.73 -28.39 5.27 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.662 2.241 . . . . 0.0 112.483 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -98.0 -38.83 9.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.981 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -87.48 -21.62 25.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 12' ' ' ASP . . . 95.6 -138.2 13.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.206 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.58 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.4 OUTLIER -81.94 -169.08 2.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.942 0.401 . . . . 0.0 110.755 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -123.99 54.15 1.35 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.499 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.798 HG11 ' HG3' ' A' ' 37' ' ' GLU . 0.9 OUTLIER -46.15 -26.54 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.641 -179.031 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -68.56 -23.94 64.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.031 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -134.78 25.21 3.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.642 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.892 HD22 HD11 ' A' ' 26' ' ' LEU . 17.6 mt -70.2 159.5 33.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.927 0.394 . . . . 0.0 111.167 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.91 137.97 40.47 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.707 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.6 Cg_exo -54.76 -19.22 18.15 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.584 2.189 . . . . 0.0 112.654 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 63' ' ' ARG . 52.2 m-20 -81.64 -57.71 3.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.291 -179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.892 HD11 HD22 ' A' ' 22' ' ' LEU . 4.0 pp -70.91 -38.1 72.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.158 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -62.22 -35.51 79.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.489 179.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 t -63.24 -36.32 83.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.633 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.712 HD12 HG22 ' A' ' 82' ' ' VAL . 25.2 tp -56.6 -50.72 71.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.644 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CE1' ' CG2' ' A' ' 49' ' ' ILE . 24.4 m-85 -55.47 -43.99 76.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.569 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -50.11 74.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.932 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -60.81 -29.3 69.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.16 -21.2 36.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.173 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.36 14.51 38.21 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.643 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.482 HD12 HD21 ' A' ' 85' ' ' LEU . 64.8 mt -86.75 121.54 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.858 0.361 . . . . 0.0 111.059 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 p -86.97 158.23 19.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.798 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -52.07 -27.12 12.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.842 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.17 -42.17 72.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -78.1 -30.17 49.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.432 HD23 HD13 ' A' ' 49' ' ' ILE . 70.6 mt -70.33 -24.77 63.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 37' ' ' GLU . 31.6 p -98.45 -5.98 31.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.705 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.89 121.14 26.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.84 0.353 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.08 -35.54 25.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.276 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' CG ' ' CZ ' ' A' ' 92' ' ' ARG . 4.1 tp10 -72.53 -59.9 2.5 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.685 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -67.16 -33.74 76.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.987 -179.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.4 p -57.6 -40.07 78.25 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.726 0.298 . . . . 0.0 110.345 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.8 tptt -61.77 -53.93 49.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.356 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.58 HD13 HG12 ' A' ' 88' ' ' VAL . 1.7 pp -66.64 -31.44 72.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.19 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.432 HD13 HD23 ' A' ' 40' ' ' LEU . 54.1 mt -69.95 -64.78 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.749 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.504 ' HB3' ' CE2' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -54.18 -36.94 63.94 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.361 -178.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -55.0 -33.17 62.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.446 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.443 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 60.7 t80 -64.87 -39.57 93.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.188 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 62' ' ' VAL . 22.6 mt -56.39 -29.98 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.274 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.75 -36.37 75.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.686 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.1 p30 -71.14 -26.51 63.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.636 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 97.1 mm-40 -86.05 11.14 12.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.503 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 97.33 18.21 29.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.496 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.47 172.33 48.63 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.007 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 59' ' ' LEU . 8.2 tp -48.43 -44.86 35.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 0.0 111.196 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.5 -35.19 79.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.392 -178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -33.73 65.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.572 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.976 HG21 HG23 ' A' ' 53' ' ' ILE . 48.6 t -64.9 -63.48 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.427 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.43 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 1.4 ptp180 -52.29 -38.54 58.64 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 110.088 177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -64.14 -48.96 74.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.909 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 66' ' ' MET . 10.7 pt-20 -68.52 -43.59 76.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.517 -177.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.445 ' N ' ' HG3' ' A' ' 65' ' ' GLU . 4.9 mmm -55.31 -30.58 60.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.053 0.454 . . . . 0.0 110.57 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -78.23 -40.38 37.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.679 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -68.43 -27.18 65.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.736 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.43 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.57 -19.2 63.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.343 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.62 71.87 2.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.488 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 106.0 165.07 23.14 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.6 t 54.98 105.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 0.0 110.951 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 54.7 89.87 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.318 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.14 66.47 1.31 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.378 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.3 t -57.91 -18.71 24.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.652 0.263 . . . . 0.0 111.331 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.15 130.97 41.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.845 0.355 . . . . 0.0 111.049 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 78' ' ' SER . 0.2 OUTLIER -116.75 149.39 39.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.936 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' ' 77' ' ' SER . 0.7 OUTLIER 85.59 -40.82 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.616 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -74.63 74.02 2.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.431 . . . . 0.0 110.826 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.58 -88.15 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.167 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.6 pt? -62.36 -39.11 92.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 0.0 110.739 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.712 HG22 HD12 ' A' ' 29' ' ' LEU . 19.4 t -62.62 -27.06 42.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.886 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.14 -37.54 82.04 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.292 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.91 -51.28 62.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.482 HD21 HD12 ' A' ' 35' ' ' ILE . 29.5 tp -59.83 -42.37 93.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.72 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.7 mtm -52.92 -37.93 61.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.301 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.449 ' CD2' ' OE1' ' A' ' 90' ' ' GLN . 1.2 t-160 -69.22 -46.85 66.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.222 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.58 HG12 HD13 ' A' ' 48' ' ' LEU . 98.5 t -52.09 -41.1 31.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.62 178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 89.1 mmm -63.9 -38.25 90.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.35 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.449 ' OE1' ' CD2' ' A' ' 87' ' ' HIS . 64.6 mt-30 -62.93 -20.48 65.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.703 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -67.71 -57.11 6.93 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.21 0.529 . . . . 0.0 110.941 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.477 ' CZ ' ' CG ' ' A' ' 44' ' ' GLU . 0.1 OUTLIER -69.82 -26.61 64.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.79 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.9 m -75.83 -38.09 58.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.307 178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -102.55 20.11 17.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.061 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.91 164.51 26.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.112 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.67 ' O ' HG23 ' A' ' 96' ' ' ILE . 3.8 tp -84.03 92.86 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 96' ' ' ILE . 1.4 m-70 69.84 -58.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.507 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 28.3 t 177.65 80.9 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.792 0.33 . . . . 0.0 110.989 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 89.9 p -68.64 152.52 45.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.853 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -153.87 -46.11 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.845 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.11 137.76 34.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.66 -170.51 12.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.456 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.24 128.83 50.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.852 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -167.74 163.03 14.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.889 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -110.82 -75.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.975 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.91 102.09 9.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.089 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.382 -1.232 . . . . 0.0 112.534 -179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.843 0.354 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.25 26.46 8.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.464 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -83.65 160.16 21.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 0.0 110.872 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.17 162.75 30.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.23 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -127.22 75.11 1.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.691 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.54 119.8 61.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.251 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.9 p 56.44 -163.2 0.17 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -168.21 66.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.265 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' A' ' 50' ' ' TYR . 1.5 t -82.07 99.9 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.347 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.92 57.28 1.27 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.722 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -87.17 153.77 21.24 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.59 141.44 30.27 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-O 120.772 0.32 . . . . 0.0 110.826 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -76.1 -23.2 12.26 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.713 2.275 . . . . 0.0 112.64 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.42 -34.22 5.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.189 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -87.39 -25.79 23.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.779 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.97 -150.55 19.6 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.642 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.62 147.78 29.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.955 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -82.85 61.19 5.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.711 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.2 m -48.57 -25.91 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.205 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -71.16 -21.29 62.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.48 19.63 5.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.571 -179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.993 HD22 HD11 ' A' ' 26' ' ' LEU . 17.5 mt -70.64 159.28 34.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.808 0.337 . . . . 0.0 110.975 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -84.26 141.0 39.46 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.026 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.491 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 52.7 Cg_exo -54.36 -21.03 21.87 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.65 2.234 . . . . 0.0 112.371 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -82.16 -56.3 4.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.308 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.993 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -71.17 -37.43 72.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.25 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.504 ' N ' HD12 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -58.67 -39.67 81.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.38 . . . . 0.0 110.425 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.448 ' N ' ' HD2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -63.27 -36.16 82.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.641 179.108 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.65 HD12 HG22 ' A' ' 82' ' ' VAL . 14.8 tp -56.38 -43.33 79.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.729 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.502 ' CG ' HD21 ' A' ' 40' ' ' LEU . 18.5 m-85 -66.85 -49.42 65.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.615 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.2 m -60.7 -50.57 72.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.63 ' HB3' HG11 ' A' ' 82' ' ' VAL . 11.9 mtt180 -59.11 -30.23 67.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.521 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.65 4.63 24.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.567 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.86 7.57 88.25 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.986 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.53 HD11 ' HG ' ' A' ' 85' ' ' LEU . 48.7 mt -87.1 122.57 39.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.837 0.351 . . . . 0.0 111.319 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.35 158.28 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.708 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.711 ' HG3' HG11 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -52.38 -29.88 26.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.772 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.22 -38.76 68.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.402 ' O ' ' HB ' ' A' ' 45' ' ' THR . 37.0 mt-30 -78.02 -32.39 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.502 HD21 ' CG ' ' A' ' 30' ' ' PHE . 57.9 mt -69.61 -24.21 63.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.722 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 37' ' ' GLU . 20.4 p -96.72 -7.45 33.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.528 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 46' ' ' SER . 22.7 t0 -81.41 115.4 20.73 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.826 0.346 . . . . 0.0 110.595 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.22 -35.53 3.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.778 -178.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -72.22 -59.93 2.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 111.493 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -67.6 -34.89 77.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.487 -178.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -56.19 -41.17 75.14 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.412 179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.46 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -61.58 -56.25 21.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.346 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.686 HD13 HG12 ' A' ' 88' ' ' VAL . 1.8 pp -63.51 -30.31 71.45 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.911 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 30' ' ' PHE . 80.6 mt -68.81 -64.41 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.023 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CE1' ' HA ' ' A' ' 47' ' ' LYS . 1.7 p90 -55.48 -39.13 70.03 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.117 -179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.433 ' OD1' ' CE1' ' A' ' 50' ' ' TYR . 0.9 OUTLIER -52.34 -34.59 48.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.521 179.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.47 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 54.7 t80 -64.33 -38.78 92.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.806 178.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 62' ' ' VAL . 48.6 mt -56.62 -30.81 32.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.136 178.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 69.0 tt0 -69.5 -33.66 73.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.684 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.0 OUTLIER -75.46 -26.0 57.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.729 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 78.4 mm-40 -86.21 11.39 12.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.52 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 99.33 17.14 27.72 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.585 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.84 169.59 45.41 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.995 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' CG2' ' A' ' 53' ' ' ILE . 14.0 tp -48.06 -39.72 20.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.712 0.292 . . . . 0.0 111.145 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 64' ' ' GLN . 24.6 mm-40 -65.73 -35.44 80.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.327 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 56' ' ' GLN . . . -73.09 -35.96 66.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.768 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.976 HG21 HG23 ' A' ' 53' ' ' ILE . 46.2 t -65.24 -62.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.877 0.37 . . . . 0.0 110.97 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -52.78 -39.03 61.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.186 0.517 . . . . 0.0 110.053 177.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.408 ' CG ' ' O ' ' A' ' 60' ' ' GLU . 50.2 mt-30 -63.85 -50.1 70.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.876 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 16.5 pt-20 -69.47 -40.13 77.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.367 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.503 ' HG2' HD11 ' A' ' 81' ' ' LEU . 2.3 mmt -56.77 -41.99 78.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.217 0.532 . . . . 0.0 110.001 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -44.25 21.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.278 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -71.04 -25.7 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.809 -177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.7 -9.04 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 43.99 -101.58 0.03 OUTLIER Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.91 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 173.26 118.39 0.49 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.429 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.0 m -63.81 109.93 1.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.835 0.35 . . . . 0.0 110.965 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 97.19 -27.35 18.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.428 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.25 -134.67 1.68 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.39 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.06 17.21 18.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.641 0.258 . . . . 0.0 111.24 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -75.91 117.38 17.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.842 0.354 . . . . 0.0 111.074 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.0 t -119.01 119.34 33.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.485 179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 1.5 p 169.3 -40.84 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.653 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.99 105.37 3.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.956 0.408 . . . . 0.0 111.133 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.08 -93.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.502 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.503 HD11 ' HG2' ' A' ' 66' ' ' MET . 2.6 pt? -60.79 -39.65 89.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.0 110.958 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.65 HG22 HD12 ' A' ' 29' ' ' LEU . 22.8 t -63.19 -24.95 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.804 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.82 -36.87 83.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.209 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.36 -52.16 59.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.888 0.375 . . . . 0.0 110.715 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 35' ' ' ILE . 3.9 tp -51.11 -48.12 61.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.57 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.5 mtt -50.29 -40.85 49.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.706 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -44.08 77.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.237 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.686 HG12 HD13 ' A' ' 48' ' ' LEU . 93.9 t -55.8 -40.28 60.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.527 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 85.7 mmm -62.94 -37.64 87.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.557 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -61.23 -21.33 63.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.522 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -68.59 -57.83 5.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.045 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.54 ' HB2' HD22 ' A' ' 48' ' ' LEU . 2.6 tpt180 -73.32 -15.28 61.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.622 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.9 t -75.67 -36.67 60.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.914 0.387 . . . . 0.0 110.871 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -21.56 35.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.053 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.4 121.13 20.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.932 0.396 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 96' ' ' ILE . 5.5 tp -119.3 102.99 13.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.895 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -83.4 67.34 9.27 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.937 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 47.4 p 177.62 37.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.851 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.77 -162.97 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.9 t0 60.35 63.75 1.33 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.824 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -166.64 172.27 10.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.16 122.45 2.09 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.591 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.89 99.92 12.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.885 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.77 -34.92 69.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.89 109.73 0.62 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.911 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.03 147.15 30.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.031 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.369 -1.239 . . . . 0.0 112.559 -179.923 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.818 0.342 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.27 -24.27 32.92 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.44 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.42 ' O ' ' CD2' ' A' ' 3' ' ' PHE . 17.4 p90 -130.81 102.2 5.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.849 0.357 . . . . 0.0 110.826 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.52 156.35 19.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.089 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -109.68 55.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.741 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.0 t -61.41 119.79 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.231 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.1 m -91.05 111.04 22.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.752 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -91.37 -24.25 19.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.174 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 9' ' ' VAL . 43.7 t 68.36 8.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.743 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 45.6 25.68 1.5 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.901 -0.666 . . . . 0.0 113.357 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.564 ' CZ2' ' CZ ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -89.59 153.44 20.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.99 0.395 . . . . 0.0 110.301 179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.8 OUTLIER -89.3 140.62 28.66 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.712 0.292 . . . . 0.0 110.769 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.45 -36.8 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.743 2.295 . . . . 0.0 112.591 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -91.6 -35.95 13.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.965 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 48.0 m-80 -87.7 -30.13 20.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.786 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.29 -144.99 16.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.612 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.748 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -82.43 152.64 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 111.082 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -88.09 57.9 4.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.845 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.74 HG21 ' HG2' ' A' ' 37' ' ' GLU . 1.7 m -49.13 -25.87 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.28 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.85 -20.11 60.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.125 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -130.32 21.39 5.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.42 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.068 HD22 HD11 ' A' ' 26' ' ' LEU . 17.6 mt -70.37 159.2 34.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.885 0.374 . . . . 0.0 111.053 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -85.25 142.86 38.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.085 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 47.5 Cg_exo -56.4 -18.86 26.44 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.673 2.248 . . . . 0.0 112.456 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -81.2 -58.81 2.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.917 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.068 HD11 HD22 ' A' ' 22' ' ' LEU . 3.7 pp -71.76 -40.85 69.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.217 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.458 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -57.26 -34.09 68.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.021 0.439 . . . . 0.0 110.124 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.6 t -64.23 -38.04 89.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.609 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.029 HD13 HD12 ' A' ' 81' ' ' LEU . 1.3 tp -56.68 -58.26 8.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.279 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -51.11 -42.13 60.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.467 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.6 m -62.7 -56.3 18.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.713 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.454 ' CZ ' ' HG3' ' A' ' 76' ' ' GLN . 0.2 OUTLIER -59.32 -25.5 64.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.763 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.98 -19.01 41.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.27 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.73 13.96 53.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.7 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.453 HD12 HD21 ' A' ' 85' ' ' LEU . 60.7 mt -87.26 122.15 38.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.889 0.376 . . . . 0.0 111.152 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 p -87.73 159.13 18.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.864 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.74 ' HG2' HG21 ' A' ' 19' ' ' VAL . 0.8 OUTLIER -53.15 -31.65 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.97 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.97 -41.92 68.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.8 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -77.5 -34.59 54.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.683 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.497 HD23 HD13 ' A' ' 49' ' ' ILE . 82.0 mt -70.55 -22.72 62.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.979 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.724 HG23 ' O ' ' A' ' 37' ' ' GLU . 34.8 p -97.03 -5.01 38.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.739 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -81.37 124.34 29.31 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.829 0.347 . . . . 0.0 110.78 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.47 -36.71 45.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.635 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -72.08 -59.7 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.815 0.34 . . . . 0.0 111.43 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.407 ' O ' ' HG ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -66.42 -32.45 73.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.011 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 91.6 p -58.34 -41.18 84.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.36 . . . . 0.0 110.36 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 4.2 tptm -61.3 -53.02 62.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.473 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.751 HD13 HG12 ' A' ' 88' ' ' VAL . 1.6 pp -67.42 -31.46 71.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.25 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.497 HD13 HD23 ' A' ' 40' ' ' LEU . 55.7 mt -68.2 -65.09 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.535 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.564 ' CZ ' ' CZ2' ' A' ' 11' ' ' TRP . 1.0 OUTLIER -54.89 -36.0 64.68 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.511 -0.476 . . . . 0.0 109.904 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -56.31 -34.05 66.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.389 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.531 ' CD2' HG21 ' A' ' 88' ' ' VAL . 47.7 t80 -64.46 -35.09 79.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.158 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.836 HG23 HG21 ' A' ' 62' ' ' VAL . 28.1 mt -62.77 -27.37 42.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.132 178.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -71.64 -33.34 68.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.53 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -73.27 -26.29 61.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.453 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.42 ' O ' ' HB1' ' A' ' 61' ' ' ALA . 12.6 mm100 -85.0 3.49 38.27 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.379 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 103.47 19.62 12.08 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.431 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' C ' HG22 ' A' ' 53' ' ' ILE . . . 82.86 167.77 41.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.475 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.486 ' CD1' HD22 ' A' ' 26' ' ' LEU . 28.2 tp -49.3 -37.54 24.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 0.0 111.122 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.47 -34.08 77.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.208 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.422 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.16 -35.43 66.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.379 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.836 HG21 HG23 ' A' ' 53' ' ' ILE . 45.5 t -65.71 -54.75 24.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.366 . . . . 0.0 110.815 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -53.62 -46.75 70.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.077 0.465 . . . . 0.0 110.087 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -63.09 -50.03 72.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.818 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 9.8 pt-20 -69.53 -37.52 77.14 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.323 -178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 81' ' ' LEU . 1.7 mmt -57.76 -32.44 67.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.985 0.422 . . . . 0.0 110.423 179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -77.89 -41.66 35.87 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.067 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -71.06 -26.59 63.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.07 -21.68 58.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -133.65 96.18 0.29 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.384 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -48.06 139.64 10.48 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.609 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.42 -178.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.68 135.03 12.03 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.524 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.93 -23.48 29.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.388 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.52 49.81 0.8 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.0 110.905 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HG3' ' CZ ' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -74.57 139.79 43.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.822 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.61 110.27 19.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.44 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 1.7 p -66.81 -12.34 58.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.344 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -71.22 96.18 1.37 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.128 0.489 . . . . 0.0 110.718 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 157.25 -101.54 0.21 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.003 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.029 HD12 HD13 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -65.22 -34.14 77.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.532 0.206 . . . . 0.0 111.33 179.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.46 ' HA ' ' CD1' ' A' ' 29' ' ' LEU . 5.9 t -64.46 -32.58 58.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.822 0.344 . . . . 0.0 111.053 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.63 -43.8 66.4 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.029 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 87' ' ' HIS . . . -65.38 -48.1 74.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.815 0.341 . . . . 0.0 110.783 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.453 HD21 HD12 ' A' ' 35' ' ' ILE . 13.2 tp -54.41 -46.04 73.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.33 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -35.39 61.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.276 178.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 3.3 t60 -68.81 -32.19 71.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.167 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.751 HG12 HD13 ' A' ' 48' ' ' LEU . 58.4 t -69.62 -42.19 80.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.564 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 11.0 mmt -62.43 -38.78 91.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.11 178.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -54.44 -21.97 11.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.179 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.64 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 9.8 tptt -70.25 -43.56 70.29 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.492 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.635 ' HG3' HD21 ' A' ' 48' ' ' LEU . 23.1 mmm-85 -74.82 -31.48 61.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.582 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.0 m -76.96 -30.71 56.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.114 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -105.85 5.14 30.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.782 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 91' ' ' LYS . . . -75.82 173.91 10.54 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.248 0.546 . . . . 0.0 111.301 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.643 ' N ' HD12 ' A' ' 96' ' ' ILE . 1.6 mp -111.93 95.76 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.873 177.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -56.86 89.69 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.095 0.474 . . . . 0.0 110.179 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -129.25 160.26 33.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.788 -178.003 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.0 m -162.76 -84.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 53.87 91.62 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.877 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.415 ' O ' ' CG ' ' A' ' 101' ' ' GLU . 10.8 pt-20 -173.52 67.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.076 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 57.07 -113.58 4.55 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.487 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -54.58 118.36 4.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.351 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -71.54 66.45 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.66 119.45 39.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.964 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -80.97 104.41 11.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.025 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.08 0 CA-C-O 118.403 -1.22 . . . . 0.0 112.516 -179.929 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.806 0.336 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.71 31.61 4.78 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.419 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -83.73 138.66 33.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.803 0.335 . . . . 0.0 110.886 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.83 157.25 19.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -162.67 62.18 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.1 t -58.05 137.13 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.19 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.3 p -149.04 134.35 18.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.833 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.626 ' O ' HD23 ' A' ' 59' ' ' LEU . 8.9 t60 -109.39 61.17 0.6 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 50' ' ' TYR . 2.2 t -71.68 -66.38 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.939 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.49 44.66 10.62 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.582 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.485 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -87.97 153.88 20.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.762 0.315 . . . . 0.0 110.342 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -88.36 139.61 30.17 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.775 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.94 -37.16 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.652 2.235 . . . . 0.0 112.568 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -88.94 -41.1 12.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.08 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -87.15 -27.21 23.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.974 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.15 -144.26 17.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.459 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.45 ' CD1' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -81.57 138.92 35.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.833 0.349 . . . . 0.0 110.804 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -75.69 64.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.123 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.573 HG11 ' HG3' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -52.44 -25.62 7.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.21 -19.56 61.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -130.1 20.52 5.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.466 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.034 HD22 HD11 ' A' ' 26' ' ' LEU . 18.3 mt -70.46 159.21 34.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.876 0.369 . . . . 0.0 111.17 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -85.08 142.05 38.14 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.01 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 27' ' ' ARG . 46.3 Cg_exo -55.75 -19.74 25.75 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.604 2.203 . . . . 0.0 112.543 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.453 ' CB ' ' HA ' ' A' ' 63' ' ' ARG . 13.8 m-20 -82.17 -57.43 3.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.155 -179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.034 HD11 HD22 ' A' ' 22' ' ' LEU . 3.8 pp -70.48 -32.75 70.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.235 -179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.495 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 0.3 OUTLIER -64.96 -34.85 79.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.847 0.356 . . . . 0.0 110.203 179.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.85 -36.25 82.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.518 178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.993 HD13 HD12 ' A' ' 81' ' ' LEU . 7.3 tp -56.13 -58.58 7.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.316 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.505 ' CG ' HD21 ' A' ' 40' ' ' LEU . 20.9 m-85 -50.27 -40.83 49.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.739 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m -62.7 -54.97 31.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.789 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.617 ' HB3' HG11 ' A' ' 82' ' ' VAL . 8.6 mtt85 -58.39 -29.38 65.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.792 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.35 -21.05 36.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.184 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.34 17.75 41.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.557 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.438 HD12 HD21 ' A' ' 85' ' ' LEU . 66.5 mt -87.07 118.97 34.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.864 0.364 . . . . 0.0 111.228 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.1 p -88.07 160.58 17.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 41' ' ' THR . 30.4 mp0 -51.9 -28.42 16.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.067 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.97 -44.56 70.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.662 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.467 ' HB3' HG21 ' A' ' 45' ' ' THR . 53.0 mt-30 -79.15 -31.88 44.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.731 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.505 HD21 ' CG ' ' A' ' 30' ' ' PHE . 91.6 mt -70.24 -27.89 64.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.636 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 37' ' ' GLU . 30.3 p -97.71 -3.41 39.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.512 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -81.62 119.87 24.35 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.83 0.348 . . . . 0.0 110.625 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.08 -35.21 24.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.454 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -72.61 -59.93 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.454 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.483 ' HA ' HD23 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.6 -37.05 81.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.223 -179.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.3 p -55.69 -40.37 72.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.789 0.328 . . . . 0.0 110.286 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' O ' ' CD1' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -60.46 -55.84 28.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.191 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.512 HD13 HG12 ' A' ' 88' ' ' VAL . 1.4 pp -65.48 -30.79 71.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.521 -178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 45' ' ' THR . 54.3 mt -67.62 -63.92 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.447 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CD1' ' O ' ' A' ' 47' ' ' LYS . 2.5 p90 -52.29 -36.15 52.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.934 0.397 . . . . 0.0 110.376 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.92 -33.28 62.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.394 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.472 ' CD1' ' OD2' ' A' ' 55' ' ' ASP . 79.2 t80 -64.63 -41.92 95.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.241 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.023 HG23 HG21 ' A' ' 62' ' ' VAL . 43.3 mt -55.69 -29.66 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.331 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -69.91 -36.32 75.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.746 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD2' ' CD1' ' A' ' 52' ' ' PHE . 1.2 p30 -71.01 -26.42 63.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.617 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.402 ' O ' ' CB ' ' A' ' 61' ' ' ALA . 17.0 mm100 -86.11 9.77 16.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.475 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.42 ' HA3' ' CB ' ' A' ' 61' ' ' ALA . . . 98.73 17.96 26.74 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.594 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 62' ' ' VAL . . . 83.79 169.93 45.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.823 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 8' ' ' HIS . 14.4 tp -48.87 -42.14 35.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.726 0.298 . . . . 0.0 111.016 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -63.6 -35.24 79.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.21 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.42 ' CB ' ' HA3' ' A' ' 57' ' ' GLY . . . -73.02 -34.25 66.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.484 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 1.023 HG21 HG23 ' A' ' 53' ' ' ILE . 21.7 t -66.76 -63.35 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.208 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.453 ' HA ' ' CB ' ' A' ' 25' ' ' ASP . 0.3 OUTLIER -51.85 -41.14 61.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.016 0.436 . . . . 0.0 110.233 178.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -63.14 -52.99 60.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.278 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 62' ' ' VAL . 20.2 pt-20 -70.78 -29.0 65.09 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.859 0.361 . . . . 0.0 111.138 -179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.417 ' O ' ' N ' ' A' ' 71' ' ' GLY . 1.2 mmt -63.87 -34.37 77.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.695 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -76.49 -37.16 57.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.614 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.3 mtp180 -71.14 -23.68 62.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.581 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -87.82 -21.9 24.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.021 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 151.91 -44.3 0.65 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.462 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 66' ' ' MET . . . 69.31 -157.53 53.45 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.61 69.37 2.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 110.972 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.83 131.25 1.45 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.531 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.68 -131.46 10.43 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.532 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.6 m -80.51 64.88 5.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.82 0.343 . . . . 0.0 110.972 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -74.53 110.01 8.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.677 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.1 t -118.46 120.16 36.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.303 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.624 ' HB2' HG21 ' A' ' 82' ' ' VAL . 60.9 p -78.85 -1.05 33.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.402 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.6 98.6 1.51 Allowed 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.176 0.512 . . . . 0.0 110.854 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.85 -102.7 0.23 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.019 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.993 HD12 HD13 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -65.21 -34.64 78.86 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.624 HG21 ' HB2' ' A' ' 78' ' ' SER . 6.0 t -64.77 -35.06 74.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.79 0.328 . . . . 0.0 111.378 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.39 -43.9 67.67 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.554 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.39 -48.41 72.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.866 0.365 . . . . 0.0 110.87 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.522 HD22 HD21 ' A' ' 29' ' ' LEU . 15.7 tp -55.97 -47.17 78.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.892 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.4 mtm -53.41 -28.84 31.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.814 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -41.88 25.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.783 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 48' ' ' LEU . 48.7 t -58.25 -42.36 83.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.928 0.394 . . . . 0.0 110.318 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 38.8 mmm -63.37 -33.42 75.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.306 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -65.04 -22.88 67.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.814 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -68.34 -57.68 5.55 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.951 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.96 -23.7 63.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.315 -178.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.9 m -74.43 -25.26 59.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.536 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.48 2.54 36.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.53 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.91 169.68 16.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.214 0.531 . . . . 0.0 111.434 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.7 mt -133.8 82.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.386 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.06 -41.09 2.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 110.335 178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.78 25.98 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.255 178.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.0 p -70.57 176.89 3.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.987 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 59.62 94.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -58.48 -23.12 57.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.029 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 168.33 -93.78 0.11 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.413 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -61.1 134.94 57.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.967 0.413 . . . . 0.0 110.739 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.23 -24.89 62.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.905 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -91.86 -171.51 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.859 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -81.03 130.68 35.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.152 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.419 -1.212 . . . . 0.0 112.522 -179.982 . . . . . . . . 0 0 . 1 stop_ save_